data_2j5p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2j5p _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.434 HD23 ' CE2' ' A' 1269 ' ' PHE . 10.4 mt . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 121.089 0.471 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1266 ' ' ASP . . . . . 0.439 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.9 t70 -79.33 144.14 61.52 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.554 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 -25.78 20.58 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.555 2.17 . . . . 0.0 112.627 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.471 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 63.1 mt -101.94 -2.65 29.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 38.8 t80 -47.57 -55.09 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.47 -45.31 66.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.946 0.403 . . . . 0.0 110.905 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -67.32 -38.21 84.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.24 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.41 94.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.665 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.447 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 23.5 t -62.11 -47.87 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' 1278 ' ' GLU . 33.1 tt0 -63.55 -33.91 76.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.881 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1275 ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.14 -50.47 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.625 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.5 m -70.1 -37.59 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.471 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.529 ' HB ' ' N ' ' A' 1326 ' ' PRO . 55.0 p -70.09 -49.48 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.1 mt-10 -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.285 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -91.39 -7.18 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.9 mmm180 57.52 17.85 4.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -145.56 133.23 21.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.774 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.414 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.74 116.38 28.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 3.2 p -132.57 138.98 47.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.869 0.366 . . . . 0.0 111.22 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.517 HG22 ' CE1' ' A' 1295 ' ' TYR . 19.7 mt -67.24 -40.14 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 47.6 t -68.51 -41.52 79.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.51 -49.93 73.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.638 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' 1291 ' ' PHE . 12.0 t -65.92 -30.11 48.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.74 -51.16 70.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.124 0.488 . . . . 0.0 110.011 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -76.2 -37.07 58.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.162 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.04 -33.34 61.73 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.512 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.69 21.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.403 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 54.16 52.86 11.93 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.051 0.453 . . . . 0.0 110.226 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.455 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 19.8 pt -129.83 148.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.544 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.61 148.07 22.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.22 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.9 t80 -45.31 -50.23 12.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.4 p30 -50.84 -41.82 58.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.705 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.455 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.8 -49.68 69.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.253 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.482 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -53.98 -50.0 67.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.5 -29.83 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.189 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -50.55 51.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.144 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.439 HG12 ' CB ' ' A' 1266 ' ' ASP . 34.0 mt -60.43 -43.71 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.953 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' 1305 ' ' MET . 22.2 mt -68.63 -33.95 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.759 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -51.98 65.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.415 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.415 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 7.0 mt-30 -59.06 -36.11 74.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.462 ' C ' HG23 ' A' 1311 ' ' VAL . 14.3 mtm -58.37 -37.14 74.63 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.518 ' N ' HG23 ' A' 1311 ' ' VAL . 36.8 tt0 -69.7 -32.24 70.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.32 62.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.343 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.549 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.6 OUTLIER -89.62 -20.31 23.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.792 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.31 12.98 32.04 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.912 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.549 HG13 ' HB2' ' A' 1308 ' ' GLN . 10.4 mt -83.23 -35.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 122.618 0.367 . . . . 0.0 111.204 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' 1306 ' ' GLU . 27.5 m -122.38 154.47 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.449 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.469 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.6 OUTLIER -102.77 -177.85 3.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.615 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.509 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.001 0.429 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.455 ' HD2' HG22 ' A' 1311 ' ' VAL . 0.2 OUTLIER -107.42 140.26 40.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.369 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' 1311 ' ' VAL . 5.8 tt0 -86.05 132.69 33.99 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.803 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.414 ' CG2' ' N ' ' A' 1282 ' ' ALA . 26.9 t -91.21 118.59 36.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.933 0.396 . . . . 0.0 110.106 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.469 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.0 -10.82 15.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.385 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -99.88 130.68 25.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.09 159.59 23.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 113.039 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.529 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.1 Cg_exo -51.67 163.74 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.903 2.402 . . . . 0.0 112.587 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 122.715 2.277 . . . . 0.0 112.412 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.448 HD22 ' NE2' ' A' 1308 ' ' GLN . 7.5 mt . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.971 0.415 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.33 144.27 94.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.75 -24.83 13.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.191 1.927 . . . . 0.0 112.273 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 59.2 mt -102.16 -5.28 24.61 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 38.4 t80 -47.71 -53.39 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -52.6 -45.42 66.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.96 -37.95 82.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.634 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.29 -39.16 93.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.305 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.458 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 19.2 t -62.83 -49.18 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' 1278 ' ' GLU . 22.2 tt0 -62.79 -32.5 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.792 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.421 ' CE1' ' HE2' ' A' 1279 ' ' LYS . 2.7 t80 -67.95 -50.58 55.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.68 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.3 m -69.72 -38.01 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.54 ' HB ' ' N ' ' A' 1326 ' ' PRO . 57.6 p -69.73 -49.91 48.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.113 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.2 mt-10 -59.09 -36.95 76.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.999 0.428 . . . . 0.0 110.292 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1279 ' ' LYS . . . . . 0.421 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 4.0 mtmt -89.79 -9.52 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.008 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.1 mmm180 59.97 16.65 5.98 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.833 0.349 . . . . 0.0 110.478 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 3.8 mttp -145.55 134.43 22.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -115.18 116.61 28.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.802 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 3.2 p -132.55 139.72 47.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.275 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.535 HG23 ' CE1' ' A' 1295 ' ' TYR . 24.6 mt -68.56 -39.31 80.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.203 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.502 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 48.1 t -69.13 -42.45 75.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.29 69.22 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.569 -0.825 . . . . 0.0 111.583 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' 1291 ' ' PHE . 17.6 t -65.31 -30.34 49.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.597 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.27 -52.01 67.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 110.097 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -36.19 58.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.125 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -33.13 61.84 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.559 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.38 21.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.631 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 55.8 51.96 11.54 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.128 0.489 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.419 ' CG2' ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -128.7 147.77 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.85 150.23 18.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.024 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.593 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.34 -51.26 15.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.397 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 5.9 p30 -50.7 -40.07 53.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.56 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.419 ' NH1' ' CG2' ' A' 1293 ' ' ILE . 0.4 OUTLIER -64.98 -50.28 66.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.329 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.482 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.99 -49.93 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.32 -29.9 71.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.209 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -68.49 -50.48 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.99 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 40.7 mt -60.74 -46.41 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.774 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.439 HG22 ' HG3' ' A' 1320 ' ' ARG . 18.7 mt -66.17 -31.45 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.948 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -63.73 -52.26 61.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.524 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -59.22 -32.0 69.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.643 178.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.433 ' CB ' HG23 ' A' 1311 ' ' VAL . 12.7 mtm -62.63 -39.55 94.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.508 ' N ' HG23 ' A' 1311 ' ' VAL . 3.2 tt0 -67.38 -32.05 72.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.283 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.09 -42.05 63.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.248 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.478 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -76.21 -20.24 57.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.774 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.46 13.94 31.48 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.055 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.432 ' CD1' HG23 ' A' 1273 ' ' VAL . 10.4 mt -81.21 -36.79 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.806 0.442 . . . . 0.0 111.492 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.508 HG23 ' N ' ' A' 1306 ' ' GLU . 33.3 m -121.38 159.57 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.207 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.469 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.5 OUTLIER -103.84 -178.06 3.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.078 0.466 . . . . 0.0 111.732 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 36.4 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.973 0.416 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.439 ' HG3' HG22 ' A' 1302 ' ' ILE . 4.6 mmt180 -107.43 140.31 40.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.368 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' 1311 ' ' VAL . 18.0 tt0 -86.44 132.63 33.89 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.879 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 23.6 t -91.35 118.71 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.23 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.469 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.67 -12.79 15.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.326 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -97.3 131.61 27.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.338 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.55 159.3 22.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.418 2.079 . . . . 0.0 113.012 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.54 ' N ' ' HB ' ' A' 1277 ' ' THR . 71.0 Cg_exo -51.57 156.42 6.28 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.965 2.443 . . . . 0.0 112.712 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.701 2.267 . . . . 0.0 112.516 -179.783 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.947 0.403 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1266 ' ' ASP . . . . . 0.405 ' CB ' HG12 ' A' 1301 ' ' ILE . 18.6 t70 -72.95 142.39 82.88 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.154 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -51.23 -25.04 16.53 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.323 2.015 . . . . 0.0 112.49 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.518 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 41.9 mt -102.14 -3.63 27.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 43.6 t80 -47.79 -53.02 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -52.72 -44.06 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.044 0.45 . . . . 0.0 110.539 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -66.58 -40.49 88.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.145 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.593 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.97 -39.74 94.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.739 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' 1269 ' ' PHE . 16.2 t -61.4 -51.72 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' 1278 ' ' GLU . 19.9 tt0 -60.74 -32.04 71.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.857 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.451 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -67.29 -52.14 44.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.8 m -69.17 -35.31 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.491 ' HB ' ' N ' ' A' 1326 ' ' PRO . 69.3 p -72.19 -49.06 38.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.2 mt-10 -60.35 -35.3 75.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.192 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.7 -5.12 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.939 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.6 mmm180 53.63 20.69 2.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.882 0.373 . . . . 0.0 110.649 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -145.61 129.87 17.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.636 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.411 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -111.98 116.47 30.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.742 0.306 . . . . 0.0 110.631 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 11.3 t -132.46 139.86 48.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.267 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.515 HG22 ' CE1' ' A' 1295 ' ' TYR . 16.4 mt -68.63 -40.75 82.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.272 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.505 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 28.6 t -67.82 -41.87 82.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.28 -49.94 73.03 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.823 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' 1291 ' ' PHE . 12.7 t -65.99 -29.79 47.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 17.4 mt-30 -60.76 -52.66 64.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.126 0.489 . . . . 0.0 109.867 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -76.27 -34.87 59.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.961 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.51 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.5 OUTLIER -73.8 -37.01 65.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.762 0.315 . . . . 0.0 111.508 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 1.8 m-85 -103.19 -5.15 23.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.839 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 55.02 8.49 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 148.53 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.384 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -53.76 149.81 14.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.125 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.4 t80 -47.09 -51.94 16.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 111.507 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -38.35 46.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.588 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -49.33 65.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.249 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.477 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -54.64 -49.86 69.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.563 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.36 -29.86 71.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -51.4 48.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.012 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.405 HG12 ' CB ' ' A' 1266 ' ' ASP . 41.8 mt -60.01 -45.21 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.83 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' 1305 ' ' MET . 21.5 mt -66.27 -32.56 58.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -50.23 67.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.588 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.5 mt-30 -57.16 -34.49 68.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.242 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.505 ' C ' HG23 ' A' 1311 ' ' VAL . 16.0 mtm -63.33 -39.15 93.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.27 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' 1311 ' ' VAL . 1.9 tt0 -66.41 -31.67 72.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.591 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.48 44.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.23 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.43 ' NE2' ' CD2' ' A' 1265 ' ' LEU . 0.8 OUTLIER -75.39 -20.21 59.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.756 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 99.8 16.07 29.64 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.001 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' 1305 ' ' MET . 9.6 mt -84.03 -36.8 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 122.566 0.346 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' 1306 ' ' GLU . 27.1 m -119.93 161.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.341 . . . . 0.0 111.211 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.482 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.01 178.18 4.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.371 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.54 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 47.1 m-80 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.937 0.399 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.469 ' HD2' HG22 ' A' 1311 ' ' VAL . 0.0 OUTLIER -107.56 140.28 40.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.475 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' 1311 ' ' VAL . 47.0 tt0 -89.66 132.68 35.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.819 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' A' 1282 ' ' ALA . 22.0 t -92.29 118.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.29 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.482 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.39 -13.06 15.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1324 ' ' ALA . . . . . 0.401 ' HB1' ' CG2' ' A' 1310 ' ' ILE . . . -95.39 129.37 35.22 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -80.96 159.11 20.97 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.491 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.6 Cg_exo -52.34 164.37 1.33 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.977 2.452 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 122.655 2.236 . . . . 0.0 112.302 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.425 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 11.3 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.985 0.421 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.06 145.8 44.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.229 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.62 -23.54 20.09 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.286 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 58.0 mt -102.04 -3.39 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.852 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.48 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 42.5 t80 -47.6 -56.62 6.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -39.06 60.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.952 0.406 . . . . 0.0 110.368 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -68.45 -42.51 78.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.02 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.593 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.82 -40.97 96.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.48 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 53.8 t -61.36 -47.85 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.441 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -64.17 -33.29 75.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.898 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.438 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.58 -50.42 63.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.59 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.7 m -69.59 -38.22 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.275 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.511 ' HB ' ' N ' ' A' 1326 ' ' PRO . 42.6 p -69.04 -48.93 61.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.155 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.39 -37.17 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.433 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -92.37 -5.56 51.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.108 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' 1276 ' ' VAL . 9.0 mmm180 57.34 17.63 3.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 19.7 mttm -145.45 134.17 22.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.58 116.56 28.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.895 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.59 138.56 47.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.896 0.379 . . . . 0.0 111.257 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.538 HG23 ' CE1' ' A' 1295 ' ' TYR . 32.1 mt -67.81 -38.07 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.493 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.1 t -69.24 -44.3 72.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.049 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.55 -49.22 80.86 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.687 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' 1291 ' ' PHE . 14.8 t -65.36 -31.38 53.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.611 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -59.48 -52.16 66.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 109.991 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -76.2 -35.8 58.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.283 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.408 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.96 -33.83 61.97 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.599 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.3 -7.26 21.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.657 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 56.18 53.33 9.1 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 110.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.417 ' CG2' ' NH1' ' A' 1297 ' ' ARG . 13.3 pt -129.82 147.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.246 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.88 150.43 18.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.966 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.592 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.38 -51.24 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.424 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -39.84 53.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.614 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.417 ' NH1' ' CG2' ' A' 1293 ' ' ILE . 0.3 OUTLIER -65.61 -49.62 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.346 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -54.0 -48.79 70.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.501 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.73 70.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.136 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -68.74 -50.77 47.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 38.9 mt -60.18 -43.62 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.912 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.4 mt -69.09 -32.63 54.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.57 -50.92 70.67 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.418 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 0.0 OUTLIER -61.13 -35.72 77.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.249 178.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' 1302 ' ' ILE . 11.3 mtm -57.0 -38.19 72.73 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.492 ' N ' HG21 ' A' 1311 ' ' VAL . 3.0 tm-20 -69.63 -32.92 71.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.355 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.19 -28.78 61.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.692 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.532 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -91.43 -20.32 21.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.94 15.94 24.98 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.992 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' 1308 ' ' GLN . 12.8 mt -85.31 -36.63 11.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.802 0.441 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.492 HG21 ' N ' ' A' 1306 ' ' GLU . 30.2 m -121.23 158.31 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.475 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.1 OUTLIER -105.3 -178.56 3.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.031 0.443 . . . . 0.0 111.618 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.656 -179.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.982 0.42 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.411 ' HG3' HG22 ' A' 1302 ' ' ILE . 6.0 mmt180 -107.07 140.32 40.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.281 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' 1311 ' ' VAL . 2.0 tt0 -86.29 132.68 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.836 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' 1282 ' ' ALA . 25.4 t -91.66 118.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 110.243 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.475 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.32 -7.87 16.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.272 -179.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -102.58 130.44 23.96 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.406 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.3 159.37 20.07 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.485 2.123 . . . . 0.0 112.947 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.511 ' N ' ' HB ' ' A' 1277 ' ' THR . 55.6 Cg_exo -52.19 164.35 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.908 2.406 . . . . 0.0 112.507 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--N 1.343 0.276 0 C-N-CA 122.64 2.226 . . . . 0.0 112.239 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' 1269 ' ' PHE . 10.7 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.831 0.348 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.06 144.9 45.16 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.095 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.52 -24.24 16.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.231 1.954 . . . . 0.0 112.485 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.503 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 57.9 mt -102.11 -4.38 26.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.504 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 44.9 t80 -47.48 -54.99 10.0 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -40.01 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -69.07 -42.22 76.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.14 -39.68 95.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.504 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 42.5 t -61.99 -49.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.39 -30.54 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.854 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.451 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -68.6 -51.68 39.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.2 m -69.04 -37.43 77.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.498 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.488 ' HB ' ' N ' ' A' 1326 ' ' PRO . 48.2 p -69.67 -49.69 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.28 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.1 mt-10 -60.29 -35.57 75.87 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.936 0.398 . . . . 0.0 110.399 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -93.03 -5.16 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.092 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 18.4 mmm180 55.5 18.73 2.82 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.812 0.339 . . . . 0.0 110.81 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.1 mttt -145.64 131.18 18.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -112.88 116.37 29.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.683 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 1.8 p -132.49 142.47 49.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.209 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.42 HG23 ' CE1' ' A' 1295 ' ' TYR . 46.2 mt -71.02 -42.32 76.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.275 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 9.2 t -67.71 -40.58 84.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -61.07 -51.16 60.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.715 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' 1291 ' ' PHE . 23.9 t -64.38 -29.77 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.292 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' 1293 ' ' ILE . 16.1 tt0 -60.19 -54.41 46.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 110.203 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -31.66 58.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.76 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.459 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 4.5 tp60 -75.03 -36.36 61.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.721 0.296 . . . . 0.0 111.544 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.29 -6.3 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.934 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 57.7 52.62 8.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.032 0.444 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' A' 1288 ' ' GLN . 12.8 pt -130.21 149.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.061 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.72 148.57 26.75 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.146 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.42 ' CE1' HG23 ' A' 1284 ' ' ILE . 80.6 t80 -46.5 -51.62 14.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.454 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.78 -40.14 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.152 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -48.87 69.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1298 ' ' ALA . . . . . . . . . . . . . . . -54.03 -47.95 71.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.504 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1299 ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' 1284 ' ' ILE . . . -65.2 -29.89 70.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.018 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -67.57 -49.01 65.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.141 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 38.4 mt -61.26 -46.72 96.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.949 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1302 ' ' ILE . . . . . . . . . . . . . 11.1 mt -65.54 -34.46 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.887 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -48.89 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.426 ' CB ' ' CE2' ' A' 1269 ' ' PHE . 16.8 mt-30 -61.81 -35.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.231 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.442 ' HB3' ' CG1' ' A' 1311 ' ' VAL . 0.3 OUTLIER -56.95 -38.83 73.49 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.498 ' N ' HG21 ' A' 1311 ' ' VAL . 1.4 tm-20 -70.48 -33.34 71.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.4 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.39 63.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.585 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.553 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.6 OUTLIER -90.81 -20.35 22.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.877 -178.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.88 16.34 26.25 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.817 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' 1308 ' ' GLN . 13.4 mt -84.47 -34.76 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.271 -0.464 . . . . 0.0 111.04 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' 1306 ' ' GLU . 27.8 m -120.21 159.87 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.481 ' CA ' HD13 ' A' 1323 ' ' LEU . 1.4 p -100.75 -178.65 3.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 111.307 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.437 179.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.978 0.418 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.408 ' CD ' HG22 ' A' 1311 ' ' VAL . 1.4 mtt-85 -107.48 140.41 40.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.428 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' 1311 ' ' VAL . 20.5 tp10 -84.11 132.76 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.547 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' 1282 ' ' ALA . 22.0 t -90.4 118.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.98 0.419 . . . . 0.0 110.467 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.481 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.53 -12.22 15.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.214 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -96.65 131.64 27.78 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.233 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.21 158.12 17.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.464 2.109 . . . . 0.0 113.302 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.488 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -52.81 164.3 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.076 2.517 . . . . 0.0 112.669 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 N--CA 1.462 -0.368 0 C-N-CA 123.009 2.472 . . . . 0.0 111.846 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.436 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 10.5 mt . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.56 142.86 86.8 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.979 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.73 -24.87 13.97 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.319 2.013 . . . . 0.0 112.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.5 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 61.7 mt -102.14 -5.03 24.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 40.8 t80 -47.57 -53.49 14.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.8 -42.5 65.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.057 0.455 . . . . 0.0 110.396 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -66.75 -42.42 86.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.141 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.599 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.25 -39.3 94.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.79 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.473 HG23 ' CE1' ' A' 1269 ' ' PHE . 18.9 t -61.81 -50.61 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -62.24 -32.51 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.443 ' CD2' ' CE1' ' A' 1291 ' ' PHE . 2.4 t80 -67.17 -50.76 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.669 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.9 m -70.22 -36.78 69.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.345 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.535 ' HB ' ' N ' ' A' 1326 ' ' PRO . 50.7 p -71.23 -48.37 51.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.319 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' 1274 ' ' GLN . 34.1 mt-10 -61.36 -35.61 77.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -93.76 -4.11 50.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.989 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' 1276 ' ' VAL . 16.0 mmm180 53.95 19.5 2.02 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.55 132.51 20.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.412 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -115.15 116.4 28.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.922 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 7.5 p -132.65 140.47 48.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.11 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CE1' ' A' 1295 ' ' TYR . 22.1 mt -68.79 -40.64 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.28 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 42.1 t -67.58 -42.31 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.05 -49.25 80.63 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.777 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' 1291 ' ' PHE . 14.6 t -65.91 -30.41 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.718 0.294 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.61 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.3 mt-30 -60.73 -51.05 70.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.179 0.514 . . . . 0.0 110.001 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -76.34 -36.68 58.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.169 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.416 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.9 OUTLIER -75.02 -34.34 61.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.612 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.599 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.0 m-85 -103.27 -6.54 21.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.602 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 54.92 54.85 8.47 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 12.9 pt -131.17 147.8 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.434 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.28 148.43 25.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.06 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.61 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 90.2 t80 -45.69 -50.75 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.547 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.73 -41.53 56.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -50.05 68.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.316 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -54.01 -49.97 67.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.48 -29.76 70.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.121 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.36 -50.59 52.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.92 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 43.2 mt -59.87 -46.56 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.757 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.5 mt -65.84 -31.98 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.4 -52.12 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.55 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -58.25 -31.95 67.89 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.614 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' 1302 ' ' ILE . 12.2 mtm -62.49 -39.68 94.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' 1311 ' ' VAL . 3.2 tt0 -66.79 -31.95 72.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.583 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -75.18 -41.98 56.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.472 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.462 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -75.86 -20.32 58.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.883 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.13 16.87 26.57 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.003 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.428 ' CD1' HG23 ' A' 1273 ' ' VAL . 12.2 mt -83.48 -39.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.831 0.452 . . . . 0.0 111.167 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' 1306 ' ' GLU . 35.6 m -118.87 160.39 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.028 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.508 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.7 OUTLIER -95.34 178.59 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 111.442 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.416 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 8.9 m-80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.117 0.484 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.5 140.43 40.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.234 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.4 tp10 -84.61 132.71 34.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.092 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' 1282 ' ' ALA . 25.2 t -92.47 118.73 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.276 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.508 HD13 ' CA ' ' A' 1312 ' ' SER . 0.3 OUTLIER -109.01 -15.56 14.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.286 -179.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -93.18 131.38 33.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.299 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.5 159.29 22.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.432 2.088 . . . . 0.0 113.01 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.535 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.55 164.39 0.91 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.922 2.415 . . . . 0.0 112.69 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.705 2.27 . . . . 0.0 112.34 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.445 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 9.9 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.116 0.484 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1266 ' ' ASP . . . . . 0.443 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -81.33 143.74 52.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.491 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.63 -26.37 22.57 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.398 2.065 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 44.8 mt -102.03 -0.59 33.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.873 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.519 ' CE1' HG22 ' A' 1273 ' ' VAL . 41.2 t80 -47.65 -57.02 6.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -41.75 63.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.934 0.397 . . . . 0.0 110.417 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -43.07 88.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.264 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.608 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.89 -41.78 95.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.327 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.519 HG22 ' CE1' ' A' 1269 ' ' PHE . 98.8 t -60.67 -47.76 91.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.4 ' HA ' ' OG1' ' A' 1277 ' ' THR . 33.1 tt0 -64.37 -32.49 74.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.764 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.429 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.75 -50.32 63.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.2 m -68.7 -37.62 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.257 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.483 ' HB ' ' N ' ' A' 1326 ' ' PRO . 53.9 p -70.17 -49.21 52.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.241 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.36 -35.64 74.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.349 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1279 ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 1.5 mtmt -93.03 -7.68 45.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.035 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 2.5 mmm180 57.99 17.72 4.59 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.815 0.341 . . . . 0.0 110.602 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -145.54 133.25 21.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.409 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.76 116.54 28.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.676 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 13.2 p -132.42 138.08 47.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 111.265 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' 1295 ' ' TYR . 23.3 mt -66.01 -42.86 92.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.394 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 1.1 t -68.65 -37.99 80.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.805 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.49 -51.05 59.02 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.74 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.2 t -65.57 -29.73 47.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-O 120.904 0.383 . . . . 0.0 110.37 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' 1293 ' ' ILE . 16.1 tt0 -60.47 -55.13 37.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.184 0.516 . . . . 0.0 110.281 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -76.12 -30.37 58.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.553 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -75.06 -36.62 61.78 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.77 0.319 . . . . 0.0 111.531 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.608 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.23 -6.08 22.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 27.8 mtm105 58.46 48.4 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.041 0.448 . . . . 0.0 110.549 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.43 ' HB ' ' HD2' ' A' 1297 ' ' ARG . 14.9 pt -125.5 158.39 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.184 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -64.31 148.13 50.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.186 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.436 ' CE1' HG22 ' A' 1284 ' ' ILE . 91.2 t80 -45.66 -51.16 12.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.697 0.284 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.65 -41.94 55.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.967 0.413 . . . . 0.0 110.066 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.59 -49.79 69.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.161 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1298 ' ' ALA . . . . . . . . . . . . . . . -53.78 -49.39 68.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1299 ' ' ALA . . . . . 0.409 ' N ' HG21 ' A' 1284 ' ' ILE . . . -63.87 -29.9 71.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.113 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -50.56 50.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.245 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' 1297 ' ' ARG . 20.8 mt -59.45 -42.46 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.838 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' 1305 ' ' MET . 22.2 mt -69.26 -34.5 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.716 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -51.61 67.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.364 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.408 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 21.8 mt-30 -59.32 -36.86 76.44 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.359 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.473 ' C ' HG23 ' A' 1311 ' ' VAL . 18.9 mtm -57.12 -38.52 73.56 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.542 ' N ' HG23 ' A' 1311 ' ' VAL . 18.1 tt0 -69.44 -33.03 72.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.394 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.72 62.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.47 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.542 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.7 OUTLIER -90.73 -20.39 22.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.807 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.13 13.33 29.24 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.933 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.542 HG13 ' HB2' ' A' 1308 ' ' GLN . 11.8 mt -82.9 -37.84 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.053 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' 1306 ' ' GLU . 27.1 m -120.54 158.13 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.218 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.485 ' CA ' HD13 ' A' 1323 ' ' LEU . 1.2 p -101.22 -179.46 4.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.122 0.487 . . . . 0.0 111.686 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.501 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 44.1 m-80 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.954 0.407 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.466 ' HD2' HG22 ' A' 1311 ' ' VAL . 0.0 OUTLIER -107.41 140.37 40.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.388 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' 1311 ' ' VAL . 17.9 tt0 -87.06 132.7 33.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.978 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' 1282 ' ' ALA . 22.7 t -92.66 118.73 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.485 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.25 -11.47 15.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.227 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -97.87 131.56 26.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.238 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.07 159.15 15.51 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.542 2.162 . . . . 0.0 112.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.483 ' N ' ' HB ' ' A' 1277 ' ' THR . 52.1 Cg_exo -52.78 164.39 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.912 2.408 . . . . 0.0 112.469 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.582 2.188 . . . . 0.0 112.295 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.429 HD22 ' NE2' ' A' 1308 ' ' GLN . 1.8 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.904 0.383 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.86 144.12 32.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.51 -23.67 19.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.323 2.015 . . . . 0.0 112.368 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 62.3 mt -102.06 -3.81 27.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.921 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 43.7 t80 -47.51 -55.51 8.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 37.8 t0 -52.49 -41.59 63.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.37 -43.32 86.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.314 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.606 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.1 -41.04 97.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.251 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.539 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 99.0 t -61.08 -47.89 91.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.58 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.639 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.419 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.4 -51.23 59.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.654 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' 1280 ' ' ARG . 32.5 m -68.47 -36.7 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.482 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.503 ' HB ' ' N ' ' A' 1326 ' ' PRO . 45.6 p -70.6 -49.92 42.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.37 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.0 mt-10 -60.14 -33.93 72.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.369 . . . . 0.0 110.354 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -95.22 -5.58 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.018 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 55.99 18.52 3.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.839 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.53 132.51 20.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.788 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -114.62 116.29 28.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.823 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 1.9 t -132.63 138.26 47.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CE1' ' A' 1295 ' ' TYR . 26.1 mt -66.49 -38.88 82.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.046 0.451 . . . . 0.0 110.117 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.486 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 27.5 t -69.68 -40.75 76.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.829 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -61.51 -48.43 84.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.529 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' 1291 ' ' PHE . 15.1 t -67.16 -29.66 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 120.745 0.307 . . . . 0.0 110.709 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -61.34 -54.49 43.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.186 0.517 . . . . 0.0 110.093 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -30.84 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.531 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -74.93 -38.11 61.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.23 -4.51 24.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.804 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 55.47 54.99 7.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.045 0.45 . . . . 0.0 110.485 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.413 ' CB ' ' HD2' ' A' 1297 ' ' ARG . 10.2 pt -131.49 157.59 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.476 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -63.5 148.2 50.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.981 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.2 t80 -45.41 -51.52 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.551 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -40.63 55.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.676 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.551 ' HD3' HD13 ' A' 1301 ' ' ILE . 0.0 OUTLIER -66.44 -48.2 70.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.477 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.9 -49.63 68.16 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.019 0.438 . . . . 0.0 110.649 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.88 71.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.067 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -68.05 -50.22 56.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.039 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.551 HD13 ' HD3' ' A' 1297 ' ' ARG . 33.9 mt -60.68 -45.83 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' 1305 ' ' MET . 20.8 mt -66.56 -32.16 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.843 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -52.1 63.6 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.573 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.4 OUTLIER -58.73 -33.02 69.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.711 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' 1302 ' ' ILE . 14.0 mtm -60.98 -40.87 95.08 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.539 ' N ' HG21 ' A' 1311 ' ' VAL . 1.4 tt0 -66.16 -33.23 75.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.827 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.466 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.489 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -75.51 -20.37 58.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.783 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.19 15.88 26.82 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.046 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.448 HD11 ' HG2' ' A' 1305 ' ' MET . 13.2 mt -82.71 -38.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.817 0.447 . . . . 0.0 111.317 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.539 HG21 ' N ' ' A' 1306 ' ' GLU . 34.8 m -120.67 164.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.485 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -105.96 -178.12 3.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.069 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.676 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.002 0.429 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.442 ' HG3' HG22 ' A' 1302 ' ' ILE . 3.4 mtt180 -107.45 140.31 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.346 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1311 ' ' VAL . 53.5 tt0 -81.9 132.8 35.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.647 0.26 . . . . 0.0 111.067 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 21.5 t -90.26 118.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.141 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.485 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.25 -18.83 13.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.154 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -90.89 131.54 37.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.109 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.59 159.36 19.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.453 2.102 . . . . 0.0 113.026 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 60.2 Cg_exo -51.6 158.01 4.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.005 2.47 . . . . 0.0 112.502 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.643 2.228 . . . . 0.0 112.422 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 9.6 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.92 0.39 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -87.98 145.07 35.66 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.426 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.21 -24.28 20.11 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.368 2.046 . . . . 0.0 112.505 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.488 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 40.8 mt -102.14 -1.76 30.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.896 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.1 t80 -47.69 -55.21 9.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.0 t0 -52.51 -44.35 65.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 0.0 110.893 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1271 ' ' GLN . . . . . 0.406 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 19.1 mt-30 -68.0 -37.93 82.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.076 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.63 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.9 95.2 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.661 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 26.9 t -61.78 -47.81 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' 1278 ' ' GLU . 14.5 tt0 -63.49 -33.28 75.22 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.752 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.407 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -66.58 -51.61 54.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.414 HG21 ' N ' ' A' 1277 ' ' THR . 32.7 m -68.9 -38.31 78.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.588 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.525 ' HB ' ' N ' ' A' 1326 ' ' PRO . 56.2 p -70.01 -48.42 58.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.12 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' 1274 ' ' GLN . 10.5 mm-40 -59.02 -37.16 76.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.369 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -92.81 -6.04 49.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.3 mmm180 57.64 17.48 4.06 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.783 0.325 . . . . 0.0 110.847 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.63 134.14 22.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.764 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.86 116.4 28.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.705 0.288 . . . . 0.0 110.704 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 2.4 p -132.57 143.16 49.52 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.9 0.381 . . . . 0.0 111.41 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' 1295 ' ' TYR . 50.0 mt -71.09 -39.51 74.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.11 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.44 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 38.6 t -66.77 -44.54 81.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.872 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1286 ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.57 -51.1 60.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.951 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' 1291 ' ' PHE . 16.5 t -65.03 -31.83 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.011 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.494 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 38.3 mt-30 -59.74 -51.77 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.069 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -76.24 -35.86 58.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.184 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' 1286 ' ' GLY . 0.1 OUTLIER -75.06 -33.37 61.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.497 -179.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.63 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.18 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.537 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 55.63 51.29 12.83 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.117 0.485 . . . . 0.0 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.417 ' CG2' ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -127.13 149.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.324 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.8 151.04 21.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.004 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.494 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 1.1 t80 -46.51 -54.59 8.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.716 0.293 . . . . 0.0 111.333 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.55 -36.55 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.417 ' NH1' ' CG2' ' A' 1293 ' ' ILE . 0.8 OUTLIER -65.69 -49.31 69.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.412 ' HB1' ' HG3' ' A' 1288 ' ' GLN . . . -54.01 -50.09 67.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.698 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.01 -29.77 71.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.19 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -68.8 -49.93 54.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.148 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' 1297 ' ' ARG . 26.6 mt -61.4 -44.43 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.853 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' 1305 ' ' MET . 25.0 mt -67.55 -33.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.81 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -52.06 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.284 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.436 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.2 mt-30 -58.83 -36.84 75.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.254 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.483 ' C ' HG23 ' A' 1311 ' ' VAL . 12.7 mtm -57.7 -37.79 74.11 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' 1311 ' ' VAL . 7.1 tt0 -69.4 -32.69 71.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.146 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.76 -30.43 62.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.376 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.544 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -88.52 -20.28 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.8 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.46 13.78 29.6 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.983 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.544 HG13 ' HB2' ' A' 1308 ' ' GLN . 10.5 mt -83.99 -36.23 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.673 0.389 . . . . 0.0 111.319 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' 1306 ' ' GLU . 27.2 m -121.05 152.66 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.412 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.47 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.6 OUTLIER -97.27 -177.93 4.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.422 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.431 179.859 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.893 0.378 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.458 ' HD2' HG22 ' A' 1311 ' ' VAL . 0.3 OUTLIER -107.4 140.42 40.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' 1311 ' ' VAL . 36.3 tt0 -80.46 132.67 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.17 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' 1282 ' ' ALA . 31.3 t -91.81 118.71 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.47 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.95 -8.48 15.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.338 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -100.27 129.87 27.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.244 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.04 159.15 23.89 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.505 2.137 . . . . 0.0 113.029 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.525 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.7 Cg_exo -51.64 159.66 3.24 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.894 2.396 . . . . 0.0 112.503 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 122.61 2.207 . . . . 0.0 112.306 179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 9.2 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.918 0.389 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1266 ' ' ASP . . . . . 0.401 ' CB ' HG12 ' A' 1301 ' ' ILE . 20.6 t70 -86.56 144.8 38.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.48 -24.55 22.37 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.463 2.109 . . . . 0.0 112.497 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.452 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 44.2 mt -101.95 -1.36 32.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.506 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 42.7 t80 -47.6 -56.27 7.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -52.39 -42.44 64.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -69.85 -37.14 76.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.183 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -67.0 -40.42 87.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.753 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.506 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 57.5 t -62.52 -47.37 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.452 ' HA ' ' OG1' ' A' 1277 ' ' THR . 50.7 tt0 -64.04 -32.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.677 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.418 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.98 -51.1 59.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.478 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.3 m -68.3 -38.18 79.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.247 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.514 ' HB ' ' N ' ' A' 1326 ' ' PRO . 43.5 p -69.46 -49.28 56.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.249 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.4 mm-40 -59.89 -35.79 75.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.988 0.423 . . . . 0.0 110.411 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -6.18 48.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.025 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 19.9 mmm180 55.95 18.93 3.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.812 0.339 . . . . 0.0 110.553 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1281 ' ' LYS . . . . . 0.402 ' HA ' HG22 ' A' 1322 ' ' VAL . 0.0 OUTLIER -145.56 131.29 18.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.643 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -113.55 116.41 29.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.633 0.254 . . . . 0.0 110.62 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 25.5 t -132.47 135.23 45.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.434 HG22 ' CE1' ' A' 1295 ' ' TYR . 36.8 mt -64.51 -41.54 92.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.199 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 31.6 t -70.19 -38.53 75.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.664 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.58 -49.43 73.53 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.479 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.8 t -66.63 -29.67 47.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.315 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1288 ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.95 -55.67 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.163 0.506 . . . . 0.0 110.321 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -28.81 57.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -75.06 -37.29 61.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.367 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.17 -5.23 23.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.727 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 57.9 49.09 12.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.492 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' 1297 ' ' ARG . 11.2 pt -124.86 163.97 24.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.068 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -70.58 147.98 44.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.623 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.434 ' CE1' HG22 ' A' 1284 ' ' ILE . 91.2 t80 -45.6 -50.52 13.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.76 -41.91 57.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.598 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.539 ' HD3' HD13 ' A' 1301 ' ' ILE . 0.0 OUTLIER -67.16 -47.43 71.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.17 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.4 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -53.91 -49.13 69.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.956 0.408 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1299 ' ' ALA . . . . . 0.418 ' N ' HG21 ' A' 1284 ' ' ILE . . . -64.82 -29.72 70.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.807 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -51.28 59.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.313 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.539 HD13 ' HD3' ' A' 1297 ' ' ARG . 25.6 mt -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.053 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' 1305 ' ' MET . 22.0 mt -67.93 -33.79 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.733 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.03 -51.38 69.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.427 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 11.3 mt-30 -59.66 -36.51 76.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.281 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' 1302 ' ' ILE . 15.1 mtm -57.45 -37.64 73.16 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.475 ' N ' HG21 ' A' 1311 ' ' VAL . 5.4 tt0 -69.55 -32.88 71.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.55 61.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.69 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.528 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -89.2 -20.44 24.18 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.43 17.09 22.93 Favored Glycine 0 C--N 1.328 0.131 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.949 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.528 HG13 ' HB2' ' A' 1308 ' ' GLN . 13.8 mt -86.25 -36.22 10.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 122.811 0.444 . . . . 0.0 111.265 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.475 HG21 ' N ' ' A' 1306 ' ' GLU . 32.6 m -120.63 164.01 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.492 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.68 -177.96 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.131 0.491 . . . . 0.0 111.708 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 14.1 mp0 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.59 -179.889 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 38.3 m-80 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.068 0.461 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.437 ' HG3' HG22 ' A' 1302 ' ' ILE . 2.5 mmt180 -107.46 140.37 40.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.595 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.9 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.711 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' 1281 ' ' LYS . 20.3 t -90.28 118.68 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 0.0 110.29 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.492 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.77 -6.49 16.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.484 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -105.46 132.47 20.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.413 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.26 159.35 20.17 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.433 2.089 . . . . 0.0 112.924 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.514 ' N ' ' HB ' ' A' 1277 ' ' THR . 65.1 Cg_exo -51.69 157.39 5.43 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.944 2.429 . . . . 0.0 112.6 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 9.8 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.966 0.412 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.28 144.4 46.67 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.325 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.29 -24.4 20.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.472 2.115 . . . . 0.0 112.556 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.506 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 41.4 mt -102.04 -1.73 31.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.95 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.5 t80 -47.54 -55.46 9.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.52 -41.35 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.995 0.426 . . . . 0.0 110.391 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1271 ' ' GLN . . . . . 0.514 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 0.0 OUTLIER -66.67 -43.48 84.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.013 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.41 -40.26 96.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.454 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 25.3 t -61.75 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' 1278 ' ' GLU . 23.1 tt0 -64.17 -32.23 73.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.705 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.465 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.46 -51.42 57.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.454 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.416 HG21 ' N ' ' A' 1277 ' ' THR . 33.8 m -69.05 -39.93 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.623 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.521 ' HB ' ' N ' ' A' 1326 ' ' PRO . 76.2 p -67.74 -49.86 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.365 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.2 mt-10 -59.91 -36.63 77.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.964 0.411 . . . . 0.0 110.479 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.22 -6.25 53.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.016 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.1 mmm180 57.35 17.51 3.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.813 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.6 mttt -145.66 134.28 22.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.749 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.59 116.39 28.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.679 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 5.0 p -132.54 140.76 48.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.137 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.514 HG23 ' CE1' ' A' 1295 ' ' TYR . 21.9 mt -69.55 -40.79 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.313 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 37.1 t -66.91 -43.78 82.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.116 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.3 -49.53 77.49 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.793 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' 1291 ' ' PHE . 15.9 t -65.12 -30.71 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.649 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 13.0 mt-30 -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.217 0.532 . . . . 0.0 109.978 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -35.8 58.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.186 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.421 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.1 tp60 -75.01 -34.91 61.98 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.612 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.0 m-85 -103.2 -6.66 21.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.606 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 55.6 55.15 7.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.039 0.447 . . . . 0.0 110.458 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.88 147.87 32.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.49 147.93 22.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.182 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.3 t80 -45.3 -50.24 12.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 111.446 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.78 -42.6 58.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -49.23 72.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.471 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.9 -50.12 67.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.07 -29.69 71.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.063 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -68.08 -51.08 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.208 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.53 -43.38 90.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.037 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.9 mt -68.98 -33.63 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.915 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.14 -52.05 65.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.236 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.431 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 25.4 mt-30 -59.41 -36.92 76.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.226 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.428 ' CB ' HG23 ' A' 1311 ' ' VAL . 13.5 mtm -57.35 -37.81 73.15 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' 1311 ' ' VAL . 3.1 tt0 -69.39 -33.07 72.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.01 -29.75 63.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.261 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.545 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -89.25 -20.29 24.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.782 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.77 12.74 31.61 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.949 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' 1308 ' ' GLN . 10.4 mt -83.07 -36.19 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.654 0.382 . . . . 0.0 111.341 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' 1306 ' ' GLU . 35.4 m -122.75 155.11 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.378 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.455 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -102.53 -177.97 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.188 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.343 179.777 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 19.8 m-80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.952 0.406 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1320 ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -107.48 140.32 40.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.6 132.66 34.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.889 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' 1282 ' ' ALA . 31.8 t -92.24 118.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.455 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -108.51 -4.76 16.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.381 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1324 ' ' ALA . . . . . 0.405 ' HB3' ' CG2' ' A' 1310 ' ' ILE . . . -105.24 130.66 22.73 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.395 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.59 158.74 22.1 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.563 2.175 . . . . 0.0 113.153 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.521 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.8 Cg_exo -52.2 163.19 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.044 2.496 . . . . 0.0 112.712 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--N 1.344 0.312 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 8.4 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.951 0.405 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1266 ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' 1268 ' ' LEU . 19.3 t70 -84.87 143.02 39.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.051 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.11 -23.87 23.75 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.388 2.059 . . . . 0.0 112.421 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 74.4 mt -97.73 -6.65 32.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.524 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.518 ' CE1' HG22 ' A' 1273 ' ' VAL . 41.5 t80 -47.29 -55.95 7.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.42 -40.99 62.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.957 0.408 . . . . 0.0 110.318 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1271 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 0.1 OUTLIER -64.79 -49.16 71.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.892 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.61 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -60.31 -40.77 91.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.625 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.518 HG22 ' CE1' ' A' 1269 ' ' PHE . 84.3 t -61.23 -48.52 88.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1274 ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -65.46 -30.29 71.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.877 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.401 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.1 t80 -68.13 -49.08 63.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.438 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' 1277 ' ' THR . 35.2 m -69.75 -40.75 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.293 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.516 ' HB ' ' N ' ' A' 1326 ' ' PRO . 76.4 p -67.62 -48.52 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.18 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -59.11 -38.12 78.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.493 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -90.68 -6.56 54.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.028 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.2 mmm180 59.76 15.71 5.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.938 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.55 136.94 25.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.785 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -116.3 116.36 27.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.908 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 13.1 t -132.52 139.14 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.199 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.517 HG23 ' CE1' ' A' 1295 ' ' TYR . 31.3 mt -68.43 -38.46 79.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.8 t -68.78 -42.47 77.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.871 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.73 -48.23 87.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.661 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' 1291 ' ' PHE . 14.2 t -66.05 -30.94 51.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 110.673 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 21.9 mt-30 -60.88 -50.49 73.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.144 0.497 . . . . 0.0 110.048 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -76.32 -36.53 58.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.157 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.94 -33.95 62.01 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.566 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.61 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.14 -6.38 22.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.535 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 13.8 mtp-105 53.95 54.96 8.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.097 0.475 . . . . 0.0 110.23 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.464 ' HB ' ' HD3' ' A' 1297 ' ' ARG . 13.9 pt -130.86 152.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.578 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -58.75 148.14 39.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.791 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.588 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 91.2 t80 -44.96 -51.85 9.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.54 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -40.99 57.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.464 ' HD3' ' HB ' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.93 -47.87 76.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.99 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -56.37 -50.18 72.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.88 70.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.302 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -68.08 -49.84 58.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.258 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' 1297 ' ' ARG . 40.2 mt -60.18 -44.21 94.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.059 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' 1320 ' ' ARG . 19.4 mt -68.68 -33.51 60.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.836 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -52.04 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.32 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.433 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 29.1 mt-30 -60.05 -36.39 77.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.341 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.456 ' HG2' HD11 ' A' 1310 ' ' ILE . 13.7 mtm -57.05 -38.89 73.87 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' 1311 ' ' VAL . 0.4 OUTLIER -68.81 -33.94 74.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.239 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -71.47 -30.82 66.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.47 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.554 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.8 OUTLIER -88.78 -20.21 25.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.868 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.05 12.69 31.07 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.894 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.554 HG13 ' HB2' ' A' 1308 ' ' GLN . 11.1 mt -82.53 -36.03 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 122.8 0.44 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' 1306 ' ' GLU . 35.8 m -124.01 158.98 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.254 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.523 ' CA ' HD13 ' A' 1323 ' ' LEU . 1.0 OUTLIER -98.66 179.25 4.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 0.0 111.602 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.438 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 63.2 m-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.063 0.459 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.421 ' HG3' HG22 ' A' 1302 ' ' ILE . 2.9 mmt180 -107.28 140.33 40.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.204 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.5 tp10 -83.39 132.72 34.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.976 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 25.0 t -91.39 118.78 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.982 0.42 . . . . 0.0 110.222 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.523 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -109.02 -6.23 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.448 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -104.68 132.49 20.87 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.414 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.83 158.56 16.01 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.493 2.129 . . . . 0.0 113.043 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.516 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.0 Cg_exo -53.27 163.49 2.37 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.97 2.447 . . . . 0.0 112.526 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.298 179.888 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.422 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 9.9 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.044 0.449 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.62 143.99 41.96 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.404 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.35 -25.53 18.55 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.519 2.146 . . . . 0.0 112.869 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 36.6 mt -102.06 -0.15 34.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.509 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 43.5 t80 -47.7 -56.38 7.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -42.78 64.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1271 ' ' GLN . . . . . 0.403 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 16.4 mt-30 -69.48 -36.51 76.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.241 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.617 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -67.75 -41.65 83.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.684 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.509 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 97.9 t -61.99 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.4 OUTLIER -64.77 -32.41 74.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.615 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.408 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -67.41 -50.71 58.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.666 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' 1280 ' ' ARG . 32.8 m -68.23 -37.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.335 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.486 ' HB ' ' N ' ' A' 1326 ' ' PRO . 43.2 p -69.98 -48.83 56.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.222 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' 1274 ' ' GLN . 6.2 mm-40 -59.66 -35.16 73.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.527 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -95.97 -4.16 43.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.8 mmm180 54.95 19.42 2.66 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.906 0.384 . . . . 0.0 110.873 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.4 mttp -145.46 131.64 19.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -113.96 116.42 29.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.642 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 30.2 t -132.46 141.84 48.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 111.477 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' 1295 ' ' TYR . 62.2 mt -70.29 -43.44 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 27.7 t -68.06 -40.59 82.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.883 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.07 60.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.781 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' 1291 ' ' PHE . 22.3 t -65.19 -29.93 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.266 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' 1293 ' ' ILE . 13.3 tt0 -59.8 -51.86 67.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -76.28 -35.59 58.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.065 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -33.3 61.7 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.596 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.617 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.16 -7.85 20.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.762 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 56.62 51.78 10.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.161 0.505 . . . . 0.0 110.29 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.408 ' O ' ' CG ' ' A' 1288 ' ' GLN . 19.1 pt -129.17 146.03 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.11 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -50.89 149.77 6.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.319 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.461 ' CE1' ' CG2' ' A' 1284 ' ' ILE . 87.8 t80 -47.64 -53.43 14.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.444 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.77 -36.95 39.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -67.07 -50.21 62.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.175 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.402 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -55.21 -46.35 75.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.628 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1299 ' ' ALA . . . . . 0.41 ' N ' HG21 ' A' 1284 ' ' ILE . . . -65.91 -29.9 70.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.175 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -49.36 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.315 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 29.0 mt -60.66 -42.43 91.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.965 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' 1305 ' ' MET . 26.5 mt -68.76 -35.29 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -51.09 70.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.486 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.409 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 17.4 mt-30 -59.88 -37.04 78.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.428 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.449 ' HG2' HD11 ' A' 1310 ' ' ILE . 19.6 mtm -56.98 -38.39 72.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.499 ' N ' HG23 ' A' 1311 ' ' VAL . 2.2 tt0 -69.93 -32.81 71.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.37 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.54 -31.47 65.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.426 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.544 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.7 OUTLIER -88.12 -20.3 25.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.918 -178.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.63 13.81 29.1 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.544 HG13 ' HB2' ' A' 1308 ' ' GLN . 12.2 mt -82.85 -36.42 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 122.892 0.477 . . . . 0.0 111.251 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' 1306 ' ' GLU . 26.7 m -121.31 160.49 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.541 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.44 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -106.97 -178.53 3.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.516 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.65 -179.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.925 0.393 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' 1311 ' ' VAL . 0.0 OUTLIER -107.06 140.24 40.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.351 179.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' 1311 ' ' VAL . 15.3 tp10 -75.37 132.58 41.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.992 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 20.6 t -87.3 118.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.44 HD13 ' CA ' ' A' 1312 ' ' SER . 0.7 OUTLIER -105.7 -19.04 13.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.269 -178.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -91.96 133.49 30.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.262 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.19 159.02 15.26 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.498 2.132 . . . . 0.0 113.02 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.486 ' N ' ' HB ' ' A' 1277 ' ' THR . 56.6 Cg_exo -52.01 159.35 3.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.903 2.402 . . . . 0.0 112.477 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 112.394 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 9.4 mt . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.996 0.427 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.87 143.64 43.62 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.43 -24.18 27.08 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.394 2.063 . . . . 0.0 112.272 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 65.9 mt -97.53 -5.37 35.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.6 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.448 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.0 t80 -47.47 -55.93 8.06 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.52 -40.77 62.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.396 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.52 -43.26 81.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.082 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.585 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.08 -41.19 99.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.905 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 29.7 t -61.1 -48.51 88.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' 1278 ' ' GLU . 45.0 tt0 -63.18 -33.56 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.438 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -65.9 -51.6 57.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.62 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' 1277 ' ' THR . 33.2 m -69.31 -38.46 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.7 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.517 ' HB ' ' N ' ' A' 1326 ' ' PRO . 51.4 p -69.23 -49.86 52.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.21 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.4 mt-10 -59.8 -36.37 76.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.971 0.415 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -91.81 -6.49 51.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.018 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.6 mmm180 56.9 18.12 3.7 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.887 0.375 . . . . 0.0 110.744 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 132.35 20.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.737 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.407 ' CB ' HG13 ' A' 1311 ' ' VAL . . . -113.98 116.49 29.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.29 141.37 48.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.903 0.382 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.435 ' CG2' ' CE1' ' A' 1295 ' ' TYR . 25.4 mt -69.13 -43.31 81.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 21.3 t -67.01 -40.3 87.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.978 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.65 -51.12 60.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.1 t -64.83 -29.91 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.311 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' 1293 ' ' ILE . 10.7 tt0 -59.75 -52.68 64.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.092 0.472 . . . . 0.0 110.135 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 -35.23 58.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.18 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.41 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -34.67 61.78 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.632 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.585 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.14 -7.38 21.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 56.82 55.02 6.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.135 0.493 . . . . 0.0 110.526 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' 1288 ' ' GLN . 13.3 pt -133.23 145.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -51.06 148.86 7.71 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.435 ' CE1' ' CG2' ' A' 1284 ' ' ILE . 89.2 t80 -47.05 -52.7 14.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.543 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.72 -38.5 47.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 110.052 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -50.59 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.068 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1298 ' ' ALA . . . . . . . . . . . . . . . -54.53 -44.43 72.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.429 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1299 ' ' ALA . . . . . 0.407 ' N ' HG21 ' A' 1284 ' ' ILE . . . -66.94 -29.74 69.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -50.55 53.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 20.8 mt -59.92 -42.33 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.01 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.425 HG22 ' HG3' ' A' 1320 ' ' ARG . 20.9 mt -69.45 -34.6 62.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.774 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.94 -52.05 65.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.393 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.426 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 31.6 mt-30 -58.41 -38.03 76.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.259 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.41 ' CB ' HG23 ' A' 1311 ' ' VAL . 21.3 mtm -57.53 -37.33 72.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.326 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' 1311 ' ' VAL . 2.2 tt0 -69.21 -32.66 72.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.181 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.545 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.4 OUTLIER -87.25 -20.31 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.715 -178.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.5 12.94 31.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.009 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' 1308 ' ' GLN . 10.3 mt -83.65 -34.92 10.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.473 -0.363 . . . . 0.0 111.403 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' 1306 ' ' GLU . 35.6 m -124.44 154.4 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.622 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.409 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.1 OUTLIER -104.47 179.65 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.901 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 52.5 m-80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.875 0.369 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.425 ' HG3' HG22 ' A' 1302 ' ' ILE . 4.7 mtt180 -107.22 140.2 40.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.54 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' 1311 ' ' VAL . 19.7 tp10 -81.95 132.66 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.767 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 21.5 t -88.81 118.61 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 110.047 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.409 HD13 ' CA ' ' A' 1312 ' ' SER . 0.7 OUTLIER -106.31 -13.03 15.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.38 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -99.22 132.34 23.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.275 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.46 159.04 22.57 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.525 2.15 . . . . 0.0 113.026 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.517 ' N ' ' HB ' ' A' 1277 ' ' THR . 57.2 Cg_exo -51.64 152.31 12.97 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.038 2.492 . . . . 0.0 112.687 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 C--N 1.344 0.34 0 C-N-CA 122.625 2.217 . . . . 0.0 112.318 179.857 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.434 HD22 ' NE2' ' A' 1308 ' ' GLN . 3.3 mt . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.105 0.479 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1266 ' ' ASP . . . . . 0.417 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -80.38 141.74 53.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -51.73 -24.13 17.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.349 2.033 . . . . 0.0 112.584 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.504 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 59.2 mt -102.11 -4.51 25.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.035 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 39.9 t80 -47.67 -53.11 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -46.08 66.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.0 110.294 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.9 -43.25 96.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.25 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -62.1 -39.36 92.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.982 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.464 HG23 ' CE1' ' A' 1269 ' ' PHE . 17.2 t -61.65 -49.57 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.424 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.0 OUTLIER -62.61 -33.28 74.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.841 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.416 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.49 -50.87 61.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.0 m -69.57 -38.02 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.432 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.445 ' HB ' ' N ' ' A' 1326 ' ' PRO . 67.1 p -69.31 -50.25 48.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.0 mm-40 -59.17 -36.78 75.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.484 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -92.69 -6.14 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 29.1 mmm180 56.01 18.74 3.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.817 0.341 . . . . 0.0 110.651 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 24.1 mttp -145.62 133.67 21.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -116.85 116.23 27.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.898 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.54 143.25 49.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.022 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.524 HG23 ' CE1' ' A' 1295 ' ' TYR . 16.1 mt -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 14.8 t -67.38 -40.59 85.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.059 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.65 -50.41 67.94 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.778 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' 1291 ' ' PHE . 13.4 t -65.51 -30.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 110.635 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.7 mt-30 -60.76 -51.54 68.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.061 0.458 . . . . 0.0 109.936 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -36.58 58.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.097 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.405 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.98 -34.37 61.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.714 0.293 . . . . 0.0 111.626 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.15 -6.51 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.562 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 54.67 54.97 8.46 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.444 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 14.7 pt -131.97 150.39 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.583 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.61 148.32 26.82 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.252 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.1 t80 -45.96 -50.99 14.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.559 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.76 -40.67 55.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.444 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.88 -49.74 69.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.98 -49.54 68.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.0 71.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -49.8 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.985 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' 1297 ' ' ARG . 33.6 mt -60.71 -45.55 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.842 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' 1305 ' ' MET . 21.0 mt -66.79 -32.46 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.864 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -52.2 59.67 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.517 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.8 OUTLIER -57.86 -33.32 68.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.758 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.502 ' C ' HG23 ' A' 1311 ' ' VAL . 14.3 mtm -62.7 -39.37 93.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.558 ' N ' HG23 ' A' 1311 ' ' VAL . 28.1 tt0 -66.35 -32.28 73.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.416 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.88 -42.11 58.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.281 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.452 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -74.4 -20.19 60.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.604 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.42 15.3 30.29 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.415 ' CD1' HG23 ' A' 1273 ' ' VAL . 10.0 mt -83.64 -35.28 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.65 0.38 . . . . 0.0 111.502 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.558 HG23 ' N ' ' A' 1306 ' ' GLU . 29.6 m -122.4 159.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.573 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.413 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.19 178.19 4.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.819 -179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.483 ' HD2' HG22 ' A' 1311 ' ' VAL . 2.2 mtt-85 -107.18 140.2 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.655 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' 1311 ' ' VAL . 13.5 tt0 -83.61 132.72 34.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.749 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 19.3 t -87.92 118.57 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.321 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.413 HD13 ' CA ' ' A' 1312 ' ' SER . 0.8 OUTLIER -105.81 -10.25 16.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.053 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -100.21 129.91 27.16 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.192 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -82.62 158.48 16.54 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.573 2.182 . . . . 0.0 113.175 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.445 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -53.97 164.26 2.63 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.993 2.462 . . . . 0.0 112.32 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--N 1.344 0.331 0 C-N-CA 122.701 2.268 . . . . 0.0 112.432 179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.428 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 6.7 mt . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.029 0.442 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 8.7 t0 -75.77 141.38 72.0 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.0 -24.57 10.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.441 2.094 . . . . 0.0 112.945 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.497 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 60.0 mt -102.18 -5.03 24.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 45.9 t80 -47.66 -52.67 17.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.6 t0 -52.67 -42.2 64.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 0.0 110.328 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.56 -43.06 81.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.989 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.625 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -61.64 -38.98 89.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.873 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.515 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 21.2 t -62.13 -52.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.8 OUTLIER -61.43 -30.62 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.941 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.466 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 3.1 t80 -68.91 -51.04 44.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.697 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1276 ' ' VAL . . . . . . . . . . . . . 35.3 m -69.74 -36.93 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.403 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.521 ' HB ' ' N ' ' A' 1326 ' ' PRO . 65.9 p -69.68 -50.76 40.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.352 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.5 mm-40 -61.01 -35.19 76.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -7.99 52.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.793 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1280 ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 56.65 18.04 3.44 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 7.7 mttm -145.66 133.44 21.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.647 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -115.47 116.44 28.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.723 0.297 . . . . 0.0 110.779 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 11.1 t -132.49 141.31 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.457 ' CG2' ' CE1' ' A' 1295 ' ' TYR . 72.3 mt -68.6 -47.62 76.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.4 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 25.8 t -63.8 -40.68 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.043 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.96 62.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.969 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.2 t -64.35 -29.96 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' 1293 ' ' ILE . 0.0 OUTLIER -60.8 -50.84 71.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.108 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -36.35 58.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.994 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.09 -32.91 61.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.725 -179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.2 -7.78 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.761 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 59.05 50.35 8.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' 1288 ' ' GLN . 10.2 pt -126.56 171.39 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -77.01 154.06 42.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.924 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.457 ' CE1' ' CG2' ' A' 1284 ' ' ILE . 82.6 t80 -49.11 -55.84 10.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.822 0.311 . . . . 0.0 111.251 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -33.42 22.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.113 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -70.32 -50.89 34.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.865 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.407 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -55.78 -46.74 77.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.555 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1299 ' ' ALA . . . . . 0.41 ' N ' HG21 ' A' 1284 ' ' ILE . . . -66.79 -29.98 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.98 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -67.42 -48.93 65.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.893 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 50.1 mt -61.39 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.789 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.419 HD11 HG12 ' A' 1284 ' ' ILE . 20.0 mt -63.09 -31.69 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.734 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -47.6 82.98 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.611 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.8 mt-30 -60.64 -33.4 72.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.197 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.454 ' HB3' ' CG1' ' A' 1311 ' ' VAL . 0.6 OUTLIER -61.6 -40.32 94.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' 1311 ' ' VAL . 12.5 tt0 -65.86 -35.72 81.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.871 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.93 -41.36 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.265 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.428 ' NE2' ' CD2' ' A' 1265 ' ' LEU . 0.8 OUTLIER -74.72 -20.4 59.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.762 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 98.07 15.76 35.03 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.773 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.413 ' CD1' HG23 ' A' 1273 ' ' VAL . 8.6 mt -82.41 -36.18 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 122.791 0.436 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' 1306 ' ' GLU . 26.8 m -120.23 162.41 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.449 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.53 -177.96 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.73 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.9 m-80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.965 0.412 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.403 ' CD ' HG22 ' A' 1311 ' ' VAL . 0.2 OUTLIER -107.32 140.28 40.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.439 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' 1311 ' ' VAL . 14.4 tt0 -88.41 132.81 34.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 21.2 t -90.67 118.69 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.487 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.449 HD13 ' CA ' ' A' 1312 ' ' SER . 0.7 OUTLIER -107.19 -18.3 13.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.021 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -91.46 130.17 40.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.292 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.01 158.61 23.94 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.474 2.116 . . . . 0.0 113.133 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.521 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.1 Cg_exo -52.44 161.46 2.8 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.017 2.478 . . . . 0.0 112.57 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1327 ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' 1274 ' ' GLN . 18.9 Cg_endo . . . . . 0 C--N 1.344 0.334 0 C-N-CA 122.757 2.305 . . . . 0.0 112.241 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.421 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 12.3 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.25 144.49 62.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.215 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.62 -23.27 19.28 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.47 2.114 . . . . 0.0 112.16 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.469 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 85.4 mt -99.2 -6.92 27.3 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.793 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 38.4 t80 -47.54 -56.14 7.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.49 -40.1 61.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.848 0.356 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1271 ' ' GLN . . . . . 0.429 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 17.4 mt-30 -71.0 -38.89 72.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.134 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.26 -40.01 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 47.2 t -62.86 -47.55 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.432 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.5 OUTLIER -63.67 -33.55 75.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.729 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.412 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.14 -51.26 59.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.588 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.5 m -69.51 -37.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.437 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.517 ' HB ' ' N ' ' A' 1326 ' ' PRO . 44.5 p -69.96 -49.2 54.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.6 mt-10 -60.34 -35.91 76.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -92.33 -6.18 50.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.911 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.5 mmm180 56.93 17.7 3.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.766 0.317 . . . . 0.0 110.85 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 133.4 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.822 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.409 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -113.51 116.53 29.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.782 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 1.4 t -132.44 136.13 46.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.518 HG23 ' CE1' ' A' 1295 ' ' TYR . 32.1 mt -66.41 -37.9 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.138 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.497 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.8 t -69.35 -43.11 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.85 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.17 -48.57 85.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.714 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' 1291 ' ' PHE . 12.0 t -66.02 -31.27 52.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.683 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 19.3 mt-30 -59.92 -51.22 70.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 109.998 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -36.77 58.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.261 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.404 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.96 -33.91 61.96 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.611 -179.005 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.11 -7.01 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.568 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 54.65 54.08 9.73 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.009 0.433 . . . . 0.0 110.261 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.21 146.72 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.516 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.44 149.0 10.57 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.314 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.6 t80 -46.48 -51.79 14.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.8 -39.7 53.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.197 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -50.67 64.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.482 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.88 -49.78 67.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.997 0.427 . . . . 0.0 110.544 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.11 -29.68 70.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -68.2 -51.63 43.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 36.4 mt -59.57 -44.33 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.94 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.412 HG22 ' HG3' ' A' 1320 ' ' ARG . 20.0 mt -67.91 -32.93 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -52.11 66.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.422 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.421 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 0.1 OUTLIER -60.2 -36.9 78.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' 1302 ' ' ILE . 16.9 mtm -56.94 -36.38 70.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 CA-C-O 121.557 0.694 . . . . 0.0 109.174 178.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.51 ' N ' HG21 ' A' 1311 ' ' VAL . 4.6 tp10 -70.21 -33.14 71.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.055 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.41 62.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.475 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.539 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.4 OUTLIER -88.07 -20.43 25.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.908 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.57 16.05 25.51 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.958 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' 1308 ' ' GLN . 14.0 mt -85.26 -36.64 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.303 -0.448 . . . . 0.0 111.184 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.51 HG21 ' N ' ' A' 1306 ' ' GLU . 35.0 m -120.58 156.64 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.474 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.3 -178.19 3.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.108 0.48 . . . . 0.0 111.657 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.515 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 27.4 m-80 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.9 0.381 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.412 ' HG3' HG22 ' A' 1302 ' ' ILE . 7.8 mmt180 -107.24 140.27 40.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.168 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' 1311 ' ' VAL . 4.9 tp10 -87.48 132.67 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' 1282 ' ' ALA . 22.0 t -91.79 118.69 37.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 110.099 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.474 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.82 -4.92 17.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.457 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -105.79 130.98 22.15 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.3 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.02 159.42 23.94 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.461 2.107 . . . . 0.0 113.041 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.517 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.47 158.49 3.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.081 2.521 . . . . 0.0 112.582 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.345 0.389 0 C-N-CA 122.691 2.261 . . . . 0.0 112.442 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 10.9 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.922 0.391 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.48 144.98 81.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.376 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.46 -24.25 21.38 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.377 2.051 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.474 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 44.3 mt -101.98 -1.76 31.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.909 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.489 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.1 t80 -47.7 -56.51 7.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.37 -41.81 63.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.074 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.1 -37.48 75.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.91 -41.65 91.18 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.689 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.489 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 57.6 t -61.75 -48.48 88.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.46 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.786 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.423 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -66.87 -51.74 51.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.547 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.413 HG21 ' N ' ' A' 1277 ' ' THR . 33.4 m -67.6 -37.43 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.121 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.506 ' HB ' ' N ' ' A' 1326 ' ' PRO . 42.6 p -69.47 -49.45 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.178 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.6 -35.03 73.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1279 ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 2.7 mtmt -93.91 -6.98 44.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.018 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.4 mmm180 58.04 17.2 4.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.625 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.6 133.58 21.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -113.34 116.44 29.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.607 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 4.4 t -132.39 138.26 47.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.359 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.526 HG23 ' CE1' ' A' 1295 ' ' TYR . 24.1 mt -67.92 -38.77 80.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.161 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.478 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.0 t -69.69 -42.83 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.962 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.72 -50.18 70.47 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.584 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.2 t -65.44 -29.92 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.723 0.297 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -60.41 -52.72 64.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.105 0.479 . . . . 0.0 110.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -76.31 -34.59 59.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.027 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.427 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.5 tp60 -75.12 -34.01 61.64 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.394 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.44 22.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.704 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 54.77 51.53 13.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.174 0.512 . . . . 0.0 110.047 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.415 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 16.6 pt -126.89 150.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.36 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -57.61 147.64 35.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.85 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.604 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 86.8 t80 -44.84 -49.5 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 111.47 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.77 -43.47 58.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.807 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.486 ' HD3' HD13 ' A' 1301 ' ' ILE . 0.0 OUTLIER -65.3 -47.27 77.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.417 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.492 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.8 -49.94 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.675 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -64.3 -29.78 70.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.015 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -49.79 56.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.409 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.486 HD13 ' HD3' ' A' 1297 ' ' ARG . 38.2 mt -60.88 -42.51 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.776 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.411 HG21 ' HD2' ' A' 1320 ' ' ARG . 29.1 mt -69.06 -35.3 68.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.741 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -52.01 66.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.384 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.437 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.1 mt-30 -59.32 -37.58 78.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.354 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.457 ' C ' HG23 ' A' 1311 ' ' VAL . 17.4 mtm -57.13 -37.43 71.99 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' 1311 ' ' VAL . 2.8 tt0 -70.25 -32.33 70.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.141 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.67 -29.01 62.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.338 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.526 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -90.13 -20.33 23.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.741 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.85 13.76 28.74 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.063 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' 1308 ' ' GLN . 11.1 mt -84.39 -35.84 11.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 122.799 0.439 . . . . 0.0 111.456 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' 1306 ' ' GLU . 30.3 m -122.03 155.84 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.732 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1312 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.74 -177.98 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.978 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.758 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 23.7 m-80 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.89 0.376 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' 1311 ' ' VAL . 8.8 mtt-85 -107.18 140.13 40.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.399 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.0 tp10 -80.0 132.64 36.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.056 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 18.2 t -88.55 118.56 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1323 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.73 -13.88 15.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -97.47 132.6 24.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.35 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.51 159.02 19.5 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.553 2.169 . . . . 0.0 113.074 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.506 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.9 Cg_exo -52.16 161.09 2.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.913 2.409 . . . . 0.0 112.66 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.345 0.356 0 C-N-CA 122.669 2.246 . . . . 0.0 112.25 179.885 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.476 ' HA ' ' OE1' ' A' 1304 ' ' GLN . 6.9 mt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.975 0.417 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.62 143.78 79.43 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.197 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.66 -23.63 15.72 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.256 1.971 . . . . 0.0 112.217 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.508 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 59.5 mt -102.08 -5.48 24.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 39.4 t80 -47.71 -54.13 13.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -52.61 -41.69 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -67.52 -42.67 82.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -62.78 -39.12 93.21 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.72 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.467 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 21.6 t -62.04 -51.27 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.7 tt0 -61.79 -31.57 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.894 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.436 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -68.25 -50.88 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.632 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.2 m -69.18 -37.27 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.287 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.498 ' HB ' ' N ' ' A' 1326 ' ' PRO . 74.1 p -69.64 -50.64 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' 1274 ' ' GLN . 8.3 mm-40 -59.46 -36.09 75.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.404 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -8.25 48.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 57.71 17.74 4.3 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.462 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 29.7 mttt -145.61 132.1 19.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.792 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -113.02 116.49 30.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.727 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 34.6 t -132.29 139.87 48.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 111.276 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.431 HG22 ' CE1' ' A' 1295 ' ' TYR . 22.5 mt -68.48 -43.31 83.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 2.8 t -67.16 -41.18 86.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.978 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.49 -51.14 60.59 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.79 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.8 t -64.52 -29.96 48.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.958 0.409 . . . . 0.0 110.263 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' 1293 ' ' ILE . 15.7 tt0 -59.63 -53.07 62.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.248 0.547 . . . . 0.0 110.208 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -35.16 59.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.102 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.403 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -75.09 -33.34 61.64 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.683 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.27 -7.71 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 57.56 52.39 8.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.067 0.461 . . . . 0.0 110.494 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1293 ' ' ILE . . . . . 0.414 ' CG2' ' NH1' ' A' 1297 ' ' ARG . 13.2 pt -130.01 148.33 33.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.031 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.48 150.28 16.93 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.924 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.431 ' CE1' HG22 ' A' 1284 ' ' ILE . 89.1 t80 -47.59 -51.28 21.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.78 -38.54 48.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.529 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.414 ' NH1' ' CG2' ' A' 1293 ' ' ILE . 0.1 OUTLIER -66.92 -49.38 65.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.139 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1298 ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.77 73.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.666 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1299 ' ' ALA . . . . . 0.402 ' N ' HG21 ' A' 1284 ' ' ILE . . . -67.05 -29.87 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.063 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -49.97 57.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.046 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 39.9 mt -60.57 -45.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.786 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.8 mt -66.12 -32.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.853 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -52.2 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.508 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -60.14 -32.03 70.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.758 178.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' 1302 ' ' ILE . 13.8 mtm -61.3 -39.05 89.03 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.517 ' N ' HG21 ' A' 1311 ' ' VAL . 1.7 tt0 -67.22 -32.93 74.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.372 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.05 -42.11 63.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.42 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.479 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -76.31 -20.28 57.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.871 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.53 16.37 27.01 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.997 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.446 ' CD1' HG23 ' A' 1273 ' ' VAL . 13.0 mt -83.12 -37.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 122.76 0.424 . . . . 0.0 111.279 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.517 HG21 ' N ' ' A' 1306 ' ' GLU . 34.8 m -120.65 159.54 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.428 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -107.6 -177.92 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.867 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.419 179.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 11.7 m-80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.947 0.403 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1320 ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.45 140.3 40.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.566 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.52 132.71 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.253 . . . . 0.0 110.622 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 18.3 t -89.51 118.69 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.94 0.4 . . . . 0.0 110.319 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.428 HD13 ' CA ' ' A' 1312 ' ' SER . 0.8 OUTLIER -106.51 -19.99 13.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.931 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -89.67 129.86 45.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.176 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.9 158.88 21.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.094 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.498 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.1 Cg_exo -53.13 164.32 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.922 2.414 . . . . 0.0 112.411 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 122.617 2.211 . . . . 0.0 112.232 179.859 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1265 ' ' LEU . . . . . 0.439 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 10.2 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.89 0.376 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -85.87 145.11 40.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.365 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -52.52 -24.03 21.04 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1268 ' ' LEU . . . . . 0.496 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 45.2 mt -102.05 -1.52 31.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.862 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1269 ' ' PHE . . . . . 0.474 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.6 t80 -47.56 -56.88 6.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.34 -41.04 62.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.78 -42.3 86.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1272 ' ' ALA . . . . . 0.591 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.01 -41.9 94.91 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1273 ' ' VAL . . . . . 0.474 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 61.1 t -60.11 -48.16 89.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1274 ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.5 tt0 -64.13 -33.26 75.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.744 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1275 ' ' PHE . . . . . 0.435 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -65.65 -50.7 64.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.585 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1276 ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' 1277 ' ' THR . 33.5 m -69.28 -40.26 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.492 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1277 ' ' THR . . . . . 0.527 ' HB ' ' N ' ' A' 1326 ' ' PRO . 67.0 p -67.99 -49.53 61.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1278 ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' 1274 ' ' GLN . 11.7 mm-40 -59.68 -36.3 76.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -92.28 -6.06 51.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.22 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 28.0 mmm180 58.24 16.84 4.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 110.9 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 2.9 mttm -145.61 134.75 22.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1282 ' ' ALA . . . . . 0.411 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -115.67 116.43 28.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.665 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1283 ' ' SER . . . . . . . . . . . . . 8.7 p -132.52 140.76 48.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CE1' ' A' 1295 ' ' TYR . 21.2 mt -69.22 -40.5 80.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.287 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 45.5 t -67.8 -42.79 81.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.014 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.46 78.29 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.706 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1287 ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' 1291 ' ' PHE . 15.5 t -65.49 -30.74 51.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 15.1 mt-30 -60.22 -51.37 69.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.216 0.532 . . . . 0.0 109.949 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -36.1 58.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.233 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1290 ' ' GLN . . . . . 0.414 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.02 -34.64 61.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.618 -178.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1291 ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.31 -6.48 21.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.551 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 54.96 55.01 8.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 110.381 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 15.2 pt -131.73 147.26 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.435 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.99 149.29 11.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.284 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.0 t80 -46.77 -51.46 16.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.458 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -39.45 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.458 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1297 ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' 1301 ' ' ILE . 0.3 OUTLIER -66.23 -49.49 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.27 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1298 ' ' ALA . . . . . 0.47 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.95 -49.36 68.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.642 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1299 ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' 1284 ' ' ILE . . . -63.81 -29.79 70.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -68.55 -50.52 51.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.244 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1301 ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' 1297 ' ' ARG . 29.5 mt -60.13 -43.49 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.833 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1302 ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' 1305 ' ' MET . 20.2 mt -68.83 -33.69 60.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.928 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.89 66.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.335 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1304 ' ' GLN . . . . . 0.439 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 22.9 mt-30 -59.43 -36.76 76.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.303 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1305 ' ' MET . . . . . 0.471 ' HG2' HD11 ' A' 1310 ' ' ILE . 17.1 mtm -57.01 -38.54 73.24 Favored 'General case' 0 C--O 1.228 -0.058 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1306 ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' 1311 ' ' VAL . 5.1 tt0 -69.46 -33.04 72.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.303 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.09 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.404 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1308 ' ' GLN . . . . . 0.534 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.6 OUTLIER -89.18 -20.32 24.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.26 13.89 27.52 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.963 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1310 ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' 1308 ' ' GLN . 12.4 mt -83.67 -38.49 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 122.743 0.417 . . . . 0.0 111.266 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1311 ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' 1306 ' ' GLU . 32.6 m -120.22 155.78 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.144 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1312 ' ' SER . . . . . 0.465 ' CA ' HD13 ' A' 1323 ' ' LEU . 1.0 OUTLIER -96.46 -179.9 4.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.623 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.396 180.0 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.025 0.44 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1320 ' ' ARG . . . . . 0.409 ' HG3' HG22 ' A' 1302 ' ' ILE . 2.7 mmt180 -107.6 140.33 40.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.31 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1321 ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.3 tt0 -85.44 132.67 34.18 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.862 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1322 ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' A' 1282 ' ' ALA . 29.4 t -92.86 118.69 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.967 0.413 . . . . 0.0 110.139 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1323 ' ' LEU . . . . . 0.465 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.11 -13.54 14.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.233 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -95.57 130.41 32.03 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.24 159.29 23.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.531 2.154 . . . . 0.0 113.028 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1326 ' ' PRO . . . . . 0.527 ' N ' ' HB ' ' A' 1277 ' ' THR . 63.0 Cg_exo -51.68 159.67 3.28 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.06 2.507 . . . . 0.0 112.678 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.266 179.921 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 75.9 m80 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.781 0.324 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -166.79 -99.33 0.13 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.534 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -57.95 -21.72 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.726 0.298 . . . . 0.0 111.375 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -54.87 -37.24 66.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 111.161 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.2 -38.13 3.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.434 HD23 ' CE2' ' A' 1269 ' ' PHE . 10.4 mt -75.49 160.03 30.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.167 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1266 ' ' ASP . . . . . 0.439 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.9 t70 -79.33 144.14 61.52 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.554 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 -25.78 20.58 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.555 2.17 . . . . 0.0 112.627 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.471 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 63.1 mt -101.94 -2.65 29.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 38.8 t80 -47.57 -55.09 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.47 -45.31 66.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.946 0.403 . . . . 0.0 110.905 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -67.32 -38.21 84.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.24 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.41 94.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.665 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.447 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 23.5 t -62.11 -47.87 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' 1278 ' ' GLU . 33.1 tt0 -63.55 -33.91 76.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.881 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1275 ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.14 -50.47 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.625 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.5 m -70.1 -37.59 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.471 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.529 ' HB ' ' N ' ' A' 1326 ' ' PRO . 55.0 p -70.09 -49.48 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.1 mt-10 -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.285 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -91.39 -7.18 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.9 mmm180 57.52 17.85 4.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -145.56 133.23 21.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.774 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.414 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.74 116.38 28.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 3.2 p -132.57 138.98 47.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.869 0.366 . . . . 0.0 111.22 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.517 HG22 ' CE1' ' A' 1295 ' ' TYR . 19.7 mt -67.24 -40.14 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 47.6 t -68.51 -41.52 79.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.51 -49.93 73.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.638 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' 1291 ' ' PHE . 12.0 t -65.92 -30.11 48.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.74 -51.16 70.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.124 0.488 . . . . 0.0 110.011 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -76.2 -37.07 58.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.162 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.04 -33.34 61.73 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.512 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.69 21.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.403 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 54.16 52.86 11.93 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.051 0.453 . . . . 0.0 110.226 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.455 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 19.8 pt -129.83 148.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.544 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.61 148.07 22.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.22 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.9 t80 -45.31 -50.23 12.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.4 p30 -50.84 -41.82 58.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.705 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.455 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.8 -49.68 69.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.253 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.482 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -53.98 -50.0 67.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.5 -29.83 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.189 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -50.55 51.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.144 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.439 HG12 ' CB ' ' A' 1266 ' ' ASP . 34.0 mt -60.43 -43.71 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.953 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' 1305 ' ' MET . 22.2 mt -68.63 -33.95 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.759 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -51.98 65.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.415 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.415 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 7.0 mt-30 -59.06 -36.11 74.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.462 ' C ' HG23 ' A' 1311 ' ' VAL . 14.3 mtm -58.37 -37.14 74.63 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.518 ' N ' HG23 ' A' 1311 ' ' VAL . 36.8 tt0 -69.7 -32.24 70.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.32 62.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.343 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.549 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.6 OUTLIER -89.62 -20.31 23.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.792 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.31 12.98 32.04 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.912 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.549 HG13 ' HB2' ' A' 1308 ' ' GLN . 10.4 mt -83.23 -35.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 122.618 0.367 . . . . 0.0 111.204 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' 1306 ' ' GLU . 27.5 m -122.38 154.47 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.449 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.469 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.6 OUTLIER -102.77 -177.85 3.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.615 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -65.78 135.45 54.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.509 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.68 133.45 49.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.255 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -119.25 -39.59 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.887 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.77 -157.98 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.51 91.78 7.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.32 . . . . 0.0 111.173 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.93 10.02 86.52 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.321 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -97.79 122.16 40.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 111.4 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.455 ' HD2' HG22 ' A' 1311 ' ' VAL . 0.2 OUTLIER -107.42 140.26 40.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.369 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' 1311 ' ' VAL . 5.8 tt0 -86.05 132.69 33.99 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.803 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.414 ' CG2' ' N ' ' A' 1282 ' ' ALA . 26.9 t -91.21 118.59 36.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.933 0.396 . . . . 0.0 110.106 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.469 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.0 -10.82 15.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.385 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -99.88 130.68 25.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.09 159.59 23.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 113.039 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.529 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.1 Cg_exo -51.67 163.74 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.903 2.402 . . . . 0.0 112.587 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.96 -35.51 11.92 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.715 2.277 . . . . 0.0 112.412 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -100.62 -51.03 3.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.898 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 2.6 m-70 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.862 0.363 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -155.35 -63.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.494 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -62.24 -28.4 69.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.353 . . . . 0.0 111.216 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -57.37 -28.53 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.89 -37.31 6.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.571 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.448 HD22 ' NE2' ' A' 1308 ' ' GLN . 7.5 mt -72.59 160.07 32.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.225 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.33 144.27 94.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.75 -24.83 13.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.191 1.927 . . . . 0.0 112.273 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 59.2 mt -102.16 -5.28 24.61 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 38.4 t80 -47.71 -53.39 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -52.6 -45.42 66.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.96 -37.95 82.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.634 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.29 -39.16 93.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.305 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.458 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 19.2 t -62.83 -49.18 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' 1278 ' ' GLU . 22.2 tt0 -62.79 -32.5 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.792 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.421 ' CE1' ' HE2' ' A' 1279 ' ' LYS . 2.7 t80 -67.95 -50.58 55.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.68 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.3 m -69.72 -38.01 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.54 ' HB ' ' N ' ' A' 1326 ' ' PRO . 57.6 p -69.73 -49.91 48.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.113 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.2 mt-10 -59.09 -36.95 76.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.999 0.428 . . . . 0.0 110.292 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1279 ' ' LYS . . . . . 0.421 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 4.0 mtmt -89.79 -9.52 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.008 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.1 mmm180 59.97 16.65 5.98 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.833 0.349 . . . . 0.0 110.478 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 3.8 mttp -145.55 134.43 22.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -115.18 116.61 28.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.802 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 3.2 p -132.55 139.72 47.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.275 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.535 HG23 ' CE1' ' A' 1295 ' ' TYR . 24.6 mt -68.56 -39.31 80.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.203 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.502 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 48.1 t -69.13 -42.45 75.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.29 69.22 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.569 -0.825 . . . . 0.0 111.583 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' 1291 ' ' PHE . 17.6 t -65.31 -30.34 49.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.597 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.27 -52.01 67.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 110.097 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -36.19 58.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.125 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -33.13 61.84 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.559 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.38 21.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.631 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 55.8 51.96 11.54 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.128 0.489 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.419 ' CG2' ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -128.7 147.77 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.85 150.23 18.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.024 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.593 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.34 -51.26 15.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.397 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 5.9 p30 -50.7 -40.07 53.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.56 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.419 ' NH1' ' CG2' ' A' 1293 ' ' ILE . 0.4 OUTLIER -64.98 -50.28 66.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.329 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.482 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.99 -49.93 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.32 -29.9 71.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.209 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -68.49 -50.48 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.99 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 40.7 mt -60.74 -46.41 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.774 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.439 HG22 ' HG3' ' A' 1320 ' ' ARG . 18.7 mt -66.17 -31.45 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.948 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -63.73 -52.26 61.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.524 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -59.22 -32.0 69.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.643 178.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.433 ' CB ' HG23 ' A' 1311 ' ' VAL . 12.7 mtm -62.63 -39.55 94.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.508 ' N ' HG23 ' A' 1311 ' ' VAL . 3.2 tt0 -67.38 -32.05 72.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.283 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.09 -42.05 63.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.248 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.478 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -76.21 -20.24 57.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.774 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.46 13.94 31.48 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.055 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.432 ' CD1' HG23 ' A' 1273 ' ' VAL . 10.4 mt -81.21 -36.79 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.806 0.442 . . . . 0.0 111.492 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.508 HG23 ' N ' ' A' 1306 ' ' GLU . 33.3 m -121.38 159.57 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.207 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.469 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.5 OUTLIER -103.84 -178.06 3.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.078 0.466 . . . . 0.0 111.732 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -65.88 135.91 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1314 ' ' GLN . . . . . 0.401 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 4.1 mt-30 -67.75 135.39 52.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.09 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -124.93 -44.27 0.28 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.855 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.17 -159.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.3 p30 -92.6 91.74 7.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 0.0 111.14 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.87 10.04 86.5 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.359 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -98.89 122.13 41.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.14 0.47 . . . . 0.0 111.597 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.439 ' HG3' HG22 ' A' 1302 ' ' ILE . 4.6 mmt180 -107.43 140.31 40.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.368 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' 1311 ' ' VAL . 18.0 tt0 -86.44 132.63 33.89 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.879 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 23.6 t -91.35 118.71 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.23 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.469 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.67 -12.79 15.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.326 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -97.3 131.61 27.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.338 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.55 159.3 22.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.418 2.079 . . . . 0.0 113.012 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.54 ' N ' ' HB ' ' A' 1277 ' ' THR . 71.0 Cg_exo -51.57 156.42 6.28 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.965 2.443 . . . . 0.0 112.712 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.36 -59.17 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.701 2.267 . . . . 0.0 112.516 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -108.77 52.1 0.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.903 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.913 0.387 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 171.82 -36.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -60.83 -28.32 68.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.734 0.302 . . . . 0.0 111.173 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.36 -31.22 65.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.52 -34.95 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.686 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt -68.96 160.09 31.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1266 ' ' ASP . . . . . 0.405 ' CB ' HG12 ' A' 1301 ' ' ILE . 18.6 t70 -72.95 142.39 82.88 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.154 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -51.23 -25.04 16.53 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.323 2.015 . . . . 0.0 112.49 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.518 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 41.9 mt -102.14 -3.63 27.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 43.6 t80 -47.79 -53.02 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -52.72 -44.06 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.044 0.45 . . . . 0.0 110.539 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -66.58 -40.49 88.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.145 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.593 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.97 -39.74 94.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.739 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' 1269 ' ' PHE . 16.2 t -61.4 -51.72 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' 1278 ' ' GLU . 19.9 tt0 -60.74 -32.04 71.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.857 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.451 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -67.29 -52.14 44.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.8 m -69.17 -35.31 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.491 ' HB ' ' N ' ' A' 1326 ' ' PRO . 69.3 p -72.19 -49.06 38.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.2 mt-10 -60.35 -35.3 75.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.192 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.7 -5.12 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.939 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.6 mmm180 53.63 20.69 2.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.882 0.373 . . . . 0.0 110.649 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -145.61 129.87 17.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.636 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.411 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -111.98 116.47 30.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.742 0.306 . . . . 0.0 110.631 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 11.3 t -132.46 139.86 48.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.267 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.515 HG22 ' CE1' ' A' 1295 ' ' TYR . 16.4 mt -68.63 -40.75 82.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.272 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.505 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 28.6 t -67.82 -41.87 82.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.28 -49.94 73.03 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.823 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' 1291 ' ' PHE . 12.7 t -65.99 -29.79 47.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 17.4 mt-30 -60.76 -52.66 64.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.126 0.489 . . . . 0.0 109.867 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -76.27 -34.87 59.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.961 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.51 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.5 OUTLIER -73.8 -37.01 65.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.762 0.315 . . . . 0.0 111.508 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 1.8 m-85 -103.19 -5.15 23.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.839 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 55.02 8.49 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 148.53 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.384 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -53.76 149.81 14.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.125 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.4 t80 -47.09 -51.94 16.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 111.507 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -38.35 46.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.588 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -49.33 65.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.249 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.477 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -54.64 -49.86 69.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.563 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.36 -29.86 71.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -51.4 48.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.012 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.405 HG12 ' CB ' ' A' 1266 ' ' ASP . 41.8 mt -60.01 -45.21 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.83 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' 1305 ' ' MET . 21.5 mt -66.27 -32.56 58.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -50.23 67.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.588 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.5 mt-30 -57.16 -34.49 68.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.242 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.505 ' C ' HG23 ' A' 1311 ' ' VAL . 16.0 mtm -63.33 -39.15 93.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.27 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' 1311 ' ' VAL . 1.9 tt0 -66.41 -31.67 72.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.591 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.48 44.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.23 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.43 ' NE2' ' CD2' ' A' 1265 ' ' LEU . 0.8 OUTLIER -75.39 -20.21 59.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.756 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 99.8 16.07 29.64 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.001 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' 1305 ' ' MET . 9.6 mt -84.03 -36.8 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 122.566 0.346 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' 1306 ' ' GLU . 27.1 m -119.93 161.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.341 . . . . 0.0 111.211 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.482 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.01 178.18 4.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.371 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.87 132.53 48.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.54 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -67.84 130.98 44.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.292 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -118.25 -40.32 0.69 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.873 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.03 -156.66 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -96.29 91.88 6.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 111.219 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.9 10.09 86.47 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.456 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -98.08 122.11 40.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.227 0.513 . . . . 0.0 111.292 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.469 ' HD2' HG22 ' A' 1311 ' ' VAL . 0.0 OUTLIER -107.56 140.28 40.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.475 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' 1311 ' ' VAL . 47.0 tt0 -89.66 132.68 35.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.819 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' A' 1282 ' ' ALA . 22.0 t -92.29 118.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.29 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.482 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.39 -13.06 15.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1324 ' ' ALA . . . . . 0.401 ' HB1' ' CG2' ' A' 1310 ' ' ILE . . . -95.39 129.37 35.22 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -80.96 159.11 20.97 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.491 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.6 Cg_exo -52.34 164.37 1.33 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.977 2.452 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.56 -33.11 87.87 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.655 2.236 . . . . 0.0 112.302 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.07 33.05 3.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.871 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 34.1 m170 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.84 0.353 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -166.2 111.88 0.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.345 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -60.87 -25.23 66.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.73 0.3 . . . . 0.0 111.245 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -55.68 -35.11 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.118 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.6 -27.46 8.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.11 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.425 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 11.3 mt -92.24 160.01 15.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.076 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.06 145.8 44.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.229 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.62 -23.54 20.09 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.286 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 58.0 mt -102.04 -3.39 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.852 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.48 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 42.5 t80 -47.6 -56.62 6.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -39.06 60.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.952 0.406 . . . . 0.0 110.368 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -68.45 -42.51 78.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.02 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.593 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.82 -40.97 96.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.48 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 53.8 t -61.36 -47.85 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.441 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -64.17 -33.29 75.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.898 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.438 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.58 -50.42 63.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.59 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.7 m -69.59 -38.22 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.275 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.511 ' HB ' ' N ' ' A' 1326 ' ' PRO . 42.6 p -69.04 -48.93 61.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.155 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.39 -37.17 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.433 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -92.37 -5.56 51.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.108 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' 1276 ' ' VAL . 9.0 mmm180 57.34 17.63 3.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 19.7 mttm -145.45 134.17 22.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.58 116.56 28.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.895 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.59 138.56 47.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.896 0.379 . . . . 0.0 111.257 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.538 HG23 ' CE1' ' A' 1295 ' ' TYR . 32.1 mt -67.81 -38.07 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.493 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.1 t -69.24 -44.3 72.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.049 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.55 -49.22 80.86 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.687 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' 1291 ' ' PHE . 14.8 t -65.36 -31.38 53.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.611 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -59.48 -52.16 66.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 109.991 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -76.2 -35.8 58.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.283 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.408 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.96 -33.83 61.97 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.599 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.3 -7.26 21.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.657 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 56.18 53.33 9.1 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 110.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.417 ' CG2' ' NH1' ' A' 1297 ' ' ARG . 13.3 pt -129.82 147.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.246 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.88 150.43 18.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.966 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.592 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.38 -51.24 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.424 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -39.84 53.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.614 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.417 ' NH1' ' CG2' ' A' 1293 ' ' ILE . 0.3 OUTLIER -65.61 -49.62 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.346 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -54.0 -48.79 70.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.501 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.73 70.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.136 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -68.74 -50.77 47.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 38.9 mt -60.18 -43.62 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.912 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.4 mt -69.09 -32.63 54.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.57 -50.92 70.67 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.418 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 0.0 OUTLIER -61.13 -35.72 77.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.249 178.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' 1302 ' ' ILE . 11.3 mtm -57.0 -38.19 72.73 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.492 ' N ' HG21 ' A' 1311 ' ' VAL . 3.0 tm-20 -69.63 -32.92 71.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.355 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.19 -28.78 61.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.692 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.532 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -91.43 -20.32 21.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.94 15.94 24.98 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.992 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' 1308 ' ' GLN . 12.8 mt -85.31 -36.63 11.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.802 0.441 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.492 HG21 ' N ' ' A' 1306 ' ' GLU . 30.2 m -121.23 158.31 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.475 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.1 OUTLIER -105.3 -178.56 3.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.031 0.443 . . . . 0.0 111.618 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.82 135.82 55.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.656 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -67.74 133.24 48.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.085 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -123.16 -42.34 0.4 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.793 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.56 -157.02 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -95.64 91.76 6.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 111.154 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.85 10.08 86.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.292 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -100.17 122.3 42.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 111.598 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.411 ' HG3' HG22 ' A' 1302 ' ' ILE . 6.0 mmt180 -107.07 140.32 40.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.281 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' 1311 ' ' VAL . 2.0 tt0 -86.29 132.68 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.836 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' 1282 ' ' ALA . 25.4 t -91.66 118.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 110.243 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.475 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.32 -7.87 16.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.272 -179.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -102.58 130.44 23.96 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.406 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.3 159.37 20.07 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.485 2.123 . . . . 0.0 112.947 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.511 ' N ' ' HB ' ' A' 1277 ' ' THR . 55.6 Cg_exo -52.19 164.35 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.908 2.406 . . . . 0.0 112.507 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.5 -35.89 7.46 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.64 2.226 . . . . 0.0 112.239 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -137.14 -65.21 0.55 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.824 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.844 0.354 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 140.6 73.06 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -59.88 -24.31 64.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.33 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -54.87 -35.73 64.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.105 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.52 -31.09 6.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' 1269 ' ' PHE . 10.7 mt -78.18 160.06 28.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.06 144.9 45.16 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.095 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.52 -24.24 16.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.231 1.954 . . . . 0.0 112.485 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.503 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 57.9 mt -102.11 -4.38 26.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.504 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 44.9 t80 -47.48 -54.99 10.0 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -40.01 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -69.07 -42.22 76.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.14 -39.68 95.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.504 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 42.5 t -61.99 -49.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.39 -30.54 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.854 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.451 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -68.6 -51.68 39.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.2 m -69.04 -37.43 77.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.498 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.488 ' HB ' ' N ' ' A' 1326 ' ' PRO . 48.2 p -69.67 -49.69 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.28 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.1 mt-10 -60.29 -35.57 75.87 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.936 0.398 . . . . 0.0 110.399 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -93.03 -5.16 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.092 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 18.4 mmm180 55.5 18.73 2.82 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.812 0.339 . . . . 0.0 110.81 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.1 mttt -145.64 131.18 18.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -112.88 116.37 29.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.683 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 1.8 p -132.49 142.47 49.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.209 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.42 HG23 ' CE1' ' A' 1295 ' ' TYR . 46.2 mt -71.02 -42.32 76.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.275 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 9.2 t -67.71 -40.58 84.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -61.07 -51.16 60.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.715 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' 1291 ' ' PHE . 23.9 t -64.38 -29.77 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.292 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' 1293 ' ' ILE . 16.1 tt0 -60.19 -54.41 46.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 110.203 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -31.66 58.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.76 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.459 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 4.5 tp60 -75.03 -36.36 61.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.721 0.296 . . . . 0.0 111.544 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.29 -6.3 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.934 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 57.7 52.62 8.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.032 0.444 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' A' 1288 ' ' GLN . 12.8 pt -130.21 149.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.061 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.72 148.57 26.75 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.146 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.42 ' CE1' HG23 ' A' 1284 ' ' ILE . 80.6 t80 -46.5 -51.62 14.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.454 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.78 -40.14 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.152 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -48.87 69.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1298 ' ' ALA . . . . . . . . . . . . . . . -54.03 -47.95 71.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.504 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1299 ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' 1284 ' ' ILE . . . -65.2 -29.89 70.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.018 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -67.57 -49.01 65.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.141 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 38.4 mt -61.26 -46.72 96.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.949 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1302 ' ' ILE . . . . . . . . . . . . . 11.1 mt -65.54 -34.46 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.887 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -48.89 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.426 ' CB ' ' CE2' ' A' 1269 ' ' PHE . 16.8 mt-30 -61.81 -35.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.231 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.442 ' HB3' ' CG1' ' A' 1311 ' ' VAL . 0.3 OUTLIER -56.95 -38.83 73.49 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.498 ' N ' HG21 ' A' 1311 ' ' VAL . 1.4 tm-20 -70.48 -33.34 71.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.4 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.39 63.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.585 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.553 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.6 OUTLIER -90.81 -20.35 22.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.877 -178.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.88 16.34 26.25 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.817 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' 1308 ' ' GLN . 13.4 mt -84.47 -34.76 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.271 -0.464 . . . . 0.0 111.04 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' 1306 ' ' GLU . 27.8 m -120.21 159.87 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.481 ' CA ' HD13 ' A' 1323 ' ' LEU . 1.4 p -100.75 -178.65 3.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 111.307 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -65.84 133.14 50.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.437 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -67.76 132.58 47.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.107 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -125.1 -43.81 0.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.764 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.1 t60 -80.35 -154.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.48 91.69 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 111.21 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.95 10.12 86.44 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.504 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -103.68 122.02 44.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.202 0.501 . . . . 0.0 111.432 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.408 ' CD ' HG22 ' A' 1311 ' ' VAL . 1.4 mtt-85 -107.48 140.41 40.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.428 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' 1311 ' ' VAL . 20.5 tp10 -84.11 132.76 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.547 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' 1282 ' ' ALA . 22.0 t -90.4 118.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.98 0.419 . . . . 0.0 110.467 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.481 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.53 -12.22 15.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.214 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -96.65 131.64 27.78 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.233 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.21 158.12 17.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.464 2.109 . . . . 0.0 113.302 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.488 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -52.81 164.3 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.076 2.517 . . . . 0.0 112.669 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1327 ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' 1328 ' ' PHE . 60.9 Cg_endo -83.8 -151.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.009 2.472 . . . . 0.0 111.846 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1328 ' ' PHE . . . . . 0.419 ' H ' ' HB2' ' A' 1327 ' ' PRO . 24.4 m-85 -61.2 -33.46 73.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.881 0.372 . . . . 0.0 110.937 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.901 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.771 0.319 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 88.41 -124.43 7.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.19 68.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.35 -29.41 63.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.026 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.38 -34.92 6.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.718 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.436 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 10.5 mt -85.64 160.02 19.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.083 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.56 142.86 86.8 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.979 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.73 -24.87 13.97 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.319 2.013 . . . . 0.0 112.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.5 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 61.7 mt -102.14 -5.03 24.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 40.8 t80 -47.57 -53.49 14.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.8 -42.5 65.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.057 0.455 . . . . 0.0 110.396 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -66.75 -42.42 86.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.141 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.599 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.25 -39.3 94.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.79 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.473 HG23 ' CE1' ' A' 1269 ' ' PHE . 18.9 t -61.81 -50.61 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -62.24 -32.51 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.443 ' CD2' ' CE1' ' A' 1291 ' ' PHE . 2.4 t80 -67.17 -50.76 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.669 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.9 m -70.22 -36.78 69.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.345 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.535 ' HB ' ' N ' ' A' 1326 ' ' PRO . 50.7 p -71.23 -48.37 51.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.319 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' 1274 ' ' GLN . 34.1 mt-10 -61.36 -35.61 77.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -93.76 -4.11 50.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.989 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' 1276 ' ' VAL . 16.0 mmm180 53.95 19.5 2.02 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.55 132.51 20.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.412 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -115.15 116.4 28.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.922 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 7.5 p -132.65 140.47 48.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.11 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CE1' ' A' 1295 ' ' TYR . 22.1 mt -68.79 -40.64 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.28 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 42.1 t -67.58 -42.31 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.05 -49.25 80.63 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.777 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' 1291 ' ' PHE . 14.6 t -65.91 -30.41 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.718 0.294 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.61 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.3 mt-30 -60.73 -51.05 70.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.179 0.514 . . . . 0.0 110.001 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -76.34 -36.68 58.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.169 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.416 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.9 OUTLIER -75.02 -34.34 61.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.612 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.599 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.0 m-85 -103.27 -6.54 21.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.602 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 54.92 54.85 8.47 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 12.9 pt -131.17 147.8 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.434 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.28 148.43 25.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.06 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.61 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 90.2 t80 -45.69 -50.75 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.547 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.73 -41.53 56.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -50.05 68.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.316 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -54.01 -49.97 67.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.48 -29.76 70.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.121 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.36 -50.59 52.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.92 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 43.2 mt -59.87 -46.56 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.757 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.5 mt -65.84 -31.98 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.4 -52.12 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.55 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -58.25 -31.95 67.89 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.614 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' 1302 ' ' ILE . 12.2 mtm -62.49 -39.68 94.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' 1311 ' ' VAL . 3.2 tt0 -66.79 -31.95 72.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.583 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -75.18 -41.98 56.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.472 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.462 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -75.86 -20.32 58.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.883 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.13 16.87 26.57 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.003 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.428 ' CD1' HG23 ' A' 1273 ' ' VAL . 12.2 mt -83.48 -39.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.831 0.452 . . . . 0.0 111.167 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' 1306 ' ' GLU . 35.6 m -118.87 160.39 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.028 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.508 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.7 OUTLIER -95.34 178.59 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 111.442 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.89 134.76 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.416 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 141.12 56.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.056 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -146.71 -46.8 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.746 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.36 -157.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 4.4 p30 -104.96 91.7 3.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 111.174 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.72 10.14 86.43 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.495 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -110.69 122.01 46.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.313 0.557 . . . . 0.0 111.847 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.5 140.43 40.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.234 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.4 tp10 -84.61 132.71 34.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.092 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' 1282 ' ' ALA . 25.2 t -92.47 118.73 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.276 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.508 HD13 ' CA ' ' A' 1312 ' ' SER . 0.3 OUTLIER -109.01 -15.56 14.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.286 -179.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -93.18 131.38 33.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.299 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.5 159.29 22.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.432 2.088 . . . . 0.0 113.01 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.535 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.55 164.39 0.91 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.922 2.415 . . . . 0.0 112.69 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.76 -35.07 16.98 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.705 2.27 . . . . 0.0 112.34 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -98.25 36.69 1.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.934 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.871 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 15.0 m80 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.815 0.341 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -123.47 37.95 2.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.554 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -58.14 -22.01 49.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.693 0.283 . . . . 0.0 111.276 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -54.82 -36.7 65.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.92 -38.33 3.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.805 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.445 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 9.9 mt -72.74 160.02 32.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.125 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1266 ' ' ASP . . . . . 0.443 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -81.33 143.74 52.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.491 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.63 -26.37 22.57 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.398 2.065 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 44.8 mt -102.03 -0.59 33.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.873 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.519 ' CE1' HG22 ' A' 1273 ' ' VAL . 41.2 t80 -47.65 -57.02 6.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -41.75 63.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.934 0.397 . . . . 0.0 110.417 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -43.07 88.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.264 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.608 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.89 -41.78 95.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.327 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.519 HG22 ' CE1' ' A' 1269 ' ' PHE . 98.8 t -60.67 -47.76 91.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.4 ' HA ' ' OG1' ' A' 1277 ' ' THR . 33.1 tt0 -64.37 -32.49 74.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.764 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.429 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.75 -50.32 63.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.2 m -68.7 -37.62 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.257 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.483 ' HB ' ' N ' ' A' 1326 ' ' PRO . 53.9 p -70.17 -49.21 52.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.241 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.36 -35.64 74.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.349 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1279 ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 1.5 mtmt -93.03 -7.68 45.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.035 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 2.5 mmm180 57.99 17.72 4.59 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.815 0.341 . . . . 0.0 110.602 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -145.54 133.25 21.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.409 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.76 116.54 28.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.676 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 13.2 p -132.42 138.08 47.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 111.265 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' 1295 ' ' TYR . 23.3 mt -66.01 -42.86 92.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.394 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 1.1 t -68.65 -37.99 80.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.805 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.49 -51.05 59.02 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.74 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.2 t -65.57 -29.73 47.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-O 120.904 0.383 . . . . 0.0 110.37 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' 1293 ' ' ILE . 16.1 tt0 -60.47 -55.13 37.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.184 0.516 . . . . 0.0 110.281 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -76.12 -30.37 58.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.553 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -75.06 -36.62 61.78 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.77 0.319 . . . . 0.0 111.531 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.608 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.23 -6.08 22.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 27.8 mtm105 58.46 48.4 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.041 0.448 . . . . 0.0 110.549 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.43 ' HB ' ' HD2' ' A' 1297 ' ' ARG . 14.9 pt -125.5 158.39 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.184 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -64.31 148.13 50.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.186 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.436 ' CE1' HG22 ' A' 1284 ' ' ILE . 91.2 t80 -45.66 -51.16 12.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.697 0.284 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.65 -41.94 55.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.967 0.413 . . . . 0.0 110.066 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.59 -49.79 69.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.161 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1298 ' ' ALA . . . . . . . . . . . . . . . -53.78 -49.39 68.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1299 ' ' ALA . . . . . 0.409 ' N ' HG21 ' A' 1284 ' ' ILE . . . -63.87 -29.9 71.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.113 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -50.56 50.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.245 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' 1297 ' ' ARG . 20.8 mt -59.45 -42.46 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.838 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' 1305 ' ' MET . 22.2 mt -69.26 -34.5 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.716 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -51.61 67.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.364 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.408 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 21.8 mt-30 -59.32 -36.86 76.44 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.359 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.473 ' C ' HG23 ' A' 1311 ' ' VAL . 18.9 mtm -57.12 -38.52 73.56 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.542 ' N ' HG23 ' A' 1311 ' ' VAL . 18.1 tt0 -69.44 -33.03 72.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.394 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.72 62.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.47 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.542 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.7 OUTLIER -90.73 -20.39 22.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.807 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.13 13.33 29.24 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.933 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.542 HG13 ' HB2' ' A' 1308 ' ' GLN . 11.8 mt -82.9 -37.84 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.053 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' 1306 ' ' GLU . 27.1 m -120.54 158.13 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.218 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.485 ' CA ' HD13 ' A' 1323 ' ' LEU . 1.2 p -101.22 -179.46 4.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.122 0.487 . . . . 0.0 111.686 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.87 134.72 53.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.501 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1314 ' ' GLN . . . . . 0.4 ' HG3' ' NH1' ' A' 1320 ' ' ARG . 0.0 OUTLIER -67.78 141.4 56.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.067 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -131.62 -45.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.899 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.4 -156.0 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.94 91.91 5.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.864 0.364 . . . . 0.0 111.323 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 78.48 10.1 86.48 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.693 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -100.41 121.99 42.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.325 0.563 . . . . 0.0 111.491 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.466 ' HD2' HG22 ' A' 1311 ' ' VAL . 0.0 OUTLIER -107.41 140.37 40.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.388 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' 1311 ' ' VAL . 17.9 tt0 -87.06 132.7 33.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.978 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' 1282 ' ' ALA . 22.7 t -92.66 118.73 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.485 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.25 -11.47 15.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.227 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -97.87 131.56 26.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.238 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.07 159.15 15.51 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.542 2.162 . . . . 0.0 112.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.483 ' N ' ' HB ' ' A' 1277 ' ' THR . 52.1 Cg_exo -52.78 164.39 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.912 2.408 . . . . 0.0 112.469 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.46 -35.83 7.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.582 2.188 . . . . 0.0 112.295 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -137.26 34.07 2.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.85 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 42.9 m170 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.782 0.325 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -148.92 61.42 0.43 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.417 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.17 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.751 0.31 . . . . 0.0 111.175 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -57.74 -27.24 62.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.61 -38.11 5.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.941 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.429 HD22 ' NE2' ' A' 1308 ' ' GLN . 1.8 mt -80.22 160.02 25.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.86 144.12 32.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.51 -23.67 19.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.323 2.015 . . . . 0.0 112.368 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 62.3 mt -102.06 -3.81 27.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.921 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 43.7 t80 -47.51 -55.51 8.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 37.8 t0 -52.49 -41.59 63.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.37 -43.32 86.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.314 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.606 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.1 -41.04 97.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.251 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.539 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 99.0 t -61.08 -47.89 91.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.58 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.639 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.419 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.4 -51.23 59.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.654 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' 1280 ' ' ARG . 32.5 m -68.47 -36.7 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.482 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.503 ' HB ' ' N ' ' A' 1326 ' ' PRO . 45.6 p -70.6 -49.92 42.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.37 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.0 mt-10 -60.14 -33.93 72.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.369 . . . . 0.0 110.354 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -95.22 -5.58 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.018 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 55.99 18.52 3.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.839 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.53 132.51 20.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.788 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -114.62 116.29 28.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.823 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 1.9 t -132.63 138.26 47.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CE1' ' A' 1295 ' ' TYR . 26.1 mt -66.49 -38.88 82.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.046 0.451 . . . . 0.0 110.117 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.486 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 27.5 t -69.68 -40.75 76.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.829 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -61.51 -48.43 84.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.529 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' 1291 ' ' PHE . 15.1 t -67.16 -29.66 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 120.745 0.307 . . . . 0.0 110.709 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -61.34 -54.49 43.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.186 0.517 . . . . 0.0 110.093 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -30.84 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.531 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -74.93 -38.11 61.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.23 -4.51 24.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.804 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 55.47 54.99 7.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.045 0.45 . . . . 0.0 110.485 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.413 ' CB ' ' HD2' ' A' 1297 ' ' ARG . 10.2 pt -131.49 157.59 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.476 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -63.5 148.2 50.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.981 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.2 t80 -45.41 -51.52 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.551 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -40.63 55.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.676 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.551 ' HD3' HD13 ' A' 1301 ' ' ILE . 0.0 OUTLIER -66.44 -48.2 70.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.477 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.9 -49.63 68.16 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.019 0.438 . . . . 0.0 110.649 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.88 71.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.067 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -68.05 -50.22 56.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.039 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.551 HD13 ' HD3' ' A' 1297 ' ' ARG . 33.9 mt -60.68 -45.83 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' 1305 ' ' MET . 20.8 mt -66.56 -32.16 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.843 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -52.1 63.6 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.573 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.4 OUTLIER -58.73 -33.02 69.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.711 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' 1302 ' ' ILE . 14.0 mtm -60.98 -40.87 95.08 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.539 ' N ' HG21 ' A' 1311 ' ' VAL . 1.4 tt0 -66.16 -33.23 75.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.827 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.466 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.489 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -75.51 -20.37 58.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.783 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.19 15.88 26.82 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.046 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.448 HD11 ' HG2' ' A' 1305 ' ' MET . 13.2 mt -82.71 -38.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.817 0.447 . . . . 0.0 111.317 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.539 HG21 ' N ' ' A' 1306 ' ' GLU . 34.8 m -120.67 164.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.485 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -105.96 -178.12 3.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.069 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -65.89 131.79 47.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -67.85 130.98 44.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.168 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -117.86 -46.77 0.46 Allowed Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.877 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -161.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.4 p30 -90.62 91.63 8.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.76 10.13 86.44 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.354 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -101.26 122.1 43.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.146 0.473 . . . . 0.0 111.63 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.442 ' HG3' HG22 ' A' 1302 ' ' ILE . 3.4 mtt180 -107.45 140.31 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.346 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1311 ' ' VAL . 53.5 tt0 -81.9 132.8 35.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.647 0.26 . . . . 0.0 111.067 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 21.5 t -90.26 118.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.141 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.485 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.25 -18.83 13.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.154 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -90.89 131.54 37.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.109 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.59 159.36 19.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.453 2.102 . . . . 0.0 113.026 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 60.2 Cg_exo -51.6 158.01 4.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.005 2.47 . . . . 0.0 112.502 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.86 -36.44 3.59 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.643 2.228 . . . . 0.0 112.422 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -110.06 57.16 0.62 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.889 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 7.5 m80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.807 0.337 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -111.45 51.48 0.7 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.424 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -58.94 -30.68 68.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.215 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.78 -27.12 62.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.018 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -28.05 8.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 9.6 mt -87.2 160.01 18.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -87.98 145.07 35.66 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.426 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.21 -24.28 20.11 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.368 2.046 . . . . 0.0 112.505 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.488 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 40.8 mt -102.14 -1.76 30.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.896 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.1 t80 -47.69 -55.21 9.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.0 t0 -52.51 -44.35 65.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 0.0 110.893 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1271 ' ' GLN . . . . . 0.406 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 19.1 mt-30 -68.0 -37.93 82.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.076 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.63 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.9 95.2 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.661 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 26.9 t -61.78 -47.81 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' 1278 ' ' GLU . 14.5 tt0 -63.49 -33.28 75.22 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.752 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.407 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -66.58 -51.61 54.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.414 HG21 ' N ' ' A' 1277 ' ' THR . 32.7 m -68.9 -38.31 78.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.588 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.525 ' HB ' ' N ' ' A' 1326 ' ' PRO . 56.2 p -70.01 -48.42 58.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.12 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' 1274 ' ' GLN . 10.5 mm-40 -59.02 -37.16 76.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.369 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -92.81 -6.04 49.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.3 mmm180 57.64 17.48 4.06 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.783 0.325 . . . . 0.0 110.847 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.63 134.14 22.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.764 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.86 116.4 28.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.705 0.288 . . . . 0.0 110.704 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 2.4 p -132.57 143.16 49.52 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.9 0.381 . . . . 0.0 111.41 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' 1295 ' ' TYR . 50.0 mt -71.09 -39.51 74.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.11 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.44 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 38.6 t -66.77 -44.54 81.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.872 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1286 ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.57 -51.1 60.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.951 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' 1291 ' ' PHE . 16.5 t -65.03 -31.83 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.011 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.494 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 38.3 mt-30 -59.74 -51.77 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.069 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -76.24 -35.86 58.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.184 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' 1286 ' ' GLY . 0.1 OUTLIER -75.06 -33.37 61.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.497 -179.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.63 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.18 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.537 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 55.63 51.29 12.83 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.117 0.485 . . . . 0.0 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.417 ' CG2' ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -127.13 149.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.324 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.8 151.04 21.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.004 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.494 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 1.1 t80 -46.51 -54.59 8.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.716 0.293 . . . . 0.0 111.333 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.55 -36.55 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.417 ' NH1' ' CG2' ' A' 1293 ' ' ILE . 0.8 OUTLIER -65.69 -49.31 69.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.412 ' HB1' ' HG3' ' A' 1288 ' ' GLN . . . -54.01 -50.09 67.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.698 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.01 -29.77 71.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.19 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -68.8 -49.93 54.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.148 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' 1297 ' ' ARG . 26.6 mt -61.4 -44.43 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.853 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' 1305 ' ' MET . 25.0 mt -67.55 -33.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.81 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -52.06 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.284 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.436 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.2 mt-30 -58.83 -36.84 75.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.254 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.483 ' C ' HG23 ' A' 1311 ' ' VAL . 12.7 mtm -57.7 -37.79 74.11 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' 1311 ' ' VAL . 7.1 tt0 -69.4 -32.69 71.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.146 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.76 -30.43 62.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.376 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.544 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -88.52 -20.28 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.8 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.46 13.78 29.6 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.983 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.544 HG13 ' HB2' ' A' 1308 ' ' GLN . 10.5 mt -83.99 -36.23 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.673 0.389 . . . . 0.0 111.319 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' 1306 ' ' GLU . 27.2 m -121.05 152.66 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.412 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.47 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.6 OUTLIER -97.27 -177.93 4.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.422 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -65.84 133.17 50.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.431 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.78 132.42 47.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.183 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -127.04 -44.08 0.24 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.97 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.4 t60 -76.98 -154.7 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.56 91.88 4.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.369 . . . . 0.0 111.16 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.9 10.2 86.39 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.265 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -107.78 122.13 46.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.067 0.433 . . . . 0.0 111.458 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.458 ' HD2' HG22 ' A' 1311 ' ' VAL . 0.3 OUTLIER -107.4 140.42 40.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' 1311 ' ' VAL . 36.3 tt0 -80.46 132.67 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.17 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' 1282 ' ' ALA . 31.3 t -91.81 118.71 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.47 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.95 -8.48 15.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.338 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -100.27 129.87 27.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.244 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.04 159.15 23.89 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.505 2.137 . . . . 0.0 113.029 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.525 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.7 Cg_exo -51.64 159.66 3.24 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.894 2.396 . . . . 0.0 112.503 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.86 -73.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.61 2.207 . . . . 0.0 112.306 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -123.46 71.61 1.09 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 5.0 p-80 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.852 0.358 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 146.56 87.78 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.55 63.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.247 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -57.75 -29.18 64.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.968 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.71 -39.09 4.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.872 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 9.2 mt -82.98 160.0 22.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1266 ' ' ASP . . . . . 0.401 ' CB ' HG12 ' A' 1301 ' ' ILE . 20.6 t70 -86.56 144.8 38.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.48 -24.55 22.37 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.463 2.109 . . . . 0.0 112.497 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.452 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 44.2 mt -101.95 -1.36 32.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.506 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 42.7 t80 -47.6 -56.27 7.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -52.39 -42.44 64.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -69.85 -37.14 76.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.183 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -67.0 -40.42 87.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.753 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.506 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 57.5 t -62.52 -47.37 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.452 ' HA ' ' OG1' ' A' 1277 ' ' THR . 50.7 tt0 -64.04 -32.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.677 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.418 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.98 -51.1 59.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.478 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.3 m -68.3 -38.18 79.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.247 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.514 ' HB ' ' N ' ' A' 1326 ' ' PRO . 43.5 p -69.46 -49.28 56.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.249 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.4 mm-40 -59.89 -35.79 75.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.988 0.423 . . . . 0.0 110.411 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -6.18 48.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.025 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 19.9 mmm180 55.95 18.93 3.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.812 0.339 . . . . 0.0 110.553 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1281 ' ' LYS . . . . . 0.402 ' HA ' HG22 ' A' 1322 ' ' VAL . 0.0 OUTLIER -145.56 131.29 18.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.643 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -113.55 116.41 29.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.633 0.254 . . . . 0.0 110.62 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 25.5 t -132.47 135.23 45.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.434 HG22 ' CE1' ' A' 1295 ' ' TYR . 36.8 mt -64.51 -41.54 92.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.199 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 31.6 t -70.19 -38.53 75.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.664 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.58 -49.43 73.53 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.479 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.8 t -66.63 -29.67 47.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.315 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1288 ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.95 -55.67 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.163 0.506 . . . . 0.0 110.321 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -28.81 57.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -75.06 -37.29 61.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.367 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.17 -5.23 23.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.727 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 57.9 49.09 12.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.492 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' 1297 ' ' ARG . 11.2 pt -124.86 163.97 24.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.068 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -70.58 147.98 44.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.623 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.434 ' CE1' HG22 ' A' 1284 ' ' ILE . 91.2 t80 -45.6 -50.52 13.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.76 -41.91 57.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.598 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.539 ' HD3' HD13 ' A' 1301 ' ' ILE . 0.0 OUTLIER -67.16 -47.43 71.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.17 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.4 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -53.91 -49.13 69.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.956 0.408 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1299 ' ' ALA . . . . . 0.418 ' N ' HG21 ' A' 1284 ' ' ILE . . . -64.82 -29.72 70.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.807 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -51.28 59.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.313 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.539 HD13 ' HD3' ' A' 1297 ' ' ARG . 25.6 mt -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.053 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' 1305 ' ' MET . 22.0 mt -67.93 -33.79 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.733 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.03 -51.38 69.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.427 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 11.3 mt-30 -59.66 -36.51 76.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.281 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' 1302 ' ' ILE . 15.1 mtm -57.45 -37.64 73.16 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.475 ' N ' HG21 ' A' 1311 ' ' VAL . 5.4 tt0 -69.55 -32.88 71.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.55 61.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.69 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.528 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -89.2 -20.44 24.18 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.43 17.09 22.93 Favored Glycine 0 C--N 1.328 0.131 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.949 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.528 HG13 ' HB2' ' A' 1308 ' ' GLN . 13.8 mt -86.25 -36.22 10.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 122.811 0.444 . . . . 0.0 111.265 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.475 HG21 ' N ' ' A' 1306 ' ' GLU . 32.6 m -120.63 164.01 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.492 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.68 -177.96 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.131 0.491 . . . . 0.0 111.708 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -65.82 136.24 55.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.59 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1314 ' ' GLN . . . . . 0.404 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 32.4 mt-30 -67.67 133.62 49.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.138 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -121.48 -46.99 0.3 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.908 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -84.73 -156.36 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.2 p30 -93.88 91.68 7.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.772 0.32 . . . . 0.0 111.243 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.96 10.08 86.48 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.479 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -98.6 122.06 41.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.201 0.501 . . . . 0.0 111.454 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.437 ' HG3' HG22 ' A' 1302 ' ' ILE . 2.5 mmt180 -107.46 140.37 40.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.595 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.9 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.711 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' 1281 ' ' LYS . 20.3 t -90.28 118.68 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 0.0 110.29 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.492 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.77 -6.49 16.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.484 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -105.46 132.47 20.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.413 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.26 159.35 20.17 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.433 2.089 . . . . 0.0 112.924 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.514 ' N ' ' HB ' ' A' 1277 ' ' THR . 65.1 Cg_exo -51.69 157.39 5.43 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.944 2.429 . . . . 0.0 112.6 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.37 -36.91 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.79 30.97 6.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.796 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 5.2 m80 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.829 0.347 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 86.51 46.97 5.04 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.17 67.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.361 . . . . 0.0 111.062 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -67.89 -21.54 65.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.074 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.21 -31.04 8.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.8 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 9.8 mt -77.51 160.02 28.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.28 144.4 46.67 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.325 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.29 -24.4 20.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.472 2.115 . . . . 0.0 112.556 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.506 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 41.4 mt -102.04 -1.73 31.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.95 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.5 t80 -47.54 -55.46 9.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.52 -41.35 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.995 0.426 . . . . 0.0 110.391 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1271 ' ' GLN . . . . . 0.514 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 0.0 OUTLIER -66.67 -43.48 84.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.013 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.41 -40.26 96.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.454 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 25.3 t -61.75 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' 1278 ' ' GLU . 23.1 tt0 -64.17 -32.23 73.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.705 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.465 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.46 -51.42 57.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.454 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.416 HG21 ' N ' ' A' 1277 ' ' THR . 33.8 m -69.05 -39.93 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.623 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.521 ' HB ' ' N ' ' A' 1326 ' ' PRO . 76.2 p -67.74 -49.86 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.365 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.2 mt-10 -59.91 -36.63 77.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.964 0.411 . . . . 0.0 110.479 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.22 -6.25 53.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.016 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.1 mmm180 57.35 17.51 3.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.813 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.6 mttt -145.66 134.28 22.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.749 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -114.59 116.39 28.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.679 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 5.0 p -132.54 140.76 48.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.137 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.514 HG23 ' CE1' ' A' 1295 ' ' TYR . 21.9 mt -69.55 -40.79 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.313 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 37.1 t -66.91 -43.78 82.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.116 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.3 -49.53 77.49 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.793 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' 1291 ' ' PHE . 15.9 t -65.12 -30.71 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.649 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 13.0 mt-30 -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.217 0.532 . . . . 0.0 109.978 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -35.8 58.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.186 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.421 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.1 tp60 -75.01 -34.91 61.98 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.612 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.0 m-85 -103.2 -6.66 21.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.606 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 55.6 55.15 7.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.039 0.447 . . . . 0.0 110.458 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.88 147.87 32.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.49 147.93 22.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.182 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.3 t80 -45.3 -50.24 12.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 111.446 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.78 -42.6 58.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -49.23 72.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.471 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.9 -50.12 67.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.07 -29.69 71.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.063 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -68.08 -51.08 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.208 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.53 -43.38 90.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.037 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.9 mt -68.98 -33.63 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.915 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.14 -52.05 65.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.236 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.431 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 25.4 mt-30 -59.41 -36.92 76.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.226 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.428 ' CB ' HG23 ' A' 1311 ' ' VAL . 13.5 mtm -57.35 -37.81 73.15 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' 1311 ' ' VAL . 3.1 tt0 -69.39 -33.07 72.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.01 -29.75 63.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.261 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.545 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -89.25 -20.29 24.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.782 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.77 12.74 31.61 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.949 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' 1308 ' ' GLN . 10.4 mt -83.07 -36.19 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.654 0.382 . . . . 0.0 111.341 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' 1306 ' ' GLU . 35.4 m -122.75 155.11 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.378 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.455 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -102.53 -177.97 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.188 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.82 132.17 48.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.343 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -67.91 130.93 44.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.326 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -116.96 -40.45 0.76 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.884 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.47 -165.3 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.6 p30 -86.92 91.77 8.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.054 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.83 10.06 86.49 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.21 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -98.91 122.04 41.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.076 0.438 . . . . 0.0 111.543 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1320 ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -107.48 140.32 40.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.6 132.66 34.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.889 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' 1282 ' ' ALA . 31.8 t -92.24 118.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.455 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -108.51 -4.76 16.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.381 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1324 ' ' ALA . . . . . 0.405 ' HB3' ' CG2' ' A' 1310 ' ' ILE . . . -105.24 130.66 22.73 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.395 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.59 158.74 22.1 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.563 2.175 . . . . 0.0 113.153 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.521 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.8 Cg_exo -52.2 163.19 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.044 2.496 . . . . 0.0 112.712 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.99 -37.03 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -130.17 -45.52 1.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.001 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 39.1 t70 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.936 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 95.99 38.74 4.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.493 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -69.05 -30.82 69.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.63 -27.37 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.72 -29.66 8.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.807 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 8.4 mt -74.31 160.01 31.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.951 0.405 . . . . 0.0 110.932 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1266 ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' 1268 ' ' LEU . 19.3 t70 -84.87 143.02 39.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.051 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.11 -23.87 23.75 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.388 2.059 . . . . 0.0 112.421 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 74.4 mt -97.73 -6.65 32.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.524 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.518 ' CE1' HG22 ' A' 1273 ' ' VAL . 41.5 t80 -47.29 -55.95 7.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.42 -40.99 62.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.957 0.408 . . . . 0.0 110.318 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1271 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 0.1 OUTLIER -64.79 -49.16 71.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.892 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.61 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -60.31 -40.77 91.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.625 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.518 HG22 ' CE1' ' A' 1269 ' ' PHE . 84.3 t -61.23 -48.52 88.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1274 ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -65.46 -30.29 71.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.877 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.401 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.1 t80 -68.13 -49.08 63.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.438 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' 1277 ' ' THR . 35.2 m -69.75 -40.75 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.293 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.516 ' HB ' ' N ' ' A' 1326 ' ' PRO . 76.4 p -67.62 -48.52 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.18 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -59.11 -38.12 78.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.493 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -90.68 -6.56 54.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.028 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.2 mmm180 59.76 15.71 5.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.938 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.55 136.94 25.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.785 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -116.3 116.36 27.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.908 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 13.1 t -132.52 139.14 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.199 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.517 HG23 ' CE1' ' A' 1295 ' ' TYR . 31.3 mt -68.43 -38.46 79.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.8 t -68.78 -42.47 77.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.871 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.73 -48.23 87.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.661 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' 1291 ' ' PHE . 14.2 t -66.05 -30.94 51.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 110.673 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 21.9 mt-30 -60.88 -50.49 73.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.144 0.497 . . . . 0.0 110.048 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -76.32 -36.53 58.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.157 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.94 -33.95 62.01 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.566 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.61 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.14 -6.38 22.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.535 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 13.8 mtp-105 53.95 54.96 8.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.097 0.475 . . . . 0.0 110.23 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.464 ' HB ' ' HD3' ' A' 1297 ' ' ARG . 13.9 pt -130.86 152.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.578 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -58.75 148.14 39.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.791 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.588 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 91.2 t80 -44.96 -51.85 9.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.54 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -40.99 57.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.464 ' HD3' ' HB ' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.93 -47.87 76.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.99 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -56.37 -50.18 72.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.88 70.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.302 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -68.08 -49.84 58.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.258 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' 1297 ' ' ARG . 40.2 mt -60.18 -44.21 94.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.059 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' 1320 ' ' ARG . 19.4 mt -68.68 -33.51 60.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.836 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -52.04 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.32 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.433 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 29.1 mt-30 -60.05 -36.39 77.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.341 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.456 ' HG2' HD11 ' A' 1310 ' ' ILE . 13.7 mtm -57.05 -38.89 73.87 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' 1311 ' ' VAL . 0.4 OUTLIER -68.81 -33.94 74.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.239 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -71.47 -30.82 66.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.47 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.554 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.8 OUTLIER -88.78 -20.21 25.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.868 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.05 12.69 31.07 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.894 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.554 HG13 ' HB2' ' A' 1308 ' ' GLN . 11.1 mt -82.53 -36.03 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 122.8 0.44 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' 1306 ' ' GLU . 35.8 m -124.01 158.98 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.254 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.523 ' CA ' HD13 ' A' 1323 ' ' LEU . 1.0 OUTLIER -98.66 179.25 4.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 0.0 111.602 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.85 135.06 54.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.438 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.73 139.49 56.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.039 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -140.18 -46.67 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.808 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -74.05 -157.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -102.37 91.67 4.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 111.103 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.73 10.0 86.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.481 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -107.75 122.13 46.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.229 0.514 . . . . 0.0 111.781 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.421 ' HG3' HG22 ' A' 1302 ' ' ILE . 2.9 mmt180 -107.28 140.33 40.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.204 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.5 tp10 -83.39 132.72 34.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.976 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 25.0 t -91.39 118.78 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.982 0.42 . . . . 0.0 110.222 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.523 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -109.02 -6.23 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.448 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -104.68 132.49 20.87 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.414 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.83 158.56 16.01 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.493 2.129 . . . . 0.0 113.043 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.516 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.0 Cg_exo -53.27 163.49 2.37 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.97 2.447 . . . . 0.0 112.526 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.75 -36.43 2.13 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.298 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -132.93 51.66 2.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.9 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.867 0.365 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -93.9 44.12 2.39 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -64.02 -29.02 70.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 111.155 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -57.85 -27.91 63.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.53 -36.09 6.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 0.0 110.81 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.422 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 9.9 mt -73.68 160.03 32.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.62 143.99 41.96 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.404 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.35 -25.53 18.55 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.519 2.146 . . . . 0.0 112.869 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 36.6 mt -102.06 -0.15 34.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.509 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 43.5 t80 -47.7 -56.38 7.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -42.78 64.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1271 ' ' GLN . . . . . 0.403 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 16.4 mt-30 -69.48 -36.51 76.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.241 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.617 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -67.75 -41.65 83.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.684 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.509 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 97.9 t -61.99 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.4 OUTLIER -64.77 -32.41 74.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.615 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.408 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -67.41 -50.71 58.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.666 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' 1280 ' ' ARG . 32.8 m -68.23 -37.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.335 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.486 ' HB ' ' N ' ' A' 1326 ' ' PRO . 43.2 p -69.98 -48.83 56.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.222 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' 1274 ' ' GLN . 6.2 mm-40 -59.66 -35.16 73.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.527 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -95.97 -4.16 43.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.8 mmm180 54.95 19.42 2.66 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.906 0.384 . . . . 0.0 110.873 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.4 mttp -145.46 131.64 19.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -113.96 116.42 29.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.642 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 30.2 t -132.46 141.84 48.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 111.477 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' 1295 ' ' TYR . 62.2 mt -70.29 -43.44 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 27.7 t -68.06 -40.59 82.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.883 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.07 60.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.781 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' 1291 ' ' PHE . 22.3 t -65.19 -29.93 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.266 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' 1293 ' ' ILE . 13.3 tt0 -59.8 -51.86 67.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -76.28 -35.59 58.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.065 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -33.3 61.7 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.596 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.617 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.16 -7.85 20.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.762 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 56.62 51.78 10.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.161 0.505 . . . . 0.0 110.29 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.408 ' O ' ' CG ' ' A' 1288 ' ' GLN . 19.1 pt -129.17 146.03 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.11 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -50.89 149.77 6.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.319 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.461 ' CE1' ' CG2' ' A' 1284 ' ' ILE . 87.8 t80 -47.64 -53.43 14.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.444 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.77 -36.95 39.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -67.07 -50.21 62.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.175 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.402 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -55.21 -46.35 75.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.628 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1299 ' ' ALA . . . . . 0.41 ' N ' HG21 ' A' 1284 ' ' ILE . . . -65.91 -29.9 70.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.175 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -49.36 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.315 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 29.0 mt -60.66 -42.43 91.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.965 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' 1305 ' ' MET . 26.5 mt -68.76 -35.29 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -51.09 70.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.486 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.409 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 17.4 mt-30 -59.88 -37.04 78.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.428 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.449 ' HG2' HD11 ' A' 1310 ' ' ILE . 19.6 mtm -56.98 -38.39 72.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.499 ' N ' HG23 ' A' 1311 ' ' VAL . 2.2 tt0 -69.93 -32.81 71.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.37 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.54 -31.47 65.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.426 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.544 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.7 OUTLIER -88.12 -20.3 25.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.918 -178.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.63 13.81 29.1 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.544 HG13 ' HB2' ' A' 1308 ' ' GLN . 12.2 mt -82.85 -36.42 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 122.892 0.477 . . . . 0.0 111.251 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' 1306 ' ' GLU . 26.7 m -121.31 160.49 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.541 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.44 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -106.97 -178.53 3.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.516 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.95 134.89 53.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.65 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 149.98 49.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.894 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -137.01 -45.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.243 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1316 ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' 1317 ' ' ASN . 9.7 t-160 -76.29 -112.45 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1317 ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' 1316 ' ' HIS . 0.5 OUTLIER -138.1 91.78 2.6 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.902 0.382 . . . . 0.0 111.123 179.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.7 10.08 86.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.996 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -107.12 123.62 48.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 0.0 111.411 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' 1311 ' ' VAL . 0.0 OUTLIER -107.06 140.24 40.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.351 179.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' 1311 ' ' VAL . 15.3 tp10 -75.37 132.58 41.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.992 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 20.6 t -87.3 118.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.44 HD13 ' CA ' ' A' 1312 ' ' SER . 0.7 OUTLIER -105.7 -19.04 13.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.269 -178.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -91.96 133.49 30.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.262 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.19 159.02 15.26 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.498 2.132 . . . . 0.0 113.02 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.486 ' N ' ' HB ' ' A' 1277 ' ' THR . 56.6 Cg_exo -52.01 159.35 3.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.903 2.402 . . . . 0.0 112.477 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.83 -36.91 1.34 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 112.394 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -130.53 64.11 1.56 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.911 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 8.6 m80 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.793 0.33 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -159.31 -84.32 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -67.94 -28.96 67.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.3 -25.89 64.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.46 -35.08 5.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.859 0.361 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 9.4 mt -92.42 160.06 15.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.87 143.64 43.62 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.43 -24.18 27.08 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.394 2.063 . . . . 0.0 112.272 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 65.9 mt -97.53 -5.37 35.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.6 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.448 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.0 t80 -47.47 -55.93 8.06 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.52 -40.77 62.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.396 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.52 -43.26 81.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.082 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.585 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.08 -41.19 99.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.905 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 29.7 t -61.1 -48.51 88.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' 1278 ' ' GLU . 45.0 tt0 -63.18 -33.56 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.438 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -65.9 -51.6 57.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.62 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' 1277 ' ' THR . 33.2 m -69.31 -38.46 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.7 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.517 ' HB ' ' N ' ' A' 1326 ' ' PRO . 51.4 p -69.23 -49.86 52.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.21 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.4 mt-10 -59.8 -36.37 76.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.971 0.415 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -91.81 -6.49 51.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.018 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.6 mmm180 56.9 18.12 3.7 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.887 0.375 . . . . 0.0 110.744 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 132.35 20.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.737 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.407 ' CB ' HG13 ' A' 1311 ' ' VAL . . . -113.98 116.49 29.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.29 141.37 48.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.903 0.382 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.435 ' CG2' ' CE1' ' A' 1295 ' ' TYR . 25.4 mt -69.13 -43.31 81.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 21.3 t -67.01 -40.3 87.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.978 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.65 -51.12 60.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.1 t -64.83 -29.91 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.311 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' 1293 ' ' ILE . 10.7 tt0 -59.75 -52.68 64.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.092 0.472 . . . . 0.0 110.135 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 -35.23 58.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.18 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.41 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -34.67 61.78 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.632 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.585 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.14 -7.38 21.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 56.82 55.02 6.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.135 0.493 . . . . 0.0 110.526 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' 1288 ' ' GLN . 13.3 pt -133.23 145.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -51.06 148.86 7.71 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.435 ' CE1' ' CG2' ' A' 1284 ' ' ILE . 89.2 t80 -47.05 -52.7 14.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.543 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.72 -38.5 47.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 110.052 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -50.59 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.068 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1298 ' ' ALA . . . . . . . . . . . . . . . -54.53 -44.43 72.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.429 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1299 ' ' ALA . . . . . 0.407 ' N ' HG21 ' A' 1284 ' ' ILE . . . -66.94 -29.74 69.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -50.55 53.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 20.8 mt -59.92 -42.33 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.01 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.425 HG22 ' HG3' ' A' 1320 ' ' ARG . 20.9 mt -69.45 -34.6 62.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.774 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.94 -52.05 65.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.393 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.426 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 31.6 mt-30 -58.41 -38.03 76.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.259 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.41 ' CB ' HG23 ' A' 1311 ' ' VAL . 21.3 mtm -57.53 -37.33 72.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.326 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' 1311 ' ' VAL . 2.2 tt0 -69.21 -32.66 72.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.181 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.545 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.4 OUTLIER -87.25 -20.31 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.715 -178.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.5 12.94 31.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.009 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' 1308 ' ' GLN . 10.3 mt -83.65 -34.92 10.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.473 -0.363 . . . . 0.0 111.403 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' 1306 ' ' GLU . 35.6 m -124.44 154.4 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.622 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.409 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.1 OUTLIER -104.47 179.65 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.93 131.47 46.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -67.99 148.36 51.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.989 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -124.25 -58.5 0.18 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.634 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1316 ' ' HIS . . . . . 0.413 ' CE1' ' OD1' ' A' 1317 ' ' ASN . 21.1 t-160 -63.85 -106.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.949 -0.148 . . . . 0.0 110.806 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1317 ' ' ASN . . . . . 0.413 ' OD1' ' CE1' ' A' 1316 ' ' HIS . 18.2 p-10 -138.11 91.83 2.6 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 120.892 0.377 . . . . 0.0 111.089 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.89 1.72 79.6 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.026 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -88.52 122.22 31.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.944 0.372 . . . . 0.0 111.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.425 ' HG3' HG22 ' A' 1302 ' ' ILE . 4.7 mtt180 -107.22 140.2 40.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.54 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' 1311 ' ' VAL . 19.7 tp10 -81.95 132.66 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.767 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 21.5 t -88.81 118.61 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 110.047 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.409 HD13 ' CA ' ' A' 1312 ' ' SER . 0.7 OUTLIER -106.31 -13.03 15.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.38 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -99.22 132.34 23.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.275 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.46 159.04 22.57 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.525 2.15 . . . . 0.0 113.026 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.517 ' N ' ' HB ' ' A' 1277 ' ' THR . 57.2 Cg_exo -51.64 152.31 12.97 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.038 2.492 . . . . 0.0 112.687 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -63.23 -70.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.625 2.217 . . . . 0.0 112.318 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 2.7 m-85 65.21 -74.52 0.05 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.045 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.926 179.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 76.2 m80 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.807 0.337 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 64.44 53.49 35.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.602 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -67.19 -30.78 70.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -59.0 -27.28 65.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.6 -34.1 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.664 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.434 HD22 ' NE2' ' A' 1308 ' ' GLN . 3.3 mt -75.1 160.15 30.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.995 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1266 ' ' ASP . . . . . 0.417 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -80.38 141.74 53.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -51.73 -24.13 17.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.349 2.033 . . . . 0.0 112.584 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.504 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 59.2 mt -102.11 -4.51 25.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.035 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 39.9 t80 -47.67 -53.11 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -46.08 66.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.0 110.294 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.9 -43.25 96.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.25 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -62.1 -39.36 92.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.982 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.464 HG23 ' CE1' ' A' 1269 ' ' PHE . 17.2 t -61.65 -49.57 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.424 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.0 OUTLIER -62.61 -33.28 74.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.841 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.416 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.49 -50.87 61.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.0 m -69.57 -38.02 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.432 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.445 ' HB ' ' N ' ' A' 1326 ' ' PRO . 67.1 p -69.31 -50.25 48.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.0 mm-40 -59.17 -36.78 75.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.484 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -92.69 -6.14 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 29.1 mmm180 56.01 18.74 3.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.817 0.341 . . . . 0.0 110.651 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 24.1 mttp -145.62 133.67 21.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -116.85 116.23 27.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.898 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.54 143.25 49.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.022 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.524 HG23 ' CE1' ' A' 1295 ' ' TYR . 16.1 mt -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 14.8 t -67.38 -40.59 85.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.059 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.65 -50.41 67.94 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.778 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' 1291 ' ' PHE . 13.4 t -65.51 -30.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 110.635 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.7 mt-30 -60.76 -51.54 68.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.061 0.458 . . . . 0.0 109.936 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -36.58 58.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.097 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.405 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.98 -34.37 61.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.714 0.293 . . . . 0.0 111.626 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.15 -6.51 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.562 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 54.67 54.97 8.46 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.444 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 14.7 pt -131.97 150.39 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.583 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.61 148.32 26.82 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.252 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.1 t80 -45.96 -50.99 14.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.559 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.76 -40.67 55.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.444 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.88 -49.74 69.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.98 -49.54 68.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.0 71.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -49.8 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.985 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' 1297 ' ' ARG . 33.6 mt -60.71 -45.55 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.842 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' 1305 ' ' MET . 21.0 mt -66.79 -32.46 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.864 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -52.2 59.67 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.517 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.8 OUTLIER -57.86 -33.32 68.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.758 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.502 ' C ' HG23 ' A' 1311 ' ' VAL . 14.3 mtm -62.7 -39.37 93.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.558 ' N ' HG23 ' A' 1311 ' ' VAL . 28.1 tt0 -66.35 -32.28 73.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.416 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.88 -42.11 58.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.281 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.452 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -74.4 -20.19 60.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.604 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.42 15.3 30.29 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.415 ' CD1' HG23 ' A' 1273 ' ' VAL . 10.0 mt -83.64 -35.28 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.65 0.38 . . . . 0.0 111.502 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.558 HG23 ' N ' ' A' 1306 ' ' GLU . 29.6 m -122.4 159.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.573 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.413 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.19 178.19 4.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -66.01 131.53 46.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.819 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -67.95 144.01 55.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.957 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -119.36 -50.97 0.29 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.601 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1316 ' ' HIS . . . . . 0.461 ' CE1' ' ND2' ' A' 1317 ' ' ASN . 14.1 t-160 -71.56 -106.34 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.99 -0.124 . . . . 0.0 110.718 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1317 ' ' ASN . . . . . 0.461 ' ND2' ' CE1' ' A' 1316 ' ' HIS . 7.0 p30 -138.04 91.87 2.61 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.957 0.408 . . . . 0.0 111.065 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.84 1.0 77.01 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.022 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -87.13 122.24 30.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.483 ' HD2' HG22 ' A' 1311 ' ' VAL . 2.2 mtt-85 -107.18 140.2 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.655 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' 1311 ' ' VAL . 13.5 tt0 -83.61 132.72 34.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.749 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 19.3 t -87.92 118.57 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.321 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.413 HD13 ' CA ' ' A' 1312 ' ' SER . 0.8 OUTLIER -105.81 -10.25 16.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.053 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -100.21 129.91 27.16 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.192 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -82.62 158.48 16.54 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.573 2.182 . . . . 0.0 113.175 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.445 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -53.97 164.26 2.63 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.993 2.462 . . . . 0.0 112.32 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.38 -42.92 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.701 2.268 . . . . 0.0 112.432 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -139.8 63.52 1.48 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.881 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.779 0.323 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 105.27 -114.54 4.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -57.41 -27.54 62.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 111.273 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -58.99 -29.07 66.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.06 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.76 -30.67 7.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.966 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.428 ' CD2' ' NE2' ' A' 1308 ' ' GLN . 6.7 mt -69.01 160.0 31.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.029 0.442 . . . . 0.0 111.266 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 8.7 t0 -75.77 141.38 72.0 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.0 -24.57 10.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.441 2.094 . . . . 0.0 112.945 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.497 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 60.0 mt -102.18 -5.03 24.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 45.9 t80 -47.66 -52.67 17.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.6 t0 -52.67 -42.2 64.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 0.0 110.328 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.56 -43.06 81.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.989 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.625 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -61.64 -38.98 89.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.873 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.515 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 21.2 t -62.13 -52.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.8 OUTLIER -61.43 -30.62 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.941 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.466 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 3.1 t80 -68.91 -51.04 44.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.697 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1276 ' ' VAL . . . . . . . . . . . . . 35.3 m -69.74 -36.93 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.403 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.521 ' HB ' ' N ' ' A' 1326 ' ' PRO . 65.9 p -69.68 -50.76 40.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.352 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.5 mm-40 -61.01 -35.19 76.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -7.99 52.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.793 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1280 ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 56.65 18.04 3.44 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 7.7 mttm -145.66 133.44 21.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.647 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -115.47 116.44 28.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.723 0.297 . . . . 0.0 110.779 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 11.1 t -132.49 141.31 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.457 ' CG2' ' CE1' ' A' 1295 ' ' TYR . 72.3 mt -68.6 -47.62 76.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.4 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 25.8 t -63.8 -40.68 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.043 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.96 62.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.969 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.2 t -64.35 -29.96 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' 1293 ' ' ILE . 0.0 OUTLIER -60.8 -50.84 71.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.108 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -36.35 58.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.994 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.09 -32.91 61.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.725 -179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.2 -7.78 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.761 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 59.05 50.35 8.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' 1288 ' ' GLN . 10.2 pt -126.56 171.39 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -77.01 154.06 42.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.924 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.457 ' CE1' ' CG2' ' A' 1284 ' ' ILE . 82.6 t80 -49.11 -55.84 10.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.822 0.311 . . . . 0.0 111.251 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -33.42 22.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.113 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -70.32 -50.89 34.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.865 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.407 ' CB ' HG21 ' A' 1284 ' ' ILE . . . -55.78 -46.74 77.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.555 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1299 ' ' ALA . . . . . 0.41 ' N ' HG21 ' A' 1284 ' ' ILE . . . -66.79 -29.98 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.98 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -67.42 -48.93 65.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.893 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 50.1 mt -61.39 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.789 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.419 HD11 HG12 ' A' 1284 ' ' ILE . 20.0 mt -63.09 -31.69 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.734 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -47.6 82.98 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.611 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.8 mt-30 -60.64 -33.4 72.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.197 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.454 ' HB3' ' CG1' ' A' 1311 ' ' VAL . 0.6 OUTLIER -61.6 -40.32 94.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' 1311 ' ' VAL . 12.5 tt0 -65.86 -35.72 81.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.871 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.93 -41.36 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.265 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.428 ' NE2' ' CD2' ' A' 1265 ' ' LEU . 0.8 OUTLIER -74.72 -20.4 59.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.762 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 98.07 15.76 35.03 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.773 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.413 ' CD1' HG23 ' A' 1273 ' ' VAL . 8.6 mt -82.41 -36.18 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 122.791 0.436 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' 1306 ' ' GLU . 26.8 m -120.23 162.41 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.449 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.53 -177.96 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -65.87 131.49 46.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 130.95 44.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.381 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -109.08 -44.09 1.13 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.927 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.4 -161.54 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.28 91.79 8.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.78 10.09 86.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.157 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -91.49 122.14 33.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.403 ' CD ' HG22 ' A' 1311 ' ' VAL . 0.2 OUTLIER -107.32 140.28 40.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.439 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' 1311 ' ' VAL . 14.4 tt0 -88.41 132.81 34.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 21.2 t -90.67 118.69 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.487 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.449 HD13 ' CA ' ' A' 1312 ' ' SER . 0.7 OUTLIER -107.19 -18.3 13.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.021 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -91.46 130.17 40.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.292 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.01 158.61 23.94 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.474 2.116 . . . . 0.0 113.133 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.521 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.1 Cg_exo -52.44 161.46 2.8 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.017 2.478 . . . . 0.0 112.57 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1327 ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' 1274 ' ' GLN . 18.9 Cg_endo -59.36 -32.03 95.94 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.757 2.305 . . . . 0.0 112.241 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -91.31 48.43 1.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.952 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.754 0.312 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -175.19 77.82 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.45 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -65.48 -25.16 67.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.764 0.316 . . . . 0.0 111.306 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -56.84 -31.95 65.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 -35.35 5.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.821 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.421 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 12.3 mt -74.46 160.06 31.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.033 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.25 144.49 62.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.215 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.62 -23.27 19.28 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.47 2.114 . . . . 0.0 112.16 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.469 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 85.4 mt -99.2 -6.92 27.3 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.793 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 38.4 t80 -47.54 -56.14 7.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.49 -40.1 61.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.848 0.356 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1271 ' ' GLN . . . . . 0.429 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 17.4 mt-30 -71.0 -38.89 72.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.134 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.26 -40.01 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 47.2 t -62.86 -47.55 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.432 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.5 OUTLIER -63.67 -33.55 75.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.729 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.412 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.14 -51.26 59.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.588 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' 1280 ' ' ARG . 33.5 m -69.51 -37.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.437 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.517 ' HB ' ' N ' ' A' 1326 ' ' PRO . 44.5 p -69.96 -49.2 54.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.6 mt-10 -60.34 -35.91 76.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -92.33 -6.18 50.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.911 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.5 mmm180 56.93 17.7 3.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.766 0.317 . . . . 0.0 110.85 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 133.4 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.822 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.409 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -113.51 116.53 29.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.782 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 1.4 t -132.44 136.13 46.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.518 HG23 ' CE1' ' A' 1295 ' ' TYR . 32.1 mt -66.41 -37.9 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.138 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.497 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.8 t -69.35 -43.11 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.85 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.17 -48.57 85.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.714 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' 1291 ' ' PHE . 12.0 t -66.02 -31.27 52.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.683 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 19.3 mt-30 -59.92 -51.22 70.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 109.998 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -36.77 58.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.261 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.404 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.96 -33.91 61.96 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.611 -179.005 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.11 -7.01 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.568 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 54.65 54.08 9.73 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.009 0.433 . . . . 0.0 110.261 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.21 146.72 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.516 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.44 149.0 10.57 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.314 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.6 t80 -46.48 -51.79 14.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.8 -39.7 53.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.197 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -50.67 64.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.482 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.88 -49.78 67.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.997 0.427 . . . . 0.0 110.544 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -63.11 -29.68 70.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -68.2 -51.63 43.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 36.4 mt -59.57 -44.33 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.94 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.412 HG22 ' HG3' ' A' 1320 ' ' ARG . 20.0 mt -67.91 -32.93 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -52.11 66.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.422 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.421 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 0.1 OUTLIER -60.2 -36.9 78.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' 1302 ' ' ILE . 16.9 mtm -56.94 -36.38 70.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 CA-C-O 121.557 0.694 . . . . 0.0 109.174 178.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.51 ' N ' HG21 ' A' 1311 ' ' VAL . 4.6 tp10 -70.21 -33.14 71.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.055 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.41 62.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.475 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.539 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.4 OUTLIER -88.07 -20.43 25.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.908 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.57 16.05 25.51 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.958 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' 1308 ' ' GLN . 14.0 mt -85.26 -36.64 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.303 -0.448 . . . . 0.0 111.184 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.51 HG21 ' N ' ' A' 1306 ' ' GLU . 35.0 m -120.58 156.64 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.474 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.3 -178.19 3.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.108 0.48 . . . . 0.0 111.657 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.86 135.14 54.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.515 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -67.72 133.99 50.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.173 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -123.73 -42.96 0.36 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.797 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.56 -160.49 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.3 p30 -92.55 91.78 7.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.86 10.1 86.46 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.119 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -98.65 122.23 41.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 0.0 111.637 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.412 ' HG3' HG22 ' A' 1302 ' ' ILE . 7.8 mmt180 -107.24 140.27 40.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.168 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' 1311 ' ' VAL . 4.9 tp10 -87.48 132.67 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' 1282 ' ' ALA . 22.0 t -91.79 118.69 37.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 110.099 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.474 HD13 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.82 -4.92 17.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.457 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -105.79 130.98 22.15 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.3 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.02 159.42 23.94 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.461 2.107 . . . . 0.0 113.041 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.517 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.47 158.49 3.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.081 2.521 . . . . 0.0 112.582 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.94 -74.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.691 2.261 . . . . 0.0 112.442 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -123.34 -45.52 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.96 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.926 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 5.2 t60 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.801 0.334 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -105.08 -38.27 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -63.3 -24.74 67.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.319 . . . . 0.0 111.246 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -55.89 -33.22 64.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.117 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.26 -34.72 5.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 10.9 mt -83.19 155.18 23.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.48 144.98 81.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.376 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.46 -24.25 21.38 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.377 2.051 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.474 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 44.3 mt -101.98 -1.76 31.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.909 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.489 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.1 t80 -47.7 -56.51 7.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.37 -41.81 63.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.074 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.1 -37.48 75.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.91 -41.65 91.18 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.689 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.489 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 57.6 t -61.75 -48.48 88.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.46 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.786 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.423 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -66.87 -51.74 51.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.547 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.413 HG21 ' N ' ' A' 1277 ' ' THR . 33.4 m -67.6 -37.43 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.121 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.506 ' HB ' ' N ' ' A' 1326 ' ' PRO . 42.6 p -69.47 -49.45 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.178 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.6 -35.03 73.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1279 ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 2.7 mtmt -93.91 -6.98 44.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.018 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.4 mmm180 58.04 17.2 4.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.625 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.6 133.58 21.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -113.34 116.44 29.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.607 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 4.4 t -132.39 138.26 47.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.359 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.526 HG23 ' CE1' ' A' 1295 ' ' TYR . 24.1 mt -67.92 -38.77 80.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.161 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.478 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.0 t -69.69 -42.83 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.962 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.72 -50.18 70.47 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.584 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.2 t -65.44 -29.92 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.723 0.297 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -60.41 -52.72 64.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.105 0.479 . . . . 0.0 110.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -76.31 -34.59 59.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.027 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.427 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.5 tp60 -75.12 -34.01 61.64 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.394 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.44 22.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.704 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 54.77 51.53 13.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.174 0.512 . . . . 0.0 110.047 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.415 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 16.6 pt -126.89 150.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.36 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -57.61 147.64 35.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.85 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.604 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 86.8 t80 -44.84 -49.5 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 111.47 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.77 -43.47 58.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.807 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.486 ' HD3' HD13 ' A' 1301 ' ' ILE . 0.0 OUTLIER -65.3 -47.27 77.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.417 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.492 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.8 -49.94 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.675 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1299 ' ' ALA . . . . . . . . . . . . . . . -64.3 -29.78 70.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.015 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -49.79 56.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.409 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.486 HD13 ' HD3' ' A' 1297 ' ' ARG . 38.2 mt -60.88 -42.51 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.776 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.411 HG21 ' HD2' ' A' 1320 ' ' ARG . 29.1 mt -69.06 -35.3 68.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.741 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -52.01 66.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.384 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.437 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.1 mt-30 -59.32 -37.58 78.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.354 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.457 ' C ' HG23 ' A' 1311 ' ' VAL . 17.4 mtm -57.13 -37.43 71.99 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' 1311 ' ' VAL . 2.8 tt0 -70.25 -32.33 70.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.141 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.67 -29.01 62.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.338 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.526 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.5 OUTLIER -90.13 -20.33 23.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.741 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.85 13.76 28.74 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.063 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' 1308 ' ' GLN . 11.1 mt -84.39 -35.84 11.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 122.799 0.439 . . . . 0.0 111.456 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' 1306 ' ' GLU . 30.3 m -122.03 155.84 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.732 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1312 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.74 -177.98 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.978 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.04 131.92 47.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.758 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -67.89 156.18 37.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.985 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -129.92 -57.3 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.701 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1316 ' ' HIS . . . . . 0.412 ' CE1' ' OD1' ' A' 1317 ' ' ASN . 20.0 t-160 -66.94 -104.07 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.508 0.154 . . . . 0.0 110.806 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1317 ' ' ASN . . . . . 0.412 ' OD1' ' CE1' ' A' 1316 ' ' HIS . 8.8 p-10 -138.08 91.85 2.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.851 0.358 . . . . 0.0 111.009 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.8 1.59 78.66 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.932 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -87.27 122.37 30.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.89 0.376 . . . . 0.0 111.079 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' 1311 ' ' VAL . 8.8 mtt-85 -107.18 140.13 40.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.399 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.0 tp10 -80.0 132.64 36.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.056 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 18.2 t -88.55 118.56 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1323 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.73 -13.88 15.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -97.47 132.6 24.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.35 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.51 159.02 19.5 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.553 2.169 . . . . 0.0 113.074 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.506 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.9 Cg_exo -52.16 161.09 2.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.913 2.409 . . . . 0.0 112.66 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.91 -36.52 2.58 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.669 2.246 . . . . 0.0 112.25 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -60.81 -34.25 74.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.858 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 19.5 t-80 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.826 0.346 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 164.26 101.37 0.16 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.548 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -69.59 -27.47 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 111.246 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -56.42 -29.36 61.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.022 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.51 -44.87 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.967 0.413 . . . . 0.0 110.631 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.476 ' HA ' ' OE1' ' A' 1304 ' ' GLN . 6.9 mt -70.93 157.5 38.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.141 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.62 143.78 79.43 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.197 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.66 -23.63 15.72 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.256 1.971 . . . . 0.0 112.217 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.508 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 59.5 mt -102.08 -5.48 24.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' 1304 ' ' GLN . 39.4 t80 -47.71 -54.13 13.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -52.61 -41.69 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -67.52 -42.67 82.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -62.78 -39.12 93.21 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.72 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.467 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 21.6 t -62.04 -51.27 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.7 tt0 -61.79 -31.57 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.894 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.436 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -68.25 -50.88 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.632 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' 1280 ' ' ARG . 34.2 m -69.18 -37.27 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.287 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.498 ' HB ' ' N ' ' A' 1326 ' ' PRO . 74.1 p -69.64 -50.64 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' 1274 ' ' GLN . 8.3 mm-40 -59.46 -36.09 75.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.404 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -8.25 48.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 57.71 17.74 4.3 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.462 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 29.7 mttt -145.61 132.1 19.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.792 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1282 ' ' ALA . . . . . . . . . . . . . . . -113.02 116.49 30.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.727 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 34.6 t -132.29 139.87 48.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 111.276 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.431 HG22 ' CE1' ' A' 1295 ' ' TYR . 22.5 mt -68.48 -43.31 83.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 2.8 t -67.16 -41.18 86.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.978 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.49 -51.14 60.59 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.79 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' 1291 ' ' PHE . 21.8 t -64.52 -29.96 48.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.958 0.409 . . . . 0.0 110.263 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' 1293 ' ' ILE . 15.7 tt0 -59.63 -53.07 62.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.248 0.547 . . . . 0.0 110.208 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -35.16 59.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.102 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.403 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -75.09 -33.34 61.64 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.683 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.27 -7.71 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 57.56 52.39 8.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.067 0.461 . . . . 0.0 110.494 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1293 ' ' ILE . . . . . 0.414 ' CG2' ' NH1' ' A' 1297 ' ' ARG . 13.2 pt -130.01 148.33 33.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.031 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.48 150.28 16.93 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.924 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.431 ' CE1' HG22 ' A' 1284 ' ' ILE . 89.1 t80 -47.59 -51.28 21.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.78 -38.54 48.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.529 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.414 ' NH1' ' CG2' ' A' 1293 ' ' ILE . 0.1 OUTLIER -66.92 -49.38 65.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.139 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1298 ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.77 73.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.666 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1299 ' ' ALA . . . . . 0.402 ' N ' HG21 ' A' 1284 ' ' ILE . . . -67.05 -29.87 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.063 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -49.97 57.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.046 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1301 ' ' ILE . . . . . . . . . . . . . 39.9 mt -60.57 -45.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.786 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.8 mt -66.12 -32.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.853 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -52.2 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.508 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -60.14 -32.03 70.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.758 178.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' 1302 ' ' ILE . 13.8 mtm -61.3 -39.05 89.03 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.517 ' N ' HG21 ' A' 1311 ' ' VAL . 1.7 tt0 -67.22 -32.93 74.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.372 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.05 -42.11 63.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.42 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.479 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -76.31 -20.28 57.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.871 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.53 16.37 27.01 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.997 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.446 ' CD1' HG23 ' A' 1273 ' ' VAL . 13.0 mt -83.12 -37.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 122.76 0.424 . . . . 0.0 111.279 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.517 HG21 ' N ' ' A' 1306 ' ' GLU . 34.8 m -120.65 159.54 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.428 ' CA ' HD13 ' A' 1323 ' ' LEU . 0.3 OUTLIER -107.6 -177.92 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.867 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -65.74 130.68 44.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.419 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -67.91 131.37 45.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.384 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -104.55 -36.88 2.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.935 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -92.94 -158.64 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -86.24 91.83 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 111.216 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.99 10.12 86.45 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.423 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -93.12 122.01 35.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.11 0.455 . . . . 0.0 111.198 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1320 ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.45 140.3 40.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.566 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.52 132.71 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.253 . . . . 0.0 110.622 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1322 ' ' VAL . . . . . . . . . . . . . 18.3 t -89.51 118.69 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.94 0.4 . . . . 0.0 110.319 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.428 HD13 ' CA ' ' A' 1312 ' ' SER . 0.8 OUTLIER -106.51 -19.99 13.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.931 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -89.67 129.86 45.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.176 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.9 158.88 21.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.094 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.498 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.1 Cg_exo -53.13 164.32 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.922 2.414 . . . . 0.0 112.411 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.34 -35.21 14.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.617 2.211 . . . . 0.0 112.232 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -129.5 -68.75 0.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.894 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 98.95 -44.29 1.73 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.547 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.21 67.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.254 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.46 -34.94 64.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.05 -34.39 5.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1265 ' ' LEU . . . . . 0.439 ' CD2' ' HB3' ' A' 1304 ' ' GLN . 10.2 mt -89.1 159.89 17.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.144 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -85.87 145.11 40.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.365 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -52.52 -24.03 21.04 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1268 ' ' LEU . . . . . 0.496 ' HB3' ' HD2' ' A' 1291 ' ' PHE . 45.2 mt -102.05 -1.52 31.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.862 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1269 ' ' PHE . . . . . 0.474 ' CE1' ' CG2' ' A' 1273 ' ' VAL . 41.6 t80 -47.56 -56.88 6.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.34 -41.04 62.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.78 -42.3 86.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1272 ' ' ALA . . . . . 0.591 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.01 -41.9 94.91 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1273 ' ' VAL . . . . . 0.474 ' CG2' ' CE1' ' A' 1269 ' ' PHE . 61.1 t -60.11 -48.16 89.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1274 ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.5 tt0 -64.13 -33.26 75.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.744 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1275 ' ' PHE . . . . . 0.435 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -65.65 -50.7 64.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.585 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1276 ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' 1277 ' ' THR . 33.5 m -69.28 -40.26 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.492 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1277 ' ' THR . . . . . 0.527 ' HB ' ' N ' ' A' 1326 ' ' PRO . 67.0 p -67.99 -49.53 61.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1278 ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' 1274 ' ' GLN . 11.7 mm-40 -59.68 -36.3 76.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -92.28 -6.06 51.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.22 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 28.0 mmm180 58.24 16.84 4.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 110.9 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 2.9 mttm -145.61 134.75 22.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1282 ' ' ALA . . . . . 0.411 ' N ' ' CG2' ' A' 1322 ' ' VAL . . . -115.67 116.43 28.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.665 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1283 ' ' SER . . . . . . . . . . . . . 8.7 p -132.52 140.76 48.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CE1' ' A' 1295 ' ' TYR . 21.2 mt -69.22 -40.5 80.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.287 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 45.5 t -67.8 -42.79 81.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.014 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.46 78.29 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.706 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1287 ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' 1291 ' ' PHE . 15.5 t -65.49 -30.74 51.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 15.1 mt-30 -60.22 -51.37 69.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.216 0.532 . . . . 0.0 109.949 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -36.1 58.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.233 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1290 ' ' GLN . . . . . 0.414 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.02 -34.64 61.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.618 -178.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1291 ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.31 -6.48 21.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.551 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 54.96 55.01 8.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 110.381 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 15.2 pt -131.73 147.26 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.435 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.99 149.29 11.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.284 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.0 t80 -46.77 -51.46 16.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.458 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -39.45 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.458 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1297 ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' 1301 ' ' ILE . 0.3 OUTLIER -66.23 -49.49 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.27 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1298 ' ' ALA . . . . . 0.47 ' CB ' HG22 ' A' 1284 ' ' ILE . . . -53.95 -49.36 68.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.642 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1299 ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' 1284 ' ' ILE . . . -63.81 -29.79 70.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -68.55 -50.52 51.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.244 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1301 ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' 1297 ' ' ARG . 29.5 mt -60.13 -43.49 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.833 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1302 ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' 1305 ' ' MET . 20.2 mt -68.83 -33.69 60.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.928 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.89 66.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.335 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1304 ' ' GLN . . . . . 0.439 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 22.9 mt-30 -59.43 -36.76 76.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.303 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1305 ' ' MET . . . . . 0.471 ' HG2' HD11 ' A' 1310 ' ' ILE . 17.1 mtm -57.01 -38.54 73.24 Favored 'General case' 0 C--O 1.228 -0.058 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1306 ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' 1311 ' ' VAL . 5.1 tt0 -69.46 -33.04 72.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.303 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.09 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.404 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1308 ' ' GLN . . . . . 0.534 ' HB2' HG13 ' A' 1310 ' ' ILE . 0.6 OUTLIER -89.18 -20.32 24.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.26 13.89 27.52 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.963 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1310 ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' 1308 ' ' GLN . 12.4 mt -83.67 -38.49 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 122.743 0.417 . . . . 0.0 111.266 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1311 ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' 1306 ' ' GLU . 32.6 m -120.22 155.78 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.144 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1312 ' ' SER . . . . . 0.465 ' CA ' HD13 ' A' 1323 ' ' LEU . 1.0 OUTLIER -96.46 -179.9 4.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.623 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -65.9 134.69 53.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.396 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 138.69 56.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.077 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -136.64 -46.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.789 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.76 -157.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 4.9 p30 -100.52 91.79 4.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.887 0.375 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.78 10.06 86.48 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.462 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -105.04 122.09 45.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.16 0.48 . . . . 0.0 111.65 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1320 ' ' ARG . . . . . 0.409 ' HG3' HG22 ' A' 1302 ' ' ILE . 2.7 mmt180 -107.6 140.33 40.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.31 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1321 ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.3 tt0 -85.44 132.67 34.18 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.862 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1322 ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' A' 1282 ' ' ALA . 29.4 t -92.86 118.69 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.967 0.413 . . . . 0.0 110.139 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1323 ' ' LEU . . . . . 0.465 HD13 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.11 -13.54 14.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.233 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1324 ' ' ALA . . . . . . . . . . . . . . . -95.57 130.41 32.03 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.24 159.29 23.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.531 2.154 . . . . 0.0 113.028 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1326 ' ' PRO . . . . . 0.527 ' N ' ' HB ' ' A' 1277 ' ' THR . 63.0 Cg_exo -51.68 159.67 3.28 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.06 2.507 . . . . 0.0 112.678 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.17 -36.88 2.2 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -120.26 27.29 8.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.957 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.856 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.4 mt . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 121.089 0.471 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1266 ' ' ASP . . . . . 0.449 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.9 t70 -79.33 144.14 61.52 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.554 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 -25.78 20.58 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.555 2.17 . . . . 0.0 112.627 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.557 HD13 ' HB3' ' A' 1291 ' ' PHE . 63.1 mt -101.94 -2.65 29.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.856 ' CD2' HD22 ' A' 1265 ' ' LEU . 38.8 t80 -47.57 -55.09 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.47 -45.31 66.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.946 0.403 . . . . 0.0 110.905 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -67.32 -38.21 84.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.24 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.627 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.41 94.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.665 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' 1269 ' ' PHE . 23.5 t -62.11 -47.87 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' 1278 ' ' GLU . 33.1 tt0 -63.55 -33.91 76.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.881 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.4 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.14 -50.47 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -70.1 -37.59 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.471 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.835 HG22 ' O ' ' A' 1324 ' ' ALA . 55.0 p -70.09 -49.48 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.1 mt-10 -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.285 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -91.39 -7.18 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.9 mmm180 57.52 17.85 4.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -145.56 133.23 21.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.774 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.74 116.38 28.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.832 ' O ' HG23 ' A' 1287 ' ' VAL . 3.2 p -132.57 138.98 47.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.869 0.366 . . . . 0.0 111.22 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' 1299 ' ' ALA . 19.7 mt -67.24 -40.14 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 47.6 t -68.51 -41.52 79.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.51 -49.93 73.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.638 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' 1283 ' ' SER . 12.0 t -65.92 -30.11 48.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.603 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.74 -51.16 70.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.124 0.488 . . . . 0.0 110.011 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -76.2 -37.07 58.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.162 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.41 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.04 -33.34 61.73 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.512 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.69 21.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.403 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 54.16 52.86 11.93 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.051 0.453 . . . . 0.0 110.226 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.478 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 19.8 pt -129.83 148.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.544 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.61 148.07 22.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.22 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.603 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.9 t80 -45.31 -50.23 12.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.4 p30 -50.84 -41.82 58.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.705 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.478 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.8 -49.68 69.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.253 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.521 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -53.98 -50.0 67.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.5 -29.83 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.189 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -50.55 51.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.144 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.581 HG21 ' CB ' ' A' 1272 ' ' ALA . 34.0 mt -60.43 -43.71 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.953 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.559 HG22 ' HE ' ' A' 1320 ' ' ARG . 22.2 mt -68.63 -33.95 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.759 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -51.98 65.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.415 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.425 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 7.0 mt-30 -59.06 -36.11 74.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.569 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.3 mtm -58.37 -37.14 74.63 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.618 ' N ' HG22 ' A' 1311 ' ' VAL . 36.8 tt0 -69.7 -32.24 70.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.32 62.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.343 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.667 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -89.62 -20.31 23.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.792 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.31 12.98 32.04 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.912 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -83.23 -35.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 122.618 0.367 . . . . 0.0 111.204 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' 1306 ' ' GLU . 27.5 m -122.38 154.47 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.449 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.492 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.6 OUTLIER -102.77 -177.85 3.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.615 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.509 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.001 0.429 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.559 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.2 OUTLIER -107.42 140.26 40.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.369 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' 1311 ' ' VAL . 5.8 tt0 -86.05 132.69 33.99 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.803 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' 1282 ' ' ALA . 26.9 t -91.21 118.59 36.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.933 0.396 . . . . 0.0 110.106 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.0 -10.82 15.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.385 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' 1277 ' ' THR . . . -99.88 130.68 25.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.09 159.59 23.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 113.039 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.524 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.1 Cg_exo -51.67 163.74 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.903 2.402 . . . . 0.0 112.587 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 122.715 2.277 . . . . 0.0 112.412 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.782 HD13 ' CD1' ' A' 1269 ' ' PHE . 7.5 mt . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.971 0.415 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.33 144.27 94.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.75 -24.83 13.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.191 1.927 . . . . 0.0 112.273 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.2 mt -102.16 -5.28 24.61 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.835 ' O ' HG23 ' A' 1273 ' ' VAL . 38.4 t80 -47.71 -53.39 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -52.6 -45.42 66.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.408 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.4 mt-30 -67.96 -37.95 82.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.634 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.29 -39.16 93.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.305 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' 1269 ' ' PHE . 19.2 t -62.83 -49.18 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' 1278 ' ' GLU . 22.2 tt0 -62.79 -32.5 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.792 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.429 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -67.95 -50.58 55.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.68 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.3 m -69.72 -38.01 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.844 HG22 ' O ' ' A' 1324 ' ' ALA . 57.6 p -69.73 -49.91 48.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.113 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.2 mt-10 -59.09 -36.95 76.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.999 0.428 . . . . 0.0 110.292 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1279 ' ' LYS . . . . . 0.414 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 4.0 mtmt -89.79 -9.52 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.008 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.1 mmm180 59.97 16.65 5.98 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.833 0.349 . . . . 0.0 110.478 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 3.8 mttp -145.55 134.43 22.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.623 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.18 116.61 28.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.802 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.834 ' O ' HG23 ' A' 1287 ' ' VAL . 3.2 p -132.55 139.72 47.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.601 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 24.6 mt -68.56 -39.31 80.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.203 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.504 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 48.1 t -69.13 -42.45 75.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.29 69.22 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.569 -0.825 . . . . 0.0 111.583 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' 1283 ' ' SER . 17.6 t -65.31 -30.34 49.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.597 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.27 -52.01 67.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 110.097 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -36.19 58.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.125 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.411 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -74.98 -33.13 61.84 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.559 -179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.38 21.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.631 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 55.8 51.96 11.54 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.128 0.489 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.688 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -128.7 147.77 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.85 150.23 18.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.024 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.593 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.34 -51.26 15.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.397 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 5.9 p30 -50.7 -40.07 53.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.56 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.688 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.4 OUTLIER -64.98 -50.28 66.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.329 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.601 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.99 -49.93 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.507 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.32 -29.9 71.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.209 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -68.49 -50.48 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.99 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.585 HG21 ' CB ' ' A' 1272 ' ' ALA . 40.7 mt -60.74 -46.41 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.774 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.463 HG21 ' HG3' ' A' 1320 ' ' ARG . 18.7 mt -66.17 -31.45 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.948 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -63.73 -52.26 61.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -59.22 -32.0 69.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.643 178.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.591 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.7 mtm -62.63 -39.55 94.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.619 ' N ' HG22 ' A' 1311 ' ' VAL . 3.2 tt0 -67.38 -32.05 72.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.283 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.09 -42.05 63.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.248 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.406 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.1 OUTLIER -76.21 -20.24 57.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.774 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.46 13.94 31.48 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.055 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -81.21 -36.79 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.806 0.442 . . . . 0.0 111.492 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.619 HG22 ' N ' ' A' 1306 ' ' GLU . 33.3 m -121.38 159.57 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.207 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.459 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.5 OUTLIER -103.84 -178.06 3.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.078 0.466 . . . . 0.0 111.732 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 36.4 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.973 0.416 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.463 ' HG3' HG21 ' A' 1302 ' ' ILE . 4.6 mmt180 -107.43 140.31 40.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.368 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' 1311 ' ' VAL . 18.0 tt0 -86.44 132.63 33.89 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.879 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.576 HG22 ' HB2' ' A' 1282 ' ' ALA . 23.6 t -91.35 118.71 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.23 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.459 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.67 -12.79 15.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.326 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.844 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.3 131.61 27.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.55 159.3 22.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.418 2.079 . . . . 0.0 113.012 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.539 ' N ' ' HB ' ' A' 1277 ' ' THR . 71.0 Cg_exo -51.57 156.42 6.28 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.965 2.443 . . . . 0.0 112.712 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.701 2.267 . . . . 0.0 112.516 -179.783 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.947 0.403 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1266 ' ' ASP . . . . . 0.413 ' CB ' HG12 ' A' 1301 ' ' ILE . 18.6 t70 -72.95 142.39 82.88 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.154 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -51.23 -25.04 16.53 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.323 2.015 . . . . 0.0 112.49 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' 1291 ' ' PHE . 41.9 mt -102.14 -3.63 27.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' 1273 ' ' VAL . 43.6 t80 -47.79 -53.02 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -52.72 -44.06 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.044 0.45 . . . . 0.0 110.539 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.426 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 7.1 mt-30 -66.58 -40.49 88.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.145 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.603 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.97 -39.74 94.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.739 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' 1269 ' ' PHE . 16.2 t -61.4 -51.72 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' 1278 ' ' GLU . 19.9 tt0 -60.74 -32.04 71.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.857 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.466 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -67.29 -52.14 44.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.8 m -69.17 -35.31 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.855 HG22 ' O ' ' A' 1324 ' ' ALA . 69.3 p -72.19 -49.06 38.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.2 mt-10 -60.35 -35.3 75.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.192 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.7 -5.12 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.939 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.6 mmm180 53.63 20.69 2.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.882 0.373 . . . . 0.0 110.649 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -145.61 129.87 17.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.636 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.645 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -111.98 116.47 30.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.742 0.306 . . . . 0.0 110.631 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.837 ' O ' HG23 ' A' 1287 ' ' VAL . 11.3 t -132.46 139.86 48.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' 1299 ' ' ALA . 16.4 mt -68.63 -40.75 82.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.272 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 28.6 t -67.82 -41.87 82.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1286 ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.28 -49.94 73.03 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.823 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' 1283 ' ' SER . 12.7 t -65.99 -29.79 47.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 17.4 mt-30 -60.76 -52.66 64.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.126 0.489 . . . . 0.0 109.867 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -76.27 -34.87 59.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.961 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.522 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -73.8 -37.01 65.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.762 0.315 . . . . 0.0 111.508 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' 1268 ' ' LEU . 1.8 m-85 -103.19 -5.15 23.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.839 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 55.02 8.49 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 148.53 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.384 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -53.76 149.81 14.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.125 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.597 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.4 t80 -47.09 -51.94 16.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 111.507 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -38.35 46.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.588 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -49.33 65.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.249 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.535 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.64 -49.86 69.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.563 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.36 -29.86 71.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -51.4 48.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.012 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.603 HG21 ' CB ' ' A' 1272 ' ' ALA . 41.8 mt -60.01 -45.21 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.83 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' 1305 ' ' MET . 21.5 mt -66.27 -32.56 58.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -50.23 67.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.612 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.5 mt-30 -57.16 -34.49 68.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.242 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.595 ' HB3' HG13 ' A' 1311 ' ' VAL . 16.0 mtm -63.33 -39.15 93.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.27 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.603 ' N ' HG22 ' A' 1311 ' ' VAL . 1.9 tt0 -66.41 -31.67 72.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.591 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.48 44.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.23 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -20.21 59.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.756 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 99.8 16.07 29.64 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.001 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' 1324 ' ' ALA . 9.6 mt -84.03 -36.8 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 122.566 0.346 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' 1306 ' ' GLU . 27.1 m -119.93 161.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.341 . . . . 0.0 111.211 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.462 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.01 178.18 4.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.371 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.54 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 47.1 m-80 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.937 0.399 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.446 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.56 140.28 40.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.475 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' 1311 ' ' VAL . 47.0 tt0 -89.66 132.68 35.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.819 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -92.29 118.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.29 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.462 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.39 -13.06 15.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.855 ' O ' HG22 ' A' 1277 ' ' THR . . . -95.39 129.37 35.22 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -80.96 159.11 20.97 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.494 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.6 Cg_exo -52.34 164.37 1.33 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.977 2.452 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 122.655 2.236 . . . . 0.0 112.302 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.857 HD22 ' CD2' ' A' 1269 ' ' PHE . 11.3 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.985 0.421 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.06 145.8 44.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.229 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.62 -23.54 20.09 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.286 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' 1291 ' ' PHE . 58.0 mt -102.04 -3.39 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.852 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.857 ' CD2' HD22 ' A' 1265 ' ' LEU . 42.5 t80 -47.6 -56.62 6.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -39.06 60.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.952 0.406 . . . . 0.0 110.368 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -68.45 -42.51 78.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.02 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.633 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -64.82 -40.97 96.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.58 ' CG1' HD13 ' A' 1310 ' ' ILE . 53.8 t -61.36 -47.85 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.441 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -64.17 -33.29 75.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.898 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.438 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.58 -50.42 63.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.59 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.7 m -69.59 -38.22 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.275 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.888 HG22 ' O ' ' A' 1324 ' ' ALA . 42.6 p -69.04 -48.93 61.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.155 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.39 -37.17 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.433 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -92.37 -5.56 51.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.108 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' 1276 ' ' VAL . 9.0 mmm180 57.34 17.63 3.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 19.7 mttm -145.45 134.17 22.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.58 116.56 28.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.895 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.875 ' O ' HG23 ' A' 1287 ' ' VAL . 1.0 OUTLIER -132.59 138.56 47.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.896 0.379 . . . . 0.0 111.257 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.606 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 32.1 mt -67.81 -38.07 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.493 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.1 t -69.24 -44.3 72.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.049 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1286 ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -59.55 -49.22 80.86 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.687 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' 1283 ' ' SER . 14.8 t -65.36 -31.38 53.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.611 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -59.48 -52.16 66.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 109.991 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -76.2 -35.8 58.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.283 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.431 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.96 -33.83 61.97 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.599 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.3 -7.26 21.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.657 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 56.18 53.33 9.1 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 110.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.689 HG22 ' NH1' ' A' 1297 ' ' ARG . 13.3 pt -129.82 147.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.246 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.88 150.43 18.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.966 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.592 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.38 -51.24 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.424 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -39.84 53.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.614 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.689 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.3 OUTLIER -65.61 -49.62 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.346 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.606 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.0 -48.79 70.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.501 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.11 -29.73 70.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.136 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -68.74 -50.77 47.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.633 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.9 mt -60.18 -43.62 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.4 mt -69.09 -32.63 54.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.57 -50.92 70.67 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.462 ' HG2' HD23 ' A' 1265 ' ' LEU . 0.0 OUTLIER -61.13 -35.72 77.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.249 178.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.682 ' HB3' HG13 ' A' 1311 ' ' VAL . 11.3 mtm -57.0 -38.19 72.73 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.602 ' N ' HG22 ' A' 1311 ' ' VAL . 3.0 tm-20 -69.63 -32.92 71.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.355 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.19 -28.78 61.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.692 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.643 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -91.43 -20.32 21.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.94 15.94 24.98 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.992 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.719 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.8 mt -85.31 -36.63 11.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.802 0.441 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' 1305 ' ' MET . 30.2 m -121.23 158.31 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.489 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.1 OUTLIER -105.3 -178.56 3.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.031 0.443 . . . . 0.0 111.618 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.656 -179.853 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.982 0.42 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.438 ' HG3' HG21 ' A' 1302 ' ' ILE . 6.0 mmt180 -107.07 140.32 40.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.281 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' 1311 ' ' VAL . 2.0 tt0 -86.29 132.68 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.836 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.4 t -91.66 118.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 110.243 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.32 -7.87 16.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.272 -179.115 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.888 ' O ' HG22 ' A' 1277 ' ' THR . . . -102.58 130.44 23.96 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.406 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.3 159.37 20.07 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.485 2.123 . . . . 0.0 112.947 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 55.6 Cg_exo -52.19 164.35 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.908 2.406 . . . . 0.0 112.507 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--N 1.343 0.276 0 C-N-CA 122.64 2.226 . . . . 0.0 112.239 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.7 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.831 0.348 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.06 144.9 45.16 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.095 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.52 -24.24 16.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.231 1.954 . . . . 0.0 112.485 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' 1291 ' ' PHE . 57.9 mt -102.11 -4.38 26.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' 1265 ' ' LEU . 44.9 t80 -47.48 -54.99 10.0 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -40.01 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.418 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 3.0 mt-30 -69.07 -42.22 76.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.619 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.14 -39.68 95.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.668 HG13 HD13 ' A' 1310 ' ' ILE . 42.5 t -61.99 -49.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.39 -30.54 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.854 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.465 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -68.6 -51.68 39.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -69.04 -37.43 77.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.498 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.837 HG22 ' O ' ' A' 1324 ' ' ALA . 48.2 p -69.67 -49.69 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.28 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.1 mt-10 -60.29 -35.57 75.87 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.936 0.398 . . . . 0.0 110.399 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -93.03 -5.16 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.092 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 18.4 mmm180 55.5 18.73 2.82 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.812 0.339 . . . . 0.0 110.81 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.1 mttt -145.64 131.18 18.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -112.88 116.37 29.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.683 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.79 ' O ' HG23 ' A' 1287 ' ' VAL . 1.8 p -132.49 142.47 49.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.209 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' 1299 ' ' ALA . 46.2 mt -71.02 -42.32 76.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.275 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 9.2 t -67.71 -40.58 84.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -61.07 -51.16 60.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.715 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' 1283 ' ' SER . 23.9 t -64.38 -29.77 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.292 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' 1293 ' ' ILE . 6.3 tt0 -60.19 -54.41 46.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 110.203 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -31.66 58.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.76 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.47 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 4.5 tp60 -75.03 -36.36 61.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.721 0.296 . . . . 0.0 111.544 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.29 -6.3 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.934 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 57.7 52.62 8.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.032 0.444 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.436 ' O ' ' HG3' ' A' 1288 ' ' GLN . 12.8 pt -130.21 149.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.061 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.72 148.57 26.75 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.146 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1295 ' ' TYR . . . . . . . . . . . . . 80.6 t80 -46.5 -51.62 14.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.454 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.78 -40.14 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.152 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.409 ' HE ' HG21 ' A' 1293 ' ' ILE . 0.0 OUTLIER -66.14 -48.87 69.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.449 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -54.03 -47.95 71.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.504 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.583 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -65.2 -29.89 70.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.018 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -67.57 -49.01 65.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.141 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.612 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.4 mt -61.26 -46.72 96.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.949 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.452 HG22 ' HE ' ' A' 1320 ' ' ARG . 11.1 mt -65.54 -34.46 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.887 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -48.89 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.426 ' CB ' ' CE2' ' A' 1269 ' ' PHE . 16.8 mt-30 -61.81 -35.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.231 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.646 ' HB3' HG13 ' A' 1311 ' ' VAL . 0.3 OUTLIER -56.95 -38.83 73.49 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.598 ' N ' HG22 ' A' 1311 ' ' VAL . 1.4 tm-20 -70.48 -33.34 71.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.4 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.39 63.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.585 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.615 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -90.81 -20.35 22.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.877 -178.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.88 16.34 26.25 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.817 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.4 mt -84.47 -34.76 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.271 -0.464 . . . . 0.0 111.04 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' 1305 ' ' MET . 27.8 m -120.21 159.87 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.418 ' CA ' HD11 ' A' 1323 ' ' LEU . 1.4 p -100.75 -178.65 3.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 111.307 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.437 179.82 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.978 0.418 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.562 ' HD2' HG21 ' A' 1311 ' ' VAL . 1.4 mtt-85 -107.48 140.41 40.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.428 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' 1311 ' ' VAL . 20.5 tp10 -84.11 132.76 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.547 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -90.4 118.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.98 0.419 . . . . 0.0 110.467 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.418 HD11 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.53 -12.22 15.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.214 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' 1277 ' ' THR . . . -96.65 131.64 27.78 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.233 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.21 158.12 17.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.464 2.109 . . . . 0.0 113.302 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.491 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -52.81 164.3 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.076 2.517 . . . . 0.0 112.669 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 N--CA 1.462 -0.368 0 C-N-CA 123.009 2.472 . . . . 0.0 111.846 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' 1269 ' ' PHE . 10.5 mt . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.56 142.86 86.8 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.979 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.73 -24.87 13.97 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.319 2.013 . . . . 0.0 112.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' 1291 ' ' PHE . 61.7 mt -102.14 -5.03 24.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.82 ' O ' HG23 ' A' 1273 ' ' VAL . 40.8 t80 -47.57 -53.49 14.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.8 -42.5 65.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.057 0.455 . . . . 0.0 110.396 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -66.75 -42.42 86.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.141 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.25 -39.3 94.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.79 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' 1269 ' ' PHE . 18.9 t -61.81 -50.61 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -62.24 -32.51 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.443 ' CD2' ' CE1' ' A' 1291 ' ' PHE . 2.4 t80 -67.17 -50.76 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.669 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.638 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.9 m -70.22 -36.78 69.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.345 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.858 HG22 ' O ' ' A' 1324 ' ' ALA . 50.7 p -71.23 -48.37 51.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.319 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' 1274 ' ' GLN . 34.1 mt-10 -61.36 -35.61 77.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -93.76 -4.11 50.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.989 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' 1276 ' ' VAL . 16.0 mmm180 53.95 19.5 2.02 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.55 132.51 20.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.638 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.15 116.4 28.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.922 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.859 ' O ' HG23 ' A' 1287 ' ' VAL . 7.5 p -132.65 140.47 48.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 22.1 mt -68.79 -40.64 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.28 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.507 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 42.1 t -67.58 -42.31 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.05 -49.25 80.63 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.777 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' 1283 ' ' SER . 14.6 t -65.91 -30.41 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.718 0.294 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.3 mt-30 -60.73 -51.05 70.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.179 0.514 . . . . 0.0 110.001 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -76.34 -36.68 58.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.169 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.44 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.9 OUTLIER -75.02 -34.34 61.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.612 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.602 ' HB3' HD13 ' A' 1268 ' ' LEU . 2.0 m-85 -103.27 -6.54 21.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.602 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 54.92 54.85 8.47 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.486 HD11 HG12 ' A' 1287 ' ' VAL . 12.9 pt -131.17 147.8 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.434 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.28 148.43 25.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.06 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 90.2 t80 -45.69 -50.75 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.547 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.73 -41.53 56.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -50.05 68.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.316 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.551 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.01 -49.97 67.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.526 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.48 -29.76 70.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.121 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.36 -50.59 52.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.92 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' 1272 ' ' ALA . 43.2 mt -59.87 -46.56 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.757 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.5 mt -65.84 -31.98 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.4 -52.12 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.576 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -58.25 -31.95 67.89 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.614 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.668 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.2 mtm -62.49 -39.68 94.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.608 ' N ' HG22 ' A' 1311 ' ' VAL . 3.2 tt0 -66.79 -31.95 72.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.583 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -75.18 -41.98 56.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.472 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.86 -20.32 58.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.883 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.13 16.87 26.57 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.003 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.733 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.2 mt -83.48 -39.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.831 0.452 . . . . 0.0 111.167 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' 1305 ' ' MET . 35.6 m -118.87 160.39 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.028 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.467 ' CA ' HD11 ' A' 1323 ' ' LEU . 0.7 OUTLIER -95.34 178.59 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 111.442 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.416 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 8.9 m-80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.117 0.484 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.453 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.5 140.43 40.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.234 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.4 tp10 -84.61 132.71 34.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.092 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.617 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.2 t -92.47 118.73 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.276 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.467 HD11 ' CA ' ' A' 1312 ' ' SER . 0.3 OUTLIER -109.01 -15.56 14.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.286 -179.118 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.858 ' O ' HG22 ' A' 1277 ' ' THR . . . -93.18 131.38 33.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.299 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.5 159.29 22.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.432 2.088 . . . . 0.0 113.01 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.534 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.55 164.39 0.91 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.922 2.415 . . . . 0.0 112.69 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.705 2.27 . . . . 0.0 112.34 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.853 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.9 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.116 0.484 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1266 ' ' ASP . . . . . 0.452 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -81.33 143.74 52.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.491 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.63 -26.37 22.57 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.398 2.065 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.8 mt -102.03 -0.59 33.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.873 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.853 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.2 t80 -47.65 -57.02 6.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -41.75 63.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.934 0.397 . . . . 0.0 110.417 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.468 ' OE1' HD23 ' A' 1268 ' ' LEU . 0.8 OUTLIER -66.07 -43.07 88.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.264 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.89 -41.78 95.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.327 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' 1277 ' ' THR . 98.8 t -60.67 -47.76 91.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.444 ' HA ' ' HG1' ' A' 1277 ' ' THR . 33.1 tt0 -64.37 -32.49 74.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.764 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.432 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.75 -50.32 63.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.626 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -68.7 -37.62 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.257 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 53.9 p -70.17 -49.21 52.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.241 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.36 -35.64 74.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.349 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -93.03 -7.68 45.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.035 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 2.5 mmm180 57.99 17.72 4.59 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.815 0.341 . . . . 0.0 110.602 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -145.54 133.25 21.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.626 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.76 116.54 28.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.676 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.722 ' O ' HG23 ' A' 1287 ' ' VAL . 13.2 p -132.42 138.08 47.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 111.265 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' 1299 ' ' ALA . 23.3 mt -66.01 -42.86 92.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.394 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 1.1 t -68.65 -37.99 80.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.805 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.49 -51.05 59.02 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.74 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -65.57 -29.73 47.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-O 120.904 0.383 . . . . 0.0 110.37 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' 1293 ' ' ILE . 7.2 tt0 -60.47 -55.13 37.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.184 0.516 . . . . 0.0 110.281 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -76.12 -30.37 58.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.553 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -75.06 -36.62 61.78 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.77 0.319 . . . . 0.0 111.531 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.23 -6.08 22.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 27.8 mtm105 58.46 48.4 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.041 0.448 . . . . 0.0 110.549 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.477 HG21 HD12 ' A' 1268 ' ' LEU . 14.9 pt -125.5 158.39 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.184 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -64.31 148.13 50.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.186 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.516 ' CE1' HG21 ' A' 1284 ' ' ILE . 91.2 t80 -45.66 -51.16 12.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.697 0.284 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.65 -41.94 55.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.967 0.413 . . . . 0.0 110.066 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.59 -49.79 69.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.161 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.78 -49.39 68.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.57 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.87 -29.9 71.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.113 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -50.56 50.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.245 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.594 HG21 ' CB ' ' A' 1272 ' ' ALA . 20.8 mt -59.45 -42.46 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.838 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.502 HG22 ' HE ' ' A' 1320 ' ' ARG . 22.2 mt -69.26 -34.5 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.716 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -51.61 67.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.364 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.416 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 21.8 mt-30 -59.32 -36.86 76.44 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.359 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.574 ' HB3' HG13 ' A' 1311 ' ' VAL . 18.9 mtm -57.12 -38.52 73.56 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.626 ' N ' HG22 ' A' 1311 ' ' VAL . 18.1 tt0 -69.44 -33.03 72.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.394 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.72 62.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.47 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.674 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -90.73 -20.39 22.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.807 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.13 13.33 29.24 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.933 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.742 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.8 mt -82.9 -37.84 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.053 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' 1306 ' ' GLU . 27.1 m -120.54 158.13 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.218 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.492 ' CB ' HD11 ' A' 1323 ' ' LEU . 1.2 p -101.22 -179.46 4.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.122 0.487 . . . . 0.0 111.686 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.501 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 44.1 m-80 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.954 0.407 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.502 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.41 140.37 40.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.388 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 17.9 tt0 -87.06 132.7 33.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.978 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.7 t -92.66 118.73 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.25 -11.47 15.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.227 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.87 131.56 26.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.238 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.07 159.15 15.51 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.542 2.162 . . . . 0.0 112.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.484 ' N ' ' HB ' ' A' 1277 ' ' THR . 52.1 Cg_exo -52.78 164.39 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.912 2.408 . . . . 0.0 112.469 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.582 2.188 . . . . 0.0 112.295 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.413 ' CD2' ' HG2' ' A' 1304 ' ' GLN . 1.8 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.904 0.383 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.86 144.12 32.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.51 -23.67 19.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.323 2.015 . . . . 0.0 112.368 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.586 HD23 ' OE1' ' A' 1271 ' ' GLN . 62.3 mt -102.06 -3.81 27.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.921 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' A' 1310 ' ' ILE . 43.7 t80 -47.51 -55.51 8.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 37.8 t0 -52.49 -41.59 63.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.586 ' OE1' HD23 ' A' 1268 ' ' LEU . 0.8 OUTLIER -66.37 -43.32 86.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.314 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.626 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -64.1 -41.04 97.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.251 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' 1269 ' ' PHE . 99.0 t -61.08 -47.89 91.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.58 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.639 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.432 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.4 -51.23 59.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.654 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.5 m -68.47 -36.7 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.482 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.886 HG22 ' O ' ' A' 1324 ' ' ALA . 45.6 p -70.6 -49.92 42.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.37 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.0 mt-10 -60.14 -33.93 72.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.369 . . . . 0.0 110.354 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -95.22 -5.58 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.018 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 55.99 18.52 3.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.839 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1281 ' ' LYS . . . . . 0.404 ' N ' HG21 ' A' 1322 ' ' VAL . 10.5 mttt -145.53 132.51 20.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.62 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.62 116.29 28.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.823 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.787 ' O ' HG23 ' A' 1287 ' ' VAL . 1.9 t -132.63 138.26 47.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 26.1 mt -66.49 -38.88 82.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.046 0.451 . . . . 0.0 110.117 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.486 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 27.5 t -69.68 -40.75 76.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.829 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1286 ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -61.51 -48.43 84.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' 1283 ' ' SER . 15.1 t -67.16 -29.66 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 120.745 0.307 . . . . 0.0 110.709 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -61.34 -54.49 43.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.186 0.517 . . . . 0.0 110.093 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -30.84 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.531 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' 1286 ' ' GLY . 4.1 tp60 -74.93 -38.11 61.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.23 -4.51 24.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.804 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 55.47 54.99 7.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.045 0.45 . . . . 0.0 110.485 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.436 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 10.2 pt -131.49 157.59 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.476 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -63.5 148.2 50.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.981 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.597 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.2 t80 -45.41 -51.52 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.551 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.79 -40.63 55.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.676 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.467 ' HD3' HD11 ' A' 1301 ' ' ILE . 0.0 OUTLIER -66.44 -48.2 70.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.562 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.9 -49.63 68.16 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.019 0.438 . . . . 0.0 110.649 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.515 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.98 -29.88 71.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.067 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -68.05 -50.22 56.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.039 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.626 HG21 ' CB ' ' A' 1272 ' ' ALA . 33.9 mt -60.68 -45.83 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.51 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.8 mt -66.56 -32.16 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.843 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -52.1 63.6 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.4 OUTLIER -58.73 -33.02 69.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.711 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.654 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.0 mtm -60.98 -40.87 95.08 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.613 ' N ' HG22 ' A' 1311 ' ' VAL . 1.4 tt0 -66.16 -33.23 75.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.827 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.466 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -20.37 58.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.783 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.19 15.88 26.82 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.046 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.2 mt -82.71 -38.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.817 0.447 . . . . 0.0 111.317 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' 1305 ' ' MET . 34.8 m -120.67 164.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.438 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -105.96 -178.12 3.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.069 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.676 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.002 0.429 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.51 ' HG3' HG21 ' A' 1302 ' ' ILE . 3.4 mtt180 -107.45 140.31 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.346 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' 1311 ' ' VAL . 53.5 tt0 -81.9 132.8 35.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.647 0.26 . . . . 0.0 111.067 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.5 t -90.26 118.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.141 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.438 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.25 -18.83 13.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.154 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' 1277 ' ' THR . . . -90.89 131.54 37.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.109 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.59 159.36 19.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.453 2.102 . . . . 0.0 113.026 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.496 ' N ' ' HB ' ' A' 1277 ' ' THR . 60.2 Cg_exo -51.6 158.01 4.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.005 2.47 . . . . 0.0 112.502 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.643 2.228 . . . . 0.0 112.422 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.804 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.6 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.92 0.39 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1266 ' ' ASP . . . . . 0.404 ' CB ' HG12 ' A' 1301 ' ' ILE . 24.8 t70 -87.98 145.07 35.66 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.426 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.21 -24.28 20.11 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.368 2.046 . . . . 0.0 112.505 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' 1291 ' ' PHE . 40.8 mt -102.14 -1.76 30.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.896 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.804 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.1 t80 -47.69 -55.21 9.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.0 t0 -52.51 -44.35 65.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 0.0 110.893 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.425 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 5.9 mt-30 -68.0 -37.93 82.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.076 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.631 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.9 95.2 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.661 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' 1269 ' ' PHE . 26.9 t -61.78 -47.81 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' 1278 ' ' GLU . 14.5 tt0 -63.49 -33.28 75.22 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.752 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.406 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -66.58 -51.61 54.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.7 m -68.9 -38.31 78.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.588 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.86 HG22 ' O ' ' A' 1324 ' ' ALA . 56.2 p -70.01 -48.42 58.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.12 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' 1274 ' ' GLN . 10.5 mm-40 -59.02 -37.16 76.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.369 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -92.81 -6.04 49.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.3 mmm180 57.64 17.48 4.06 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.783 0.325 . . . . 0.0 110.847 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.63 134.14 22.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.764 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' 1322 ' ' VAL . . . -114.86 116.4 28.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.705 0.288 . . . . 0.0 110.704 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.857 ' O ' HG23 ' A' 1287 ' ' VAL . 2.4 p -132.57 143.16 49.52 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.9 0.381 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.837 HG23 ' HB3' ' A' 1298 ' ' ALA . 50.0 mt -71.09 -39.51 74.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.11 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.441 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 38.6 t -66.77 -44.54 81.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.872 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1286 ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.57 -51.1 60.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.951 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' 1283 ' ' SER . 16.5 t -65.03 -31.83 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.011 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.499 ' HG3' ' HB2' ' A' 1298 ' ' ALA . 38.3 mt-30 -59.74 -51.77 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.069 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -76.24 -35.86 58.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.184 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' 1286 ' ' GLY . 0.1 OUTLIER -75.06 -33.37 61.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.497 -179.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.18 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.537 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 55.63 51.29 12.83 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.117 0.485 . . . . 0.0 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.696 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -127.13 149.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.324 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.8 151.04 21.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.004 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.558 ' CE1' HG21 ' A' 1284 ' ' ILE . 1.1 t80 -46.51 -54.59 8.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.716 0.293 . . . . 0.0 111.333 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.55 -36.55 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.696 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.8 OUTLIER -65.69 -49.31 69.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.837 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -54.01 -50.09 67.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.698 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.01 -29.77 71.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -68.8 -49.93 54.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.148 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.63 HG21 ' CB ' ' A' 1272 ' ' ALA . 26.6 mt -61.4 -44.43 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.853 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.533 HG22 ' HE ' ' A' 1320 ' ' ARG . 25.0 mt -67.55 -33.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.81 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -52.06 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.284 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.2 mt-30 -58.83 -36.84 75.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.254 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.578 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.7 mtm -57.7 -37.79 74.11 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.608 ' N ' HG22 ' A' 1311 ' ' VAL . 7.1 tt0 -69.4 -32.69 71.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.146 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.76 -30.43 62.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.376 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.681 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -88.52 -20.28 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.8 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.46 13.78 29.6 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.983 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.795 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.5 mt -83.99 -36.23 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.673 0.389 . . . . 0.0 111.319 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' 1306 ' ' GLU . 27.2 m -121.05 152.66 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.412 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.521 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.6 OUTLIER -97.27 -177.93 4.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.422 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.431 179.859 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.893 0.378 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.533 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.3 OUTLIER -107.4 140.42 40.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' 1311 ' ' VAL . 36.3 tt0 -80.46 132.67 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.17 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' 1282 ' ' ALA . 31.3 t -91.81 118.71 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.95 -8.48 15.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.338 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.86 ' O ' HG22 ' A' 1277 ' ' THR . . . -100.27 129.87 27.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.244 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.04 159.15 23.89 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.505 2.137 . . . . 0.0 113.029 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.519 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.7 Cg_exo -51.64 159.66 3.24 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.894 2.396 . . . . 0.0 112.503 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 122.61 2.207 . . . . 0.0 112.306 179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.751 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.2 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.918 0.389 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1266 ' ' ASP . . . . . 0.409 ' CB ' HG12 ' A' 1301 ' ' ILE . 20.6 t70 -86.56 144.8 38.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.48 -24.55 22.37 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.463 2.109 . . . . 0.0 112.497 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.2 mt -101.95 -1.36 32.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.751 ' CD2' HD22 ' A' 1265 ' ' LEU . 42.7 t80 -47.6 -56.27 7.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -52.39 -42.44 64.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.405 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.4 mt-30 -69.85 -37.14 76.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.183 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.649 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -67.0 -40.42 87.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.753 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.591 ' CG1' HD13 ' A' 1310 ' ' ILE . 57.5 t -62.52 -47.37 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.451 ' HA ' ' OG1' ' A' 1277 ' ' THR . 12.8 tt0 -64.04 -32.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.677 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.433 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.98 -51.1 59.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.478 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.3 m -68.3 -38.18 79.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.247 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 43.5 p -69.46 -49.28 56.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.249 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.4 mm-40 -59.89 -35.79 75.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.988 0.423 . . . . 0.0 110.411 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -6.18 48.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.025 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 19.9 mmm180 55.95 18.93 3.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.812 0.339 . . . . 0.0 110.553 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.56 131.29 18.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.643 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.643 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.55 116.41 29.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.633 0.254 . . . . 0.0 110.62 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.737 ' O ' HG23 ' A' 1287 ' ' VAL . 25.5 t -132.47 135.23 45.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' 1299 ' ' ALA . 36.8 mt -64.51 -41.54 92.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.199 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 31.6 t -70.19 -38.53 75.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.664 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.58 -49.43 73.53 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.479 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' 1283 ' ' SER . 21.8 t -66.63 -29.67 47.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.315 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1288 ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -60.95 -55.67 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.163 0.506 . . . . 0.0 110.321 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -28.81 57.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -75.06 -37.29 61.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.367 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.17 -5.23 23.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.727 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 57.9 49.09 12.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.492 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' 1297 ' ' ARG . 11.2 pt -124.86 163.97 24.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.068 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -70.58 147.98 44.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.623 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.499 ' CE1' HG21 ' A' 1284 ' ' ILE . 91.2 t80 -45.6 -50.52 13.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.76 -41.91 57.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.598 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.498 ' HD3' HD11 ' A' 1301 ' ' ILE . 0.0 OUTLIER -67.16 -47.43 71.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.17 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.91 -49.13 69.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.956 0.408 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.82 -29.72 70.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.807 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -51.28 59.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.313 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.649 HG21 ' CB ' ' A' 1272 ' ' ALA . 25.6 mt -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.053 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.58 HG21 ' HG3' ' A' 1320 ' ' ARG . 22.0 mt -67.93 -33.79 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.733 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.03 -51.38 69.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.435 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 11.3 mt-30 -59.66 -36.51 76.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.281 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.704 ' HB3' HG13 ' A' 1311 ' ' VAL . 15.1 mtm -57.45 -37.64 73.16 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.587 ' N ' HG22 ' A' 1311 ' ' VAL . 5.4 tt0 -69.55 -32.88 71.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.55 61.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.69 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.684 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -89.2 -20.44 24.18 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.43 17.09 22.93 Favored Glycine 0 C--N 1.328 0.131 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.949 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.8 mt -86.25 -36.22 10.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 122.811 0.444 . . . . 0.0 111.265 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.704 HG13 ' HB3' ' A' 1305 ' ' MET . 32.6 m -120.63 164.01 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.446 ' CA ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.68 -177.96 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.131 0.491 . . . . 0.0 111.708 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 14.1 mp0 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.59 -179.889 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 38.3 m-80 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.068 0.461 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.5 mmt180 -107.46 140.37 40.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.595 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.9 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.711 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 20.3 t -90.28 118.68 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 0.0 110.29 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.446 HD11 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.77 -6.49 16.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.484 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.46 132.47 20.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.413 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.26 159.35 20.17 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.433 2.089 . . . . 0.0 112.924 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.507 ' N ' ' HB ' ' A' 1277 ' ' THR . 65.1 Cg_exo -51.69 157.39 5.43 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.944 2.429 . . . . 0.0 112.6 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.84 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.8 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.966 0.412 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.28 144.4 46.67 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.325 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.29 -24.4 20.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.472 2.115 . . . . 0.0 112.556 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' 1291 ' ' PHE . 41.4 mt -102.04 -1.73 31.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.95 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.84 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.5 t80 -47.54 -55.46 9.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.52 -41.35 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.995 0.426 . . . . 0.0 110.391 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 1.6 mt-30 -66.67 -43.48 84.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.013 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.63 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.41 -40.26 96.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' 1269 ' ' PHE . 25.3 t -61.75 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' 1278 ' ' GLU . 23.1 tt0 -64.17 -32.23 73.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.705 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.479 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.46 -51.42 57.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.454 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.8 m -69.05 -39.93 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.623 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.801 HG22 ' O ' ' A' 1324 ' ' ALA . 76.2 p -67.74 -49.86 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.365 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.2 mt-10 -59.91 -36.63 77.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.964 0.411 . . . . 0.0 110.479 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.22 -6.25 53.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.016 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.1 mmm180 57.35 17.51 3.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.813 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.6 mttt -145.66 134.28 22.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.749 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.641 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.59 116.39 28.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.679 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.877 ' O ' HG23 ' A' 1287 ' ' VAL . 5.0 p -132.54 140.76 48.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.137 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 21.9 mt -69.55 -40.79 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.313 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 37.1 t -66.91 -43.78 82.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.116 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1286 ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -59.3 -49.53 77.49 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.793 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' 1283 ' ' SER . 15.9 t -65.12 -30.71 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.649 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 13.0 mt-30 -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.217 0.532 . . . . 0.0 109.978 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -35.8 58.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.186 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.446 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.1 tp60 -75.01 -34.91 61.98 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.612 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.0 m-85 -103.2 -6.66 21.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.606 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 55.6 55.15 7.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.039 0.447 . . . . 0.0 110.458 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.429 HG21 ' HE ' ' A' 1297 ' ' ARG . 13.5 pt -131.88 147.87 32.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.49 147.93 22.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.182 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.3 t80 -45.3 -50.24 12.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 111.446 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.78 -42.6 58.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.429 ' HE ' HG21 ' A' 1293 ' ' ILE . 0.0 OUTLIER -64.3 -49.23 72.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -53.9 -50.12 67.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.07 -29.69 71.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.063 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -68.08 -51.08 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.208 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.63 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.4 mt -59.53 -43.38 90.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.462 HG21 ' HG3' ' A' 1320 ' ' ARG . 19.9 mt -68.98 -33.63 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.915 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.14 -52.05 65.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.236 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.443 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 25.4 mt-30 -59.41 -36.92 76.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.226 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.601 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.5 mtm -57.35 -37.81 73.15 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' 1311 ' ' VAL . 3.1 tt0 -69.39 -33.07 72.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.01 -29.75 63.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.261 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.668 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -89.25 -20.29 24.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.782 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.77 12.74 31.61 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.949 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -83.07 -36.19 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.654 0.382 . . . . 0.0 111.341 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' 1306 ' ' GLU . 35.4 m -122.75 155.11 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.378 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.539 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -102.53 -177.97 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.188 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.343 179.777 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 19.8 m-80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.952 0.406 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.462 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.48 140.32 40.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.6 132.66 34.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.889 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' 1282 ' ' ALA . 31.8 t -92.24 118.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.539 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -108.51 -4.76 16.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.381 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.801 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.24 130.66 22.73 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.395 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.59 158.74 22.1 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.563 2.175 . . . . 0.0 113.153 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.523 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.8 Cg_exo -52.2 163.19 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.044 2.496 . . . . 0.0 112.712 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--N 1.344 0.312 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.791 HD22 ' CD2' ' A' 1269 ' ' PHE . 8.4 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.951 0.405 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1266 ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' 1268 ' ' LEU . 19.3 t70 -84.87 143.02 39.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.051 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.11 -23.87 23.75 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.388 2.059 . . . . 0.0 112.421 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.566 HD12 ' NH1' ' A' 1297 ' ' ARG . 74.4 mt -97.73 -6.65 32.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.524 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.791 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.5 t80 -47.29 -55.95 7.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.42 -40.99 62.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.957 0.408 . . . . 0.0 110.318 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.566 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 1.4 mt-30 -64.79 -49.16 71.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.892 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.641 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -60.31 -40.77 91.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.625 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' 1277 ' ' THR . 84.3 t -61.23 -48.52 88.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.406 ' HA ' ' HG1' ' A' 1277 ' ' THR . 77.3 mt-30 -65.46 -30.29 71.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.877 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.402 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.1 t80 -68.13 -49.08 63.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.438 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' 1282 ' ' ALA . 35.2 m -69.75 -40.75 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.293 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.834 HG22 ' O ' ' A' 1324 ' ' ALA . 76.4 p -67.62 -48.52 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.18 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -59.11 -38.12 78.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.493 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -90.68 -6.56 54.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.028 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.2 mmm180 59.76 15.71 5.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.938 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.55 136.94 25.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.785 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -116.3 116.36 27.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.908 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.871 ' O ' HG23 ' A' 1287 ' ' VAL . 13.1 t -132.52 139.14 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.199 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CB ' ' A' 1298 ' ' ALA . 31.3 mt -68.43 -38.46 79.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.8 t -68.78 -42.47 77.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.871 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1286 ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.73 -48.23 87.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.661 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' 1283 ' ' SER . 14.2 t -66.05 -30.94 51.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 110.673 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 21.9 mt-30 -60.88 -50.49 73.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.144 0.497 . . . . 0.0 110.048 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -76.32 -36.53 58.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.157 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.412 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.94 -33.95 62.01 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.566 -179.133 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.14 -6.38 22.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.535 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1292 ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' 1292 ' ' ARG . 13.8 mtp-105 53.95 54.96 8.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.097 0.475 . . . . 0.0 110.23 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.484 HG21 ' NH1' ' A' 1297 ' ' ARG . 13.9 pt -130.86 152.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.578 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -58.75 148.14 39.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.791 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.588 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 91.2 t80 -44.96 -51.85 9.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.54 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.82 -40.99 57.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.744 HH12 HD11 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.93 -47.87 76.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.99 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -56.37 -50.18 72.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -62.54 -29.88 70.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -68.08 -49.84 58.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.258 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.744 HD11 HH12 ' A' 1297 ' ' ARG . 40.2 mt -60.18 -44.21 94.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.059 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.491 HG21 ' HG3' ' A' 1320 ' ' ARG . 19.4 mt -68.68 -33.51 60.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.836 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -52.04 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.32 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.441 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 29.1 mt-30 -60.05 -36.39 77.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.341 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.593 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.7 mtm -57.05 -38.89 73.87 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.632 ' N ' HG22 ' A' 1311 ' ' VAL . 0.4 OUTLIER -68.81 -33.94 74.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.239 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -71.47 -30.82 66.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.47 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.63 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -88.78 -20.21 25.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.868 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.05 12.69 31.07 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.894 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.74 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.1 mt -82.53 -36.03 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 122.8 0.44 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.632 HG22 ' N ' ' A' 1306 ' ' GLU . 35.8 m -124.01 158.98 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.254 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.466 ' CA ' HD11 ' A' 1323 ' ' LEU . 1.0 OUTLIER -98.66 179.25 4.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 0.0 111.602 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.438 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 63.2 m-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.063 0.459 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.491 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.9 mmt180 -107.28 140.33 40.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.204 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.5 tp10 -83.39 132.72 34.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.976 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.0 t -91.39 118.78 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.982 0.42 . . . . 0.0 110.222 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.466 HD11 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -109.02 -6.23 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.448 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.834 ' O ' HG22 ' A' 1277 ' ' THR . . . -104.68 132.49 20.87 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.414 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.83 158.56 16.01 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.493 2.129 . . . . 0.0 113.043 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.51 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.0 Cg_exo -53.27 163.49 2.37 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.97 2.447 . . . . 0.0 112.526 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.298 179.888 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.805 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.9 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.044 0.449 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1266 ' ' ASP . . . . . 0.405 ' CB ' HG12 ' A' 1301 ' ' ILE . 10.0 t70 -84.62 143.99 41.96 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.404 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.35 -25.53 18.55 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.519 2.146 . . . . 0.0 112.869 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' 1291 ' ' PHE . 36.6 mt -102.06 -0.15 34.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.805 ' CD2' HD22 ' A' 1265 ' ' LEU . 43.5 t80 -47.7 -56.38 7.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -42.78 64.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.418 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 5.3 mt-30 -69.48 -36.51 76.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.241 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.673 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -67.75 -41.65 83.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.684 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.553 HG13 HG21 ' A' 1310 ' ' ILE . 97.9 t -61.99 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.4 OUTLIER -64.77 -32.41 74.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.615 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.408 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -67.41 -50.71 58.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.666 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.8 m -68.23 -37.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.335 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.887 HG22 ' O ' ' A' 1324 ' ' ALA . 43.2 p -69.98 -48.83 56.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.222 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' 1274 ' ' GLN . 6.2 mm-40 -59.66 -35.16 73.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.527 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -95.97 -4.16 43.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.8 mmm180 54.95 19.42 2.66 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.906 0.384 . . . . 0.0 110.873 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1281 ' ' LYS . . . . . 0.427 ' N ' HG21 ' A' 1322 ' ' VAL . 1.4 mttp -145.46 131.64 19.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.96 116.42 29.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.642 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.815 ' O ' HG23 ' A' 1287 ' ' VAL . 30.2 t -132.46 141.84 48.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.651 HD13 ' HB2' ' A' 1299 ' ' ALA . 62.2 mt -70.29 -43.44 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 27.7 t -68.06 -40.59 82.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.883 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.07 60.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.781 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' 1283 ' ' SER . 22.3 t -65.19 -29.93 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.266 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' 1293 ' ' ILE . 13.3 tt0 -59.8 -51.86 67.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -76.28 -35.59 58.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.065 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.414 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.06 -33.3 61.7 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.596 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.16 -7.85 20.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.762 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 56.62 51.78 10.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.161 0.505 . . . . 0.0 110.29 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.464 HG21 HD12 ' A' 1268 ' ' LEU . 19.1 pt -129.17 146.03 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.11 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -50.89 149.77 6.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.319 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' 1284 ' ' ILE . 87.8 t80 -47.64 -53.43 14.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.444 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.77 -36.95 39.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -67.07 -50.21 62.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.175 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -55.21 -46.35 75.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.628 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.651 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -65.91 -29.9 70.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.175 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -49.36 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.315 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.673 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.0 mt -60.66 -42.43 91.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.965 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.554 ' HA ' ' HE3' ' A' 1305 ' ' MET . 26.5 mt -68.76 -35.29 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -51.09 70.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.486 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.417 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 17.4 mt-30 -59.88 -37.04 78.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.428 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.611 ' HB3' HG13 ' A' 1311 ' ' VAL . 19.6 mtm -56.98 -38.39 72.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.604 ' N ' HG22 ' A' 1311 ' ' VAL . 2.2 tt0 -69.93 -32.81 71.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.37 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.54 -31.47 65.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.426 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.661 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -88.12 -20.3 25.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.918 -178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.63 13.81 29.1 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.719 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.2 mt -82.85 -36.42 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 122.892 0.477 . . . . 0.0 111.251 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' 1305 ' ' MET . 26.7 m -121.31 160.49 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.541 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.435 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -106.97 -178.53 3.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.516 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.65 -179.954 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.925 0.393 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.534 ' HD3' HG21 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.06 140.24 40.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.351 179.314 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' 1311 ' ' VAL . 15.3 tp10 -75.37 132.58 41.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.992 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 20.6 t -87.3 118.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -105.7 -19.04 13.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.269 -178.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.887 ' O ' HG22 ' A' 1277 ' ' THR . . . -91.96 133.49 30.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.262 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.19 159.02 15.26 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.498 2.132 . . . . 0.0 113.02 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.489 ' N ' ' HB ' ' A' 1277 ' ' THR . 56.6 Cg_exo -52.01 159.35 3.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.903 2.402 . . . . 0.0 112.477 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 112.394 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.741 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.4 mt . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.996 0.427 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.87 143.64 43.62 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.43 -24.18 27.08 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.394 2.063 . . . . 0.0 112.272 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' 1291 ' ' PHE . 65.9 mt -97.53 -5.37 35.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.6 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.741 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.0 t80 -47.47 -55.93 8.06 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.52 -40.77 62.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.396 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.568 ' OE1' HD23 ' A' 1268 ' ' LEU . 0.9 OUTLIER -67.52 -43.26 81.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.082 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.08 -41.19 99.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.905 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' 1269 ' ' PHE . 29.7 t -61.1 -48.51 88.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' 1278 ' ' GLU . 45.0 tt0 -63.18 -33.56 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.441 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -65.9 -51.6 57.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.62 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.638 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.2 m -69.31 -38.46 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.7 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.85 HG22 ' O ' ' A' 1324 ' ' ALA . 51.4 p -69.23 -49.86 52.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.21 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.4 mt-10 -59.8 -36.37 76.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.971 0.415 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -91.81 -6.49 51.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.018 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.6 mmm180 56.9 18.12 3.7 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.887 0.375 . . . . 0.0 110.744 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 132.35 20.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.737 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.638 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.98 116.49 29.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.788 ' O ' HG23 ' A' 1287 ' ' VAL . 0.5 OUTLIER -132.29 141.37 48.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.903 0.382 . . . . 0.0 111.139 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' 1299 ' ' ALA . 25.4 mt -69.13 -43.31 81.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 21.3 t -67.01 -40.3 87.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.978 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.65 -51.12 60.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' 1283 ' ' SER . 21.1 t -64.83 -29.91 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.311 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' 1293 ' ' ILE . 4.0 tt0 -59.75 -52.68 64.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.092 0.472 . . . . 0.0 110.135 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 -35.23 58.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.18 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.435 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -34.67 61.78 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.632 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.14 -7.38 21.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 56.82 55.02 6.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.135 0.493 . . . . 0.0 110.526 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' 1288 ' ' GLN . 13.3 pt -133.23 145.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -51.06 148.86 7.71 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.491 ' CE1' HG21 ' A' 1284 ' ' ILE . 89.2 t80 -47.05 -52.7 14.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.543 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.72 -38.5 47.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 110.052 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -50.59 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.068 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.53 -44.43 72.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.429 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -66.94 -29.74 69.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -50.55 53.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.567 HG21 ' CB ' ' A' 1272 ' ' ALA . 20.8 mt -59.92 -42.33 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.01 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.544 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.9 mt -69.45 -34.6 62.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.774 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.94 -52.05 65.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.393 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.434 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 31.6 mt-30 -58.41 -38.03 76.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.259 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.566 ' HB3' HG13 ' A' 1311 ' ' VAL . 21.3 mtm -57.53 -37.33 72.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.326 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.626 ' N ' HG22 ' A' 1311 ' ' VAL . 2.2 tt0 -69.21 -32.66 72.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.181 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.675 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -87.25 -20.31 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.715 -178.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.5 12.94 31.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.009 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.3 mt -83.65 -34.92 10.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.473 -0.363 . . . . 0.0 111.403 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' 1306 ' ' GLU . 35.6 m -124.44 154.4 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.622 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.44 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.1 OUTLIER -104.47 179.65 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.901 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 52.5 m-80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.875 0.369 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.544 ' HG3' HG21 ' A' 1302 ' ' ILE . 4.7 mtt180 -107.22 140.2 40.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.54 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' 1311 ' ' VAL . 19.7 tp10 -81.95 132.66 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.767 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.5 t -88.81 118.61 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 110.047 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -106.31 -13.03 15.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.38 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' 1277 ' ' THR . . . -99.22 132.34 23.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.275 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.46 159.04 22.57 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.525 2.15 . . . . 0.0 113.026 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.515 ' N ' ' HB ' ' A' 1277 ' ' THR . 57.2 Cg_exo -51.64 152.31 12.97 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.038 2.492 . . . . 0.0 112.687 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 C--N 1.344 0.34 0 C-N-CA 122.625 2.217 . . . . 0.0 112.318 179.857 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.422 HD13 ' CD1' ' A' 1269 ' ' PHE . 3.3 mt . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.105 0.479 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1266 ' ' ASP . . . . . 0.425 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -80.38 141.74 53.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -51.73 -24.13 17.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.349 2.033 . . . . 0.0 112.584 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.598 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.2 mt -102.11 -4.51 25.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.035 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.843 ' O ' HG23 ' A' 1273 ' ' VAL . 39.9 t80 -47.67 -53.11 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -46.08 66.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.0 110.294 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.491 ' OE1' HD23 ' A' 1268 ' ' LEU . 1.3 mp0 -63.9 -43.25 96.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.25 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.602 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -62.1 -39.36 92.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.982 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' 1269 ' ' PHE . 17.2 t -61.65 -49.57 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.425 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.0 OUTLIER -62.61 -33.28 74.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.841 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.415 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.49 -50.87 61.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.0 m -69.57 -38.02 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.432 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.84 HG22 ' O ' ' A' 1324 ' ' ALA . 67.1 p -69.31 -50.25 48.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.0 mm-40 -59.17 -36.78 75.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.484 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -92.69 -6.14 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 29.1 mmm180 56.01 18.74 3.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.817 0.341 . . . . 0.0 110.651 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1281 ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' 1322 ' ' VAL . 24.1 mttp -145.62 133.67 21.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.61 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -116.85 116.23 27.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.898 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.814 ' O ' HG23 ' A' 1287 ' ' VAL . 0.5 OUTLIER -132.54 143.25 49.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.022 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 16.1 mt -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 14.8 t -67.38 -40.59 85.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.059 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1286 ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.65 -50.41 67.94 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.778 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' 1283 ' ' SER . 13.4 t -65.51 -30.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 110.635 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.7 mt-30 -60.76 -51.54 68.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.061 0.458 . . . . 0.0 109.936 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -36.58 58.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.097 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.427 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.98 -34.37 61.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.714 0.293 . . . . 0.0 111.626 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.15 -6.51 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.562 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 54.67 54.97 8.46 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.483 HG21 HD12 ' A' 1268 ' ' LEU . 14.7 pt -131.97 150.39 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.583 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.61 148.32 26.82 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.252 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.1 t80 -45.96 -50.99 14.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.559 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.76 -40.67 55.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.467 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.88 -49.74 69.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.558 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.98 -49.54 68.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.86 -30.0 71.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -49.8 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.985 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.557 HG21 ' CB ' ' A' 1272 ' ' ALA . 33.6 mt -60.71 -45.55 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.842 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.474 HG22 ' HE ' ' A' 1320 ' ' ARG . 21.0 mt -66.79 -32.46 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.864 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -52.2 59.67 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.6 OUTLIER -57.86 -33.32 68.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.758 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.604 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.3 mtm -62.7 -39.37 93.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' 1311 ' ' VAL . 28.1 tt0 -66.35 -32.28 73.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.416 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.88 -42.11 58.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.281 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -20.19 60.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.604 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.42 15.3 30.29 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.743 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.0 mt -83.64 -35.28 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.65 0.38 . . . . 0.0 111.502 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' 1306 ' ' GLU . 29.6 m -122.4 159.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.573 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.42 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.19 178.19 4.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.819 -179.992 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.474 ' HE ' HG22 ' A' 1302 ' ' ILE . 2.2 mtt-85 -107.18 140.2 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.655 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1311 ' ' VAL . 13.5 tt0 -83.61 132.72 34.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.749 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' 1282 ' ' ALA . 19.3 t -87.92 118.57 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.321 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.42 HD11 ' CB ' ' A' 1312 ' ' SER . 0.8 OUTLIER -105.81 -10.25 16.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.053 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' 1277 ' ' THR . . . -100.21 129.91 27.16 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.192 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -82.62 158.48 16.54 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.573 2.182 . . . . 0.0 113.175 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.439 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -53.97 164.26 2.63 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.993 2.462 . . . . 0.0 112.32 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--N 1.344 0.331 0 C-N-CA 122.701 2.268 . . . . 0.0 112.432 179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.518 HD13 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.029 0.442 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 8.7 t0 -75.77 141.38 72.0 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.0 -24.57 10.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.441 2.094 . . . . 0.0 112.945 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' 1291 ' ' PHE . 60.0 mt -102.18 -5.03 24.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' 1273 ' ' VAL . 45.9 t80 -47.66 -52.67 17.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.6 t0 -52.67 -42.2 64.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 0.0 110.328 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.56 -43.06 81.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.989 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -61.64 -38.98 89.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.873 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' 1269 ' ' PHE . 21.2 t -62.13 -52.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.476 ' HG3' ' HG3' ' A' 1327 ' ' PRO . 0.1 OUTLIER -61.43 -30.62 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.941 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.479 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 3.1 t80 -68.91 -51.04 44.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.697 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' 1282 ' ' ALA . 35.3 m -69.74 -36.93 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.403 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.837 HG22 ' O ' ' A' 1324 ' ' ALA . 65.9 p -69.68 -50.76 40.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.352 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.5 mm-40 -61.01 -35.19 76.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -7.99 52.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.793 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1280 ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 56.65 18.04 3.44 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1281 ' ' LYS . . . . . 0.401 ' N ' HG21 ' A' 1322 ' ' VAL . 7.7 mttm -145.66 133.44 21.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.644 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.47 116.44 28.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.723 0.297 . . . . 0.0 110.779 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.825 ' O ' HG23 ' A' 1287 ' ' VAL . 11.1 t -132.49 141.31 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.16 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.707 HD13 ' HB2' ' A' 1299 ' ' ALA . 72.3 mt -68.6 -47.62 76.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.4 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 25.8 t -63.8 -40.68 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.043 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.96 62.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.969 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -64.35 -29.96 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' 1293 ' ' ILE . 0.0 OUTLIER -60.8 -50.84 71.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.108 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -36.35 58.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.994 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.412 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -32.91 61.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.725 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.2 -7.78 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.761 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 59.05 50.35 8.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.53 ' O ' ' NE2' ' A' 1288 ' ' GLN . 10.2 pt -126.56 171.39 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -77.01 154.06 42.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.924 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.5 ' CE1' HG21 ' A' 1284 ' ' ILE . 82.6 t80 -49.11 -55.84 10.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.822 0.311 . . . . 0.0 111.251 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.65 -33.42 22.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.113 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -70.32 -50.89 34.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.865 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.494 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -55.78 -46.74 77.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.555 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.707 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -66.79 -29.98 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.98 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -67.42 -48.93 65.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.893 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.567 HG21 ' CB ' ' A' 1272 ' ' ALA . 50.1 mt -61.39 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.789 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' 1284 ' ' ILE . 20.0 mt -63.09 -31.69 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.734 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -47.6 82.98 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.635 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.8 mt-30 -60.64 -33.4 72.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.197 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.683 ' HB3' HG13 ' A' 1311 ' ' VAL . 0.6 OUTLIER -61.6 -40.32 94.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.605 ' N ' HG22 ' A' 1311 ' ' VAL . 12.5 tt0 -65.86 -35.72 81.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.871 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.93 -41.36 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.265 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -20.4 59.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.762 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 98.07 15.76 35.03 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.773 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.783 HG23 ' HB3' ' A' 1324 ' ' ALA . 8.6 mt -82.41 -36.18 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 122.791 0.436 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.683 HG13 ' HB3' ' A' 1305 ' ' MET . 26.8 m -120.23 162.41 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.475 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.53 -177.96 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.73 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.9 m-80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.965 0.412 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.538 ' HD2' HG21 ' A' 1311 ' ' VAL . 0.2 OUTLIER -107.32 140.28 40.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.439 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' 1311 ' ' VAL . 14.4 tt0 -88.41 132.81 34.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.2 t -90.67 118.69 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.487 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -107.19 -18.3 13.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.021 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' 1277 ' ' THR . . . -91.46 130.17 40.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.292 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.01 158.61 23.94 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.474 2.116 . . . . 0.0 113.133 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.523 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.1 Cg_exo -52.44 161.46 2.8 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.017 2.478 . . . . 0.0 112.57 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1327 ' ' PRO . . . . . 0.476 ' HG3' ' HG3' ' A' 1274 ' ' GLN . 18.9 Cg_endo . . . . . 0 C--N 1.344 0.334 0 C-N-CA 122.757 2.305 . . . . 0.0 112.241 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.706 HD13 ' CD1' ' A' 1269 ' ' PHE . 12.3 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.25 144.49 62.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.215 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.62 -23.27 19.28 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.47 2.114 . . . . 0.0 112.16 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' 1291 ' ' PHE . 85.4 mt -99.2 -6.92 27.3 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.793 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.706 ' CD1' HD13 ' A' 1265 ' ' LEU . 38.4 t80 -47.54 -56.14 7.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.49 -40.1 61.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.848 0.356 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.45 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.8 mt-30 -71.0 -38.89 72.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.134 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.61 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.26 -40.01 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' 1269 ' ' PHE . 47.2 t -62.86 -47.55 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.431 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.5 OUTLIER -63.67 -33.55 75.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.729 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.411 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.14 -51.26 59.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.588 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -69.51 -37.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.437 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.867 HG22 ' O ' ' A' 1324 ' ' ALA . 44.5 p -69.96 -49.2 54.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.6 mt-10 -60.34 -35.91 76.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -92.33 -6.18 50.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.911 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.5 mmm180 56.93 17.7 3.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.766 0.317 . . . . 0.0 110.85 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 133.4 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.822 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.645 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.51 116.53 29.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.782 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.844 ' O ' HG23 ' A' 1287 ' ' VAL . 1.4 t -132.44 136.13 46.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.574 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 32.1 mt -66.41 -37.9 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.138 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.498 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.8 t -69.35 -43.11 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.85 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1286 ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.17 -48.57 85.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.714 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' 1283 ' ' SER . 12.0 t -66.02 -31.27 52.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.683 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 19.3 mt-30 -59.92 -51.22 70.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 109.998 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -36.77 58.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.261 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.424 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.96 -33.91 61.96 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.611 -179.005 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.61 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.11 -7.01 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.568 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 54.65 54.08 9.73 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.009 0.433 . . . . 0.0 110.261 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.21 146.72 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.516 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.44 149.0 10.57 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.314 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.6 t80 -46.48 -51.79 14.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.8 -39.7 53.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.197 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -50.67 64.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.574 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.88 -49.78 67.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.997 0.427 . . . . 0.0 110.544 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.11 -29.68 70.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.061 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -68.2 -51.63 43.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.549 HG21 ' CB ' ' A' 1272 ' ' ALA . 36.4 mt -59.57 -44.33 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.94 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.454 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.0 mt -67.91 -32.93 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -52.11 66.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.422 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.427 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 0.1 OUTLIER -60.2 -36.9 78.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.617 ' HB3' HG13 ' A' 1311 ' ' VAL . 16.9 mtm -56.94 -36.38 70.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 CA-C-O 121.557 0.694 . . . . 0.0 109.174 178.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' 1311 ' ' VAL . 4.6 tp10 -70.21 -33.14 71.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.055 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.41 62.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.475 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.671 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -88.07 -20.43 25.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.908 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.57 16.05 25.51 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.958 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.637 HG23 ' HB3' ' A' 1324 ' ' ALA . 14.0 mt -85.26 -36.64 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.303 -0.448 . . . . 0.0 111.184 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' 1305 ' ' MET . 35.0 m -120.58 156.64 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.524 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.3 -178.19 3.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.108 0.48 . . . . 0.0 111.657 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.515 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 27.4 m-80 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.9 0.381 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.454 ' HG3' HG21 ' A' 1302 ' ' ILE . 7.8 mmt180 -107.24 140.27 40.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.168 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' 1311 ' ' VAL . 4.9 tp10 -87.48 132.67 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -91.79 118.69 37.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 110.099 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.524 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.82 -4.92 17.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.457 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.79 130.98 22.15 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.02 159.42 23.94 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.461 2.107 . . . . 0.0 113.041 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.518 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.47 158.49 3.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.081 2.521 . . . . 0.0 112.582 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.345 0.389 0 C-N-CA 122.691 2.261 . . . . 0.0 112.442 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.832 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.9 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.922 0.391 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1266 ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' 1301 ' ' ILE . 19.7 t70 -74.48 144.98 81.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.376 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.46 -24.25 21.38 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.377 2.051 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.563 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.3 mt -101.98 -1.76 31.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.909 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.832 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.1 t80 -47.7 -56.51 7.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.37 -41.81 63.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.074 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.411 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.5 mt-30 -70.1 -37.48 75.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.661 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -65.91 -41.65 91.18 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.689 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.608 HG13 HG21 ' A' 1310 ' ' ILE . 57.6 t -61.75 -48.48 88.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.461 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.786 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.435 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -66.87 -51.74 51.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.547 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.4 m -67.6 -37.43 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.121 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 42.6 p -69.47 -49.45 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.178 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.6 -35.03 73.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1279 ' ' LYS . . . . . 0.413 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 2.7 mtmt -93.91 -6.98 44.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.018 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.4 mmm180 58.04 17.2 4.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.625 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.6 133.58 21.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.627 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.34 116.44 29.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.818 ' O ' HG23 ' A' 1287 ' ' VAL . 4.4 t -132.39 138.26 47.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.359 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.572 HG12 HD12 ' A' 1302 ' ' ILE . 24.1 mt -67.92 -38.77 80.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.161 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.477 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.0 t -69.69 -42.83 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.962 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1286 ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.72 -50.18 70.47 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.584 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -65.44 -29.92 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.723 0.297 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -60.41 -52.72 64.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.105 0.479 . . . . 0.0 110.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -76.31 -34.59 59.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.027 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.441 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.5 tp60 -75.12 -34.01 61.64 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.394 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.624 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.44 22.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.704 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 54.77 51.53 13.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.174 0.512 . . . . 0.0 110.047 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.596 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.6 pt -126.89 150.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.36 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -57.61 147.64 35.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.85 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.604 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 86.8 t80 -44.84 -49.5 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 111.47 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.77 -43.47 58.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.807 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.596 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.0 OUTLIER -65.3 -47.27 77.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.417 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.562 ' CB ' HG23 ' A' 1284 ' ' ILE . . . -53.8 -49.94 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.675 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.3 -29.78 70.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.015 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -49.79 56.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.409 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.661 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.2 mt -60.88 -42.51 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.776 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.572 HD12 HG12 ' A' 1284 ' ' ILE . 29.1 mt -69.06 -35.3 68.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.741 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -52.01 66.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.384 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.446 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.1 mt-30 -59.32 -37.58 78.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.354 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.603 ' HB3' HG13 ' A' 1311 ' ' VAL . 17.4 mtm -57.13 -37.43 71.99 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' 1311 ' ' VAL . 2.8 tt0 -70.25 -32.33 70.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.141 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.67 -29.01 62.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.338 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.665 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -90.13 -20.33 23.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.741 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.85 13.76 28.74 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.063 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.1 mt -84.39 -35.84 11.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 122.799 0.439 . . . . 0.0 111.456 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' 1306 ' ' GLU . 30.3 m -122.03 155.84 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.732 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.495 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.74 -177.98 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.758 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 23.7 m-80 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.89 0.376 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1320 ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -107.18 140.13 40.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.399 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.0 tp10 -80.0 132.64 36.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.056 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' 1282 ' ' ALA . 18.2 t -88.55 118.56 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.495 HD11 ' CB ' ' A' 1312 ' ' SER . 0.6 OUTLIER -105.73 -13.88 15.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -178.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.47 132.6 24.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.35 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.51 159.02 19.5 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.553 2.169 . . . . 0.0 113.074 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.9 Cg_exo -52.16 161.09 2.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.913 2.409 . . . . 0.0 112.66 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.345 0.356 0 C-N-CA 122.669 2.246 . . . . 0.0 112.25 179.885 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' 1269 ' ' PHE . 6.9 mt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.975 0.417 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.62 143.78 79.43 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.197 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.66 -23.63 15.72 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.256 1.971 . . . . 0.0 112.217 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.5 mt -102.08 -5.48 24.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.777 ' O ' HG23 ' A' 1273 ' ' VAL . 39.4 t80 -47.71 -54.13 13.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -52.61 -41.69 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -67.52 -42.67 82.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.609 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -62.78 -39.12 93.21 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.72 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' 1269 ' ' PHE . 21.6 t -62.04 -51.27 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.7 tt0 -61.79 -31.57 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.894 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.439 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -68.25 -50.88 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.632 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -69.18 -37.27 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.287 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.845 HG22 ' O ' ' A' 1324 ' ' ALA . 74.1 p -69.64 -50.64 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' 1274 ' ' GLN . 8.3 mm-40 -59.46 -36.09 75.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.404 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -8.25 48.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 57.71 17.74 4.3 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.462 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1281 ' ' LYS . . . . . 0.408 ' N ' HG21 ' A' 1322 ' ' VAL . 29.7 mttt -145.61 132.1 19.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.792 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.648 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.02 116.49 30.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.727 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.791 ' O ' HG23 ' A' 1287 ' ' VAL . 34.6 t -132.29 139.87 48.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 111.276 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' 1299 ' ' ALA . 22.5 mt -68.48 -43.31 83.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 2.8 t -67.16 -41.18 86.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.978 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.49 -51.14 60.59 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.79 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' 1283 ' ' SER . 21.8 t -64.52 -29.96 48.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.958 0.409 . . . . 0.0 110.263 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' 1293 ' ' ILE . 5.9 tt0 -59.63 -53.07 62.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.248 0.547 . . . . 0.0 110.208 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -35.16 59.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.102 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.424 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -75.09 -33.34 61.64 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.683 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.27 -7.71 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 57.56 52.39 8.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.067 0.461 . . . . 0.0 110.494 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1293 ' ' ILE . . . . . 0.674 HG22 ' NH1' ' A' 1297 ' ' ARG . 13.2 pt -130.01 148.33 33.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.031 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.48 150.28 16.93 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.924 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.45 ' CE1' HG21 ' A' 1284 ' ' ILE . 89.1 t80 -47.59 -51.28 21.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.78 -38.54 48.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.529 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.674 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.1 OUTLIER -66.92 -49.38 65.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.139 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.469 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.62 -45.77 73.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.666 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.537 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -67.05 -29.87 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.063 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -49.97 57.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.046 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.609 HG21 ' CB ' ' A' 1272 ' ' ALA . 39.9 mt -60.57 -45.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.786 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.544 HG22 ' HE ' ' A' 1320 ' ' ARG . 19.8 mt -66.12 -32.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.853 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -52.2 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.534 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -60.14 -32.03 70.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.758 178.414 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.674 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.8 mtm -61.3 -39.05 89.03 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' 1311 ' ' VAL . 1.7 tt0 -67.22 -32.93 74.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.372 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.05 -42.11 63.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.42 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.413 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.1 OUTLIER -76.31 -20.28 57.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.871 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.53 16.37 27.01 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.997 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.0 mt -83.12 -37.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 122.76 0.424 . . . . 0.0 111.279 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' 1305 ' ' MET . 34.8 m -120.65 159.54 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.507 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -107.6 -177.92 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.867 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.419 179.81 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 11.7 m-80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.947 0.403 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.564 ' HD2' HG21 ' A' 1311 ' ' VAL . 0.7 OUTLIER -107.45 140.3 40.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.566 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.52 132.71 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.253 . . . . 0.0 110.622 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 18.3 t -89.51 118.69 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.94 0.4 . . . . 0.0 110.319 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.507 HD11 ' CB ' ' A' 1312 ' ' SER . 0.8 OUTLIER -106.51 -19.99 13.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.931 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.845 ' O ' HG22 ' A' 1277 ' ' THR . . . -89.67 129.86 45.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.9 158.88 21.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.094 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.498 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.1 Cg_exo -53.13 164.32 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.922 2.414 . . . . 0.0 112.411 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 122.617 2.211 . . . . 0.0 112.232 179.859 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1265 ' ' LEU . . . . . 0.818 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.2 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.89 0.376 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -85.87 145.11 40.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.365 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -52.52 -24.03 21.04 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1268 ' ' LEU . . . . . 0.585 HD23 ' OE1' ' A' 1271 ' ' GLN . 45.2 mt -102.05 -1.52 31.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.862 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1269 ' ' PHE . . . . . 0.818 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.6 t80 -47.56 -56.88 6.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.34 -41.04 62.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1271 ' ' GLN . . . . . 0.585 ' OE1' HD23 ' A' 1268 ' ' LEU . 0.8 OUTLIER -66.78 -42.3 86.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 178.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1272 ' ' ALA . . . . . 0.623 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -65.01 -41.9 94.91 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1273 ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' 1269 ' ' PHE . 61.1 t -60.11 -48.16 89.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1274 ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.5 tt0 -64.13 -33.26 75.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.744 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1275 ' ' PHE . . . . . 0.448 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -65.65 -50.7 64.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.585 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1276 ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -69.28 -40.26 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.492 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1277 ' ' THR . . . . . 0.853 HG22 ' O ' ' A' 1324 ' ' ALA . 67.0 p -67.99 -49.53 61.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1278 ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' 1274 ' ' GLN . 11.7 mm-40 -59.68 -36.3 76.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -92.28 -6.06 51.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.22 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 28.0 mmm180 58.24 16.84 4.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 110.9 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 2.9 mttm -145.61 134.75 22.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1282 ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' 1322 ' ' VAL . . . -115.67 116.43 28.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.665 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1283 ' ' SER . . . . . 0.879 ' O ' HG23 ' A' 1287 ' ' VAL . 8.7 p -132.52 140.76 48.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1284 ' ' ILE . . . . . 0.571 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 21.2 mt -69.22 -40.5 80.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.287 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1285 ' ' SER . . . . . 0.505 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 45.5 t -67.8 -42.79 81.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.014 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.46 78.29 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.706 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1287 ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' 1283 ' ' SER . 15.5 t -65.49 -30.74 51.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 15.1 mt-30 -60.22 -51.37 69.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.216 0.532 . . . . 0.0 109.949 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -36.1 58.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.233 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1290 ' ' GLN . . . . . 0.439 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.02 -34.64 61.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.618 -178.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1291 ' ' PHE . . . . . 0.59 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.31 -6.48 21.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.551 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 54.96 55.01 8.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 110.381 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 15.2 pt -131.73 147.26 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.435 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.99 149.29 11.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.284 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.0 t80 -46.77 -51.46 16.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.458 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -39.45 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.458 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1297 ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' 1301 ' ' ILE . 0.3 OUTLIER -66.23 -49.49 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.27 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1298 ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.95 -49.36 68.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.642 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1299 ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.81 -29.79 70.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -68.55 -50.52 51.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.244 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1301 ' ' ILE . . . . . 0.623 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.5 mt -60.13 -43.49 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.833 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1302 ' ' ILE . . . . . 0.489 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.2 mt -68.83 -33.69 60.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.928 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.89 66.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.335 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1304 ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 22.9 mt-30 -59.43 -36.76 76.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.303 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1305 ' ' MET . . . . . 0.583 ' HB3' HG13 ' A' 1311 ' ' VAL . 17.1 mtm -57.01 -38.54 73.24 Favored 'General case' 0 C--O 1.228 -0.058 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1306 ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' 1311 ' ' VAL . 5.1 tt0 -69.46 -33.04 72.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.303 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.09 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.404 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1308 ' ' GLN . . . . . 0.676 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -89.18 -20.32 24.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.26 13.89 27.52 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.963 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1310 ' ' ILE . . . . . 0.772 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.4 mt -83.67 -38.49 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 122.743 0.417 . . . . 0.0 111.266 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1311 ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' 1306 ' ' GLU . 32.6 m -120.22 155.78 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.144 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1312 ' ' SER . . . . . 0.435 ' CB ' HD11 ' A' 1323 ' ' LEU . 1.0 OUTLIER -96.46 -179.9 4.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.623 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.396 180.0 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.025 0.44 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1320 ' ' ARG . . . . . 0.489 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.7 mmt180 -107.6 140.33 40.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.31 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.3 tt0 -85.44 132.67 34.18 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.862 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1322 ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' 1282 ' ' ALA . 29.4 t -92.86 118.69 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.967 0.413 . . . . 0.0 110.139 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1323 ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.11 -13.54 14.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.233 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1324 ' ' ALA . . . . . 0.853 ' O ' HG22 ' A' 1277 ' ' THR . . . -95.57 130.41 32.03 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.24 159.29 23.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.531 2.154 . . . . 0.0 113.028 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1326 ' ' PRO . . . . . 0.525 ' N ' ' HB ' ' A' 1277 ' ' THR . 63.0 Cg_exo -51.68 159.67 3.28 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.06 2.507 . . . . 0.0 112.678 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.266 179.921 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 75.9 m80 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.781 0.324 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -166.79 -99.33 0.13 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.534 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -57.95 -21.72 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.726 0.298 . . . . 0.0 111.375 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -54.87 -37.24 66.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 111.161 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.2 -38.13 3.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.856 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.4 mt -75.49 160.03 30.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.167 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1266 ' ' ASP . . . . . 0.449 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.9 t70 -79.33 144.14 61.52 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.554 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 -25.78 20.58 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.555 2.17 . . . . 0.0 112.627 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.557 HD13 ' HB3' ' A' 1291 ' ' PHE . 63.1 mt -101.94 -2.65 29.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.856 ' CD2' HD22 ' A' 1265 ' ' LEU . 38.8 t80 -47.57 -55.09 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.47 -45.31 66.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.946 0.403 . . . . 0.0 110.905 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -67.32 -38.21 84.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.24 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.627 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.41 94.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.665 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' 1269 ' ' PHE . 23.5 t -62.11 -47.87 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' 1278 ' ' GLU . 33.1 tt0 -63.55 -33.91 76.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.881 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.4 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.14 -50.47 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -70.1 -37.59 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.471 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.835 HG22 ' O ' ' A' 1324 ' ' ALA . 55.0 p -70.09 -49.48 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.1 mt-10 -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.285 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -91.39 -7.18 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.9 mmm180 57.52 17.85 4.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -145.56 133.23 21.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.774 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.74 116.38 28.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.832 ' O ' HG23 ' A' 1287 ' ' VAL . 3.2 p -132.57 138.98 47.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.869 0.366 . . . . 0.0 111.22 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' 1299 ' ' ALA . 19.7 mt -67.24 -40.14 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 47.6 t -68.51 -41.52 79.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.51 -49.93 73.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.638 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' 1283 ' ' SER . 12.0 t -65.92 -30.11 48.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.603 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.74 -51.16 70.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.124 0.488 . . . . 0.0 110.011 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -76.2 -37.07 58.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.162 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.41 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.04 -33.34 61.73 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.512 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.69 21.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.403 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 54.16 52.86 11.93 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.051 0.453 . . . . 0.0 110.226 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.478 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 19.8 pt -129.83 148.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.544 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.61 148.07 22.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.22 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.603 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.9 t80 -45.31 -50.23 12.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.4 p30 -50.84 -41.82 58.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.705 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.478 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.8 -49.68 69.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.253 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.521 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -53.98 -50.0 67.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.5 -29.83 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.189 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -50.55 51.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.144 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.581 HG21 ' CB ' ' A' 1272 ' ' ALA . 34.0 mt -60.43 -43.71 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.953 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.559 HG22 ' HE ' ' A' 1320 ' ' ARG . 22.2 mt -68.63 -33.95 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.759 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -51.98 65.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.415 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.425 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 7.0 mt-30 -59.06 -36.11 74.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.569 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.3 mtm -58.37 -37.14 74.63 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.618 ' N ' HG22 ' A' 1311 ' ' VAL . 36.8 tt0 -69.7 -32.24 70.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.32 62.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.343 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.667 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -89.62 -20.31 23.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.792 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.31 12.98 32.04 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.912 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -83.23 -35.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 122.618 0.367 . . . . 0.0 111.204 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' 1306 ' ' GLU . 27.5 m -122.38 154.47 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.449 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.492 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.6 OUTLIER -102.77 -177.85 3.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.615 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -65.78 135.45 54.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.509 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1314 ' ' GLN . . . . . 0.417 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 33.8 mt-30 -67.68 133.45 49.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.255 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -119.25 -39.59 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.887 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.77 -157.98 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.51 91.78 7.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.32 . . . . 0.0 111.173 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.93 10.02 86.52 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.321 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -97.79 122.16 40.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 111.4 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.559 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.2 OUTLIER -107.42 140.26 40.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.369 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' 1311 ' ' VAL . 5.8 tt0 -86.05 132.69 33.99 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.803 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' 1282 ' ' ALA . 26.9 t -91.21 118.59 36.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.933 0.396 . . . . 0.0 110.106 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.0 -10.82 15.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.385 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' 1277 ' ' THR . . . -99.88 130.68 25.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.09 159.59 23.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 113.039 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.524 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.1 Cg_exo -51.67 163.74 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.903 2.402 . . . . 0.0 112.587 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.96 -35.51 11.92 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.715 2.277 . . . . 0.0 112.412 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -100.62 -51.03 3.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.898 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 2.6 m-70 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.862 0.363 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -155.35 -63.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.494 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -62.24 -28.4 69.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.353 . . . . 0.0 111.216 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -57.37 -28.53 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.89 -37.31 6.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.571 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.782 HD13 ' CD1' ' A' 1269 ' ' PHE . 7.5 mt -72.59 160.07 32.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.225 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.33 144.27 94.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.75 -24.83 13.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.191 1.927 . . . . 0.0 112.273 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.2 mt -102.16 -5.28 24.61 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.835 ' O ' HG23 ' A' 1273 ' ' VAL . 38.4 t80 -47.71 -53.39 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -52.6 -45.42 66.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.408 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.4 mt-30 -67.96 -37.95 82.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.634 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.29 -39.16 93.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.305 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' 1269 ' ' PHE . 19.2 t -62.83 -49.18 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' 1278 ' ' GLU . 22.2 tt0 -62.79 -32.5 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.792 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.429 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -67.95 -50.58 55.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.68 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.3 m -69.72 -38.01 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.844 HG22 ' O ' ' A' 1324 ' ' ALA . 57.6 p -69.73 -49.91 48.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.113 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.2 mt-10 -59.09 -36.95 76.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.999 0.428 . . . . 0.0 110.292 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1279 ' ' LYS . . . . . 0.414 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 4.0 mtmt -89.79 -9.52 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.008 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.1 mmm180 59.97 16.65 5.98 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.833 0.349 . . . . 0.0 110.478 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 3.8 mttp -145.55 134.43 22.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.623 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.18 116.61 28.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.802 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.834 ' O ' HG23 ' A' 1287 ' ' VAL . 3.2 p -132.55 139.72 47.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.601 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 24.6 mt -68.56 -39.31 80.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.203 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.504 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 48.1 t -69.13 -42.45 75.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.29 69.22 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.569 -0.825 . . . . 0.0 111.583 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' 1283 ' ' SER . 17.6 t -65.31 -30.34 49.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.597 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.27 -52.01 67.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 110.097 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -36.19 58.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.125 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.411 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -74.98 -33.13 61.84 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.559 -179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.38 21.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.631 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 55.8 51.96 11.54 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.128 0.489 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.688 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -128.7 147.77 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.85 150.23 18.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.024 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.593 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.34 -51.26 15.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.397 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 5.9 p30 -50.7 -40.07 53.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.56 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.688 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.4 OUTLIER -64.98 -50.28 66.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.329 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.601 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.99 -49.93 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.507 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.32 -29.9 71.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.209 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -68.49 -50.48 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.99 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.585 HG21 ' CB ' ' A' 1272 ' ' ALA . 40.7 mt -60.74 -46.41 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.774 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.463 HG21 ' HG3' ' A' 1320 ' ' ARG . 18.7 mt -66.17 -31.45 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.948 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -63.73 -52.26 61.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -59.22 -32.0 69.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.643 178.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.591 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.7 mtm -62.63 -39.55 94.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.619 ' N ' HG22 ' A' 1311 ' ' VAL . 3.2 tt0 -67.38 -32.05 72.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.283 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.09 -42.05 63.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.248 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.406 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.1 OUTLIER -76.21 -20.24 57.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.774 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.46 13.94 31.48 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.055 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -81.21 -36.79 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.806 0.442 . . . . 0.0 111.492 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.619 HG22 ' N ' ' A' 1306 ' ' GLU . 33.3 m -121.38 159.57 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.207 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.459 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.5 OUTLIER -103.84 -178.06 3.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.078 0.466 . . . . 0.0 111.732 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -65.88 135.91 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1314 ' ' GLN . . . . . 0.408 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 11.6 mt-30 -67.75 135.39 52.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.09 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -124.93 -44.27 0.28 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.855 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.17 -159.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.3 p30 -92.6 91.74 7.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 0.0 111.14 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.87 10.04 86.5 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.359 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -98.89 122.13 41.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.14 0.47 . . . . 0.0 111.597 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.463 ' HG3' HG21 ' A' 1302 ' ' ILE . 4.6 mmt180 -107.43 140.31 40.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.368 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' 1311 ' ' VAL . 18.0 tt0 -86.44 132.63 33.89 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.879 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.576 HG22 ' HB2' ' A' 1282 ' ' ALA . 23.6 t -91.35 118.71 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.23 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.459 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.67 -12.79 15.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.326 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.844 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.3 131.61 27.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.55 159.3 22.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.418 2.079 . . . . 0.0 113.012 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.539 ' N ' ' HB ' ' A' 1277 ' ' THR . 71.0 Cg_exo -51.57 156.42 6.28 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.965 2.443 . . . . 0.0 112.712 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.36 -59.17 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.701 2.267 . . . . 0.0 112.516 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -108.77 52.1 0.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.903 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.913 0.387 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 171.82 -36.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -60.83 -28.32 68.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.734 0.302 . . . . 0.0 111.173 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.36 -31.22 65.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.52 -34.95 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.686 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt -68.96 160.09 31.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1266 ' ' ASP . . . . . 0.413 ' CB ' HG12 ' A' 1301 ' ' ILE . 18.6 t70 -72.95 142.39 82.88 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.154 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -51.23 -25.04 16.53 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.323 2.015 . . . . 0.0 112.49 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' 1291 ' ' PHE . 41.9 mt -102.14 -3.63 27.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' 1273 ' ' VAL . 43.6 t80 -47.79 -53.02 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -52.72 -44.06 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.044 0.45 . . . . 0.0 110.539 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.426 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 7.1 mt-30 -66.58 -40.49 88.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.145 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.603 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.97 -39.74 94.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.739 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' 1269 ' ' PHE . 16.2 t -61.4 -51.72 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' 1278 ' ' GLU . 19.9 tt0 -60.74 -32.04 71.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.857 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.466 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -67.29 -52.14 44.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.8 m -69.17 -35.31 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.855 HG22 ' O ' ' A' 1324 ' ' ALA . 69.3 p -72.19 -49.06 38.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.2 mt-10 -60.35 -35.3 75.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.192 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.7 -5.12 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.939 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.6 mmm180 53.63 20.69 2.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.882 0.373 . . . . 0.0 110.649 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -145.61 129.87 17.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.636 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.645 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -111.98 116.47 30.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.742 0.306 . . . . 0.0 110.631 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.837 ' O ' HG23 ' A' 1287 ' ' VAL . 11.3 t -132.46 139.86 48.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' 1299 ' ' ALA . 16.4 mt -68.63 -40.75 82.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.272 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 28.6 t -67.82 -41.87 82.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1286 ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.28 -49.94 73.03 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.823 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' 1283 ' ' SER . 12.7 t -65.99 -29.79 47.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 17.4 mt-30 -60.76 -52.66 64.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.126 0.489 . . . . 0.0 109.867 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -76.27 -34.87 59.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.961 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.522 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -73.8 -37.01 65.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.762 0.315 . . . . 0.0 111.508 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' 1268 ' ' LEU . 1.8 m-85 -103.19 -5.15 23.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.839 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 55.02 8.49 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 148.53 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.384 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -53.76 149.81 14.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.125 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.597 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.4 t80 -47.09 -51.94 16.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 111.507 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -38.35 46.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.588 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -49.33 65.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.249 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.535 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.64 -49.86 69.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.563 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.36 -29.86 71.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -51.4 48.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.012 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.603 HG21 ' CB ' ' A' 1272 ' ' ALA . 41.8 mt -60.01 -45.21 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.83 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' 1305 ' ' MET . 21.5 mt -66.27 -32.56 58.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -50.23 67.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.612 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.5 mt-30 -57.16 -34.49 68.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.242 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.595 ' HB3' HG13 ' A' 1311 ' ' VAL . 16.0 mtm -63.33 -39.15 93.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.27 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.603 ' N ' HG22 ' A' 1311 ' ' VAL . 1.9 tt0 -66.41 -31.67 72.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.591 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.48 44.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.23 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -20.21 59.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.756 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 99.8 16.07 29.64 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.001 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' 1324 ' ' ALA . 9.6 mt -84.03 -36.8 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 122.566 0.346 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' 1306 ' ' GLU . 27.1 m -119.93 161.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.341 . . . . 0.0 111.211 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.462 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.01 178.18 4.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.371 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.87 132.53 48.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.54 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -67.84 130.98 44.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.292 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -118.25 -40.32 0.69 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.873 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1316 ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 0.9 OUTLIER -85.03 -156.66 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.529 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -96.29 91.88 6.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 111.219 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.9 10.09 86.47 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.456 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1319 ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 47.1 m-80 -98.08 122.11 40.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.227 0.513 . . . . 0.0 111.292 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.446 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.56 140.28 40.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.475 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' 1311 ' ' VAL . 47.0 tt0 -89.66 132.68 35.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.819 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -92.29 118.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.29 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.462 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.39 -13.06 15.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.855 ' O ' HG22 ' A' 1277 ' ' THR . . . -95.39 129.37 35.22 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -80.96 159.11 20.97 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.494 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.6 Cg_exo -52.34 164.37 1.33 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.977 2.452 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.56 -33.11 87.87 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.655 2.236 . . . . 0.0 112.302 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.07 33.05 3.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.871 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 34.1 m170 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.84 0.353 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -166.2 111.88 0.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.345 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -60.87 -25.23 66.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.73 0.3 . . . . 0.0 111.245 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -55.68 -35.11 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.118 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.6 -27.46 8.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.11 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.857 HD22 ' CD2' ' A' 1269 ' ' PHE . 11.3 mt -92.24 160.01 15.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.076 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.06 145.8 44.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.229 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.62 -23.54 20.09 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.286 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' 1291 ' ' PHE . 58.0 mt -102.04 -3.39 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.852 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.857 ' CD2' HD22 ' A' 1265 ' ' LEU . 42.5 t80 -47.6 -56.62 6.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -39.06 60.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.952 0.406 . . . . 0.0 110.368 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -68.45 -42.51 78.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.02 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.633 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -64.82 -40.97 96.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.58 ' CG1' HD13 ' A' 1310 ' ' ILE . 53.8 t -61.36 -47.85 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.441 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -64.17 -33.29 75.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.898 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.438 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.58 -50.42 63.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.59 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.7 m -69.59 -38.22 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.275 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.888 HG22 ' O ' ' A' 1324 ' ' ALA . 42.6 p -69.04 -48.93 61.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.155 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.39 -37.17 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.433 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -92.37 -5.56 51.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.108 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' 1276 ' ' VAL . 9.0 mmm180 57.34 17.63 3.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 19.7 mttm -145.45 134.17 22.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.58 116.56 28.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.895 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.875 ' O ' HG23 ' A' 1287 ' ' VAL . 1.0 OUTLIER -132.59 138.56 47.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.896 0.379 . . . . 0.0 111.257 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.606 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 32.1 mt -67.81 -38.07 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.493 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.1 t -69.24 -44.3 72.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.049 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1286 ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -59.55 -49.22 80.86 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.687 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' 1283 ' ' SER . 14.8 t -65.36 -31.38 53.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.611 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -59.48 -52.16 66.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 109.991 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -76.2 -35.8 58.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.283 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.431 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.96 -33.83 61.97 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.599 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.3 -7.26 21.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.657 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 56.18 53.33 9.1 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 110.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.689 HG22 ' NH1' ' A' 1297 ' ' ARG . 13.3 pt -129.82 147.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.246 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.88 150.43 18.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.966 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.592 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.38 -51.24 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.424 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -39.84 53.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.614 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.689 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.3 OUTLIER -65.61 -49.62 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.346 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.606 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.0 -48.79 70.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.501 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.11 -29.73 70.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.136 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -68.74 -50.77 47.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.633 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.9 mt -60.18 -43.62 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.4 mt -69.09 -32.63 54.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.57 -50.92 70.67 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.462 ' HG2' HD23 ' A' 1265 ' ' LEU . 0.0 OUTLIER -61.13 -35.72 77.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.249 178.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.682 ' HB3' HG13 ' A' 1311 ' ' VAL . 11.3 mtm -57.0 -38.19 72.73 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.602 ' N ' HG22 ' A' 1311 ' ' VAL . 3.0 tm-20 -69.63 -32.92 71.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.355 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.19 -28.78 61.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.692 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.643 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -91.43 -20.32 21.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.94 15.94 24.98 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.992 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.719 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.8 mt -85.31 -36.63 11.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.802 0.441 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' 1305 ' ' MET . 30.2 m -121.23 158.31 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.489 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.1 OUTLIER -105.3 -178.56 3.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.031 0.443 . . . . 0.0 111.618 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.82 135.82 55.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.656 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1314 ' ' GLN . . . . . 0.406 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 58.2 mt-30 -67.74 133.24 48.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.085 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -123.16 -42.34 0.4 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.793 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.56 -157.02 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -95.64 91.76 6.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 111.154 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.85 10.08 86.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.292 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -100.17 122.3 42.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 111.598 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.438 ' HG3' HG21 ' A' 1302 ' ' ILE . 6.0 mmt180 -107.07 140.32 40.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.281 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' 1311 ' ' VAL . 2.0 tt0 -86.29 132.68 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.836 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.4 t -91.66 118.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 110.243 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.32 -7.87 16.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.272 -179.115 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.888 ' O ' HG22 ' A' 1277 ' ' THR . . . -102.58 130.44 23.96 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.406 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.3 159.37 20.07 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.485 2.123 . . . . 0.0 112.947 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 55.6 Cg_exo -52.19 164.35 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.908 2.406 . . . . 0.0 112.507 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.5 -35.89 7.46 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.64 2.226 . . . . 0.0 112.239 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -137.14 -65.21 0.55 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.824 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.844 0.354 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 140.6 73.06 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -59.88 -24.31 64.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.33 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -54.87 -35.73 64.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.105 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.52 -31.09 6.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.7 mt -78.18 160.06 28.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.06 144.9 45.16 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.095 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.52 -24.24 16.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.231 1.954 . . . . 0.0 112.485 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' 1291 ' ' PHE . 57.9 mt -102.11 -4.38 26.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' 1265 ' ' LEU . 44.9 t80 -47.48 -54.99 10.0 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -40.01 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.418 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 3.0 mt-30 -69.07 -42.22 76.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.619 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.14 -39.68 95.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.668 HG13 HD13 ' A' 1310 ' ' ILE . 42.5 t -61.99 -49.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.39 -30.54 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.854 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.465 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -68.6 -51.68 39.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -69.04 -37.43 77.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.498 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.837 HG22 ' O ' ' A' 1324 ' ' ALA . 48.2 p -69.67 -49.69 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.28 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.1 mt-10 -60.29 -35.57 75.87 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.936 0.398 . . . . 0.0 110.399 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -93.03 -5.16 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.092 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 18.4 mmm180 55.5 18.73 2.82 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.812 0.339 . . . . 0.0 110.81 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.1 mttt -145.64 131.18 18.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -112.88 116.37 29.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.683 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.79 ' O ' HG23 ' A' 1287 ' ' VAL . 1.8 p -132.49 142.47 49.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.209 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' 1299 ' ' ALA . 46.2 mt -71.02 -42.32 76.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.275 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 9.2 t -67.71 -40.58 84.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -61.07 -51.16 60.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.715 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' 1283 ' ' SER . 23.9 t -64.38 -29.77 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.292 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' 1293 ' ' ILE . 6.3 tt0 -60.19 -54.41 46.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 110.203 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -31.66 58.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.76 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.47 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 4.5 tp60 -75.03 -36.36 61.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.721 0.296 . . . . 0.0 111.544 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.29 -6.3 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.934 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 57.7 52.62 8.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.032 0.444 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.436 ' O ' ' HG3' ' A' 1288 ' ' GLN . 12.8 pt -130.21 149.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.061 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.72 148.57 26.75 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.146 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1295 ' ' TYR . . . . . . . . . . . . . 80.6 t80 -46.5 -51.62 14.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.454 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.78 -40.14 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.152 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.409 ' HE ' HG21 ' A' 1293 ' ' ILE . 0.0 OUTLIER -66.14 -48.87 69.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.449 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -54.03 -47.95 71.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.504 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.583 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -65.2 -29.89 70.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.018 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -67.57 -49.01 65.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.141 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.612 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.4 mt -61.26 -46.72 96.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.949 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.452 HG22 ' HE ' ' A' 1320 ' ' ARG . 11.1 mt -65.54 -34.46 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.887 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -48.89 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.426 ' CB ' ' CE2' ' A' 1269 ' ' PHE . 16.8 mt-30 -61.81 -35.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.231 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.646 ' HB3' HG13 ' A' 1311 ' ' VAL . 0.3 OUTLIER -56.95 -38.83 73.49 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.598 ' N ' HG22 ' A' 1311 ' ' VAL . 1.4 tm-20 -70.48 -33.34 71.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.4 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.39 63.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.585 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.615 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -90.81 -20.35 22.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.877 -178.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.88 16.34 26.25 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.817 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.4 mt -84.47 -34.76 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.271 -0.464 . . . . 0.0 111.04 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' 1305 ' ' MET . 27.8 m -120.21 159.87 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.418 ' CA ' HD11 ' A' 1323 ' ' LEU . 1.4 p -100.75 -178.65 3.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 111.307 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -65.84 133.14 50.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.437 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1314 ' ' GLN . . . . . 0.4 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 44.5 mt-30 -67.76 132.58 47.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.107 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -125.1 -43.81 0.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.764 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1316 ' ' HIS . . . . . 0.418 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 1.1 t60 -80.35 -154.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.48 91.69 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 111.21 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.95 10.12 86.44 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.504 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1319 ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 1.9 m-80 -103.68 122.02 44.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.202 0.501 . . . . 0.0 111.432 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.562 ' HD2' HG21 ' A' 1311 ' ' VAL . 1.4 mtt-85 -107.48 140.41 40.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.428 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' 1311 ' ' VAL . 20.5 tp10 -84.11 132.76 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.547 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -90.4 118.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.98 0.419 . . . . 0.0 110.467 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.418 HD11 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.53 -12.22 15.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.214 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' 1277 ' ' THR . . . -96.65 131.64 27.78 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.233 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.21 158.12 17.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.464 2.109 . . . . 0.0 113.302 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.491 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -52.81 164.3 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.076 2.517 . . . . 0.0 112.669 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -83.8 -151.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.009 2.472 . . . . 0.0 111.846 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -61.2 -33.46 73.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.881 0.372 . . . . 0.0 110.937 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.901 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.771 0.319 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 88.41 -124.43 7.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.19 68.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.35 -29.41 63.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.026 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.38 -34.92 6.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.718 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' 1269 ' ' PHE . 10.5 mt -85.64 160.02 19.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.083 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.56 142.86 86.8 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.979 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.73 -24.87 13.97 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.319 2.013 . . . . 0.0 112.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' 1291 ' ' PHE . 61.7 mt -102.14 -5.03 24.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.82 ' O ' HG23 ' A' 1273 ' ' VAL . 40.8 t80 -47.57 -53.49 14.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.8 -42.5 65.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.057 0.455 . . . . 0.0 110.396 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -66.75 -42.42 86.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.141 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.25 -39.3 94.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.79 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' 1269 ' ' PHE . 18.9 t -61.81 -50.61 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -62.24 -32.51 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.443 ' CD2' ' CE1' ' A' 1291 ' ' PHE . 2.4 t80 -67.17 -50.76 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.669 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.638 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.9 m -70.22 -36.78 69.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.345 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.858 HG22 ' O ' ' A' 1324 ' ' ALA . 50.7 p -71.23 -48.37 51.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.319 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' 1274 ' ' GLN . 34.1 mt-10 -61.36 -35.61 77.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -93.76 -4.11 50.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.989 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' 1276 ' ' VAL . 16.0 mmm180 53.95 19.5 2.02 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.55 132.51 20.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.638 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.15 116.4 28.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.922 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.859 ' O ' HG23 ' A' 1287 ' ' VAL . 7.5 p -132.65 140.47 48.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 22.1 mt -68.79 -40.64 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.28 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.507 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 42.1 t -67.58 -42.31 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.05 -49.25 80.63 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.777 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' 1283 ' ' SER . 14.6 t -65.91 -30.41 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.718 0.294 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.3 mt-30 -60.73 -51.05 70.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.179 0.514 . . . . 0.0 110.001 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -76.34 -36.68 58.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.169 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.44 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.9 OUTLIER -75.02 -34.34 61.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.612 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.602 ' HB3' HD13 ' A' 1268 ' ' LEU . 2.0 m-85 -103.27 -6.54 21.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.602 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 54.92 54.85 8.47 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.486 HD11 HG12 ' A' 1287 ' ' VAL . 12.9 pt -131.17 147.8 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.434 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.28 148.43 25.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.06 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 90.2 t80 -45.69 -50.75 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.547 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.73 -41.53 56.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -50.05 68.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.316 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.551 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.01 -49.97 67.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.526 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.48 -29.76 70.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.121 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.36 -50.59 52.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.92 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' 1272 ' ' ALA . 43.2 mt -59.87 -46.56 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.757 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.5 mt -65.84 -31.98 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.4 -52.12 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.576 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -58.25 -31.95 67.89 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.614 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.668 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.2 mtm -62.49 -39.68 94.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.608 ' N ' HG22 ' A' 1311 ' ' VAL . 3.2 tt0 -66.79 -31.95 72.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.583 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -75.18 -41.98 56.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.472 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.86 -20.32 58.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.883 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.13 16.87 26.57 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.003 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.733 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.2 mt -83.48 -39.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.831 0.452 . . . . 0.0 111.167 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' 1305 ' ' MET . 35.6 m -118.87 160.39 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.028 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.467 ' CA ' HD11 ' A' 1323 ' ' LEU . 0.7 OUTLIER -95.34 178.59 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 111.442 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.89 134.76 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.416 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1314 ' ' GLN . . . . . 0.404 ' HG3' ' NE ' ' A' 1320 ' ' ARG . 0.0 OUTLIER -67.75 141.12 56.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.056 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -146.71 -46.8 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.746 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.36 -157.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 4.4 p30 -104.96 91.7 3.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 111.174 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.72 10.14 86.43 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.495 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -110.69 122.01 46.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.313 0.557 . . . . 0.0 111.847 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.453 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.5 140.43 40.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.234 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.4 tp10 -84.61 132.71 34.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.092 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.617 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.2 t -92.47 118.73 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.276 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.467 HD11 ' CA ' ' A' 1312 ' ' SER . 0.3 OUTLIER -109.01 -15.56 14.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.286 -179.118 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.858 ' O ' HG22 ' A' 1277 ' ' THR . . . -93.18 131.38 33.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.299 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.5 159.29 22.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.432 2.088 . . . . 0.0 113.01 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.534 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.55 164.39 0.91 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.922 2.415 . . . . 0.0 112.69 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.76 -35.07 16.98 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.705 2.27 . . . . 0.0 112.34 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -98.25 36.69 1.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.934 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.871 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 15.0 m80 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.815 0.341 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -123.47 37.95 2.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.554 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -58.14 -22.01 49.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.693 0.283 . . . . 0.0 111.276 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -54.82 -36.7 65.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.92 -38.33 3.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.805 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.853 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.9 mt -72.74 160.02 32.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.125 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1266 ' ' ASP . . . . . 0.452 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -81.33 143.74 52.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.491 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.63 -26.37 22.57 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.398 2.065 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.8 mt -102.03 -0.59 33.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.873 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.853 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.2 t80 -47.65 -57.02 6.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -41.75 63.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.934 0.397 . . . . 0.0 110.417 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.468 ' OE1' HD23 ' A' 1268 ' ' LEU . 0.8 OUTLIER -66.07 -43.07 88.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.264 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.89 -41.78 95.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.327 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' 1277 ' ' THR . 98.8 t -60.67 -47.76 91.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.444 ' HA ' ' HG1' ' A' 1277 ' ' THR . 33.1 tt0 -64.37 -32.49 74.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.764 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.432 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.75 -50.32 63.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.626 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -68.7 -37.62 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.257 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 53.9 p -70.17 -49.21 52.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.241 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.36 -35.64 74.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.349 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -93.03 -7.68 45.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.035 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 2.5 mmm180 57.99 17.72 4.59 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.815 0.341 . . . . 0.0 110.602 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -145.54 133.25 21.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.626 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.76 116.54 28.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.676 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.722 ' O ' HG23 ' A' 1287 ' ' VAL . 13.2 p -132.42 138.08 47.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 111.265 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' 1299 ' ' ALA . 23.3 mt -66.01 -42.86 92.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.394 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 1.1 t -68.65 -37.99 80.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.805 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.49 -51.05 59.02 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.74 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -65.57 -29.73 47.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-O 120.904 0.383 . . . . 0.0 110.37 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' 1293 ' ' ILE . 7.2 tt0 -60.47 -55.13 37.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.184 0.516 . . . . 0.0 110.281 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -76.12 -30.37 58.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.553 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -75.06 -36.62 61.78 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.77 0.319 . . . . 0.0 111.531 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.23 -6.08 22.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 27.8 mtm105 58.46 48.4 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.041 0.448 . . . . 0.0 110.549 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.477 HG21 HD12 ' A' 1268 ' ' LEU . 14.9 pt -125.5 158.39 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.184 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -64.31 148.13 50.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.186 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.516 ' CE1' HG21 ' A' 1284 ' ' ILE . 91.2 t80 -45.66 -51.16 12.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.697 0.284 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.65 -41.94 55.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.967 0.413 . . . . 0.0 110.066 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.59 -49.79 69.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.161 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.78 -49.39 68.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.57 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.87 -29.9 71.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.113 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -50.56 50.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.245 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.594 HG21 ' CB ' ' A' 1272 ' ' ALA . 20.8 mt -59.45 -42.46 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.838 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.502 HG22 ' HE ' ' A' 1320 ' ' ARG . 22.2 mt -69.26 -34.5 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.716 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -51.61 67.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.364 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.416 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 21.8 mt-30 -59.32 -36.86 76.44 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.359 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.574 ' HB3' HG13 ' A' 1311 ' ' VAL . 18.9 mtm -57.12 -38.52 73.56 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.626 ' N ' HG22 ' A' 1311 ' ' VAL . 18.1 tt0 -69.44 -33.03 72.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.394 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.72 62.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.47 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.674 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -90.73 -20.39 22.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.807 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.13 13.33 29.24 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.933 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.742 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.8 mt -82.9 -37.84 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.053 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' 1306 ' ' GLU . 27.1 m -120.54 158.13 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.218 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.492 ' CB ' HD11 ' A' 1323 ' ' LEU . 1.2 p -101.22 -179.46 4.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.122 0.487 . . . . 0.0 111.686 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.87 134.72 53.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.501 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1314 ' ' GLN . . . . . 0.424 ' HG3' ' HG2' ' A' 1320 ' ' ARG . 0.0 OUTLIER -67.78 141.4 56.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.067 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -131.62 -45.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.899 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1316 ' ' HIS . . . . . 0.404 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 1.0 OUTLIER -82.4 -156.0 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.94 91.91 5.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.864 0.364 . . . . 0.0 111.323 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 78.48 10.1 86.48 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.693 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1319 ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 44.1 m-80 -100.41 121.99 42.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.325 0.563 . . . . 0.0 111.491 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.502 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.41 140.37 40.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.388 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 17.9 tt0 -87.06 132.7 33.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.978 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.7 t -92.66 118.73 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.25 -11.47 15.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.227 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.87 131.56 26.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.238 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.07 159.15 15.51 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.542 2.162 . . . . 0.0 112.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.484 ' N ' ' HB ' ' A' 1277 ' ' THR . 52.1 Cg_exo -52.78 164.39 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.912 2.408 . . . . 0.0 112.469 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.46 -35.83 7.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.582 2.188 . . . . 0.0 112.295 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -137.26 34.07 2.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.85 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 42.9 m170 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.782 0.325 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -148.92 61.42 0.43 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.417 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.17 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.751 0.31 . . . . 0.0 111.175 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -57.74 -27.24 62.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.61 -38.11 5.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.941 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.413 ' CD2' ' HG2' ' A' 1304 ' ' GLN . 1.8 mt -80.22 160.02 25.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.86 144.12 32.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.51 -23.67 19.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.323 2.015 . . . . 0.0 112.368 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.586 HD23 ' OE1' ' A' 1271 ' ' GLN . 62.3 mt -102.06 -3.81 27.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.921 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' A' 1310 ' ' ILE . 43.7 t80 -47.51 -55.51 8.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 37.8 t0 -52.49 -41.59 63.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.586 ' OE1' HD23 ' A' 1268 ' ' LEU . 0.8 OUTLIER -66.37 -43.32 86.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.314 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.626 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -64.1 -41.04 97.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.251 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' 1269 ' ' PHE . 99.0 t -61.08 -47.89 91.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.58 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.639 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.432 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.4 -51.23 59.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.654 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.5 m -68.47 -36.7 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.482 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.886 HG22 ' O ' ' A' 1324 ' ' ALA . 45.6 p -70.6 -49.92 42.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.37 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.0 mt-10 -60.14 -33.93 72.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.369 . . . . 0.0 110.354 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -95.22 -5.58 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.018 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 55.99 18.52 3.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.839 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1281 ' ' LYS . . . . . 0.404 ' N ' HG21 ' A' 1322 ' ' VAL . 10.5 mttt -145.53 132.51 20.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.62 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.62 116.29 28.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.823 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.787 ' O ' HG23 ' A' 1287 ' ' VAL . 1.9 t -132.63 138.26 47.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 26.1 mt -66.49 -38.88 82.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.046 0.451 . . . . 0.0 110.117 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.486 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 27.5 t -69.68 -40.75 76.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.829 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1286 ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -61.51 -48.43 84.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' 1283 ' ' SER . 15.1 t -67.16 -29.66 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 120.745 0.307 . . . . 0.0 110.709 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -61.34 -54.49 43.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.186 0.517 . . . . 0.0 110.093 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -30.84 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.531 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' 1286 ' ' GLY . 4.1 tp60 -74.93 -38.11 61.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.23 -4.51 24.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.804 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 55.47 54.99 7.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.045 0.45 . . . . 0.0 110.485 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.436 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 10.2 pt -131.49 157.59 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.476 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -63.5 148.2 50.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.981 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.597 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.2 t80 -45.41 -51.52 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.551 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.79 -40.63 55.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.676 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.467 ' HD3' HD11 ' A' 1301 ' ' ILE . 0.0 OUTLIER -66.44 -48.2 70.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.562 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.9 -49.63 68.16 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.019 0.438 . . . . 0.0 110.649 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.515 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.98 -29.88 71.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.067 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -68.05 -50.22 56.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.039 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.626 HG21 ' CB ' ' A' 1272 ' ' ALA . 33.9 mt -60.68 -45.83 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.51 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.8 mt -66.56 -32.16 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.843 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -52.1 63.6 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.4 OUTLIER -58.73 -33.02 69.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.711 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.654 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.0 mtm -60.98 -40.87 95.08 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.613 ' N ' HG22 ' A' 1311 ' ' VAL . 1.4 tt0 -66.16 -33.23 75.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.827 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.466 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -20.37 58.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.783 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.19 15.88 26.82 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.046 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.2 mt -82.71 -38.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.817 0.447 . . . . 0.0 111.317 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' 1305 ' ' MET . 34.8 m -120.67 164.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.438 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -105.96 -178.12 3.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.069 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -65.89 131.79 47.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -67.85 130.98 44.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.168 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -117.86 -46.77 0.46 Allowed Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.877 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -161.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.4 p30 -90.62 91.63 8.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.76 10.13 86.44 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.354 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -101.26 122.1 43.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.146 0.473 . . . . 0.0 111.63 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.51 ' HG3' HG21 ' A' 1302 ' ' ILE . 3.4 mtt180 -107.45 140.31 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.346 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' 1311 ' ' VAL . 53.5 tt0 -81.9 132.8 35.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.647 0.26 . . . . 0.0 111.067 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.5 t -90.26 118.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.141 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.438 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.25 -18.83 13.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.154 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' 1277 ' ' THR . . . -90.89 131.54 37.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.109 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.59 159.36 19.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.453 2.102 . . . . 0.0 113.026 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.496 ' N ' ' HB ' ' A' 1277 ' ' THR . 60.2 Cg_exo -51.6 158.01 4.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.005 2.47 . . . . 0.0 112.502 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.86 -36.44 3.59 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.643 2.228 . . . . 0.0 112.422 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -110.06 57.16 0.62 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.889 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 7.5 m80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.807 0.337 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -111.45 51.48 0.7 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.424 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -58.94 -30.68 68.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.215 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.78 -27.12 62.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.018 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -28.05 8.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.804 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.6 mt -87.2 160.01 18.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1266 ' ' ASP . . . . . 0.404 ' CB ' HG12 ' A' 1301 ' ' ILE . 24.8 t70 -87.98 145.07 35.66 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.426 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.21 -24.28 20.11 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.368 2.046 . . . . 0.0 112.505 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' 1291 ' ' PHE . 40.8 mt -102.14 -1.76 30.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.896 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.804 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.1 t80 -47.69 -55.21 9.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.0 t0 -52.51 -44.35 65.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 0.0 110.893 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.425 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 5.9 mt-30 -68.0 -37.93 82.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.076 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.631 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.9 95.2 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.661 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' 1269 ' ' PHE . 26.9 t -61.78 -47.81 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' 1278 ' ' GLU . 14.5 tt0 -63.49 -33.28 75.22 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.752 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.406 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -66.58 -51.61 54.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.7 m -68.9 -38.31 78.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.588 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.86 HG22 ' O ' ' A' 1324 ' ' ALA . 56.2 p -70.01 -48.42 58.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.12 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' 1274 ' ' GLN . 10.5 mm-40 -59.02 -37.16 76.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.369 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -92.81 -6.04 49.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.3 mmm180 57.64 17.48 4.06 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.783 0.325 . . . . 0.0 110.847 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.63 134.14 22.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.764 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' 1322 ' ' VAL . . . -114.86 116.4 28.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.705 0.288 . . . . 0.0 110.704 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.857 ' O ' HG23 ' A' 1287 ' ' VAL . 2.4 p -132.57 143.16 49.52 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.9 0.381 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.837 HG23 ' HB3' ' A' 1298 ' ' ALA . 50.0 mt -71.09 -39.51 74.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.11 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.441 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 38.6 t -66.77 -44.54 81.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.872 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1286 ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.57 -51.1 60.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.951 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' 1283 ' ' SER . 16.5 t -65.03 -31.83 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.011 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.499 ' HG3' ' HB2' ' A' 1298 ' ' ALA . 38.3 mt-30 -59.74 -51.77 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.069 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -76.24 -35.86 58.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.184 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' 1286 ' ' GLY . 0.1 OUTLIER -75.06 -33.37 61.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.497 -179.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.18 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.537 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 55.63 51.29 12.83 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.117 0.485 . . . . 0.0 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.696 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -127.13 149.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.324 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.8 151.04 21.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.004 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.558 ' CE1' HG21 ' A' 1284 ' ' ILE . 1.1 t80 -46.51 -54.59 8.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.716 0.293 . . . . 0.0 111.333 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.55 -36.55 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.696 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.8 OUTLIER -65.69 -49.31 69.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.837 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -54.01 -50.09 67.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.698 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.01 -29.77 71.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -68.8 -49.93 54.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.148 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.63 HG21 ' CB ' ' A' 1272 ' ' ALA . 26.6 mt -61.4 -44.43 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.853 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.533 HG22 ' HE ' ' A' 1320 ' ' ARG . 25.0 mt -67.55 -33.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.81 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -52.06 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.284 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.2 mt-30 -58.83 -36.84 75.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.254 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.578 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.7 mtm -57.7 -37.79 74.11 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.608 ' N ' HG22 ' A' 1311 ' ' VAL . 7.1 tt0 -69.4 -32.69 71.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.146 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.76 -30.43 62.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.376 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.681 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -88.52 -20.28 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.8 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.46 13.78 29.6 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.983 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.795 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.5 mt -83.99 -36.23 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.673 0.389 . . . . 0.0 111.319 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' 1306 ' ' GLU . 27.2 m -121.05 152.66 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.412 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.521 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.6 OUTLIER -97.27 -177.93 4.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.422 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -65.84 133.17 50.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.431 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1314 ' ' GLN . . . . . 0.409 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 36.3 mt-30 -67.78 132.42 47.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.183 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -127.04 -44.08 0.24 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.97 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1316 ' ' HIS . . . . . 0.401 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 1.4 t60 -76.98 -154.7 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.56 91.88 4.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.369 . . . . 0.0 111.16 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.9 10.2 86.39 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.265 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1319 ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 7.3 m-20 -107.78 122.13 46.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.067 0.433 . . . . 0.0 111.458 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.533 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.3 OUTLIER -107.4 140.42 40.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' 1311 ' ' VAL . 36.3 tt0 -80.46 132.67 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.17 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' 1282 ' ' ALA . 31.3 t -91.81 118.71 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.95 -8.48 15.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.338 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.86 ' O ' HG22 ' A' 1277 ' ' THR . . . -100.27 129.87 27.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.244 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.04 159.15 23.89 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.505 2.137 . . . . 0.0 113.029 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.519 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.7 Cg_exo -51.64 159.66 3.24 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.894 2.396 . . . . 0.0 112.503 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.86 -73.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.61 2.207 . . . . 0.0 112.306 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -123.46 71.61 1.09 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 5.0 p-80 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.852 0.358 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 146.56 87.78 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.55 63.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.247 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -57.75 -29.18 64.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.968 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.71 -39.09 4.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.872 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.751 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.2 mt -82.98 160.0 22.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1266 ' ' ASP . . . . . 0.409 ' CB ' HG12 ' A' 1301 ' ' ILE . 20.6 t70 -86.56 144.8 38.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.48 -24.55 22.37 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.463 2.109 . . . . 0.0 112.497 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.2 mt -101.95 -1.36 32.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.751 ' CD2' HD22 ' A' 1265 ' ' LEU . 42.7 t80 -47.6 -56.27 7.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -52.39 -42.44 64.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.405 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.4 mt-30 -69.85 -37.14 76.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.183 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.649 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -67.0 -40.42 87.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.753 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.591 ' CG1' HD13 ' A' 1310 ' ' ILE . 57.5 t -62.52 -47.37 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.451 ' HA ' ' OG1' ' A' 1277 ' ' THR . 12.8 tt0 -64.04 -32.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.677 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.433 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.98 -51.1 59.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.478 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.3 m -68.3 -38.18 79.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.247 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 43.5 p -69.46 -49.28 56.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.249 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.4 mm-40 -59.89 -35.79 75.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.988 0.423 . . . . 0.0 110.411 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -6.18 48.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.025 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 19.9 mmm180 55.95 18.93 3.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.812 0.339 . . . . 0.0 110.553 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.56 131.29 18.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.643 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.643 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.55 116.41 29.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.633 0.254 . . . . 0.0 110.62 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.737 ' O ' HG23 ' A' 1287 ' ' VAL . 25.5 t -132.47 135.23 45.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' 1299 ' ' ALA . 36.8 mt -64.51 -41.54 92.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.199 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 31.6 t -70.19 -38.53 75.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.664 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.58 -49.43 73.53 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.479 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' 1283 ' ' SER . 21.8 t -66.63 -29.67 47.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.315 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1288 ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -60.95 -55.67 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.163 0.506 . . . . 0.0 110.321 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -28.81 57.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -75.06 -37.29 61.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.367 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.17 -5.23 23.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.727 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 57.9 49.09 12.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.492 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' 1297 ' ' ARG . 11.2 pt -124.86 163.97 24.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.068 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -70.58 147.98 44.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.623 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.499 ' CE1' HG21 ' A' 1284 ' ' ILE . 91.2 t80 -45.6 -50.52 13.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.76 -41.91 57.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.598 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.498 ' HD3' HD11 ' A' 1301 ' ' ILE . 0.0 OUTLIER -67.16 -47.43 71.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.17 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.91 -49.13 69.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.956 0.408 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.82 -29.72 70.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.807 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -51.28 59.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.313 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.649 HG21 ' CB ' ' A' 1272 ' ' ALA . 25.6 mt -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.053 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.58 HG21 ' HG3' ' A' 1320 ' ' ARG . 22.0 mt -67.93 -33.79 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.733 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.03 -51.38 69.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.435 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 11.3 mt-30 -59.66 -36.51 76.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.281 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.704 ' HB3' HG13 ' A' 1311 ' ' VAL . 15.1 mtm -57.45 -37.64 73.16 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.587 ' N ' HG22 ' A' 1311 ' ' VAL . 5.4 tt0 -69.55 -32.88 71.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.55 61.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.69 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.684 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -89.2 -20.44 24.18 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.43 17.09 22.93 Favored Glycine 0 C--N 1.328 0.131 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.949 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.8 mt -86.25 -36.22 10.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 122.811 0.444 . . . . 0.0 111.265 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.704 HG13 ' HB3' ' A' 1305 ' ' MET . 32.6 m -120.63 164.01 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.446 ' CA ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.68 -177.96 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.131 0.491 . . . . 0.0 111.708 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -65.82 136.24 55.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.59 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1314 ' ' GLN . . . . . 0.421 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 32.4 mt-30 -67.67 133.62 49.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.138 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -121.48 -46.99 0.3 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.908 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1316 ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 0.4 OUTLIER -84.73 -156.36 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.2 p30 -93.88 91.68 7.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.772 0.32 . . . . 0.0 111.243 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.96 10.08 86.48 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.479 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1319 ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 38.3 m-80 -98.6 122.06 41.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.201 0.501 . . . . 0.0 111.454 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.5 mmt180 -107.46 140.37 40.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.595 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.9 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.711 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 20.3 t -90.28 118.68 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 0.0 110.29 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.446 HD11 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.77 -6.49 16.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.484 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.46 132.47 20.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.413 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.26 159.35 20.17 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.433 2.089 . . . . 0.0 112.924 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.507 ' N ' ' HB ' ' A' 1277 ' ' THR . 65.1 Cg_exo -51.69 157.39 5.43 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.944 2.429 . . . . 0.0 112.6 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.37 -36.91 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.79 30.97 6.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.796 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 5.2 m80 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.829 0.347 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 86.51 46.97 5.04 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.17 67.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.361 . . . . 0.0 111.062 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -67.89 -21.54 65.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.074 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.21 -31.04 8.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.8 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.84 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.8 mt -77.51 160.02 28.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.28 144.4 46.67 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.325 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.29 -24.4 20.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.472 2.115 . . . . 0.0 112.556 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' 1291 ' ' PHE . 41.4 mt -102.04 -1.73 31.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.95 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.84 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.5 t80 -47.54 -55.46 9.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.52 -41.35 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.995 0.426 . . . . 0.0 110.391 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 1.6 mt-30 -66.67 -43.48 84.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.013 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.63 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.41 -40.26 96.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' 1269 ' ' PHE . 25.3 t -61.75 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' 1278 ' ' GLU . 23.1 tt0 -64.17 -32.23 73.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.705 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.479 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.46 -51.42 57.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.454 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.8 m -69.05 -39.93 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.623 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.801 HG22 ' O ' ' A' 1324 ' ' ALA . 76.2 p -67.74 -49.86 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.365 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.2 mt-10 -59.91 -36.63 77.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.964 0.411 . . . . 0.0 110.479 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.22 -6.25 53.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.016 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.1 mmm180 57.35 17.51 3.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.813 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.6 mttt -145.66 134.28 22.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.749 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.641 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.59 116.39 28.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.679 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.877 ' O ' HG23 ' A' 1287 ' ' VAL . 5.0 p -132.54 140.76 48.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.137 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 21.9 mt -69.55 -40.79 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.313 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 37.1 t -66.91 -43.78 82.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.116 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1286 ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -59.3 -49.53 77.49 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.793 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' 1283 ' ' SER . 15.9 t -65.12 -30.71 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.649 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 13.0 mt-30 -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.217 0.532 . . . . 0.0 109.978 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -35.8 58.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.186 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.446 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.1 tp60 -75.01 -34.91 61.98 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.612 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.0 m-85 -103.2 -6.66 21.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.606 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 55.6 55.15 7.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.039 0.447 . . . . 0.0 110.458 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.429 HG21 ' HE ' ' A' 1297 ' ' ARG . 13.5 pt -131.88 147.87 32.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.49 147.93 22.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.182 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.3 t80 -45.3 -50.24 12.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 111.446 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.78 -42.6 58.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.429 ' HE ' HG21 ' A' 1293 ' ' ILE . 0.0 OUTLIER -64.3 -49.23 72.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -53.9 -50.12 67.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.07 -29.69 71.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.063 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -68.08 -51.08 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.208 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.63 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.4 mt -59.53 -43.38 90.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.462 HG21 ' HG3' ' A' 1320 ' ' ARG . 19.9 mt -68.98 -33.63 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.915 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.14 -52.05 65.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.236 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.443 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 25.4 mt-30 -59.41 -36.92 76.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.226 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.601 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.5 mtm -57.35 -37.81 73.15 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' 1311 ' ' VAL . 3.1 tt0 -69.39 -33.07 72.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.01 -29.75 63.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.261 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.668 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -89.25 -20.29 24.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.782 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.77 12.74 31.61 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.949 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -83.07 -36.19 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.654 0.382 . . . . 0.0 111.341 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' 1306 ' ' GLU . 35.4 m -122.75 155.11 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.378 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.539 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -102.53 -177.97 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.188 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.82 132.17 48.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.343 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -67.91 130.93 44.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.326 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -116.96 -40.45 0.76 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.884 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.47 -165.3 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.6 p30 -86.92 91.77 8.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.054 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.83 10.06 86.49 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.21 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -98.91 122.04 41.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.076 0.438 . . . . 0.0 111.543 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.462 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.48 140.32 40.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.6 132.66 34.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.889 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' 1282 ' ' ALA . 31.8 t -92.24 118.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.539 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -108.51 -4.76 16.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.381 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.801 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.24 130.66 22.73 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.395 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.59 158.74 22.1 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.563 2.175 . . . . 0.0 113.153 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.523 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.8 Cg_exo -52.2 163.19 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.044 2.496 . . . . 0.0 112.712 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.99 -37.03 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -130.17 -45.52 1.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.001 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 39.1 t70 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.936 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 95.99 38.74 4.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.493 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -69.05 -30.82 69.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.63 -27.37 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.72 -29.66 8.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.807 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.791 HD22 ' CD2' ' A' 1269 ' ' PHE . 8.4 mt -74.31 160.01 31.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.951 0.405 . . . . 0.0 110.932 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1266 ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' 1268 ' ' LEU . 19.3 t70 -84.87 143.02 39.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.051 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.11 -23.87 23.75 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.388 2.059 . . . . 0.0 112.421 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.566 HD12 ' NH1' ' A' 1297 ' ' ARG . 74.4 mt -97.73 -6.65 32.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.524 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.791 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.5 t80 -47.29 -55.95 7.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.42 -40.99 62.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.957 0.408 . . . . 0.0 110.318 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.566 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 1.4 mt-30 -64.79 -49.16 71.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.892 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.641 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -60.31 -40.77 91.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.625 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' 1277 ' ' THR . 84.3 t -61.23 -48.52 88.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.406 ' HA ' ' HG1' ' A' 1277 ' ' THR . 77.3 mt-30 -65.46 -30.29 71.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.877 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.402 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.1 t80 -68.13 -49.08 63.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.438 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' 1282 ' ' ALA . 35.2 m -69.75 -40.75 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.293 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.834 HG22 ' O ' ' A' 1324 ' ' ALA . 76.4 p -67.62 -48.52 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.18 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -59.11 -38.12 78.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.493 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -90.68 -6.56 54.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.028 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.2 mmm180 59.76 15.71 5.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.938 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.55 136.94 25.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.785 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -116.3 116.36 27.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.908 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.871 ' O ' HG23 ' A' 1287 ' ' VAL . 13.1 t -132.52 139.14 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.199 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CB ' ' A' 1298 ' ' ALA . 31.3 mt -68.43 -38.46 79.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.8 t -68.78 -42.47 77.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.871 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1286 ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.73 -48.23 87.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.661 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' 1283 ' ' SER . 14.2 t -66.05 -30.94 51.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 110.673 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 21.9 mt-30 -60.88 -50.49 73.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.144 0.497 . . . . 0.0 110.048 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -76.32 -36.53 58.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.157 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.412 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.94 -33.95 62.01 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.566 -179.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.14 -6.38 22.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.535 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1292 ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' 1292 ' ' ARG . 13.8 mtp-105 53.95 54.96 8.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.097 0.475 . . . . 0.0 110.23 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.484 HG21 ' NH1' ' A' 1297 ' ' ARG . 13.9 pt -130.86 152.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.578 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -58.75 148.14 39.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.791 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.588 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 91.2 t80 -44.96 -51.85 9.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.54 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.82 -40.99 57.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.744 HH12 HD11 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.93 -47.87 76.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.99 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -56.37 -50.18 72.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -62.54 -29.88 70.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -68.08 -49.84 58.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.258 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.744 HD11 HH12 ' A' 1297 ' ' ARG . 40.2 mt -60.18 -44.21 94.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.059 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.491 HG21 ' HG3' ' A' 1320 ' ' ARG . 19.4 mt -68.68 -33.51 60.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.836 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -52.04 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.32 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.441 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 29.1 mt-30 -60.05 -36.39 77.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.341 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.593 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.7 mtm -57.05 -38.89 73.87 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.632 ' N ' HG22 ' A' 1311 ' ' VAL . 0.4 OUTLIER -68.81 -33.94 74.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.239 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -71.47 -30.82 66.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.47 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.63 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -88.78 -20.21 25.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.868 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.05 12.69 31.07 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.894 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.74 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.1 mt -82.53 -36.03 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 122.8 0.44 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.632 HG22 ' N ' ' A' 1306 ' ' GLU . 35.8 m -124.01 158.98 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.254 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.466 ' CA ' HD11 ' A' 1323 ' ' LEU . 1.0 OUTLIER -98.66 179.25 4.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 0.0 111.602 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.85 135.06 54.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.438 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.73 139.49 56.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.039 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -140.18 -46.67 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.808 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -74.05 -157.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -102.37 91.67 4.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 111.103 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.73 10.0 86.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.481 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -107.75 122.13 46.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.229 0.514 . . . . 0.0 111.781 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.491 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.9 mmt180 -107.28 140.33 40.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.204 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.5 tp10 -83.39 132.72 34.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.976 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.0 t -91.39 118.78 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.982 0.42 . . . . 0.0 110.222 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.466 HD11 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -109.02 -6.23 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.448 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.834 ' O ' HG22 ' A' 1277 ' ' THR . . . -104.68 132.49 20.87 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.414 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.83 158.56 16.01 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.493 2.129 . . . . 0.0 113.043 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.51 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.0 Cg_exo -53.27 163.49 2.37 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.97 2.447 . . . . 0.0 112.526 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.75 -36.43 2.13 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.298 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -132.93 51.66 2.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.9 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.867 0.365 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -93.9 44.12 2.39 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -64.02 -29.02 70.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 111.155 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -57.85 -27.91 63.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.53 -36.09 6.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 0.0 110.81 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.805 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.9 mt -73.68 160.03 32.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1266 ' ' ASP . . . . . 0.405 ' CB ' HG12 ' A' 1301 ' ' ILE . 10.0 t70 -84.62 143.99 41.96 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.404 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.35 -25.53 18.55 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.519 2.146 . . . . 0.0 112.869 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' 1291 ' ' PHE . 36.6 mt -102.06 -0.15 34.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.805 ' CD2' HD22 ' A' 1265 ' ' LEU . 43.5 t80 -47.7 -56.38 7.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -42.78 64.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.418 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 5.3 mt-30 -69.48 -36.51 76.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.241 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.673 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -67.75 -41.65 83.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.684 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.553 HG13 HG21 ' A' 1310 ' ' ILE . 97.9 t -61.99 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.4 OUTLIER -64.77 -32.41 74.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.615 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.408 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -67.41 -50.71 58.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.666 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.8 m -68.23 -37.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.335 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.887 HG22 ' O ' ' A' 1324 ' ' ALA . 43.2 p -69.98 -48.83 56.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.222 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' 1274 ' ' GLN . 6.2 mm-40 -59.66 -35.16 73.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.527 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -95.97 -4.16 43.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.8 mmm180 54.95 19.42 2.66 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.906 0.384 . . . . 0.0 110.873 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1281 ' ' LYS . . . . . 0.427 ' N ' HG21 ' A' 1322 ' ' VAL . 1.4 mttp -145.46 131.64 19.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.96 116.42 29.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.642 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.815 ' O ' HG23 ' A' 1287 ' ' VAL . 30.2 t -132.46 141.84 48.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.651 HD13 ' HB2' ' A' 1299 ' ' ALA . 62.2 mt -70.29 -43.44 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 27.7 t -68.06 -40.59 82.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.883 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.07 60.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.781 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' 1283 ' ' SER . 22.3 t -65.19 -29.93 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.266 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' 1293 ' ' ILE . 13.3 tt0 -59.8 -51.86 67.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -76.28 -35.59 58.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.065 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.414 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.06 -33.3 61.7 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.596 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.16 -7.85 20.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.762 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 56.62 51.78 10.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.161 0.505 . . . . 0.0 110.29 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.464 HG21 HD12 ' A' 1268 ' ' LEU . 19.1 pt -129.17 146.03 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.11 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -50.89 149.77 6.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.319 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' 1284 ' ' ILE . 87.8 t80 -47.64 -53.43 14.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.444 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.77 -36.95 39.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -67.07 -50.21 62.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.175 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -55.21 -46.35 75.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.628 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.651 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -65.91 -29.9 70.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.175 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -49.36 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.315 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.673 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.0 mt -60.66 -42.43 91.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.965 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.554 ' HA ' ' HE3' ' A' 1305 ' ' MET . 26.5 mt -68.76 -35.29 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -51.09 70.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.486 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.417 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 17.4 mt-30 -59.88 -37.04 78.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.428 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.611 ' HB3' HG13 ' A' 1311 ' ' VAL . 19.6 mtm -56.98 -38.39 72.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.604 ' N ' HG22 ' A' 1311 ' ' VAL . 2.2 tt0 -69.93 -32.81 71.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.37 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.54 -31.47 65.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.426 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.661 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -88.12 -20.3 25.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.918 -178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.63 13.81 29.1 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.719 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.2 mt -82.85 -36.42 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 122.892 0.477 . . . . 0.0 111.251 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' 1305 ' ' MET . 26.7 m -121.31 160.49 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.541 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.435 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -106.97 -178.53 3.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.516 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.95 134.89 53.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.65 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 149.98 49.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.894 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -137.01 -45.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.243 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.29 -112.45 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.1 91.78 2.6 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.902 0.382 . . . . 0.0 111.123 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.7 10.08 86.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.996 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -107.12 123.62 48.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 0.0 111.411 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.534 ' HD3' HG21 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.06 140.24 40.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.351 179.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' 1311 ' ' VAL . 15.3 tp10 -75.37 132.58 41.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.992 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 20.6 t -87.3 118.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -105.7 -19.04 13.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.269 -178.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.887 ' O ' HG22 ' A' 1277 ' ' THR . . . -91.96 133.49 30.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.262 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.19 159.02 15.26 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.498 2.132 . . . . 0.0 113.02 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.489 ' N ' ' HB ' ' A' 1277 ' ' THR . 56.6 Cg_exo -52.01 159.35 3.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.903 2.402 . . . . 0.0 112.477 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.83 -36.91 1.34 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 112.394 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -130.53 64.11 1.56 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.911 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 8.6 m80 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.793 0.33 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -159.31 -84.32 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -67.94 -28.96 67.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.3 -25.89 64.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.46 -35.08 5.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.859 0.361 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.741 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.4 mt -92.42 160.06 15.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.87 143.64 43.62 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.43 -24.18 27.08 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.394 2.063 . . . . 0.0 112.272 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' 1291 ' ' PHE . 65.9 mt -97.53 -5.37 35.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.6 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.741 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.0 t80 -47.47 -55.93 8.06 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.52 -40.77 62.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.396 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.568 ' OE1' HD23 ' A' 1268 ' ' LEU . 0.9 OUTLIER -67.52 -43.26 81.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.082 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.08 -41.19 99.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.905 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' 1269 ' ' PHE . 29.7 t -61.1 -48.51 88.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' 1278 ' ' GLU . 45.0 tt0 -63.18 -33.56 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.441 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -65.9 -51.6 57.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.62 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.638 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.2 m -69.31 -38.46 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.7 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.85 HG22 ' O ' ' A' 1324 ' ' ALA . 51.4 p -69.23 -49.86 52.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.21 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.4 mt-10 -59.8 -36.37 76.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.971 0.415 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -91.81 -6.49 51.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.018 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.6 mmm180 56.9 18.12 3.7 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.887 0.375 . . . . 0.0 110.744 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 132.35 20.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.737 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.638 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.98 116.49 29.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.788 ' O ' HG23 ' A' 1287 ' ' VAL . 0.5 OUTLIER -132.29 141.37 48.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.903 0.382 . . . . 0.0 111.139 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' 1299 ' ' ALA . 25.4 mt -69.13 -43.31 81.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 21.3 t -67.01 -40.3 87.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.978 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.65 -51.12 60.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' 1283 ' ' SER . 21.1 t -64.83 -29.91 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.311 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' 1293 ' ' ILE . 4.0 tt0 -59.75 -52.68 64.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.092 0.472 . . . . 0.0 110.135 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 -35.23 58.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.18 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.435 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -34.67 61.78 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.632 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.14 -7.38 21.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 56.82 55.02 6.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.135 0.493 . . . . 0.0 110.526 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' 1288 ' ' GLN . 13.3 pt -133.23 145.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -51.06 148.86 7.71 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.491 ' CE1' HG21 ' A' 1284 ' ' ILE . 89.2 t80 -47.05 -52.7 14.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.543 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.72 -38.5 47.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 110.052 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -50.59 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.068 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.53 -44.43 72.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.429 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -66.94 -29.74 69.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -50.55 53.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.567 HG21 ' CB ' ' A' 1272 ' ' ALA . 20.8 mt -59.92 -42.33 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.01 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.544 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.9 mt -69.45 -34.6 62.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.774 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.94 -52.05 65.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.393 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.434 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 31.6 mt-30 -58.41 -38.03 76.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.259 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.566 ' HB3' HG13 ' A' 1311 ' ' VAL . 21.3 mtm -57.53 -37.33 72.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.326 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.626 ' N ' HG22 ' A' 1311 ' ' VAL . 2.2 tt0 -69.21 -32.66 72.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.181 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.675 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -87.25 -20.31 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.715 -178.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.5 12.94 31.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.009 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.3 mt -83.65 -34.92 10.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.473 -0.363 . . . . 0.0 111.403 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' 1306 ' ' GLU . 35.6 m -124.44 154.4 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.622 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.44 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.1 OUTLIER -104.47 179.65 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.93 131.47 46.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -67.99 148.36 51.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.989 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -124.25 -58.5 0.18 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.634 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1316 ' ' HIS . . . . . 0.458 ' CE1' ' OD1' ' A' 1317 ' ' ASN . 1.0 OUTLIER -63.85 -106.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.949 -0.148 . . . . 0.0 110.806 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1317 ' ' ASN . . . . . 0.458 ' OD1' ' CE1' ' A' 1316 ' ' HIS . 18.2 p-10 -138.11 91.83 2.6 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 120.892 0.377 . . . . 0.0 111.089 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.89 1.72 79.6 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.026 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -88.52 122.22 31.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.944 0.372 . . . . 0.0 111.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.544 ' HG3' HG21 ' A' 1302 ' ' ILE . 4.7 mtt180 -107.22 140.2 40.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.54 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' 1311 ' ' VAL . 19.7 tp10 -81.95 132.66 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.767 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.5 t -88.81 118.61 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 110.047 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -106.31 -13.03 15.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.38 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' 1277 ' ' THR . . . -99.22 132.34 23.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.275 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.46 159.04 22.57 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.525 2.15 . . . . 0.0 113.026 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.515 ' N ' ' HB ' ' A' 1277 ' ' THR . 57.2 Cg_exo -51.64 152.31 12.97 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.038 2.492 . . . . 0.0 112.687 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -63.23 -70.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.625 2.217 . . . . 0.0 112.318 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 2.7 m-85 65.21 -74.52 0.05 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.045 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.926 179.953 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 76.2 m80 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.807 0.337 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 64.44 53.49 35.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.602 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -67.19 -30.78 70.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -59.0 -27.28 65.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.6 -34.1 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.664 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.422 HD13 ' CD1' ' A' 1269 ' ' PHE . 3.3 mt -75.1 160.15 30.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.995 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1266 ' ' ASP . . . . . 0.425 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -80.38 141.74 53.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -51.73 -24.13 17.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.349 2.033 . . . . 0.0 112.584 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.598 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.2 mt -102.11 -4.51 25.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.035 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.843 ' O ' HG23 ' A' 1273 ' ' VAL . 39.9 t80 -47.67 -53.11 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -46.08 66.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.0 110.294 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.491 ' OE1' HD23 ' A' 1268 ' ' LEU . 1.3 mp0 -63.9 -43.25 96.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.25 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.602 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -62.1 -39.36 92.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.982 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' 1269 ' ' PHE . 17.2 t -61.65 -49.57 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.425 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.0 OUTLIER -62.61 -33.28 74.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.841 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.415 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.49 -50.87 61.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.0 m -69.57 -38.02 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.432 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.84 HG22 ' O ' ' A' 1324 ' ' ALA . 67.1 p -69.31 -50.25 48.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.0 mm-40 -59.17 -36.78 75.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.484 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -92.69 -6.14 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 29.1 mmm180 56.01 18.74 3.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.817 0.341 . . . . 0.0 110.651 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1281 ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' 1322 ' ' VAL . 24.1 mttp -145.62 133.67 21.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.61 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -116.85 116.23 27.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.898 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.814 ' O ' HG23 ' A' 1287 ' ' VAL . 0.5 OUTLIER -132.54 143.25 49.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.022 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 16.1 mt -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 14.8 t -67.38 -40.59 85.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.059 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1286 ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.65 -50.41 67.94 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.778 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' 1283 ' ' SER . 13.4 t -65.51 -30.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 110.635 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.7 mt-30 -60.76 -51.54 68.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.061 0.458 . . . . 0.0 109.936 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -36.58 58.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.097 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.427 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.98 -34.37 61.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.714 0.293 . . . . 0.0 111.626 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.15 -6.51 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.562 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 54.67 54.97 8.46 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.483 HG21 HD12 ' A' 1268 ' ' LEU . 14.7 pt -131.97 150.39 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.583 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.61 148.32 26.82 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.252 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.1 t80 -45.96 -50.99 14.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.559 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.76 -40.67 55.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.467 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.88 -49.74 69.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.558 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.98 -49.54 68.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.86 -30.0 71.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -49.8 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.985 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.557 HG21 ' CB ' ' A' 1272 ' ' ALA . 33.6 mt -60.71 -45.55 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.842 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.474 HG22 ' HE ' ' A' 1320 ' ' ARG . 21.0 mt -66.79 -32.46 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.864 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -52.2 59.67 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.6 OUTLIER -57.86 -33.32 68.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.758 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.604 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.3 mtm -62.7 -39.37 93.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' 1311 ' ' VAL . 28.1 tt0 -66.35 -32.28 73.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.416 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.88 -42.11 58.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.281 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -20.19 60.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.604 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.42 15.3 30.29 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.743 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.0 mt -83.64 -35.28 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.65 0.38 . . . . 0.0 111.502 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' 1306 ' ' GLU . 29.6 m -122.4 159.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.573 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.42 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.19 178.19 4.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -66.01 131.53 46.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.819 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -67.95 144.01 55.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.957 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -119.36 -50.97 0.29 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.601 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -71.56 -106.34 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.99 -0.124 . . . . 0.0 110.718 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1317 ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' 1317 ' ' ASN . 4.8 p-10 -138.04 91.87 2.61 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.957 0.408 . . . . 0.0 111.065 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.84 1.0 77.01 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.022 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -87.13 122.24 30.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.474 ' HE ' HG22 ' A' 1302 ' ' ILE . 2.2 mtt-85 -107.18 140.2 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.655 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1311 ' ' VAL . 13.5 tt0 -83.61 132.72 34.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.749 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' 1282 ' ' ALA . 19.3 t -87.92 118.57 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.321 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.42 HD11 ' CB ' ' A' 1312 ' ' SER . 0.8 OUTLIER -105.81 -10.25 16.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.053 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' 1277 ' ' THR . . . -100.21 129.91 27.16 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.192 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -82.62 158.48 16.54 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.573 2.182 . . . . 0.0 113.175 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.439 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -53.97 164.26 2.63 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.993 2.462 . . . . 0.0 112.32 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.38 -42.92 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.701 2.268 . . . . 0.0 112.432 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -139.8 63.52 1.48 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.881 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.779 0.323 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 105.27 -114.54 4.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -57.41 -27.54 62.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 111.273 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -58.99 -29.07 66.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.06 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.76 -30.67 7.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.966 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.518 HD13 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt -69.01 160.0 31.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.029 0.442 . . . . 0.0 111.266 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 8.7 t0 -75.77 141.38 72.0 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.0 -24.57 10.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.441 2.094 . . . . 0.0 112.945 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' 1291 ' ' PHE . 60.0 mt -102.18 -5.03 24.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' 1273 ' ' VAL . 45.9 t80 -47.66 -52.67 17.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.6 t0 -52.67 -42.2 64.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 0.0 110.328 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.56 -43.06 81.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.989 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -61.64 -38.98 89.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.873 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' 1269 ' ' PHE . 21.2 t -62.13 -52.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.476 ' HG3' ' HG3' ' A' 1327 ' ' PRO . 0.1 OUTLIER -61.43 -30.62 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.941 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.479 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 3.1 t80 -68.91 -51.04 44.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.697 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' 1282 ' ' ALA . 35.3 m -69.74 -36.93 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.403 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.837 HG22 ' O ' ' A' 1324 ' ' ALA . 65.9 p -69.68 -50.76 40.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.352 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.5 mm-40 -61.01 -35.19 76.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -7.99 52.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.793 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1280 ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 56.65 18.04 3.44 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1281 ' ' LYS . . . . . 0.401 ' N ' HG21 ' A' 1322 ' ' VAL . 7.7 mttm -145.66 133.44 21.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.644 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.47 116.44 28.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.723 0.297 . . . . 0.0 110.779 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.825 ' O ' HG23 ' A' 1287 ' ' VAL . 11.1 t -132.49 141.31 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.16 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.707 HD13 ' HB2' ' A' 1299 ' ' ALA . 72.3 mt -68.6 -47.62 76.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.4 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 25.8 t -63.8 -40.68 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.043 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.96 62.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.969 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -64.35 -29.96 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' 1293 ' ' ILE . 0.0 OUTLIER -60.8 -50.84 71.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.108 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -36.35 58.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.994 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.412 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -32.91 61.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.725 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.2 -7.78 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.761 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 59.05 50.35 8.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.53 ' O ' ' NE2' ' A' 1288 ' ' GLN . 10.2 pt -126.56 171.39 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -77.01 154.06 42.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.924 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.5 ' CE1' HG21 ' A' 1284 ' ' ILE . 82.6 t80 -49.11 -55.84 10.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.822 0.311 . . . . 0.0 111.251 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.65 -33.42 22.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.113 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -70.32 -50.89 34.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.865 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.494 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -55.78 -46.74 77.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.555 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.707 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -66.79 -29.98 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.98 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -67.42 -48.93 65.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.893 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.567 HG21 ' CB ' ' A' 1272 ' ' ALA . 50.1 mt -61.39 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.789 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' 1284 ' ' ILE . 20.0 mt -63.09 -31.69 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.734 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -47.6 82.98 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.635 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.8 mt-30 -60.64 -33.4 72.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.197 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.683 ' HB3' HG13 ' A' 1311 ' ' VAL . 0.6 OUTLIER -61.6 -40.32 94.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.605 ' N ' HG22 ' A' 1311 ' ' VAL . 12.5 tt0 -65.86 -35.72 81.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.871 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.93 -41.36 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.265 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1308 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -20.4 59.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.762 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 98.07 15.76 35.03 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.773 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.783 HG23 ' HB3' ' A' 1324 ' ' ALA . 8.6 mt -82.41 -36.18 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 122.791 0.436 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.683 HG13 ' HB3' ' A' 1305 ' ' MET . 26.8 m -120.23 162.41 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.475 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.53 -177.96 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -65.87 131.49 46.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.95 130.95 44.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.381 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -109.08 -44.09 1.13 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.927 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.4 -161.54 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.28 91.79 8.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.78 10.09 86.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.157 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -91.49 122.14 33.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.538 ' HD2' HG21 ' A' 1311 ' ' VAL . 0.2 OUTLIER -107.32 140.28 40.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.439 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' 1311 ' ' VAL . 14.4 tt0 -88.41 132.81 34.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.2 t -90.67 118.69 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.487 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -107.19 -18.3 13.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.021 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' 1277 ' ' THR . . . -91.46 130.17 40.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.292 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.01 158.61 23.94 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.474 2.116 . . . . 0.0 113.133 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.523 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.1 Cg_exo -52.44 161.46 2.8 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.017 2.478 . . . . 0.0 112.57 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1327 ' ' PRO . . . . . 0.476 ' HG3' ' HG3' ' A' 1274 ' ' GLN . 18.9 Cg_endo -59.36 -32.03 95.94 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.757 2.305 . . . . 0.0 112.241 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -91.31 48.43 1.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.952 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.754 0.312 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -175.19 77.82 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.45 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -65.48 -25.16 67.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.764 0.316 . . . . 0.0 111.306 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -56.84 -31.95 65.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 -35.35 5.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.821 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.706 HD13 ' CD1' ' A' 1269 ' ' PHE . 12.3 mt -74.46 160.06 31.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.033 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.25 144.49 62.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.215 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.62 -23.27 19.28 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.47 2.114 . . . . 0.0 112.16 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' 1291 ' ' PHE . 85.4 mt -99.2 -6.92 27.3 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.793 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.706 ' CD1' HD13 ' A' 1265 ' ' LEU . 38.4 t80 -47.54 -56.14 7.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.49 -40.1 61.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.848 0.356 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.45 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.8 mt-30 -71.0 -38.89 72.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.134 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.61 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.26 -40.01 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' 1269 ' ' PHE . 47.2 t -62.86 -47.55 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.431 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.5 OUTLIER -63.67 -33.55 75.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.729 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.411 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.14 -51.26 59.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.588 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -69.51 -37.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.437 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.867 HG22 ' O ' ' A' 1324 ' ' ALA . 44.5 p -69.96 -49.2 54.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.6 mt-10 -60.34 -35.91 76.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -92.33 -6.18 50.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.911 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.5 mmm180 56.93 17.7 3.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.766 0.317 . . . . 0.0 110.85 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 133.4 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.822 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.645 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.51 116.53 29.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.782 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.844 ' O ' HG23 ' A' 1287 ' ' VAL . 1.4 t -132.44 136.13 46.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.574 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 32.1 mt -66.41 -37.9 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.138 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.498 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.8 t -69.35 -43.11 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.85 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1286 ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.17 -48.57 85.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.714 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' 1283 ' ' SER . 12.0 t -66.02 -31.27 52.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.683 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 19.3 mt-30 -59.92 -51.22 70.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 109.998 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -36.77 58.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.261 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.424 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.96 -33.91 61.96 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.611 -179.005 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.61 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.11 -7.01 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.568 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 54.65 54.08 9.73 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.009 0.433 . . . . 0.0 110.261 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.21 146.72 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.516 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.44 149.0 10.57 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.314 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.6 t80 -46.48 -51.79 14.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.8 -39.7 53.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.197 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -50.67 64.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.574 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.88 -49.78 67.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.997 0.427 . . . . 0.0 110.544 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.11 -29.68 70.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.061 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -68.2 -51.63 43.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.549 HG21 ' CB ' ' A' 1272 ' ' ALA . 36.4 mt -59.57 -44.33 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.94 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.454 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.0 mt -67.91 -32.93 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -52.11 66.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.422 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.427 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 0.1 OUTLIER -60.2 -36.9 78.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.617 ' HB3' HG13 ' A' 1311 ' ' VAL . 16.9 mtm -56.94 -36.38 70.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 CA-C-O 121.557 0.694 . . . . 0.0 109.174 178.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' 1311 ' ' VAL . 4.6 tp10 -70.21 -33.14 71.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.055 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.41 62.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.475 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.671 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -88.07 -20.43 25.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.908 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.57 16.05 25.51 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.958 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.637 HG23 ' HB3' ' A' 1324 ' ' ALA . 14.0 mt -85.26 -36.64 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.303 -0.448 . . . . 0.0 111.184 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' 1305 ' ' MET . 35.0 m -120.58 156.64 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.524 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.3 -178.19 3.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.108 0.48 . . . . 0.0 111.657 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.86 135.14 54.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.515 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -67.72 133.99 50.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.173 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -123.73 -42.96 0.36 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.797 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.56 -160.49 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.3 p30 -92.55 91.78 7.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.86 10.1 86.46 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.119 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -98.65 122.23 41.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 0.0 111.637 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.454 ' HG3' HG21 ' A' 1302 ' ' ILE . 7.8 mmt180 -107.24 140.27 40.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.168 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' 1311 ' ' VAL . 4.9 tp10 -87.48 132.67 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -91.79 118.69 37.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 110.099 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.524 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.82 -4.92 17.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.457 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.79 130.98 22.15 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.02 159.42 23.94 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.461 2.107 . . . . 0.0 113.041 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.518 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.47 158.49 3.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.081 2.521 . . . . 0.0 112.582 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.94 -74.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.691 2.261 . . . . 0.0 112.442 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -123.34 -45.52 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.96 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.926 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 5.2 t60 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.801 0.334 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -105.08 -38.27 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -63.3 -24.74 67.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.319 . . . . 0.0 111.246 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -55.89 -33.22 64.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.117 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.26 -34.72 5.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.832 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.9 mt -83.19 155.18 23.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1266 ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' 1301 ' ' ILE . 19.7 t70 -74.48 144.98 81.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.376 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.46 -24.25 21.38 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.377 2.051 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.563 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.3 mt -101.98 -1.76 31.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.909 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.832 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.1 t80 -47.7 -56.51 7.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.37 -41.81 63.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.074 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.411 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.5 mt-30 -70.1 -37.48 75.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.661 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -65.91 -41.65 91.18 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.689 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.608 HG13 HG21 ' A' 1310 ' ' ILE . 57.6 t -61.75 -48.48 88.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.461 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.786 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.435 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -66.87 -51.74 51.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.547 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.4 m -67.6 -37.43 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.121 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 42.6 p -69.47 -49.45 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.178 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.6 -35.03 73.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1279 ' ' LYS . . . . . 0.413 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 2.7 mtmt -93.91 -6.98 44.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.018 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.4 mmm180 58.04 17.2 4.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.625 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.6 133.58 21.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.627 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.34 116.44 29.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.818 ' O ' HG23 ' A' 1287 ' ' VAL . 4.4 t -132.39 138.26 47.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.359 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.572 HG12 HD12 ' A' 1302 ' ' ILE . 24.1 mt -67.92 -38.77 80.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.161 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.477 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.0 t -69.69 -42.83 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.962 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1286 ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.72 -50.18 70.47 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.584 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -65.44 -29.92 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.723 0.297 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -60.41 -52.72 64.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.105 0.479 . . . . 0.0 110.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -76.31 -34.59 59.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.027 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.441 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.5 tp60 -75.12 -34.01 61.64 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.394 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.624 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.44 22.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.704 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 54.77 51.53 13.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.174 0.512 . . . . 0.0 110.047 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.596 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.6 pt -126.89 150.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.36 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -57.61 147.64 35.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.85 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.604 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 86.8 t80 -44.84 -49.5 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 111.47 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.77 -43.47 58.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.807 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.596 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.0 OUTLIER -65.3 -47.27 77.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.417 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.562 ' CB ' HG23 ' A' 1284 ' ' ILE . . . -53.8 -49.94 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.675 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.3 -29.78 70.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.015 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -49.79 56.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.409 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.661 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.2 mt -60.88 -42.51 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.776 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.572 HD12 HG12 ' A' 1284 ' ' ILE . 29.1 mt -69.06 -35.3 68.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.741 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -52.01 66.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.384 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.446 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.1 mt-30 -59.32 -37.58 78.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.354 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.603 ' HB3' HG13 ' A' 1311 ' ' VAL . 17.4 mtm -57.13 -37.43 71.99 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' 1311 ' ' VAL . 2.8 tt0 -70.25 -32.33 70.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.141 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.67 -29.01 62.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.338 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.665 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -90.13 -20.33 23.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.741 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.85 13.76 28.74 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.063 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.1 mt -84.39 -35.84 11.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 122.799 0.439 . . . . 0.0 111.456 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' 1306 ' ' GLU . 30.3 m -122.03 155.84 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.732 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.495 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.74 -177.98 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.04 131.92 47.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.758 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -67.89 156.18 37.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.985 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -129.92 -57.3 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.701 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1316 ' ' HIS . . . . . 0.412 ' CE1' ' OD1' ' A' 1317 ' ' ASN . 20.0 t-160 -66.94 -104.07 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.508 0.154 . . . . 0.0 110.806 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1317 ' ' ASN . . . . . 0.412 ' OD1' ' CE1' ' A' 1316 ' ' HIS . 8.8 p-10 -138.08 91.85 2.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.851 0.358 . . . . 0.0 111.009 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.8 1.59 78.66 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.932 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -87.27 122.37 30.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.89 0.376 . . . . 0.0 111.079 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1320 ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -107.18 140.13 40.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.399 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.0 tp10 -80.0 132.64 36.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.056 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' 1282 ' ' ALA . 18.2 t -88.55 118.56 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.495 HD11 ' CB ' ' A' 1312 ' ' SER . 0.6 OUTLIER -105.73 -13.88 15.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -178.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.47 132.6 24.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.35 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.51 159.02 19.5 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.553 2.169 . . . . 0.0 113.074 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.9 Cg_exo -52.16 161.09 2.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.913 2.409 . . . . 0.0 112.66 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.91 -36.52 2.58 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.669 2.246 . . . . 0.0 112.25 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -60.81 -34.25 74.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.858 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 19.5 t-80 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.826 0.346 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 164.26 101.37 0.16 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.548 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -69.59 -27.47 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 111.246 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -56.42 -29.36 61.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.022 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1264 ' ' GLU . . . . . 0.426 ' O ' ' NE2' ' A' 1304 ' ' GLN . 0.6 OUTLIER -113.51 -44.87 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.967 0.413 . . . . 0.0 110.631 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.633 ' HA ' ' NE2' ' A' 1304 ' ' GLN . 6.9 mt -70.93 157.5 38.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.141 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.62 143.78 79.43 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.197 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.66 -23.63 15.72 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.256 1.971 . . . . 0.0 112.217 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.5 mt -102.08 -5.48 24.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.777 ' O ' HG23 ' A' 1273 ' ' VAL . 39.4 t80 -47.71 -54.13 13.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -52.61 -41.69 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -67.52 -42.67 82.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.609 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -62.78 -39.12 93.21 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.72 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' 1269 ' ' PHE . 21.6 t -62.04 -51.27 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.7 tt0 -61.79 -31.57 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.894 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.439 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -68.25 -50.88 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.632 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -69.18 -37.27 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.287 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.845 HG22 ' O ' ' A' 1324 ' ' ALA . 74.1 p -69.64 -50.64 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' 1274 ' ' GLN . 8.3 mm-40 -59.46 -36.09 75.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.404 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -8.25 48.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 57.71 17.74 4.3 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.462 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1281 ' ' LYS . . . . . 0.408 ' N ' HG21 ' A' 1322 ' ' VAL . 29.7 mttt -145.61 132.1 19.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.792 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.648 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.02 116.49 30.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.727 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.791 ' O ' HG23 ' A' 1287 ' ' VAL . 34.6 t -132.29 139.87 48.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 111.276 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' 1299 ' ' ALA . 22.5 mt -68.48 -43.31 83.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 2.8 t -67.16 -41.18 86.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.978 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.49 -51.14 60.59 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.79 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' 1283 ' ' SER . 21.8 t -64.52 -29.96 48.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.958 0.409 . . . . 0.0 110.263 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' 1293 ' ' ILE . 5.9 tt0 -59.63 -53.07 62.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.248 0.547 . . . . 0.0 110.208 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -35.16 59.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.102 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.424 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -75.09 -33.34 61.64 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.683 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.27 -7.71 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 57.56 52.39 8.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.067 0.461 . . . . 0.0 110.494 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1293 ' ' ILE . . . . . 0.674 HG22 ' NH1' ' A' 1297 ' ' ARG . 13.2 pt -130.01 148.33 33.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.031 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.48 150.28 16.93 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.924 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.45 ' CE1' HG21 ' A' 1284 ' ' ILE . 89.1 t80 -47.59 -51.28 21.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.78 -38.54 48.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.529 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.674 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.1 OUTLIER -66.92 -49.38 65.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.139 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.469 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.62 -45.77 73.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.666 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.537 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -67.05 -29.87 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.063 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -49.97 57.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.046 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.609 HG21 ' CB ' ' A' 1272 ' ' ALA . 39.9 mt -60.57 -45.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.786 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.544 HG22 ' HE ' ' A' 1320 ' ' ARG . 19.8 mt -66.12 -32.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.853 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -52.2 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.633 ' NE2' ' HA ' ' A' 1265 ' ' LEU . 1.3 mt-30 -60.14 -32.03 70.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.758 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.674 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.8 mtm -61.3 -39.05 89.03 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' 1311 ' ' VAL . 1.7 tt0 -67.22 -32.93 74.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.372 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.05 -42.11 63.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.42 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.413 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.1 OUTLIER -76.31 -20.28 57.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.871 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.53 16.37 27.01 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.997 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.0 mt -83.12 -37.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 122.76 0.424 . . . . 0.0 111.279 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' 1305 ' ' MET . 34.8 m -120.65 159.54 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.507 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -107.6 -177.92 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.867 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -65.74 130.68 44.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.419 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -67.91 131.37 45.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.384 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -104.55 -36.88 2.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.935 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -92.94 -158.64 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -86.24 91.83 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 111.216 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.99 10.12 86.45 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.423 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -93.12 122.01 35.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.11 0.455 . . . . 0.0 111.198 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.564 ' HD2' HG21 ' A' 1311 ' ' VAL . 0.7 OUTLIER -107.45 140.3 40.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.566 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.52 132.71 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.253 . . . . 0.0 110.622 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 18.3 t -89.51 118.69 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.94 0.4 . . . . 0.0 110.319 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.507 HD11 ' CB ' ' A' 1312 ' ' SER . 0.8 OUTLIER -106.51 -19.99 13.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.931 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.845 ' O ' HG22 ' A' 1277 ' ' THR . . . -89.67 129.86 45.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.9 158.88 21.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.094 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.498 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.1 Cg_exo -53.13 164.32 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.922 2.414 . . . . 0.0 112.411 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.34 -35.21 14.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.617 2.211 . . . . 0.0 112.232 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -129.5 -68.75 0.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.894 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 98.95 -44.29 1.73 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.547 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.21 67.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.254 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.46 -34.94 64.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.05 -34.39 5.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1265 ' ' LEU . . . . . 0.818 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.2 mt -89.1 159.89 17.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.144 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -85.87 145.11 40.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.365 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -52.52 -24.03 21.04 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1268 ' ' LEU . . . . . 0.585 HD23 ' OE1' ' A' 1271 ' ' GLN . 45.2 mt -102.05 -1.52 31.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.862 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1269 ' ' PHE . . . . . 0.818 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.6 t80 -47.56 -56.88 6.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.34 -41.04 62.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1271 ' ' GLN . . . . . 0.585 ' OE1' HD23 ' A' 1268 ' ' LEU . 0.8 OUTLIER -66.78 -42.3 86.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 178.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1272 ' ' ALA . . . . . 0.623 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -65.01 -41.9 94.91 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1273 ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' 1269 ' ' PHE . 61.1 t -60.11 -48.16 89.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1274 ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.5 tt0 -64.13 -33.26 75.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.744 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1275 ' ' PHE . . . . . 0.448 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -65.65 -50.7 64.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.585 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1276 ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -69.28 -40.26 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.492 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1277 ' ' THR . . . . . 0.853 HG22 ' O ' ' A' 1324 ' ' ALA . 67.0 p -67.99 -49.53 61.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1278 ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' 1274 ' ' GLN . 11.7 mm-40 -59.68 -36.3 76.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -92.28 -6.06 51.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.22 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 28.0 mmm180 58.24 16.84 4.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 110.9 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 2.9 mttm -145.61 134.75 22.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1282 ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' 1322 ' ' VAL . . . -115.67 116.43 28.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.665 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1283 ' ' SER . . . . . 0.879 ' O ' HG23 ' A' 1287 ' ' VAL . 8.7 p -132.52 140.76 48.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1284 ' ' ILE . . . . . 0.571 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 21.2 mt -69.22 -40.5 80.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.287 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1285 ' ' SER . . . . . 0.505 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 45.5 t -67.8 -42.79 81.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.014 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.46 78.29 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.706 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1287 ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' 1283 ' ' SER . 15.5 t -65.49 -30.74 51.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 15.1 mt-30 -60.22 -51.37 69.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.216 0.532 . . . . 0.0 109.949 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -36.1 58.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.233 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1290 ' ' GLN . . . . . 0.439 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.02 -34.64 61.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.618 -178.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1291 ' ' PHE . . . . . 0.59 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.31 -6.48 21.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.551 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 54.96 55.01 8.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 110.381 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 15.2 pt -131.73 147.26 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.435 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.99 149.29 11.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.284 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.0 t80 -46.77 -51.46 16.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.458 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -39.45 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.458 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1297 ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' 1301 ' ' ILE . 0.3 OUTLIER -66.23 -49.49 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.27 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1298 ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.95 -49.36 68.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.642 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1299 ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.81 -29.79 70.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -68.55 -50.52 51.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.244 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1301 ' ' ILE . . . . . 0.623 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.5 mt -60.13 -43.49 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.833 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1302 ' ' ILE . . . . . 0.489 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.2 mt -68.83 -33.69 60.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.928 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.89 66.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.335 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1304 ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 22.9 mt-30 -59.43 -36.76 76.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.303 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1305 ' ' MET . . . . . 0.583 ' HB3' HG13 ' A' 1311 ' ' VAL . 17.1 mtm -57.01 -38.54 73.24 Favored 'General case' 0 C--O 1.228 -0.058 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1306 ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' 1311 ' ' VAL . 5.1 tt0 -69.46 -33.04 72.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.303 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.09 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.404 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1308 ' ' GLN . . . . . 0.676 ' OE1' HD21 ' A' 1265 ' ' LEU . 0.0 OUTLIER -89.18 -20.32 24.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.26 13.89 27.52 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.963 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1310 ' ' ILE . . . . . 0.772 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.4 mt -83.67 -38.49 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 122.743 0.417 . . . . 0.0 111.266 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1311 ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' 1306 ' ' GLU . 32.6 m -120.22 155.78 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.144 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1312 ' ' SER . . . . . 0.435 ' CB ' HD11 ' A' 1323 ' ' LEU . 1.0 OUTLIER -96.46 -179.9 4.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.623 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -65.9 134.69 53.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.396 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 138.69 56.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.077 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -136.64 -46.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.789 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.76 -157.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 4.9 p30 -100.52 91.79 4.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.887 0.375 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.78 10.06 86.48 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.462 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -105.04 122.09 45.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.16 0.48 . . . . 0.0 111.65 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1320 ' ' ARG . . . . . 0.489 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.7 mmt180 -107.6 140.33 40.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.31 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.3 tt0 -85.44 132.67 34.18 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.862 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1322 ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' 1282 ' ' ALA . 29.4 t -92.86 118.69 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.967 0.413 . . . . 0.0 110.139 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1323 ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.11 -13.54 14.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.233 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1324 ' ' ALA . . . . . 0.853 ' O ' HG22 ' A' 1277 ' ' THR . . . -95.57 130.41 32.03 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.24 159.29 23.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.531 2.154 . . . . 0.0 113.028 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1326 ' ' PRO . . . . . 0.525 ' N ' ' HB ' ' A' 1277 ' ' THR . 63.0 Cg_exo -51.68 159.67 3.28 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.06 2.507 . . . . 0.0 112.678 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.17 -36.88 2.2 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -120.26 27.29 8.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.957 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.856 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.4 mt . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 121.089 0.471 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . 0.449 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.9 t70 -79.33 144.14 61.52 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.554 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 -25.78 20.58 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.555 2.17 . . . . 0.0 112.627 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.557 HD13 ' HB3' ' A' 1291 ' ' PHE . 63.1 mt -101.94 -2.65 29.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.856 ' CD2' HD22 ' A' 1265 ' ' LEU . 38.8 t80 -47.57 -55.09 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.47 -45.31 66.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.946 0.403 . . . . 0.0 110.905 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -67.32 -38.21 84.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.24 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.627 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.41 94.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.665 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' 1269 ' ' PHE . 23.5 t -62.11 -47.87 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' 1278 ' ' GLU . 33.1 tt0 -63.55 -33.91 76.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.881 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.4 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.14 -50.47 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -70.1 -37.59 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.471 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.835 HG22 ' O ' ' A' 1324 ' ' ALA . 55.0 p -70.09 -49.48 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.1 mt-10 -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.285 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -91.39 -7.18 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.9 mmm180 57.52 17.85 4.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -145.56 133.23 21.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.774 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.74 116.38 28.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.832 ' O ' HG23 ' A' 1287 ' ' VAL . 3.2 p -132.57 138.98 47.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.869 0.366 . . . . 0.0 111.22 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' 1299 ' ' ALA . 19.7 mt -67.24 -40.14 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 47.6 t -68.51 -41.52 79.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.51 -49.93 73.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.638 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' 1283 ' ' SER . 12.0 t -65.92 -30.11 48.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.603 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.74 -51.16 70.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.124 0.488 . . . . 0.0 110.011 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -76.2 -37.07 58.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.162 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.41 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.04 -33.34 61.73 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.512 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.69 21.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.403 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 54.16 52.86 11.93 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.051 0.453 . . . . 0.0 110.226 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.478 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 19.8 pt -129.83 148.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.544 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.61 148.07 22.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.22 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.603 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.9 t80 -45.31 -50.23 12.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.4 p30 -50.84 -41.82 58.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.705 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.478 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.8 -49.68 69.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.253 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.521 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -53.98 -50.0 67.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.5 -29.83 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.189 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -50.55 51.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.144 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.581 HG21 ' CB ' ' A' 1272 ' ' ALA . 34.0 mt -60.43 -43.71 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.953 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.559 HG22 ' HE ' ' A' 1320 ' ' ARG . 22.2 mt -68.63 -33.95 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.759 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -51.98 65.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.415 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.425 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 7.0 mt-30 -59.06 -36.11 74.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.569 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.3 mtm -58.37 -37.14 74.63 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.618 ' N ' HG22 ' A' 1311 ' ' VAL . 36.8 tt0 -69.7 -32.24 70.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.32 62.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.343 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.822 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.6 OUTLIER -89.62 -20.31 23.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.792 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.31 12.98 32.04 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.912 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -83.23 -35.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 122.618 0.367 . . . . 0.0 111.204 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' 1306 ' ' GLU . 27.5 m -122.38 154.47 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.449 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.492 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.6 OUTLIER -102.77 -177.85 3.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.615 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.509 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.001 0.429 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.559 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.2 OUTLIER -107.42 140.26 40.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.369 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' 1311 ' ' VAL . 5.8 tt0 -86.05 132.69 33.99 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.803 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' 1282 ' ' ALA . 26.9 t -91.21 118.59 36.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.933 0.396 . . . . 0.0 110.106 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.0 -10.82 15.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.385 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' 1277 ' ' THR . . . -99.88 130.68 25.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.09 159.59 23.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 113.039 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.524 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.1 Cg_exo -51.67 163.74 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.903 2.402 . . . . 0.0 112.587 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 122.715 2.277 . . . . 0.0 112.412 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.782 HD13 ' CD1' ' A' 1269 ' ' PHE . 7.5 mt . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.971 0.415 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.33 144.27 94.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.75 -24.83 13.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.191 1.927 . . . . 0.0 112.273 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.2 mt -102.16 -5.28 24.61 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.835 ' O ' HG23 ' A' 1273 ' ' VAL . 38.4 t80 -47.71 -53.39 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -52.6 -45.42 66.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.408 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.4 mt-30 -67.96 -37.95 82.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.634 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.29 -39.16 93.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.305 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' 1269 ' ' PHE . 19.2 t -62.83 -49.18 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' 1278 ' ' GLU . 22.2 tt0 -62.79 -32.5 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.792 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.429 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -67.95 -50.58 55.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.68 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.3 m -69.72 -38.01 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.844 HG22 ' O ' ' A' 1324 ' ' ALA . 57.6 p -69.73 -49.91 48.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.113 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.2 mt-10 -59.09 -36.95 76.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.999 0.428 . . . . 0.0 110.292 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . 0.414 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 4.0 mtmt -89.79 -9.52 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.008 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.1 mmm180 59.97 16.65 5.98 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.833 0.349 . . . . 0.0 110.478 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 3.8 mttp -145.55 134.43 22.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.623 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.18 116.61 28.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.802 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.834 ' O ' HG23 ' A' 1287 ' ' VAL . 3.2 p -132.55 139.72 47.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.601 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 24.6 mt -68.56 -39.31 80.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.203 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.504 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 48.1 t -69.13 -42.45 75.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.29 69.22 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.569 -0.825 . . . . 0.0 111.583 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' 1283 ' ' SER . 17.6 t -65.31 -30.34 49.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.597 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.27 -52.01 67.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 110.097 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -36.19 58.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.125 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.411 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -74.98 -33.13 61.84 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.559 -179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.38 21.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.631 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 55.8 51.96 11.54 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.128 0.489 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.688 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -128.7 147.77 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.85 150.23 18.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.024 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.593 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.34 -51.26 15.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.397 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 5.9 p30 -50.7 -40.07 53.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.56 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.688 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.4 OUTLIER -64.98 -50.28 66.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.329 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.601 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.99 -49.93 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.507 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.32 -29.9 71.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.209 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -68.49 -50.48 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.99 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.585 HG21 ' CB ' ' A' 1272 ' ' ALA . 40.7 mt -60.74 -46.41 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.774 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.463 HG21 ' HG3' ' A' 1320 ' ' ARG . 18.7 mt -66.17 -31.45 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.948 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -63.73 -52.26 61.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -59.22 -32.0 69.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.643 178.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.591 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.7 mtm -62.63 -39.55 94.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.619 ' N ' HG22 ' A' 1311 ' ' VAL . 3.2 tt0 -67.38 -32.05 72.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.283 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.09 -42.05 63.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.248 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.556 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -76.21 -20.24 57.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.774 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.46 13.94 31.48 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.055 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -81.21 -36.79 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.806 0.442 . . . . 0.0 111.492 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.619 HG22 ' N ' ' A' 1306 ' ' GLU . 33.3 m -121.38 159.57 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.207 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.459 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.5 OUTLIER -103.84 -178.06 3.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.078 0.466 . . . . 0.0 111.732 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 36.4 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.973 0.416 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.463 ' HG3' HG21 ' A' 1302 ' ' ILE . 4.6 mmt180 -107.43 140.31 40.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.368 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' 1311 ' ' VAL . 18.0 tt0 -86.44 132.63 33.89 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.879 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.576 HG22 ' HB2' ' A' 1282 ' ' ALA . 23.6 t -91.35 118.71 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.23 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.459 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.67 -12.79 15.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.326 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.844 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.3 131.61 27.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.55 159.3 22.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.418 2.079 . . . . 0.0 113.012 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.539 ' N ' ' HB ' ' A' 1277 ' ' THR . 71.0 Cg_exo -51.57 156.42 6.28 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.965 2.443 . . . . 0.0 112.712 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.701 2.267 . . . . 0.0 112.516 -179.783 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.947 0.403 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . 0.413 ' CB ' HG12 ' A' 1301 ' ' ILE . 18.6 t70 -72.95 142.39 82.88 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.154 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -51.23 -25.04 16.53 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.323 2.015 . . . . 0.0 112.49 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' 1291 ' ' PHE . 41.9 mt -102.14 -3.63 27.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' 1273 ' ' VAL . 43.6 t80 -47.79 -53.02 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -52.72 -44.06 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.044 0.45 . . . . 0.0 110.539 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.514 HE21 HD23 ' A' 1268 ' ' LEU . 18.8 mt-30 -66.58 -40.49 88.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.145 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.603 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.97 -39.74 94.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.739 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' 1269 ' ' PHE . 16.2 t -61.4 -51.72 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' 1278 ' ' GLU . 19.9 tt0 -60.74 -32.04 71.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.857 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.466 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -67.29 -52.14 44.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.8 m -69.17 -35.31 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.855 HG22 ' O ' ' A' 1324 ' ' ALA . 69.3 p -72.19 -49.06 38.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.2 mt-10 -60.35 -35.3 75.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.192 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.7 -5.12 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.939 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.6 mmm180 53.63 20.69 2.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.882 0.373 . . . . 0.0 110.649 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -145.61 129.87 17.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.636 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.645 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -111.98 116.47 30.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.742 0.306 . . . . 0.0 110.631 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.837 ' O ' HG23 ' A' 1287 ' ' VAL . 11.3 t -132.46 139.86 48.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' 1299 ' ' ALA . 16.4 mt -68.63 -40.75 82.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.272 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 28.6 t -67.82 -41.87 82.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.28 -49.94 73.03 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.823 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' 1283 ' ' SER . 12.7 t -65.99 -29.79 47.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 17.4 mt-30 -60.76 -52.66 64.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.126 0.489 . . . . 0.0 109.867 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -76.27 -34.87 59.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.961 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.522 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.5 OUTLIER -73.8 -37.01 65.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.762 0.315 . . . . 0.0 111.508 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' 1268 ' ' LEU . 1.8 m-85 -103.19 -5.15 23.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.839 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 55.02 8.49 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 148.53 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.384 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -53.76 149.81 14.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.125 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.597 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.4 t80 -47.09 -51.94 16.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 111.507 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -38.35 46.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.588 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -49.33 65.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.249 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.535 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.64 -49.86 69.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.563 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.36 -29.86 71.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -51.4 48.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.012 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.603 HG21 ' CB ' ' A' 1272 ' ' ALA . 41.8 mt -60.01 -45.21 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.83 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' 1305 ' ' MET . 21.5 mt -66.27 -32.56 58.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -50.23 67.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.612 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.5 mt-30 -57.16 -34.49 68.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.242 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.595 ' HB3' HG13 ' A' 1311 ' ' VAL . 16.0 mtm -63.33 -39.15 93.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.27 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.603 ' N ' HG22 ' A' 1311 ' ' VAL . 1.9 tt0 -66.41 -31.67 72.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.591 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.48 44.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.23 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.499 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -75.39 -20.21 59.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.756 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 99.8 16.07 29.64 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.001 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' 1324 ' ' ALA . 9.6 mt -84.03 -36.8 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 122.566 0.346 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' 1306 ' ' GLU . 27.1 m -119.93 161.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.341 . . . . 0.0 111.211 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.462 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.01 178.18 4.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.371 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.54 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 47.1 m-80 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.937 0.399 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.446 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.56 140.28 40.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.475 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' 1311 ' ' VAL . 47.0 tt0 -89.66 132.68 35.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.819 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -92.29 118.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.29 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.462 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.39 -13.06 15.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.855 ' O ' HG22 ' A' 1277 ' ' THR . . . -95.39 129.37 35.22 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -80.96 159.11 20.97 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.494 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.6 Cg_exo -52.34 164.37 1.33 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.977 2.452 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 122.655 2.236 . . . . 0.0 112.302 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.857 HD22 ' CD2' ' A' 1269 ' ' PHE . 11.3 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.985 0.421 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.06 145.8 44.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.229 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.62 -23.54 20.09 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.286 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' 1291 ' ' PHE . 58.0 mt -102.04 -3.39 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.852 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.857 ' CD2' HD22 ' A' 1265 ' ' LEU . 42.5 t80 -47.6 -56.62 6.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -39.06 60.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.952 0.406 . . . . 0.0 110.368 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.445 HE21 HD23 ' A' 1268 ' ' LEU . 10.6 mt-30 -68.45 -42.51 78.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.02 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.633 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -64.82 -40.97 96.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.58 ' CG1' HD13 ' A' 1310 ' ' ILE . 53.8 t -61.36 -47.85 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.441 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -64.17 -33.29 75.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.898 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.438 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.58 -50.42 63.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.59 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.7 m -69.59 -38.22 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.275 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.888 HG22 ' O ' ' A' 1324 ' ' ALA . 42.6 p -69.04 -48.93 61.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.155 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.39 -37.17 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.433 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -92.37 -5.56 51.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.108 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' 1276 ' ' VAL . 9.0 mmm180 57.34 17.63 3.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 19.7 mttm -145.45 134.17 22.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.58 116.56 28.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.895 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.875 ' O ' HG23 ' A' 1287 ' ' VAL . 1.0 OUTLIER -132.59 138.56 47.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.896 0.379 . . . . 0.0 111.257 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.606 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 32.1 mt -67.81 -38.07 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.493 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.1 t -69.24 -44.3 72.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.049 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -59.55 -49.22 80.86 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.687 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' 1283 ' ' SER . 14.8 t -65.36 -31.38 53.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.611 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -59.48 -52.16 66.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 109.991 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -76.2 -35.8 58.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.283 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.431 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.96 -33.83 61.97 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.599 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.3 -7.26 21.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.657 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 56.18 53.33 9.1 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 110.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.689 HG22 ' NH1' ' A' 1297 ' ' ARG . 13.3 pt -129.82 147.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.246 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.88 150.43 18.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.966 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.592 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.38 -51.24 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.424 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -39.84 53.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.614 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.689 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.3 OUTLIER -65.61 -49.62 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.346 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.606 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.0 -48.79 70.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.501 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.11 -29.73 70.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.136 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -68.74 -50.77 47.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.633 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.9 mt -60.18 -43.62 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.4 mt -69.09 -32.63 54.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.57 -50.92 70.67 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.462 ' HG2' HD23 ' A' 1265 ' ' LEU . 0.0 OUTLIER -61.13 -35.72 77.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.249 178.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.682 ' HB3' HG13 ' A' 1311 ' ' VAL . 11.3 mtm -57.0 -38.19 72.73 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.602 ' N ' HG22 ' A' 1311 ' ' VAL . 3.0 tm-20 -69.63 -32.92 71.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.355 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.19 -28.78 61.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.692 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.793 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -91.43 -20.32 21.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.94 15.94 24.98 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.992 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.719 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.8 mt -85.31 -36.63 11.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.802 0.441 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' 1305 ' ' MET . 30.2 m -121.23 158.31 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.489 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.1 OUTLIER -105.3 -178.56 3.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.031 0.443 . . . . 0.0 111.618 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.656 -179.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.982 0.42 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.438 ' HG3' HG21 ' A' 1302 ' ' ILE . 6.0 mmt180 -107.07 140.32 40.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.281 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' 1311 ' ' VAL . 2.0 tt0 -86.29 132.68 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.836 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.4 t -91.66 118.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 110.243 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.32 -7.87 16.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.272 -179.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.888 ' O ' HG22 ' A' 1277 ' ' THR . . . -102.58 130.44 23.96 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.406 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.3 159.37 20.07 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.485 2.123 . . . . 0.0 112.947 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 55.6 Cg_exo -52.19 164.35 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.908 2.406 . . . . 0.0 112.507 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--N 1.343 0.276 0 C-N-CA 122.64 2.226 . . . . 0.0 112.239 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.7 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.831 0.348 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.06 144.9 45.16 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.095 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.52 -24.24 16.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.231 1.954 . . . . 0.0 112.485 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' 1291 ' ' PHE . 57.9 mt -102.11 -4.38 26.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' 1265 ' ' LEU . 44.9 t80 -47.48 -54.99 10.0 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -40.01 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.418 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 3.0 mt-30 -69.07 -42.22 76.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.619 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.14 -39.68 95.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.668 HG13 HD13 ' A' 1310 ' ' ILE . 42.5 t -61.99 -49.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.39 -30.54 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.854 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.465 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -68.6 -51.68 39.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -69.04 -37.43 77.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.498 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.837 HG22 ' O ' ' A' 1324 ' ' ALA . 48.2 p -69.67 -49.69 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.28 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.1 mt-10 -60.29 -35.57 75.87 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.936 0.398 . . . . 0.0 110.399 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -93.03 -5.16 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.092 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 18.4 mmm180 55.5 18.73 2.82 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.812 0.339 . . . . 0.0 110.81 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.1 mttt -145.64 131.18 18.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -112.88 116.37 29.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.683 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.79 ' O ' HG23 ' A' 1287 ' ' VAL . 1.8 p -132.49 142.47 49.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.209 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' 1299 ' ' ALA . 46.2 mt -71.02 -42.32 76.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.275 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 9.2 t -67.71 -40.58 84.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -61.07 -51.16 60.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.715 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' 1283 ' ' SER . 23.9 t -64.38 -29.77 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.292 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' 1293 ' ' ILE . 16.1 tt0 -60.19 -54.41 46.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 110.203 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -31.66 58.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.76 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.47 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 4.5 tp60 -75.03 -36.36 61.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.721 0.296 . . . . 0.0 111.544 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.29 -6.3 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.934 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 57.7 52.62 8.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.032 0.444 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.436 ' O ' ' HG3' ' A' 1288 ' ' GLN . 12.8 pt -130.21 149.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.061 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.72 148.57 26.75 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.146 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . . . . . . . . . 80.6 t80 -46.5 -51.62 14.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.454 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.78 -40.14 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.152 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.409 ' HE ' HG21 ' A' 1293 ' ' ILE . 0.0 OUTLIER -66.14 -48.87 69.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.449 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -54.03 -47.95 71.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.504 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.583 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -65.2 -29.89 70.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.018 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -67.57 -49.01 65.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.141 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.612 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.4 mt -61.26 -46.72 96.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.949 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.452 HG22 ' HE ' ' A' 1320 ' ' ARG . 11.1 mt -65.54 -34.46 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.887 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -48.89 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.426 ' CB ' ' CE2' ' A' 1269 ' ' PHE . 16.8 mt-30 -61.81 -35.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.231 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.646 ' HB3' HG13 ' A' 1311 ' ' VAL . 0.3 OUTLIER -56.95 -38.83 73.49 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.598 ' N ' HG22 ' A' 1311 ' ' VAL . 1.4 tm-20 -70.48 -33.34 71.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.4 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.39 63.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.585 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.766 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.6 OUTLIER -90.81 -20.35 22.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.877 -178.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.88 16.34 26.25 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.817 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.4 mt -84.47 -34.76 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.271 -0.464 . . . . 0.0 111.04 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' 1305 ' ' MET . 27.8 m -120.21 159.87 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.418 ' CA ' HD11 ' A' 1323 ' ' LEU . 1.4 p -100.75 -178.65 3.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 111.307 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.437 179.82 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.978 0.418 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.562 ' HD2' HG21 ' A' 1311 ' ' VAL . 1.4 mtt-85 -107.48 140.41 40.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.428 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' 1311 ' ' VAL . 20.5 tp10 -84.11 132.76 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.547 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -90.4 118.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.98 0.419 . . . . 0.0 110.467 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.418 HD11 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.53 -12.22 15.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.214 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' 1277 ' ' THR . . . -96.65 131.64 27.78 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.233 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.21 158.12 17.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.464 2.109 . . . . 0.0 113.302 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.491 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -52.81 164.3 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.076 2.517 . . . . 0.0 112.669 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 N--CA 1.462 -0.368 0 C-N-CA 123.009 2.472 . . . . 0.0 111.846 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' 1269 ' ' PHE . 10.5 mt . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.56 142.86 86.8 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.979 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.73 -24.87 13.97 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.319 2.013 . . . . 0.0 112.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' 1291 ' ' PHE . 61.7 mt -102.14 -5.03 24.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.82 ' O ' HG23 ' A' 1273 ' ' VAL . 40.8 t80 -47.57 -53.49 14.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.8 -42.5 65.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.057 0.455 . . . . 0.0 110.396 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.416 HE21 HD23 ' A' 1268 ' ' LEU . 12.0 mt-30 -66.75 -42.42 86.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.141 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.25 -39.3 94.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.79 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' 1269 ' ' PHE . 18.9 t -61.81 -50.61 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -62.24 -32.51 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.443 ' CD2' ' CE1' ' A' 1291 ' ' PHE . 2.4 t80 -67.17 -50.76 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.669 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.638 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.9 m -70.22 -36.78 69.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.345 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.858 HG22 ' O ' ' A' 1324 ' ' ALA . 50.7 p -71.23 -48.37 51.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.319 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' 1274 ' ' GLN . 34.1 mt-10 -61.36 -35.61 77.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -93.76 -4.11 50.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.989 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' 1276 ' ' VAL . 16.0 mmm180 53.95 19.5 2.02 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.55 132.51 20.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.638 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.15 116.4 28.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.922 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.859 ' O ' HG23 ' A' 1287 ' ' VAL . 7.5 p -132.65 140.47 48.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 22.1 mt -68.79 -40.64 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.28 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.507 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 42.1 t -67.58 -42.31 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.05 -49.25 80.63 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.777 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' 1283 ' ' SER . 14.6 t -65.91 -30.41 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.718 0.294 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.3 mt-30 -60.73 -51.05 70.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.179 0.514 . . . . 0.0 110.001 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -76.34 -36.68 58.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.169 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.44 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.9 OUTLIER -75.02 -34.34 61.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.612 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.602 ' HB3' HD13 ' A' 1268 ' ' LEU . 2.0 m-85 -103.27 -6.54 21.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.602 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 54.92 54.85 8.47 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.486 HD11 HG12 ' A' 1287 ' ' VAL . 12.9 pt -131.17 147.8 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.434 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.28 148.43 25.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.06 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 90.2 t80 -45.69 -50.75 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.547 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.73 -41.53 56.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -50.05 68.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.316 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.551 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.01 -49.97 67.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.526 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.48 -29.76 70.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.121 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.36 -50.59 52.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.92 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' 1272 ' ' ALA . 43.2 mt -59.87 -46.56 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.757 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.5 mt -65.84 -31.98 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.4 -52.12 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.576 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -58.25 -31.95 67.89 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.614 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.668 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.2 mtm -62.49 -39.68 94.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.608 ' N ' HG22 ' A' 1311 ' ' VAL . 3.2 tt0 -66.79 -31.95 72.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.583 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -75.18 -41.98 56.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.472 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.53 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -75.86 -20.32 58.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.883 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.13 16.87 26.57 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.003 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.733 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.2 mt -83.48 -39.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.831 0.452 . . . . 0.0 111.167 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' 1305 ' ' MET . 35.6 m -118.87 160.39 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.028 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.467 ' CA ' HD11 ' A' 1323 ' ' LEU . 0.7 OUTLIER -95.34 178.59 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 111.442 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.416 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 8.9 m-80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.117 0.484 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.453 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.5 140.43 40.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.234 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.4 tp10 -84.61 132.71 34.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.092 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.617 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.2 t -92.47 118.73 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.276 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.467 HD11 ' CA ' ' A' 1312 ' ' SER . 0.3 OUTLIER -109.01 -15.56 14.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.286 -179.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.858 ' O ' HG22 ' A' 1277 ' ' THR . . . -93.18 131.38 33.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.299 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.5 159.29 22.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.432 2.088 . . . . 0.0 113.01 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.534 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.55 164.39 0.91 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.922 2.415 . . . . 0.0 112.69 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.705 2.27 . . . . 0.0 112.34 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.853 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.9 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.116 0.484 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . 0.452 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -81.33 143.74 52.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.491 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.63 -26.37 22.57 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.398 2.065 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.618 HD23 ' NE2' ' A' 1271 ' ' GLN . 44.8 mt -102.03 -0.59 33.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.873 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.853 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.2 t80 -47.65 -57.02 6.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -41.75 63.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.934 0.397 . . . . 0.0 110.417 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.618 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.8 OUTLIER -66.07 -43.07 88.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.264 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.89 -41.78 95.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.327 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' 1277 ' ' THR . 98.8 t -60.67 -47.76 91.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.444 ' HA ' ' HG1' ' A' 1277 ' ' THR . 33.1 tt0 -64.37 -32.49 74.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.764 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.432 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.75 -50.32 63.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.626 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -68.7 -37.62 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.257 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 53.9 p -70.17 -49.21 52.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.241 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.36 -35.64 74.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.349 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -93.03 -7.68 45.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.035 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 2.5 mmm180 57.99 17.72 4.59 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.815 0.341 . . . . 0.0 110.602 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -145.54 133.25 21.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.626 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.76 116.54 28.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.676 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.722 ' O ' HG23 ' A' 1287 ' ' VAL . 13.2 p -132.42 138.08 47.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 111.265 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' 1299 ' ' ALA . 23.3 mt -66.01 -42.86 92.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.394 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 1.1 t -68.65 -37.99 80.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.805 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.49 -51.05 59.02 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.74 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -65.57 -29.73 47.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-O 120.904 0.383 . . . . 0.0 110.37 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' 1293 ' ' ILE . 16.1 tt0 -60.47 -55.13 37.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.184 0.516 . . . . 0.0 110.281 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -76.12 -30.37 58.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.553 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -75.06 -36.62 61.78 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.77 0.319 . . . . 0.0 111.531 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.23 -6.08 22.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 27.8 mtm105 58.46 48.4 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.041 0.448 . . . . 0.0 110.549 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.477 HG21 HD12 ' A' 1268 ' ' LEU . 14.9 pt -125.5 158.39 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.184 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -64.31 148.13 50.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.186 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.516 ' CE1' HG21 ' A' 1284 ' ' ILE . 91.2 t80 -45.66 -51.16 12.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.697 0.284 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.65 -41.94 55.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.967 0.413 . . . . 0.0 110.066 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.59 -49.79 69.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.161 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.78 -49.39 68.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.57 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.87 -29.9 71.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.113 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -50.56 50.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.245 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.594 HG21 ' CB ' ' A' 1272 ' ' ALA . 20.8 mt -59.45 -42.46 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.838 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.502 HG22 ' HE ' ' A' 1320 ' ' ARG . 22.2 mt -69.26 -34.5 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.716 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -51.61 67.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.364 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.416 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 21.8 mt-30 -59.32 -36.86 76.44 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.359 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.574 ' HB3' HG13 ' A' 1311 ' ' VAL . 18.9 mtm -57.12 -38.52 73.56 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.626 ' N ' HG22 ' A' 1311 ' ' VAL . 18.1 tt0 -69.44 -33.03 72.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.394 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.72 62.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.47 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.824 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.7 OUTLIER -90.73 -20.39 22.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.807 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.13 13.33 29.24 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.933 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.742 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.8 mt -82.9 -37.84 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.053 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' 1306 ' ' GLU . 27.1 m -120.54 158.13 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.218 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.492 ' CB ' HD11 ' A' 1323 ' ' LEU . 1.2 p -101.22 -179.46 4.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.122 0.487 . . . . 0.0 111.686 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.501 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 44.1 m-80 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.954 0.407 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.502 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.41 140.37 40.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.388 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 17.9 tt0 -87.06 132.7 33.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.978 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.7 t -92.66 118.73 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.25 -11.47 15.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.227 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.87 131.56 26.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.238 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.07 159.15 15.51 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.542 2.162 . . . . 0.0 112.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.484 ' N ' ' HB ' ' A' 1277 ' ' THR . 52.1 Cg_exo -52.78 164.39 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.912 2.408 . . . . 0.0 112.469 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.582 2.188 . . . . 0.0 112.295 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.521 HD21 ' NE2' ' A' 1308 ' ' GLN . 1.8 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.904 0.383 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.86 144.12 32.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.51 -23.67 19.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.323 2.015 . . . . 0.0 112.368 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.736 HD23 ' NE2' ' A' 1271 ' ' GLN . 62.3 mt -102.06 -3.81 27.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.921 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' A' 1310 ' ' ILE . 43.7 t80 -47.51 -55.51 8.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 37.8 t0 -52.49 -41.59 63.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.736 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.5 OUTLIER -66.37 -43.32 86.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.314 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.626 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -64.1 -41.04 97.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.251 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' 1269 ' ' PHE . 99.0 t -61.08 -47.89 91.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.58 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.639 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.432 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.4 -51.23 59.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.654 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.5 m -68.47 -36.7 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.482 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.886 HG22 ' O ' ' A' 1324 ' ' ALA . 45.6 p -70.6 -49.92 42.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.37 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.0 mt-10 -60.14 -33.93 72.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.369 . . . . 0.0 110.354 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -95.22 -5.58 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.018 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 55.99 18.52 3.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.839 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . 0.404 ' N ' HG21 ' A' 1322 ' ' VAL . 10.5 mttt -145.53 132.51 20.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.62 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.62 116.29 28.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.823 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.787 ' O ' HG23 ' A' 1287 ' ' VAL . 1.9 t -132.63 138.26 47.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 26.1 mt -66.49 -38.88 82.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.046 0.451 . . . . 0.0 110.117 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.486 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 27.5 t -69.68 -40.75 76.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.829 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -61.51 -48.43 84.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' 1283 ' ' SER . 15.1 t -67.16 -29.66 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 120.745 0.307 . . . . 0.0 110.709 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -61.34 -54.49 43.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.186 0.517 . . . . 0.0 110.093 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -30.84 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.531 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' 1286 ' ' GLY . 4.1 tp60 -74.93 -38.11 61.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.23 -4.51 24.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.804 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 55.47 54.99 7.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.045 0.45 . . . . 0.0 110.485 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.436 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 10.2 pt -131.49 157.59 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.476 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -63.5 148.2 50.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.981 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.597 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.2 t80 -45.41 -51.52 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.551 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -40.63 55.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.676 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.467 ' HD3' HD11 ' A' 1301 ' ' ILE . 0.0 OUTLIER -66.44 -48.2 70.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.562 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.9 -49.63 68.16 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.019 0.438 . . . . 0.0 110.649 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.515 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.98 -29.88 71.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.067 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -68.05 -50.22 56.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.039 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.626 HG21 ' CB ' ' A' 1272 ' ' ALA . 33.9 mt -60.68 -45.83 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.51 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.8 mt -66.56 -32.16 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.843 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -52.1 63.6 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.4 OUTLIER -58.73 -33.02 69.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.711 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.654 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.0 mtm -60.98 -40.87 95.08 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.613 ' N ' HG22 ' A' 1311 ' ' VAL . 1.4 tt0 -66.16 -33.23 75.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.827 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.466 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.524 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -75.51 -20.37 58.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.783 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.19 15.88 26.82 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.046 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.2 mt -82.71 -38.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.817 0.447 . . . . 0.0 111.317 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' 1305 ' ' MET . 34.8 m -120.67 164.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.438 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -105.96 -178.12 3.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.069 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.676 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.002 0.429 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.51 ' HG3' HG21 ' A' 1302 ' ' ILE . 3.4 mtt180 -107.45 140.31 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.346 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' 1311 ' ' VAL . 53.5 tt0 -81.9 132.8 35.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.647 0.26 . . . . 0.0 111.067 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.5 t -90.26 118.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.141 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.438 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.25 -18.83 13.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.154 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' 1277 ' ' THR . . . -90.89 131.54 37.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.109 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.59 159.36 19.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.453 2.102 . . . . 0.0 113.026 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.496 ' N ' ' HB ' ' A' 1277 ' ' THR . 60.2 Cg_exo -51.6 158.01 4.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.005 2.47 . . . . 0.0 112.502 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.643 2.228 . . . . 0.0 112.422 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.829 HD21 ' NE2' ' A' 1308 ' ' GLN . 9.6 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.92 0.39 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . 0.404 ' CB ' HG12 ' A' 1301 ' ' ILE . 24.8 t70 -87.98 145.07 35.66 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.426 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.21 -24.28 20.11 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.368 2.046 . . . . 0.0 112.505 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' 1291 ' ' PHE . 40.8 mt -102.14 -1.76 30.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.896 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.804 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.1 t80 -47.69 -55.21 9.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.0 t0 -52.51 -44.35 65.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 0.0 110.893 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.455 ' NE2' HD23 ' A' 1268 ' ' LEU . 19.1 mt-30 -68.0 -37.93 82.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.076 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.631 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.9 95.2 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.661 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' 1269 ' ' PHE . 26.9 t -61.78 -47.81 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' 1278 ' ' GLU . 14.5 tt0 -63.49 -33.28 75.22 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.752 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.406 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -66.58 -51.61 54.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.7 m -68.9 -38.31 78.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.588 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.86 HG22 ' O ' ' A' 1324 ' ' ALA . 56.2 p -70.01 -48.42 58.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.12 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' 1274 ' ' GLN . 10.5 mm-40 -59.02 -37.16 76.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.369 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -92.81 -6.04 49.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.3 mmm180 57.64 17.48 4.06 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.783 0.325 . . . . 0.0 110.847 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.63 134.14 22.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.764 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' 1322 ' ' VAL . . . -114.86 116.4 28.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.705 0.288 . . . . 0.0 110.704 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.857 ' O ' HG23 ' A' 1287 ' ' VAL . 2.4 p -132.57 143.16 49.52 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.9 0.381 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.837 HG23 ' HB3' ' A' 1298 ' ' ALA . 50.0 mt -71.09 -39.51 74.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.11 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.441 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 38.6 t -66.77 -44.54 81.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.872 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.57 -51.1 60.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.951 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' 1283 ' ' SER . 16.5 t -65.03 -31.83 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.011 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.499 ' HG3' ' HB2' ' A' 1298 ' ' ALA . 38.3 mt-30 -59.74 -51.77 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.069 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -76.24 -35.86 58.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.184 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' 1286 ' ' GLY . 0.1 OUTLIER -75.06 -33.37 61.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.497 -179.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.18 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.537 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 55.63 51.29 12.83 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.117 0.485 . . . . 0.0 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.696 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -127.13 149.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.324 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.8 151.04 21.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.004 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.558 ' CE1' HG21 ' A' 1284 ' ' ILE . 1.1 t80 -46.51 -54.59 8.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.716 0.293 . . . . 0.0 111.333 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.55 -36.55 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.696 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.8 OUTLIER -65.69 -49.31 69.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.837 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -54.01 -50.09 67.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.698 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.01 -29.77 71.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -68.8 -49.93 54.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.148 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.63 HG21 ' CB ' ' A' 1272 ' ' ALA . 26.6 mt -61.4 -44.43 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.853 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.533 HG22 ' HE ' ' A' 1320 ' ' ARG . 25.0 mt -67.55 -33.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.81 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -52.06 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.284 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.2 mt-30 -58.83 -36.84 75.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.254 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.578 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.7 mtm -57.7 -37.79 74.11 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.608 ' N ' HG22 ' A' 1311 ' ' VAL . 7.1 tt0 -69.4 -32.69 71.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.146 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.76 -30.43 62.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.376 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.829 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -88.52 -20.28 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.8 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.46 13.78 29.6 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.983 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.795 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.5 mt -83.99 -36.23 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.673 0.389 . . . . 0.0 111.319 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' 1306 ' ' GLU . 27.2 m -121.05 152.66 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.412 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.521 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.6 OUTLIER -97.27 -177.93 4.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.422 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.431 179.859 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.893 0.378 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.533 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.3 OUTLIER -107.4 140.42 40.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' 1311 ' ' VAL . 36.3 tt0 -80.46 132.67 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.17 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' 1282 ' ' ALA . 31.3 t -91.81 118.71 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.95 -8.48 15.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.338 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.86 ' O ' HG22 ' A' 1277 ' ' THR . . . -100.27 129.87 27.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.244 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.04 159.15 23.89 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.505 2.137 . . . . 0.0 113.029 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.519 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.7 Cg_exo -51.64 159.66 3.24 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.894 2.396 . . . . 0.0 112.503 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 122.61 2.207 . . . . 0.0 112.306 179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.832 HD21 ' NE2' ' A' 1308 ' ' GLN . 9.2 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.918 0.389 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . 0.409 ' CB ' HG12 ' A' 1301 ' ' ILE . 20.6 t70 -86.56 144.8 38.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.48 -24.55 22.37 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.463 2.109 . . . . 0.0 112.497 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.2 mt -101.95 -1.36 32.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.751 ' CD2' HD22 ' A' 1265 ' ' LEU . 42.7 t80 -47.6 -56.27 7.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -52.39 -42.44 64.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.405 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.4 mt-30 -69.85 -37.14 76.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.183 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.649 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -67.0 -40.42 87.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.753 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.591 ' CG1' HD13 ' A' 1310 ' ' ILE . 57.5 t -62.52 -47.37 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.451 ' HA ' ' OG1' ' A' 1277 ' ' THR . 50.7 tt0 -64.04 -32.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.677 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.433 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.98 -51.1 59.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.478 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.3 m -68.3 -38.18 79.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.247 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 43.5 p -69.46 -49.28 56.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.249 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.4 mm-40 -59.89 -35.79 75.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.988 0.423 . . . . 0.0 110.411 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -6.18 48.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.025 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 19.9 mmm180 55.95 18.93 3.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.812 0.339 . . . . 0.0 110.553 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.56 131.29 18.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.643 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.643 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.55 116.41 29.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.633 0.254 . . . . 0.0 110.62 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.737 ' O ' HG23 ' A' 1287 ' ' VAL . 25.5 t -132.47 135.23 45.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' 1299 ' ' ALA . 36.8 mt -64.51 -41.54 92.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.199 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 31.6 t -70.19 -38.53 75.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.664 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.58 -49.43 73.53 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.479 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' 1283 ' ' SER . 21.8 t -66.63 -29.67 47.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.315 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.95 -55.67 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.163 0.506 . . . . 0.0 110.321 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -28.81 57.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -75.06 -37.29 61.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.367 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.17 -5.23 23.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.727 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 57.9 49.09 12.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.492 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' 1297 ' ' ARG . 11.2 pt -124.86 163.97 24.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.068 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -70.58 147.98 44.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.623 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.499 ' CE1' HG21 ' A' 1284 ' ' ILE . 91.2 t80 -45.6 -50.52 13.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.76 -41.91 57.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.598 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.498 ' HD3' HD11 ' A' 1301 ' ' ILE . 0.0 OUTLIER -67.16 -47.43 71.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.17 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.91 -49.13 69.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.956 0.408 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.82 -29.72 70.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.807 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -51.28 59.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.313 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.649 HG21 ' CB ' ' A' 1272 ' ' ALA . 25.6 mt -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.053 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.58 HG21 ' HG3' ' A' 1320 ' ' ARG . 22.0 mt -67.93 -33.79 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.733 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.03 -51.38 69.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.435 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 11.3 mt-30 -59.66 -36.51 76.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.281 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.704 ' HB3' HG13 ' A' 1311 ' ' VAL . 15.1 mtm -57.45 -37.64 73.16 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.587 ' N ' HG22 ' A' 1311 ' ' VAL . 5.4 tt0 -69.55 -32.88 71.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.55 61.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.69 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.832 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -89.2 -20.44 24.18 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.43 17.09 22.93 Favored Glycine 0 C--N 1.328 0.131 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.949 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.8 mt -86.25 -36.22 10.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 122.811 0.444 . . . . 0.0 111.265 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.704 HG13 ' HB3' ' A' 1305 ' ' MET . 32.6 m -120.63 164.01 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.446 ' CA ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.68 -177.96 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.131 0.491 . . . . 0.0 111.708 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 14.1 mp0 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.59 -179.889 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 38.3 m-80 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.068 0.461 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.5 mmt180 -107.46 140.37 40.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.595 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.9 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.711 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 20.3 t -90.28 118.68 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 0.0 110.29 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.446 HD11 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.77 -6.49 16.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.484 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.46 132.47 20.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.413 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.26 159.35 20.17 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.433 2.089 . . . . 0.0 112.924 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.507 ' N ' ' HB ' ' A' 1277 ' ' THR . 65.1 Cg_exo -51.69 157.39 5.43 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.944 2.429 . . . . 0.0 112.6 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.84 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.8 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.966 0.412 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.28 144.4 46.67 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.325 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.29 -24.4 20.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.472 2.115 . . . . 0.0 112.556 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' 1291 ' ' PHE . 41.4 mt -102.04 -1.73 31.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.95 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.84 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.5 t80 -47.54 -55.46 9.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.52 -41.35 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.995 0.426 . . . . 0.0 110.391 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 0.0 OUTLIER -66.67 -43.48 84.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.013 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.63 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.41 -40.26 96.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' 1269 ' ' PHE . 25.3 t -61.75 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' 1278 ' ' GLU . 23.1 tt0 -64.17 -32.23 73.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.705 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.479 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.46 -51.42 57.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.454 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.8 m -69.05 -39.93 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.623 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.801 HG22 ' O ' ' A' 1324 ' ' ALA . 76.2 p -67.74 -49.86 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.365 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.2 mt-10 -59.91 -36.63 77.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.964 0.411 . . . . 0.0 110.479 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.22 -6.25 53.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.016 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.1 mmm180 57.35 17.51 3.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.813 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.6 mttt -145.66 134.28 22.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.749 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.641 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.59 116.39 28.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.679 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.877 ' O ' HG23 ' A' 1287 ' ' VAL . 5.0 p -132.54 140.76 48.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.137 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 21.9 mt -69.55 -40.79 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.313 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 37.1 t -66.91 -43.78 82.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.116 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -59.3 -49.53 77.49 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.793 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' 1283 ' ' SER . 15.9 t -65.12 -30.71 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.649 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 13.0 mt-30 -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.217 0.532 . . . . 0.0 109.978 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -35.8 58.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.186 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.446 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.1 tp60 -75.01 -34.91 61.98 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.612 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.0 m-85 -103.2 -6.66 21.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.606 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 55.6 55.15 7.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.039 0.447 . . . . 0.0 110.458 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.429 HG21 ' HE ' ' A' 1297 ' ' ARG . 13.5 pt -131.88 147.87 32.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.49 147.93 22.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.182 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.3 t80 -45.3 -50.24 12.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 111.446 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.78 -42.6 58.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.429 ' HE ' HG21 ' A' 1293 ' ' ILE . 0.0 OUTLIER -64.3 -49.23 72.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -53.9 -50.12 67.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.07 -29.69 71.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.063 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -68.08 -51.08 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.208 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.63 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.4 mt -59.53 -43.38 90.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.462 HG21 ' HG3' ' A' 1320 ' ' ARG . 19.9 mt -68.98 -33.63 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.915 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.14 -52.05 65.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.236 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.443 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 25.4 mt-30 -59.41 -36.92 76.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.226 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.601 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.5 mtm -57.35 -37.81 73.15 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' 1311 ' ' VAL . 3.1 tt0 -69.39 -33.07 72.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.01 -29.75 63.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.261 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.823 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -89.25 -20.29 24.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.782 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.77 12.74 31.61 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.949 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -83.07 -36.19 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.654 0.382 . . . . 0.0 111.341 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' 1306 ' ' GLU . 35.4 m -122.75 155.11 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.378 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.539 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -102.53 -177.97 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.188 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.343 179.777 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 19.8 m-80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.952 0.406 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.462 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.48 140.32 40.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.6 132.66 34.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.889 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' 1282 ' ' ALA . 31.8 t -92.24 118.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.539 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -108.51 -4.76 16.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.381 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.801 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.24 130.66 22.73 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.395 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.59 158.74 22.1 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.563 2.175 . . . . 0.0 113.153 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.523 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.8 Cg_exo -52.2 163.19 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.044 2.496 . . . . 0.0 112.712 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--N 1.344 0.312 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.791 HD22 ' CD2' ' A' 1269 ' ' PHE . 8.4 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.951 0.405 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' 1268 ' ' LEU . 19.3 t70 -84.87 143.02 39.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.051 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.11 -23.87 23.75 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.388 2.059 . . . . 0.0 112.421 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.566 HD12 ' NH1' ' A' 1297 ' ' ARG . 74.4 mt -97.73 -6.65 32.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.524 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.791 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.5 t80 -47.29 -55.95 7.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.42 -40.99 62.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.957 0.408 . . . . 0.0 110.318 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.566 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 0.1 OUTLIER -64.79 -49.16 71.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.892 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.641 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -60.31 -40.77 91.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.625 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' 1277 ' ' THR . 84.3 t -61.23 -48.52 88.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.406 ' HA ' ' HG1' ' A' 1277 ' ' THR . 33.8 mt-30 -65.46 -30.29 71.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.877 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.402 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.1 t80 -68.13 -49.08 63.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.438 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' 1282 ' ' ALA . 35.2 m -69.75 -40.75 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.293 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.834 HG22 ' O ' ' A' 1324 ' ' ALA . 76.4 p -67.62 -48.52 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.18 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -59.11 -38.12 78.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.493 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -90.68 -6.56 54.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.028 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.2 mmm180 59.76 15.71 5.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.938 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.55 136.94 25.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.785 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -116.3 116.36 27.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.908 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.871 ' O ' HG23 ' A' 1287 ' ' VAL . 13.1 t -132.52 139.14 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.199 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CB ' ' A' 1298 ' ' ALA . 31.3 mt -68.43 -38.46 79.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.8 t -68.78 -42.47 77.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.871 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.73 -48.23 87.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.661 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' 1283 ' ' SER . 14.2 t -66.05 -30.94 51.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 110.673 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 21.9 mt-30 -60.88 -50.49 73.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.144 0.497 . . . . 0.0 110.048 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -76.32 -36.53 58.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.157 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.412 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.94 -33.95 62.01 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.566 -179.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.14 -6.38 22.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.535 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' 1292 ' ' ARG . 13.8 mtp-105 53.95 54.96 8.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.097 0.475 . . . . 0.0 110.23 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.484 HG21 ' NH1' ' A' 1297 ' ' ARG . 13.9 pt -130.86 152.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.578 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -58.75 148.14 39.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.791 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.588 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 91.2 t80 -44.96 -51.85 9.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.54 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -40.99 57.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.744 HH12 HD11 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.93 -47.87 76.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.99 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -56.37 -50.18 72.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -62.54 -29.88 70.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -68.08 -49.84 58.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.258 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.744 HD11 HH12 ' A' 1297 ' ' ARG . 40.2 mt -60.18 -44.21 94.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.059 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.491 HG21 ' HG3' ' A' 1320 ' ' ARG . 19.4 mt -68.68 -33.51 60.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.836 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -52.04 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.32 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.441 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 29.1 mt-30 -60.05 -36.39 77.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.341 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.593 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.7 mtm -57.05 -38.89 73.87 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.632 ' N ' HG22 ' A' 1311 ' ' VAL . 0.4 OUTLIER -68.81 -33.94 74.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.239 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -71.47 -30.82 66.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.47 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.788 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -88.78 -20.21 25.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.868 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.05 12.69 31.07 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.894 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.74 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.1 mt -82.53 -36.03 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 122.8 0.44 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.632 HG22 ' N ' ' A' 1306 ' ' GLU . 35.8 m -124.01 158.98 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.254 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.466 ' CA ' HD11 ' A' 1323 ' ' LEU . 1.0 OUTLIER -98.66 179.25 4.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 0.0 111.602 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.438 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 63.2 m-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.063 0.459 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.491 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.9 mmt180 -107.28 140.33 40.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.204 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.5 tp10 -83.39 132.72 34.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.976 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.0 t -91.39 118.78 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.982 0.42 . . . . 0.0 110.222 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.466 HD11 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -109.02 -6.23 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.448 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.834 ' O ' HG22 ' A' 1277 ' ' THR . . . -104.68 132.49 20.87 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.414 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.83 158.56 16.01 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.493 2.129 . . . . 0.0 113.043 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.51 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.0 Cg_exo -53.27 163.49 2.37 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.97 2.447 . . . . 0.0 112.526 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.298 179.888 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.811 HD21 ' NE2' ' A' 1308 ' ' GLN . 9.9 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.044 0.449 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . 0.405 ' CB ' HG12 ' A' 1301 ' ' ILE . 10.0 t70 -84.62 143.99 41.96 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.404 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.35 -25.53 18.55 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.519 2.146 . . . . 0.0 112.869 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' 1291 ' ' PHE . 36.6 mt -102.06 -0.15 34.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.805 ' CD2' HD22 ' A' 1265 ' ' LEU . 43.5 t80 -47.7 -56.38 7.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -42.78 64.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.477 ' NE2' HD23 ' A' 1268 ' ' LEU . 16.4 mt-30 -69.48 -36.51 76.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.241 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.673 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -67.75 -41.65 83.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.684 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.553 HG13 HG21 ' A' 1310 ' ' ILE . 97.9 t -61.99 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.4 OUTLIER -64.77 -32.41 74.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.615 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.408 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -67.41 -50.71 58.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.666 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.8 m -68.23 -37.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.335 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.887 HG22 ' O ' ' A' 1324 ' ' ALA . 43.2 p -69.98 -48.83 56.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.222 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' 1274 ' ' GLN . 6.2 mm-40 -59.66 -35.16 73.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.527 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -95.97 -4.16 43.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.8 mmm180 54.95 19.42 2.66 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.906 0.384 . . . . 0.0 110.873 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . 0.427 ' N ' HG21 ' A' 1322 ' ' VAL . 1.4 mttp -145.46 131.64 19.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.96 116.42 29.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.642 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.815 ' O ' HG23 ' A' 1287 ' ' VAL . 30.2 t -132.46 141.84 48.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.651 HD13 ' HB2' ' A' 1299 ' ' ALA . 62.2 mt -70.29 -43.44 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 27.7 t -68.06 -40.59 82.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.883 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.07 60.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.781 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' 1283 ' ' SER . 22.3 t -65.19 -29.93 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.266 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' 1293 ' ' ILE . 13.3 tt0 -59.8 -51.86 67.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -76.28 -35.59 58.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.065 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.414 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.06 -33.3 61.7 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.596 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.16 -7.85 20.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.762 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 56.62 51.78 10.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.161 0.505 . . . . 0.0 110.29 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.464 HG21 HD12 ' A' 1268 ' ' LEU . 19.1 pt -129.17 146.03 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.11 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -50.89 149.77 6.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.319 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' 1284 ' ' ILE . 87.8 t80 -47.64 -53.43 14.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.444 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.77 -36.95 39.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -67.07 -50.21 62.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.175 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -55.21 -46.35 75.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.628 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.651 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -65.91 -29.9 70.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.175 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -49.36 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.315 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.673 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.0 mt -60.66 -42.43 91.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.965 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.554 ' HA ' ' HE3' ' A' 1305 ' ' MET . 26.5 mt -68.76 -35.29 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -51.09 70.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.486 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.417 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 17.4 mt-30 -59.88 -37.04 78.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.428 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.611 ' HB3' HG13 ' A' 1311 ' ' VAL . 19.6 mtm -56.98 -38.39 72.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.604 ' N ' HG22 ' A' 1311 ' ' VAL . 2.2 tt0 -69.93 -32.81 71.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.37 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.54 -31.47 65.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.426 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.811 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.7 OUTLIER -88.12 -20.3 25.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.918 -178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.63 13.81 29.1 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.719 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.2 mt -82.85 -36.42 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 122.892 0.477 . . . . 0.0 111.251 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' 1305 ' ' MET . 26.7 m -121.31 160.49 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.541 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.435 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -106.97 -178.53 3.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.516 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.65 -179.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.925 0.393 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.534 ' HD3' HG21 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.06 140.24 40.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.351 179.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' 1311 ' ' VAL . 15.3 tp10 -75.37 132.58 41.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.992 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 20.6 t -87.3 118.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -105.7 -19.04 13.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.269 -178.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.887 ' O ' HG22 ' A' 1277 ' ' THR . . . -91.96 133.49 30.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.262 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.19 159.02 15.26 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.498 2.132 . . . . 0.0 113.02 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.489 ' N ' ' HB ' ' A' 1277 ' ' THR . 56.6 Cg_exo -52.01 159.35 3.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.903 2.402 . . . . 0.0 112.477 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 112.394 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.825 HD21 ' NE2' ' A' 1308 ' ' GLN . 9.4 mt . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.996 0.427 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.87 143.64 43.62 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.43 -24.18 27.08 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.394 2.063 . . . . 0.0 112.272 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.718 HD23 ' NE2' ' A' 1271 ' ' GLN . 65.9 mt -97.53 -5.37 35.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.6 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.741 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.0 t80 -47.47 -55.93 8.06 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.52 -40.77 62.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.396 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.718 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.2 OUTLIER -67.52 -43.26 81.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.082 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.08 -41.19 99.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.905 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' 1269 ' ' PHE . 29.7 t -61.1 -48.51 88.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' 1278 ' ' GLU . 45.0 tt0 -63.18 -33.56 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.441 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -65.9 -51.6 57.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.62 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.638 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.2 m -69.31 -38.46 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.7 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.85 HG22 ' O ' ' A' 1324 ' ' ALA . 51.4 p -69.23 -49.86 52.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.21 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.4 mt-10 -59.8 -36.37 76.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.971 0.415 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -91.81 -6.49 51.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.018 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.6 mmm180 56.9 18.12 3.7 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.887 0.375 . . . . 0.0 110.744 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 132.35 20.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.737 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.638 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.98 116.49 29.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.788 ' O ' HG23 ' A' 1287 ' ' VAL . 0.5 OUTLIER -132.29 141.37 48.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.903 0.382 . . . . 0.0 111.139 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' 1299 ' ' ALA . 25.4 mt -69.13 -43.31 81.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 21.3 t -67.01 -40.3 87.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.978 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.65 -51.12 60.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' 1283 ' ' SER . 21.1 t -64.83 -29.91 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.311 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' 1293 ' ' ILE . 10.7 tt0 -59.75 -52.68 64.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.092 0.472 . . . . 0.0 110.135 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 -35.23 58.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.18 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.435 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -34.67 61.78 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.632 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.14 -7.38 21.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 56.82 55.02 6.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.135 0.493 . . . . 0.0 110.526 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' 1288 ' ' GLN . 13.3 pt -133.23 145.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -51.06 148.86 7.71 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.491 ' CE1' HG21 ' A' 1284 ' ' ILE . 89.2 t80 -47.05 -52.7 14.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.543 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.72 -38.5 47.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 110.052 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -50.59 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.068 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.53 -44.43 72.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.429 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -66.94 -29.74 69.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -50.55 53.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.567 HG21 ' CB ' ' A' 1272 ' ' ALA . 20.8 mt -59.92 -42.33 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.01 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.544 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.9 mt -69.45 -34.6 62.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.774 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.94 -52.05 65.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.393 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.434 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 31.6 mt-30 -58.41 -38.03 76.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.259 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.566 ' HB3' HG13 ' A' 1311 ' ' VAL . 21.3 mtm -57.53 -37.33 72.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.326 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.626 ' N ' HG22 ' A' 1311 ' ' VAL . 2.2 tt0 -69.21 -32.66 72.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.181 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.825 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.4 OUTLIER -87.25 -20.31 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.715 -178.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.5 12.94 31.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.009 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.3 mt -83.65 -34.92 10.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.473 -0.363 . . . . 0.0 111.403 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' 1306 ' ' GLU . 35.6 m -124.44 154.4 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.622 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.44 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.1 OUTLIER -104.47 179.65 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.901 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 52.5 m-80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.875 0.369 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.544 ' HG3' HG21 ' A' 1302 ' ' ILE . 4.7 mtt180 -107.22 140.2 40.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.54 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' 1311 ' ' VAL . 19.7 tp10 -81.95 132.66 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.767 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.5 t -88.81 118.61 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 110.047 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -106.31 -13.03 15.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.38 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' 1277 ' ' THR . . . -99.22 132.34 23.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.275 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.46 159.04 22.57 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.525 2.15 . . . . 0.0 113.026 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.515 ' N ' ' HB ' ' A' 1277 ' ' THR . 57.2 Cg_exo -51.64 152.31 12.97 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.038 2.492 . . . . 0.0 112.687 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 C--N 1.344 0.34 0 C-N-CA 122.625 2.217 . . . . 0.0 112.318 179.857 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.541 HD21 ' NE2' ' A' 1308 ' ' GLN . 3.3 mt . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.105 0.479 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . 0.425 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -80.38 141.74 53.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -51.73 -24.13 17.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.349 2.033 . . . . 0.0 112.584 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.639 HD23 ' NE2' ' A' 1271 ' ' GLN . 59.2 mt -102.11 -4.51 25.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.035 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.843 ' O ' HG23 ' A' 1273 ' ' VAL . 39.9 t80 -47.67 -53.11 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -46.08 66.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.0 110.294 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.639 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.1 OUTLIER -63.9 -43.25 96.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.25 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.602 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -62.1 -39.36 92.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.982 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' 1269 ' ' PHE . 17.2 t -61.65 -49.57 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.425 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.0 OUTLIER -62.61 -33.28 74.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.841 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.415 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.49 -50.87 61.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.0 m -69.57 -38.02 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.432 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.84 HG22 ' O ' ' A' 1324 ' ' ALA . 67.1 p -69.31 -50.25 48.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.0 mm-40 -59.17 -36.78 75.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.484 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -92.69 -6.14 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 29.1 mmm180 56.01 18.74 3.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.817 0.341 . . . . 0.0 110.651 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' 1322 ' ' VAL . 24.1 mttp -145.62 133.67 21.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.61 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -116.85 116.23 27.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.898 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.814 ' O ' HG23 ' A' 1287 ' ' VAL . 0.5 OUTLIER -132.54 143.25 49.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.022 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 16.1 mt -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 14.8 t -67.38 -40.59 85.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.059 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.65 -50.41 67.94 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.778 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' 1283 ' ' SER . 13.4 t -65.51 -30.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 110.635 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.7 mt-30 -60.76 -51.54 68.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.061 0.458 . . . . 0.0 109.936 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -36.58 58.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.097 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.427 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.98 -34.37 61.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.714 0.293 . . . . 0.0 111.626 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.15 -6.51 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.562 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 54.67 54.97 8.46 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.483 HG21 HD12 ' A' 1268 ' ' LEU . 14.7 pt -131.97 150.39 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.583 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.61 148.32 26.82 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.252 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.1 t80 -45.96 -50.99 14.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.559 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.76 -40.67 55.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.467 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.88 -49.74 69.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.558 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.98 -49.54 68.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.86 -30.0 71.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -49.8 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.985 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.557 HG21 ' CB ' ' A' 1272 ' ' ALA . 33.6 mt -60.71 -45.55 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.842 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.474 HG22 ' HE ' ' A' 1320 ' ' ARG . 21.0 mt -66.79 -32.46 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.864 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -52.2 59.67 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.8 OUTLIER -57.86 -33.32 68.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.758 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.604 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.3 mtm -62.7 -39.37 93.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' 1311 ' ' VAL . 28.1 tt0 -66.35 -32.28 73.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.416 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.88 -42.11 58.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.281 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.541 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -74.4 -20.19 60.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.604 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.42 15.3 30.29 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.743 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.0 mt -83.64 -35.28 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.65 0.38 . . . . 0.0 111.502 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' 1306 ' ' GLU . 29.6 m -122.4 159.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.573 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.42 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.19 178.19 4.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.819 -179.992 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.474 ' HE ' HG22 ' A' 1302 ' ' ILE . 2.2 mtt-85 -107.18 140.2 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.655 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1311 ' ' VAL . 13.5 tt0 -83.61 132.72 34.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.749 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' 1282 ' ' ALA . 19.3 t -87.92 118.57 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.321 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.42 HD11 ' CB ' ' A' 1312 ' ' SER . 0.8 OUTLIER -105.81 -10.25 16.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.053 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' 1277 ' ' THR . . . -100.21 129.91 27.16 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.192 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -82.62 158.48 16.54 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.573 2.182 . . . . 0.0 113.175 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.439 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -53.97 164.26 2.63 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.993 2.462 . . . . 0.0 112.32 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--N 1.344 0.331 0 C-N-CA 122.701 2.268 . . . . 0.0 112.432 179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.518 HD13 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.029 0.442 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 8.7 t0 -75.77 141.38 72.0 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.0 -24.57 10.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.441 2.094 . . . . 0.0 112.945 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' 1291 ' ' PHE . 60.0 mt -102.18 -5.03 24.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' 1273 ' ' VAL . 45.9 t80 -47.66 -52.67 17.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.6 t0 -52.67 -42.2 64.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 0.0 110.328 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.56 -43.06 81.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.989 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -61.64 -38.98 89.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.873 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' 1269 ' ' PHE . 21.2 t -62.13 -52.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.476 ' HG3' ' HG3' ' A' 1327 ' ' PRO . 0.8 OUTLIER -61.43 -30.62 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.941 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.479 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 3.1 t80 -68.91 -51.04 44.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.697 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' 1282 ' ' ALA . 35.3 m -69.74 -36.93 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.403 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.837 HG22 ' O ' ' A' 1324 ' ' ALA . 65.9 p -69.68 -50.76 40.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.352 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.5 mm-40 -61.01 -35.19 76.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -7.99 52.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.793 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 56.65 18.04 3.44 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . 0.401 ' N ' HG21 ' A' 1322 ' ' VAL . 7.7 mttm -145.66 133.44 21.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.644 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.47 116.44 28.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.723 0.297 . . . . 0.0 110.779 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.825 ' O ' HG23 ' A' 1287 ' ' VAL . 11.1 t -132.49 141.31 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.16 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.707 HD13 ' HB2' ' A' 1299 ' ' ALA . 72.3 mt -68.6 -47.62 76.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.4 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 25.8 t -63.8 -40.68 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.043 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.96 62.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.969 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -64.35 -29.96 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.446 ' HG3' ' HA ' ' A' 1295 ' ' TYR . 0.0 OUTLIER -60.8 -50.84 71.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.108 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -36.35 58.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.994 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.412 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -32.91 61.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.725 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.2 -7.78 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.761 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 59.05 50.35 8.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' 1288 ' ' GLN . 10.2 pt -126.56 171.39 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -77.01 154.06 42.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.924 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.5 ' CE1' HG21 ' A' 1284 ' ' ILE . 82.6 t80 -49.11 -55.84 10.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.822 0.311 . . . . 0.0 111.251 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -33.42 22.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.113 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -70.32 -50.89 34.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.865 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.494 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -55.78 -46.74 77.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.555 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.707 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -66.79 -29.98 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.98 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -67.42 -48.93 65.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.893 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.567 HG21 ' CB ' ' A' 1272 ' ' ALA . 50.1 mt -61.39 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.789 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' 1284 ' ' ILE . 20.0 mt -63.09 -31.69 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.734 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -47.6 82.98 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.635 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.8 mt-30 -60.64 -33.4 72.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.197 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.683 ' HB3' HG13 ' A' 1311 ' ' VAL . 0.6 OUTLIER -61.6 -40.32 94.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.605 ' N ' HG22 ' A' 1311 ' ' VAL . 12.5 tt0 -65.86 -35.72 81.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.871 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.93 -41.36 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.265 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.511 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -74.72 -20.4 59.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.762 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 98.07 15.76 35.03 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.773 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.783 HG23 ' HB3' ' A' 1324 ' ' ALA . 8.6 mt -82.41 -36.18 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 122.791 0.436 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.683 HG13 ' HB3' ' A' 1305 ' ' MET . 26.8 m -120.23 162.41 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.475 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.53 -177.96 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.73 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.9 m-80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.965 0.412 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.538 ' HD2' HG21 ' A' 1311 ' ' VAL . 0.2 OUTLIER -107.32 140.28 40.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.439 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' 1311 ' ' VAL . 14.4 tt0 -88.41 132.81 34.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.2 t -90.67 118.69 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.487 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -107.19 -18.3 13.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.021 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' 1277 ' ' THR . . . -91.46 130.17 40.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.292 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.01 158.61 23.94 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.474 2.116 . . . . 0.0 113.133 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.523 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.1 Cg_exo -52.44 161.46 2.8 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.017 2.478 . . . . 0.0 112.57 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . 0.476 ' HG3' ' HG3' ' A' 1274 ' ' GLN . 18.9 Cg_endo . . . . . 0 C--N 1.344 0.334 0 C-N-CA 122.757 2.305 . . . . 0.0 112.241 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.821 HD21 ' NE2' ' A' 1308 ' ' GLN . 12.3 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.25 144.49 62.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.215 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.62 -23.27 19.28 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.47 2.114 . . . . 0.0 112.16 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' 1291 ' ' PHE . 85.4 mt -99.2 -6.92 27.3 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.793 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.706 ' CD1' HD13 ' A' 1265 ' ' LEU . 38.4 t80 -47.54 -56.14 7.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.49 -40.1 61.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.848 0.356 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.45 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 17.4 mt-30 -71.0 -38.89 72.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.134 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.61 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.26 -40.01 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' 1269 ' ' PHE . 47.2 t -62.86 -47.55 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.431 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.5 OUTLIER -63.67 -33.55 75.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.729 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.411 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.14 -51.26 59.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.588 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -69.51 -37.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.437 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.867 HG22 ' O ' ' A' 1324 ' ' ALA . 44.5 p -69.96 -49.2 54.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.6 mt-10 -60.34 -35.91 76.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -92.33 -6.18 50.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.911 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.5 mmm180 56.93 17.7 3.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.766 0.317 . . . . 0.0 110.85 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 133.4 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.822 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.645 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.51 116.53 29.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.782 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.844 ' O ' HG23 ' A' 1287 ' ' VAL . 1.4 t -132.44 136.13 46.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.574 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 32.1 mt -66.41 -37.9 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.138 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.498 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.8 t -69.35 -43.11 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.85 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.17 -48.57 85.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.714 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' 1283 ' ' SER . 12.0 t -66.02 -31.27 52.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.683 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 19.3 mt-30 -59.92 -51.22 70.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 109.998 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -36.77 58.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.261 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.424 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.96 -33.91 61.96 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.611 -179.005 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.61 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.11 -7.01 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.568 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 54.65 54.08 9.73 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.009 0.433 . . . . 0.0 110.261 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.21 146.72 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.516 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.44 149.0 10.57 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.314 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.6 t80 -46.48 -51.79 14.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.8 -39.7 53.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.197 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -50.67 64.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.574 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.88 -49.78 67.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.997 0.427 . . . . 0.0 110.544 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.11 -29.68 70.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.061 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -68.2 -51.63 43.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.549 HG21 ' CB ' ' A' 1272 ' ' ALA . 36.4 mt -59.57 -44.33 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.94 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.454 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.0 mt -67.91 -32.93 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -52.11 66.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.422 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.427 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 0.1 OUTLIER -60.2 -36.9 78.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.617 ' HB3' HG13 ' A' 1311 ' ' VAL . 16.9 mtm -56.94 -36.38 70.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 CA-C-O 121.557 0.694 . . . . 0.0 109.174 178.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' 1311 ' ' VAL . 4.6 tp10 -70.21 -33.14 71.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.055 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.41 62.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.475 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.821 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.4 OUTLIER -88.07 -20.43 25.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.908 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.57 16.05 25.51 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.958 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.637 HG23 ' HB3' ' A' 1324 ' ' ALA . 14.0 mt -85.26 -36.64 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.303 -0.448 . . . . 0.0 111.184 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' 1305 ' ' MET . 35.0 m -120.58 156.64 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.524 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.3 -178.19 3.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.108 0.48 . . . . 0.0 111.657 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.515 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 27.4 m-80 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.9 0.381 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.454 ' HG3' HG21 ' A' 1302 ' ' ILE . 7.8 mmt180 -107.24 140.27 40.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.168 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' 1311 ' ' VAL . 4.9 tp10 -87.48 132.67 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -91.79 118.69 37.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 110.099 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.524 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.82 -4.92 17.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.457 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.79 130.98 22.15 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.02 159.42 23.94 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.461 2.107 . . . . 0.0 113.041 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.518 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.47 158.49 3.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.081 2.521 . . . . 0.0 112.582 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.345 0.389 0 C-N-CA 122.691 2.261 . . . . 0.0 112.442 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.832 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.9 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.922 0.391 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' 1301 ' ' ILE . 19.7 t70 -74.48 144.98 81.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.376 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.46 -24.25 21.38 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.377 2.051 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.563 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.3 mt -101.98 -1.76 31.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.909 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.832 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.1 t80 -47.7 -56.51 7.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.37 -41.81 63.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.074 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.411 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.5 mt-30 -70.1 -37.48 75.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.661 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -65.91 -41.65 91.18 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.689 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.608 HG13 HG21 ' A' 1310 ' ' ILE . 57.6 t -61.75 -48.48 88.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.461 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.786 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.435 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -66.87 -51.74 51.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.547 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.4 m -67.6 -37.43 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.121 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 42.6 p -69.47 -49.45 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.178 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.6 -35.03 73.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . 0.413 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 2.7 mtmt -93.91 -6.98 44.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.018 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.4 mmm180 58.04 17.2 4.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.625 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.6 133.58 21.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.627 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.34 116.44 29.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.818 ' O ' HG23 ' A' 1287 ' ' VAL . 4.4 t -132.39 138.26 47.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.359 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.572 HG12 HD12 ' A' 1302 ' ' ILE . 24.1 mt -67.92 -38.77 80.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.161 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.477 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.0 t -69.69 -42.83 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.962 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.72 -50.18 70.47 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.584 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -65.44 -29.92 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.723 0.297 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -60.41 -52.72 64.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.105 0.479 . . . . 0.0 110.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -76.31 -34.59 59.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.027 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.441 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.5 tp60 -75.12 -34.01 61.64 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.394 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.624 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.44 22.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.704 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 54.77 51.53 13.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.174 0.512 . . . . 0.0 110.047 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.596 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.6 pt -126.89 150.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.36 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -57.61 147.64 35.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.85 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.604 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 86.8 t80 -44.84 -49.5 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 111.47 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.77 -43.47 58.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.807 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.596 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.0 OUTLIER -65.3 -47.27 77.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.417 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.562 ' CB ' HG23 ' A' 1284 ' ' ILE . . . -53.8 -49.94 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.675 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.3 -29.78 70.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.015 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -49.79 56.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.409 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.661 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.2 mt -60.88 -42.51 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.776 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.572 HD12 HG12 ' A' 1284 ' ' ILE . 29.1 mt -69.06 -35.3 68.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.741 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -52.01 66.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.384 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.446 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.1 mt-30 -59.32 -37.58 78.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.354 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.603 ' HB3' HG13 ' A' 1311 ' ' VAL . 17.4 mtm -57.13 -37.43 71.99 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' 1311 ' ' VAL . 2.8 tt0 -70.25 -32.33 70.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.141 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.67 -29.01 62.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.338 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.822 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -90.13 -20.33 23.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.741 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.85 13.76 28.74 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.063 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.1 mt -84.39 -35.84 11.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 122.799 0.439 . . . . 0.0 111.456 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' 1306 ' ' GLU . 30.3 m -122.03 155.84 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.732 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.495 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.74 -177.98 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.758 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 23.7 m-80 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.89 0.376 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -107.18 140.13 40.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.399 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.0 tp10 -80.0 132.64 36.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.056 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' 1282 ' ' ALA . 18.2 t -88.55 118.56 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.495 HD11 ' CB ' ' A' 1312 ' ' SER . 0.6 OUTLIER -105.73 -13.88 15.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -178.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.47 132.6 24.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.35 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.51 159.02 19.5 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.553 2.169 . . . . 0.0 113.074 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.9 Cg_exo -52.16 161.09 2.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.913 2.409 . . . . 0.0 112.66 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.345 0.356 0 C-N-CA 122.669 2.246 . . . . 0.0 112.25 179.885 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.563 HD21 ' NE2' ' A' 1308 ' ' GLN . 6.9 mt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.975 0.417 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.62 143.78 79.43 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.197 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.66 -23.63 15.72 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.256 1.971 . . . . 0.0 112.217 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.5 mt -102.08 -5.48 24.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.777 ' O ' HG23 ' A' 1273 ' ' VAL . 39.4 t80 -47.71 -54.13 13.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -52.61 -41.69 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -67.52 -42.67 82.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.609 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -62.78 -39.12 93.21 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.72 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' 1269 ' ' PHE . 21.6 t -62.04 -51.27 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.7 tt0 -61.79 -31.57 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.894 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.439 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -68.25 -50.88 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.632 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -69.18 -37.27 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.287 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.845 HG22 ' O ' ' A' 1324 ' ' ALA . 74.1 p -69.64 -50.64 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' 1274 ' ' GLN . 8.3 mm-40 -59.46 -36.09 75.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.404 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -8.25 48.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 57.71 17.74 4.3 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.462 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . 0.408 ' N ' HG21 ' A' 1322 ' ' VAL . 29.7 mttt -145.61 132.1 19.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.792 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.648 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.02 116.49 30.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.727 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.791 ' O ' HG23 ' A' 1287 ' ' VAL . 34.6 t -132.29 139.87 48.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 111.276 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' 1299 ' ' ALA . 22.5 mt -68.48 -43.31 83.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . . . . . . . . . 2.8 t -67.16 -41.18 86.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.978 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.49 -51.14 60.59 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.79 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' 1283 ' ' SER . 21.8 t -64.52 -29.96 48.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.958 0.409 . . . . 0.0 110.263 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' 1293 ' ' ILE . 15.7 tt0 -59.63 -53.07 62.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.248 0.547 . . . . 0.0 110.208 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -35.16 59.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.102 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.424 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -75.09 -33.34 61.64 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.683 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.27 -7.71 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 57.56 52.39 8.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.067 0.461 . . . . 0.0 110.494 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . 0.674 HG22 ' NH1' ' A' 1297 ' ' ARG . 13.2 pt -130.01 148.33 33.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.031 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.48 150.28 16.93 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.924 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.45 ' CE1' HG21 ' A' 1284 ' ' ILE . 89.1 t80 -47.59 -51.28 21.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.78 -38.54 48.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.529 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.674 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.1 OUTLIER -66.92 -49.38 65.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.139 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.469 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.62 -45.77 73.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.666 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.537 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -67.05 -29.87 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.063 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -49.97 57.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.046 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.609 HG21 ' CB ' ' A' 1272 ' ' ALA . 39.9 mt -60.57 -45.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.786 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.544 HG22 ' HE ' ' A' 1320 ' ' ARG . 19.8 mt -66.12 -32.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.853 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -52.2 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.534 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -60.14 -32.03 70.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.758 178.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.674 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.8 mtm -61.3 -39.05 89.03 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' 1311 ' ' VAL . 1.7 tt0 -67.22 -32.93 74.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.372 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.05 -42.11 63.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.42 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.563 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -76.31 -20.28 57.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.871 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.53 16.37 27.01 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.997 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.0 mt -83.12 -37.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 122.76 0.424 . . . . 0.0 111.279 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' 1305 ' ' MET . 34.8 m -120.65 159.54 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.507 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -107.6 -177.92 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.867 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.419 179.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 11.7 m-80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.947 0.403 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.564 ' HD2' HG21 ' A' 1311 ' ' VAL . 0.7 OUTLIER -107.45 140.3 40.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.566 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.52 132.71 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.253 . . . . 0.0 110.622 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 18.3 t -89.51 118.69 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.94 0.4 . . . . 0.0 110.319 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.507 HD11 ' CB ' ' A' 1312 ' ' SER . 0.8 OUTLIER -106.51 -19.99 13.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.931 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.845 ' O ' HG22 ' A' 1277 ' ' THR . . . -89.67 129.86 45.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.9 158.88 21.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.094 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.498 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.1 Cg_exo -53.13 164.32 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.922 2.414 . . . . 0.0 112.411 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 122.617 2.211 . . . . 0.0 112.232 179.859 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1265 ' ' LEU . . . . . 0.824 HD21 ' NE2' ' A' 1308 ' ' GLN . 10.2 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.89 0.376 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -85.87 145.11 40.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.365 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -52.52 -24.03 21.04 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1268 ' ' LEU . . . . . 0.735 HD23 ' NE2' ' A' 1271 ' ' GLN . 45.2 mt -102.05 -1.52 31.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.862 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1269 ' ' PHE . . . . . 0.818 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.6 t80 -47.56 -56.88 6.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.34 -41.04 62.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1271 ' ' GLN . . . . . 0.735 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.4 OUTLIER -66.78 -42.3 86.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 178.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1272 ' ' ALA . . . . . 0.623 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -65.01 -41.9 94.91 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1273 ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' 1269 ' ' PHE . 61.1 t -60.11 -48.16 89.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1274 ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.5 tt0 -64.13 -33.26 75.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.744 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1275 ' ' PHE . . . . . 0.448 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -65.65 -50.7 64.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.585 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1276 ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -69.28 -40.26 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.492 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1277 ' ' THR . . . . . 0.853 HG22 ' O ' ' A' 1324 ' ' ALA . 67.0 p -67.99 -49.53 61.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1278 ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' 1274 ' ' GLN . 11.7 mm-40 -59.68 -36.3 76.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -92.28 -6.06 51.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.22 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 28.0 mmm180 58.24 16.84 4.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 110.9 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 2.9 mttm -145.61 134.75 22.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1282 ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' 1322 ' ' VAL . . . -115.67 116.43 28.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.665 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1283 ' ' SER . . . . . 0.879 ' O ' HG23 ' A' 1287 ' ' VAL . 8.7 p -132.52 140.76 48.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1284 ' ' ILE . . . . . 0.571 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 21.2 mt -69.22 -40.5 80.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.287 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1285 ' ' SER . . . . . 0.505 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 45.5 t -67.8 -42.79 81.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.014 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.46 78.29 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.706 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1287 ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' 1283 ' ' SER . 15.5 t -65.49 -30.74 51.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 15.1 mt-30 -60.22 -51.37 69.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.216 0.532 . . . . 0.0 109.949 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -36.1 58.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.233 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1290 ' ' GLN . . . . . 0.439 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.02 -34.64 61.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.618 -178.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1291 ' ' PHE . . . . . 0.59 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.31 -6.48 21.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.551 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 54.96 55.01 8.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 110.381 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 15.2 pt -131.73 147.26 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.435 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.99 149.29 11.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.284 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.0 t80 -46.77 -51.46 16.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.458 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -39.45 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.458 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1297 ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' 1301 ' ' ILE . 0.3 OUTLIER -66.23 -49.49 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.27 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1298 ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.95 -49.36 68.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.642 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1299 ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.81 -29.79 70.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -68.55 -50.52 51.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.244 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1301 ' ' ILE . . . . . 0.623 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.5 mt -60.13 -43.49 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.833 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1302 ' ' ILE . . . . . 0.489 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.2 mt -68.83 -33.69 60.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.928 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.89 66.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.335 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1304 ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 22.9 mt-30 -59.43 -36.76 76.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.303 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1305 ' ' MET . . . . . 0.583 ' HB3' HG13 ' A' 1311 ' ' VAL . 17.1 mtm -57.01 -38.54 73.24 Favored 'General case' 0 C--O 1.228 -0.058 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1306 ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' 1311 ' ' VAL . 5.1 tt0 -69.46 -33.04 72.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.303 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.09 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.404 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1308 ' ' GLN . . . . . 0.824 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.6 OUTLIER -89.18 -20.32 24.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.26 13.89 27.52 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.963 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1310 ' ' ILE . . . . . 0.772 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.4 mt -83.67 -38.49 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 122.743 0.417 . . . . 0.0 111.266 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1311 ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' 1306 ' ' GLU . 32.6 m -120.22 155.78 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.144 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1312 ' ' SER . . . . . 0.435 ' CB ' HD11 ' A' 1323 ' ' LEU . 1.0 OUTLIER -96.46 -179.9 4.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.623 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.396 180.0 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.025 0.44 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1320 ' ' ARG . . . . . 0.489 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.7 mmt180 -107.6 140.33 40.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.31 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.3 tt0 -85.44 132.67 34.18 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.862 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1322 ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' 1282 ' ' ALA . 29.4 t -92.86 118.69 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.967 0.413 . . . . 0.0 110.139 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1323 ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.11 -13.54 14.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.233 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1324 ' ' ALA . . . . . 0.853 ' O ' HG22 ' A' 1277 ' ' THR . . . -95.57 130.41 32.03 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.24 159.29 23.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.531 2.154 . . . . 0.0 113.028 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1326 ' ' PRO . . . . . 0.525 ' N ' ' HB ' ' A' 1277 ' ' THR . 63.0 Cg_exo -51.68 159.67 3.28 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.06 2.507 . . . . 0.0 112.678 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.266 179.921 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 75.9 m80 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.781 0.324 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -166.79 -99.33 0.13 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.534 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -57.95 -21.72 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.726 0.298 . . . . 0.0 111.375 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -54.87 -37.24 66.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 111.161 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.2 -38.13 3.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.856 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.4 mt -75.49 160.03 30.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.167 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . 0.449 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.9 t70 -79.33 144.14 61.52 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.554 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 -25.78 20.58 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.555 2.17 . . . . 0.0 112.627 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.557 HD13 ' HB3' ' A' 1291 ' ' PHE . 63.1 mt -101.94 -2.65 29.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.856 ' CD2' HD22 ' A' 1265 ' ' LEU . 38.8 t80 -47.57 -55.09 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.47 -45.31 66.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.946 0.403 . . . . 0.0 110.905 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -67.32 -38.21 84.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.24 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.627 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.41 94.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.665 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' 1269 ' ' PHE . 23.5 t -62.11 -47.87 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' 1278 ' ' GLU . 33.1 tt0 -63.55 -33.91 76.62 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.881 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.4 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.14 -50.47 63.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -70.1 -37.59 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.471 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.835 HG22 ' O ' ' A' 1324 ' ' ALA . 55.0 p -70.09 -49.48 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.175 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.1 mt-10 -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.285 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -91.39 -7.18 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.9 mmm180 57.52 17.85 4.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -145.56 133.23 21.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.774 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.74 116.38 28.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.684 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.832 ' O ' HG23 ' A' 1287 ' ' VAL . 3.2 p -132.57 138.98 47.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.869 0.366 . . . . 0.0 111.22 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' 1299 ' ' ALA . 19.7 mt -67.24 -40.14 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 47.6 t -68.51 -41.52 79.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.51 -49.93 73.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.638 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' 1283 ' ' SER . 12.0 t -65.92 -30.11 48.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.636 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.603 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.74 -51.16 70.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.124 0.488 . . . . 0.0 110.011 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -76.2 -37.07 58.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.162 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.41 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.04 -33.34 61.73 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.512 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.69 21.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.403 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 54.16 52.86 11.93 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.051 0.453 . . . . 0.0 110.226 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.478 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 19.8 pt -129.83 148.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.544 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.61 148.07 22.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.22 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.603 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.9 t80 -45.31 -50.23 12.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.4 p30 -50.84 -41.82 58.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.705 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.478 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.8 -49.68 69.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.253 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.521 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -53.98 -50.0 67.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.5 -29.83 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.189 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -50.55 51.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.144 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.581 HG21 ' CB ' ' A' 1272 ' ' ALA . 34.0 mt -60.43 -43.71 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.953 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.559 HG22 ' HE ' ' A' 1320 ' ' ARG . 22.2 mt -68.63 -33.95 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.759 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -51.98 65.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.415 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.425 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 7.0 mt-30 -59.06 -36.11 74.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.569 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.3 mtm -58.37 -37.14 74.63 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.618 ' N ' HG22 ' A' 1311 ' ' VAL . 36.8 tt0 -69.7 -32.24 70.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.32 62.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.343 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.822 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.6 OUTLIER -89.62 -20.31 23.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.792 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.31 12.98 32.04 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.912 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -83.23 -35.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 122.618 0.367 . . . . 0.0 111.204 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' 1306 ' ' GLU . 27.5 m -122.38 154.47 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.449 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.492 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.6 OUTLIER -102.77 -177.85 3.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.615 -179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -65.78 135.45 54.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.509 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . 0.417 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 33.8 mt-30 -67.68 133.45 49.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.255 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -119.25 -39.59 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.887 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.77 -157.98 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.51 91.78 7.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.32 . . . . 0.0 111.173 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.93 10.02 86.52 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.321 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -97.79 122.16 40.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 111.4 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.559 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.2 OUTLIER -107.42 140.26 40.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.369 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' 1311 ' ' VAL . 5.8 tt0 -86.05 132.69 33.99 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.803 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' 1282 ' ' ALA . 26.9 t -91.21 118.59 36.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.933 0.396 . . . . 0.0 110.106 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.0 -10.82 15.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.385 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' 1277 ' ' THR . . . -99.88 130.68 25.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.09 159.59 23.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 113.039 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.524 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.1 Cg_exo -51.67 163.74 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.903 2.402 . . . . 0.0 112.587 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.96 -35.51 11.92 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.715 2.277 . . . . 0.0 112.412 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -100.62 -51.03 3.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.898 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 2.6 m-70 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.862 0.363 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -155.35 -63.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.494 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -62.24 -28.4 69.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.353 . . . . 0.0 111.216 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -57.37 -28.53 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.89 -37.31 6.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.571 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.782 HD13 ' CD1' ' A' 1269 ' ' PHE . 7.5 mt -72.59 160.07 32.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.225 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.33 144.27 94.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.75 -24.83 13.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.191 1.927 . . . . 0.0 112.273 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.2 mt -102.16 -5.28 24.61 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.835 ' O ' HG23 ' A' 1273 ' ' VAL . 38.4 t80 -47.71 -53.39 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -52.6 -45.42 66.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.408 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.4 mt-30 -67.96 -37.95 82.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.634 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.29 -39.16 93.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.305 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' 1269 ' ' PHE . 19.2 t -62.83 -49.18 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' 1278 ' ' GLU . 22.2 tt0 -62.79 -32.5 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.792 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.429 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -67.95 -50.58 55.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.68 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.3 m -69.72 -38.01 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.844 HG22 ' O ' ' A' 1324 ' ' ALA . 57.6 p -69.73 -49.91 48.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.113 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.2 mt-10 -59.09 -36.95 76.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.999 0.428 . . . . 0.0 110.292 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . 0.414 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 4.0 mtmt -89.79 -9.52 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.008 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.1 mmm180 59.97 16.65 5.98 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.833 0.349 . . . . 0.0 110.478 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 3.8 mttp -145.55 134.43 22.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.623 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.18 116.61 28.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.802 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.834 ' O ' HG23 ' A' 1287 ' ' VAL . 3.2 p -132.55 139.72 47.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.601 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 24.6 mt -68.56 -39.31 80.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.203 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.504 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 48.1 t -69.13 -42.45 75.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.29 69.22 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.569 -0.825 . . . . 0.0 111.583 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' 1283 ' ' SER . 17.6 t -65.31 -30.34 49.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.597 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -60.27 -52.01 67.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 110.097 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -36.19 58.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.125 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.411 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -74.98 -33.13 61.84 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.559 -179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.38 21.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.631 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 55.8 51.96 11.54 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.128 0.489 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.688 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -128.7 147.77 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.85 150.23 18.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.024 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.593 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.34 -51.26 15.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.397 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 5.9 p30 -50.7 -40.07 53.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.56 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.688 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.4 OUTLIER -64.98 -50.28 66.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.329 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.601 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.99 -49.93 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.507 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.32 -29.9 71.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.209 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -68.49 -50.48 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.99 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.585 HG21 ' CB ' ' A' 1272 ' ' ALA . 40.7 mt -60.74 -46.41 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.774 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.463 HG21 ' HG3' ' A' 1320 ' ' ARG . 18.7 mt -66.17 -31.45 53.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.948 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -63.73 -52.26 61.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -59.22 -32.0 69.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.643 178.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.591 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.7 mtm -62.63 -39.55 94.17 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.619 ' N ' HG22 ' A' 1311 ' ' VAL . 3.2 tt0 -67.38 -32.05 72.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.283 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.09 -42.05 63.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.248 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.556 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -76.21 -20.24 57.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.774 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.46 13.94 31.48 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.055 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -81.21 -36.79 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.806 0.442 . . . . 0.0 111.492 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.619 HG22 ' N ' ' A' 1306 ' ' GLU . 33.3 m -121.38 159.57 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.207 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.459 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.5 OUTLIER -103.84 -178.06 3.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.078 0.466 . . . . 0.0 111.732 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -65.88 135.91 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . 0.408 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 4.1 mt-30 -67.75 135.39 52.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.09 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -124.93 -44.27 0.28 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.855 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.17 -159.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.3 p30 -92.6 91.74 7.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 0.0 111.14 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.87 10.04 86.5 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.359 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -98.89 122.13 41.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.14 0.47 . . . . 0.0 111.597 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.463 ' HG3' HG21 ' A' 1302 ' ' ILE . 4.6 mmt180 -107.43 140.31 40.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.368 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' 1311 ' ' VAL . 18.0 tt0 -86.44 132.63 33.89 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.879 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.576 HG22 ' HB2' ' A' 1282 ' ' ALA . 23.6 t -91.35 118.71 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.23 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.459 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.67 -12.79 15.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.326 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.844 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.3 131.61 27.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.55 159.3 22.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.418 2.079 . . . . 0.0 113.012 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.539 ' N ' ' HB ' ' A' 1277 ' ' THR . 71.0 Cg_exo -51.57 156.42 6.28 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.965 2.443 . . . . 0.0 112.712 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.36 -59.17 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.701 2.267 . . . . 0.0 112.516 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -108.77 52.1 0.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.903 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.913 0.387 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 171.82 -36.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -60.83 -28.32 68.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.734 0.302 . . . . 0.0 111.173 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.36 -31.22 65.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.52 -34.95 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.686 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt -68.96 160.09 31.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . 0.413 ' CB ' HG12 ' A' 1301 ' ' ILE . 18.6 t70 -72.95 142.39 82.88 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.154 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -51.23 -25.04 16.53 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.323 2.015 . . . . 0.0 112.49 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' 1291 ' ' PHE . 41.9 mt -102.14 -3.63 27.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' 1273 ' ' VAL . 43.6 t80 -47.79 -53.02 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -52.72 -44.06 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.044 0.45 . . . . 0.0 110.539 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.514 HE21 HD23 ' A' 1268 ' ' LEU . 18.8 mt-30 -66.58 -40.49 88.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.145 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.603 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.97 -39.74 94.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.739 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' 1269 ' ' PHE . 16.2 t -61.4 -51.72 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' 1278 ' ' GLU . 19.9 tt0 -60.74 -32.04 71.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.857 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.466 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -67.29 -52.14 44.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.8 m -69.17 -35.31 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.855 HG22 ' O ' ' A' 1324 ' ' ALA . 69.3 p -72.19 -49.06 38.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' 1274 ' ' GLN . 14.2 mt-10 -60.35 -35.3 75.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.192 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.7 -5.12 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.939 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.6 mmm180 53.63 20.69 2.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.882 0.373 . . . . 0.0 110.649 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -145.61 129.87 17.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.636 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.645 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -111.98 116.47 30.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.742 0.306 . . . . 0.0 110.631 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.837 ' O ' HG23 ' A' 1287 ' ' VAL . 11.3 t -132.46 139.86 48.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' 1299 ' ' ALA . 16.4 mt -68.63 -40.75 82.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.272 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.506 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 28.6 t -67.82 -41.87 82.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.28 -49.94 73.03 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.823 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' 1283 ' ' SER . 12.7 t -65.99 -29.79 47.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 17.4 mt-30 -60.76 -52.66 64.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.126 0.489 . . . . 0.0 109.867 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -76.27 -34.87 59.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.961 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.522 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.5 OUTLIER -73.8 -37.01 65.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.762 0.315 . . . . 0.0 111.508 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' 1268 ' ' LEU . 1.8 m-85 -103.19 -5.15 23.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.839 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 55.02 8.49 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 148.53 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.384 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -53.76 149.81 14.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.125 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.597 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.4 t80 -47.09 -51.94 16.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 111.507 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -38.35 46.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.588 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -49.33 65.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.249 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.535 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.64 -49.86 69.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.563 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.36 -29.86 71.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -51.4 48.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.012 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.603 HG21 ' CB ' ' A' 1272 ' ' ALA . 41.8 mt -60.01 -45.21 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.83 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' 1305 ' ' MET . 21.5 mt -66.27 -32.56 58.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -50.23 67.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.612 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.5 mt-30 -57.16 -34.49 68.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.242 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.595 ' HB3' HG13 ' A' 1311 ' ' VAL . 16.0 mtm -63.33 -39.15 93.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.27 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.603 ' N ' HG22 ' A' 1311 ' ' VAL . 1.9 tt0 -66.41 -31.67 72.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.591 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.48 44.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.23 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.499 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -75.39 -20.21 59.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.756 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 99.8 16.07 29.64 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.001 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' 1324 ' ' ALA . 9.6 mt -84.03 -36.8 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 122.566 0.346 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' 1306 ' ' GLU . 27.1 m -119.93 161.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.341 . . . . 0.0 111.211 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.462 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.01 178.18 4.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.371 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.87 132.53 48.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.54 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -67.84 130.98 44.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.292 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -118.25 -40.32 0.69 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.873 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 0.9 OUTLIER -85.03 -156.66 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.529 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -96.29 91.88 6.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 111.219 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.9 10.09 86.47 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.456 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 47.1 m-80 -98.08 122.11 40.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.227 0.513 . . . . 0.0 111.292 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.446 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.56 140.28 40.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.475 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' 1311 ' ' VAL . 47.0 tt0 -89.66 132.68 35.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.819 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -92.29 118.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.29 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.462 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.39 -13.06 15.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.855 ' O ' HG22 ' A' 1277 ' ' THR . . . -95.39 129.37 35.22 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -80.96 159.11 20.97 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.494 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.6 Cg_exo -52.34 164.37 1.33 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.977 2.452 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.56 -33.11 87.87 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.655 2.236 . . . . 0.0 112.302 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.07 33.05 3.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.871 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 34.1 m170 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.84 0.353 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -166.2 111.88 0.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.345 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -60.87 -25.23 66.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.73 0.3 . . . . 0.0 111.245 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -55.68 -35.11 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.118 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.6 -27.46 8.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.11 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.857 HD22 ' CD2' ' A' 1269 ' ' PHE . 11.3 mt -92.24 160.01 15.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.076 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.06 145.8 44.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.229 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.62 -23.54 20.09 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.286 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' 1291 ' ' PHE . 58.0 mt -102.04 -3.39 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.852 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.857 ' CD2' HD22 ' A' 1265 ' ' LEU . 42.5 t80 -47.6 -56.62 6.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -39.06 60.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.952 0.406 . . . . 0.0 110.368 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.445 HE21 HD23 ' A' 1268 ' ' LEU . 10.6 mt-30 -68.45 -42.51 78.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.02 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.633 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -64.82 -40.97 96.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.58 ' CG1' HD13 ' A' 1310 ' ' ILE . 53.8 t -61.36 -47.85 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.441 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -64.17 -33.29 75.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.898 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.438 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.58 -50.42 63.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.59 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.7 m -69.59 -38.22 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.275 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.888 HG22 ' O ' ' A' 1324 ' ' ALA . 42.6 p -69.04 -48.93 61.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.155 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.39 -37.17 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.433 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -92.37 -5.56 51.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.108 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' 1276 ' ' VAL . 9.0 mmm180 57.34 17.63 3.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 19.7 mttm -145.45 134.17 22.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.58 116.56 28.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.895 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.875 ' O ' HG23 ' A' 1287 ' ' VAL . 1.0 OUTLIER -132.59 138.56 47.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.896 0.379 . . . . 0.0 111.257 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.606 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 32.1 mt -67.81 -38.07 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 0.0 110.179 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.493 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.1 t -69.24 -44.3 72.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.049 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -59.55 -49.22 80.86 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.687 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' 1283 ' ' SER . 14.8 t -65.36 -31.38 53.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.611 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -59.48 -52.16 66.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 109.991 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -76.2 -35.8 58.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.283 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.431 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.96 -33.83 61.97 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.599 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.3 -7.26 21.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.657 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 56.18 53.33 9.1 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 110.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.689 HG22 ' NH1' ' A' 1297 ' ' ARG . 13.3 pt -129.82 147.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.246 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.88 150.43 18.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.966 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.592 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.0 t80 -46.38 -51.24 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.424 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -39.84 53.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.614 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.689 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.3 OUTLIER -65.61 -49.62 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.346 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.606 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.0 -48.79 70.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.501 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.11 -29.73 70.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.136 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -68.74 -50.77 47.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.633 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.9 mt -60.18 -43.62 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.912 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.4 mt -69.09 -32.63 54.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.816 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.57 -50.92 70.67 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.462 ' HG2' HD23 ' A' 1265 ' ' LEU . 0.0 OUTLIER -61.13 -35.72 77.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.249 178.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.682 ' HB3' HG13 ' A' 1311 ' ' VAL . 11.3 mtm -57.0 -38.19 72.73 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.602 ' N ' HG22 ' A' 1311 ' ' VAL . 3.0 tm-20 -69.63 -32.92 71.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.355 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.19 -28.78 61.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.692 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.793 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -91.43 -20.32 21.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.94 15.94 24.98 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.992 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.719 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.8 mt -85.31 -36.63 11.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.802 0.441 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' 1305 ' ' MET . 30.2 m -121.23 158.31 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.489 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.1 OUTLIER -105.3 -178.56 3.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.031 0.443 . . . . 0.0 111.618 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.82 135.82 55.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.656 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . 0.406 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 58.2 mt-30 -67.74 133.24 48.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.085 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -123.16 -42.34 0.4 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.793 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.56 -157.02 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -95.64 91.76 6.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 111.154 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.85 10.08 86.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.292 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -100.17 122.3 42.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 111.598 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.438 ' HG3' HG21 ' A' 1302 ' ' ILE . 6.0 mmt180 -107.07 140.32 40.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.281 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' 1311 ' ' VAL . 2.0 tt0 -86.29 132.68 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.836 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.4 t -91.66 118.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 110.243 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.32 -7.87 16.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.272 -179.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.888 ' O ' HG22 ' A' 1277 ' ' THR . . . -102.58 130.44 23.96 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.406 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.3 159.37 20.07 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.485 2.123 . . . . 0.0 112.947 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 55.6 Cg_exo -52.19 164.35 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.908 2.406 . . . . 0.0 112.507 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.5 -35.89 7.46 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.64 2.226 . . . . 0.0 112.239 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -137.14 -65.21 0.55 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.824 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.844 0.354 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 140.6 73.06 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -59.88 -24.31 64.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.33 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -54.87 -35.73 64.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.105 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.52 -31.09 6.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.7 mt -78.18 160.06 28.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.06 144.9 45.16 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.095 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.52 -24.24 16.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.231 1.954 . . . . 0.0 112.485 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' 1291 ' ' PHE . 57.9 mt -102.11 -4.38 26.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' 1265 ' ' LEU . 44.9 t80 -47.48 -54.99 10.0 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -40.01 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.418 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 3.0 mt-30 -69.07 -42.22 76.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.619 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.14 -39.68 95.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.668 HG13 HD13 ' A' 1310 ' ' ILE . 42.5 t -61.99 -49.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.39 -30.54 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.854 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.465 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -68.6 -51.68 39.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -69.04 -37.43 77.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.498 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.837 HG22 ' O ' ' A' 1324 ' ' ALA . 48.2 p -69.67 -49.69 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.28 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.1 mt-10 -60.29 -35.57 75.87 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.936 0.398 . . . . 0.0 110.399 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -93.03 -5.16 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.092 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 18.4 mmm180 55.5 18.73 2.82 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.812 0.339 . . . . 0.0 110.81 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.1 mttt -145.64 131.18 18.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -112.88 116.37 29.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.683 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.79 ' O ' HG23 ' A' 1287 ' ' VAL . 1.8 p -132.49 142.47 49.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.209 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' 1299 ' ' ALA . 46.2 mt -71.02 -42.32 76.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.275 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 9.2 t -67.71 -40.58 84.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -61.07 -51.16 60.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.715 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' 1283 ' ' SER . 23.9 t -64.38 -29.77 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.292 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' 1293 ' ' ILE . 16.1 tt0 -60.19 -54.41 46.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 110.203 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -31.66 58.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.76 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.47 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 4.5 tp60 -75.03 -36.36 61.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.721 0.296 . . . . 0.0 111.544 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.29 -6.3 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.934 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 57.7 52.62 8.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.032 0.444 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.436 ' O ' ' HG3' ' A' 1288 ' ' GLN . 12.8 pt -130.21 149.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.061 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.72 148.57 26.75 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.146 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . . . . . . . . . 80.6 t80 -46.5 -51.62 14.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.454 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.78 -40.14 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.152 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.409 ' HE ' HG21 ' A' 1293 ' ' ILE . 0.0 OUTLIER -66.14 -48.87 69.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.449 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -54.03 -47.95 71.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.504 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.583 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -65.2 -29.89 70.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.018 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -67.57 -49.01 65.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.141 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.612 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.4 mt -61.26 -46.72 96.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.949 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.452 HG22 ' HE ' ' A' 1320 ' ' ARG . 11.1 mt -65.54 -34.46 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.887 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -48.89 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.426 ' CB ' ' CE2' ' A' 1269 ' ' PHE . 16.8 mt-30 -61.81 -35.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.231 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.646 ' HB3' HG13 ' A' 1311 ' ' VAL . 0.3 OUTLIER -56.95 -38.83 73.49 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.598 ' N ' HG22 ' A' 1311 ' ' VAL . 1.4 tm-20 -70.48 -33.34 71.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.4 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.39 63.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.585 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.766 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.6 OUTLIER -90.81 -20.35 22.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.877 -178.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.88 16.34 26.25 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.817 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.4 mt -84.47 -34.76 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.271 -0.464 . . . . 0.0 111.04 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' 1305 ' ' MET . 27.8 m -120.21 159.87 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.418 ' CA ' HD11 ' A' 1323 ' ' LEU . 1.4 p -100.75 -178.65 3.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 111.307 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -65.84 133.14 50.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.437 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . 0.4 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 44.5 mt-30 -67.76 132.58 47.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.107 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -125.1 -43.81 0.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.764 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . 0.418 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 1.1 t60 -80.35 -154.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.48 91.69 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 111.21 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.95 10.12 86.44 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.504 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 1.9 m-80 -103.68 122.02 44.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.202 0.501 . . . . 0.0 111.432 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.562 ' HD2' HG21 ' A' 1311 ' ' VAL . 1.4 mtt-85 -107.48 140.41 40.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.428 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' 1311 ' ' VAL . 20.5 tp10 -84.11 132.76 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.547 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -90.4 118.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.98 0.419 . . . . 0.0 110.467 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.418 HD11 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.53 -12.22 15.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.214 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' 1277 ' ' THR . . . -96.65 131.64 27.78 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.233 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.21 158.12 17.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.464 2.109 . . . . 0.0 113.302 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.491 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -52.81 164.3 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.076 2.517 . . . . 0.0 112.669 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -83.8 -151.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.009 2.472 . . . . 0.0 111.846 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -61.2 -33.46 73.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.881 0.372 . . . . 0.0 110.937 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.901 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.771 0.319 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 88.41 -124.43 7.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.19 68.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.35 -29.41 63.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.026 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.38 -34.92 6.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.718 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' 1269 ' ' PHE . 10.5 mt -85.64 160.02 19.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.083 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.56 142.86 86.8 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.979 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.73 -24.87 13.97 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.319 2.013 . . . . 0.0 112.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' 1291 ' ' PHE . 61.7 mt -102.14 -5.03 24.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.82 ' O ' HG23 ' A' 1273 ' ' VAL . 40.8 t80 -47.57 -53.49 14.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.8 -42.5 65.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.057 0.455 . . . . 0.0 110.396 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.416 HE21 HD23 ' A' 1268 ' ' LEU . 12.0 mt-30 -66.75 -42.42 86.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.141 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.25 -39.3 94.2 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.79 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' 1269 ' ' PHE . 18.9 t -61.81 -50.61 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -62.24 -32.51 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.443 ' CD2' ' CE1' ' A' 1291 ' ' PHE . 2.4 t80 -67.17 -50.76 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.669 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.638 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.9 m -70.22 -36.78 69.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.345 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.858 HG22 ' O ' ' A' 1324 ' ' ALA . 50.7 p -71.23 -48.37 51.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.319 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' 1274 ' ' GLN . 34.1 mt-10 -61.36 -35.61 77.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -93.76 -4.11 50.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.989 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' 1276 ' ' VAL . 16.0 mmm180 53.95 19.5 2.02 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.55 132.51 20.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.638 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.15 116.4 28.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.922 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.859 ' O ' HG23 ' A' 1287 ' ' VAL . 7.5 p -132.65 140.47 48.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 22.1 mt -68.79 -40.64 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.28 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.507 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 42.1 t -67.58 -42.31 82.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.05 -49.25 80.63 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.777 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' 1283 ' ' SER . 14.6 t -65.91 -30.41 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.718 0.294 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.3 mt-30 -60.73 -51.05 70.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.179 0.514 . . . . 0.0 110.001 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -76.34 -36.68 58.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.169 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.44 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.9 OUTLIER -75.02 -34.34 61.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.612 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.602 ' HB3' HD13 ' A' 1268 ' ' LEU . 2.0 m-85 -103.27 -6.54 21.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.602 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 54.92 54.85 8.47 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.486 HD11 HG12 ' A' 1287 ' ' VAL . 12.9 pt -131.17 147.8 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.434 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.28 148.43 25.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.06 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 90.2 t80 -45.69 -50.75 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.547 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.73 -41.53 56.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -50.05 68.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.316 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.551 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.01 -49.97 67.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.526 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.48 -29.76 70.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.121 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.36 -50.59 52.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.92 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' 1272 ' ' ALA . 43.2 mt -59.87 -46.56 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.757 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' 1305 ' ' MET . 19.5 mt -65.84 -31.98 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.4 -52.12 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.576 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -58.25 -31.95 67.89 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.614 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.668 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.2 mtm -62.49 -39.68 94.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.608 ' N ' HG22 ' A' 1311 ' ' VAL . 3.2 tt0 -66.79 -31.95 72.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.583 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -75.18 -41.98 56.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.472 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.53 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -75.86 -20.32 58.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.883 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.13 16.87 26.57 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.003 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.733 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.2 mt -83.48 -39.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.831 0.452 . . . . 0.0 111.167 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' 1305 ' ' MET . 35.6 m -118.87 160.39 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.028 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.467 ' CA ' HD11 ' A' 1323 ' ' LEU . 0.7 OUTLIER -95.34 178.59 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 111.442 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.89 134.76 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.416 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . 0.404 ' HG3' ' NE ' ' A' 1320 ' ' ARG . 0.0 OUTLIER -67.75 141.12 56.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.056 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -146.71 -46.8 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.746 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.36 -157.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 4.4 p30 -104.96 91.7 3.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 111.174 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.72 10.14 86.43 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.495 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -110.69 122.01 46.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.313 0.557 . . . . 0.0 111.847 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.453 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.5 140.43 40.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.234 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.4 tp10 -84.61 132.71 34.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.092 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.617 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.2 t -92.47 118.73 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.276 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.467 HD11 ' CA ' ' A' 1312 ' ' SER . 0.3 OUTLIER -109.01 -15.56 14.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.286 -179.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.858 ' O ' HG22 ' A' 1277 ' ' THR . . . -93.18 131.38 33.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.299 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.5 159.29 22.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.432 2.088 . . . . 0.0 113.01 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.534 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.55 164.39 0.91 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.922 2.415 . . . . 0.0 112.69 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.76 -35.07 16.98 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.705 2.27 . . . . 0.0 112.34 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -98.25 36.69 1.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.934 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.871 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 15.0 m80 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.815 0.341 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -123.47 37.95 2.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.554 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -58.14 -22.01 49.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.693 0.283 . . . . 0.0 111.276 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -54.82 -36.7 65.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.92 -38.33 3.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.805 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.853 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.9 mt -72.74 160.02 32.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.125 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . 0.452 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -81.33 143.74 52.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.491 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.63 -26.37 22.57 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.398 2.065 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.618 HD23 ' NE2' ' A' 1271 ' ' GLN . 44.8 mt -102.03 -0.59 33.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.873 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.853 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.2 t80 -47.65 -57.02 6.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -41.75 63.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.934 0.397 . . . . 0.0 110.417 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.618 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.8 OUTLIER -66.07 -43.07 88.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.264 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -64.89 -41.78 95.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.327 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' 1277 ' ' THR . 98.8 t -60.67 -47.76 91.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.444 ' HA ' ' HG1' ' A' 1277 ' ' THR . 33.1 tt0 -64.37 -32.49 74.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.764 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.432 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.75 -50.32 63.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.626 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -68.7 -37.62 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.257 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 53.9 p -70.17 -49.21 52.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.241 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -59.36 -35.64 74.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.349 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -93.03 -7.68 45.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.035 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' 1276 ' ' VAL . 2.5 mmm180 57.99 17.72 4.59 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.815 0.341 . . . . 0.0 110.602 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -145.54 133.25 21.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.626 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.76 116.54 28.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.676 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.722 ' O ' HG23 ' A' 1287 ' ' VAL . 13.2 p -132.42 138.08 47.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 111.265 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' 1299 ' ' ALA . 23.3 mt -66.01 -42.86 92.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.394 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 1.1 t -68.65 -37.99 80.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.805 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.49 -51.05 59.02 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.74 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -65.57 -29.73 47.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-O 120.904 0.383 . . . . 0.0 110.37 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' 1293 ' ' ILE . 16.1 tt0 -60.47 -55.13 37.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.184 0.516 . . . . 0.0 110.281 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -76.12 -30.37 58.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.553 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -75.06 -36.62 61.78 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.77 0.319 . . . . 0.0 111.531 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.23 -6.08 22.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 27.8 mtm105 58.46 48.4 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.041 0.448 . . . . 0.0 110.549 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.477 HG21 HD12 ' A' 1268 ' ' LEU . 14.9 pt -125.5 158.39 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.184 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -64.31 148.13 50.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.186 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.516 ' CE1' HG21 ' A' 1284 ' ' ILE . 91.2 t80 -45.66 -51.16 12.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.697 0.284 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.65 -41.94 55.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.967 0.413 . . . . 0.0 110.066 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.59 -49.79 69.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.161 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.78 -49.39 68.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.57 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.87 -29.9 71.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.113 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -50.56 50.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.245 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.594 HG21 ' CB ' ' A' 1272 ' ' ALA . 20.8 mt -59.45 -42.46 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.838 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.502 HG22 ' HE ' ' A' 1320 ' ' ARG . 22.2 mt -69.26 -34.5 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.716 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -51.61 67.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.364 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.416 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 21.8 mt-30 -59.32 -36.86 76.44 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.359 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.574 ' HB3' HG13 ' A' 1311 ' ' VAL . 18.9 mtm -57.12 -38.52 73.56 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.626 ' N ' HG22 ' A' 1311 ' ' VAL . 18.1 tt0 -69.44 -33.03 72.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.394 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.72 62.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.47 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.824 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.7 OUTLIER -90.73 -20.39 22.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.807 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.13 13.33 29.24 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.933 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.742 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.8 mt -82.9 -37.84 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.053 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' 1306 ' ' GLU . 27.1 m -120.54 158.13 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.218 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.492 ' CB ' HD11 ' A' 1323 ' ' LEU . 1.2 p -101.22 -179.46 4.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.122 0.487 . . . . 0.0 111.686 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.87 134.72 53.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.501 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . 0.424 ' HG3' ' HG2' ' A' 1320 ' ' ARG . 0.0 OUTLIER -67.78 141.4 56.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.067 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -131.62 -45.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.899 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . 0.404 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 1.0 OUTLIER -82.4 -156.0 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.94 91.91 5.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.864 0.364 . . . . 0.0 111.323 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 78.48 10.1 86.48 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.693 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 44.1 m-80 -100.41 121.99 42.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.325 0.563 . . . . 0.0 111.491 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.502 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.41 140.37 40.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.388 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 17.9 tt0 -87.06 132.7 33.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.978 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.7 t -92.66 118.73 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.25 -11.47 15.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.227 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.87 131.56 26.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.238 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.07 159.15 15.51 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.542 2.162 . . . . 0.0 112.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.484 ' N ' ' HB ' ' A' 1277 ' ' THR . 52.1 Cg_exo -52.78 164.39 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.912 2.408 . . . . 0.0 112.469 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.46 -35.83 7.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.582 2.188 . . . . 0.0 112.295 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -137.26 34.07 2.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.85 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 42.9 m170 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.782 0.325 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -148.92 61.42 0.43 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.417 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.17 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.751 0.31 . . . . 0.0 111.175 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -57.74 -27.24 62.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.61 -38.11 5.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.941 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.521 HD21 ' NE2' ' A' 1308 ' ' GLN . 1.8 mt -80.22 160.02 25.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.86 144.12 32.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.319 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.51 -23.67 19.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.323 2.015 . . . . 0.0 112.368 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.736 HD23 ' NE2' ' A' 1271 ' ' GLN . 62.3 mt -102.06 -3.81 27.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.921 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' A' 1310 ' ' ILE . 43.7 t80 -47.51 -55.51 8.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 37.8 t0 -52.49 -41.59 63.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.736 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.5 OUTLIER -66.37 -43.32 86.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.314 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.626 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -64.1 -41.04 97.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.251 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' 1269 ' ' PHE . 99.0 t -61.08 -47.89 91.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.9 OUTLIER -63.58 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.639 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.432 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.4 -51.23 59.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.654 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.5 m -68.47 -36.7 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.482 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.886 HG22 ' O ' ' A' 1324 ' ' ALA . 45.6 p -70.6 -49.92 42.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.37 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.0 mt-10 -60.14 -33.93 72.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.369 . . . . 0.0 110.354 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -95.22 -5.58 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.018 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 55.99 18.52 3.15 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.839 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . 0.404 ' N ' HG21 ' A' 1322 ' ' VAL . 10.5 mttt -145.53 132.51 20.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.62 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.62 116.29 28.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.823 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.787 ' O ' HG23 ' A' 1287 ' ' VAL . 1.9 t -132.63 138.26 47.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 26.1 mt -66.49 -38.88 82.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.046 0.451 . . . . 0.0 110.117 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.486 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 27.5 t -69.68 -40.75 76.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.829 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -61.51 -48.43 84.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.529 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' 1283 ' ' SER . 15.1 t -67.16 -29.66 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 120.745 0.307 . . . . 0.0 110.709 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.2 mt-30 -61.34 -54.49 43.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.186 0.517 . . . . 0.0 110.093 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -30.84 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.531 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' 1286 ' ' GLY . 4.1 tp60 -74.93 -38.11 61.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.23 -4.51 24.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.804 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 55.47 54.99 7.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.045 0.45 . . . . 0.0 110.485 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.436 ' CD1' ' HD2' ' A' 1297 ' ' ARG . 10.2 pt -131.49 157.59 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.476 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -63.5 148.2 50.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.981 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.597 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.2 t80 -45.41 -51.52 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.551 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -40.63 55.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.676 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.467 ' HD3' HD11 ' A' 1301 ' ' ILE . 0.0 OUTLIER -66.44 -48.2 70.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.562 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.9 -49.63 68.16 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.019 0.438 . . . . 0.0 110.649 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.515 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.98 -29.88 71.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.067 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -68.05 -50.22 56.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.039 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.626 HG21 ' CB ' ' A' 1272 ' ' ALA . 33.9 mt -60.68 -45.83 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.51 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.8 mt -66.56 -32.16 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.843 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -52.1 63.6 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.4 OUTLIER -58.73 -33.02 69.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.711 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.654 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.0 mtm -60.98 -40.87 95.08 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.613 ' N ' HG22 ' A' 1311 ' ' VAL . 1.4 tt0 -66.16 -33.23 75.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.827 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.466 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.524 HE22 ' HB3' ' A' 1304 ' ' GLN . 0.8 OUTLIER -75.51 -20.37 58.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.783 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.19 15.88 26.82 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.046 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.2 mt -82.71 -38.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.817 0.447 . . . . 0.0 111.317 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' 1305 ' ' MET . 34.8 m -120.67 164.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.438 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -105.96 -178.12 3.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.069 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -65.89 131.79 47.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.395 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -67.85 130.98 44.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.168 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -117.86 -46.77 0.46 Allowed Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.877 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -161.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.4 p30 -90.62 91.63 8.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.76 10.13 86.44 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.354 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -101.26 122.1 43.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.146 0.473 . . . . 0.0 111.63 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.51 ' HG3' HG21 ' A' 1302 ' ' ILE . 3.4 mtt180 -107.45 140.31 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.346 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' 1311 ' ' VAL . 53.5 tt0 -81.9 132.8 35.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.647 0.26 . . . . 0.0 111.067 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.5 t -90.26 118.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.141 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.438 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.25 -18.83 13.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.154 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' 1277 ' ' THR . . . -90.89 131.54 37.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.109 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.59 159.36 19.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.453 2.102 . . . . 0.0 113.026 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.496 ' N ' ' HB ' ' A' 1277 ' ' THR . 60.2 Cg_exo -51.6 158.01 4.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.005 2.47 . . . . 0.0 112.502 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.86 -36.44 3.59 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.643 2.228 . . . . 0.0 112.422 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -110.06 57.16 0.62 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.889 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 7.5 m80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.807 0.337 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -111.45 51.48 0.7 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.424 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -58.94 -30.68 68.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.215 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.78 -27.12 62.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.018 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -28.05 8.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.829 HD21 ' NE2' ' A' 1308 ' ' GLN . 9.6 mt -87.2 160.01 18.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . 0.404 ' CB ' HG12 ' A' 1301 ' ' ILE . 24.8 t70 -87.98 145.07 35.66 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.426 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.21 -24.28 20.11 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.368 2.046 . . . . 0.0 112.505 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' 1291 ' ' PHE . 40.8 mt -102.14 -1.76 30.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.896 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.804 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.1 t80 -47.69 -55.21 9.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.0 t0 -52.51 -44.35 65.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 0.0 110.893 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.455 ' NE2' HD23 ' A' 1268 ' ' LEU . 19.1 mt-30 -68.0 -37.93 82.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.076 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.631 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.1 -40.9 95.2 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.661 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' 1269 ' ' PHE . 26.9 t -61.78 -47.81 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' 1278 ' ' GLU . 14.5 tt0 -63.49 -33.28 75.22 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.752 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.406 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.7 t80 -66.58 -51.61 54.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.7 m -68.9 -38.31 78.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.588 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.86 HG22 ' O ' ' A' 1324 ' ' ALA . 56.2 p -70.01 -48.42 58.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.12 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' 1274 ' ' GLN . 10.5 mm-40 -59.02 -37.16 76.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.369 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -92.81 -6.04 49.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' 1276 ' ' VAL . 24.3 mmm180 57.64 17.48 4.06 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.783 0.325 . . . . 0.0 110.847 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.63 134.14 22.02 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.764 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' 1322 ' ' VAL . . . -114.86 116.4 28.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.705 0.288 . . . . 0.0 110.704 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.857 ' O ' HG23 ' A' 1287 ' ' VAL . 2.4 p -132.57 143.16 49.52 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.9 0.381 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.837 HG23 ' HB3' ' A' 1298 ' ' ALA . 50.0 mt -71.09 -39.51 74.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.11 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.441 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 38.6 t -66.77 -44.54 81.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.872 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.57 -51.1 60.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.951 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' 1283 ' ' SER . 16.5 t -65.03 -31.83 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.011 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.499 ' HG3' ' HB2' ' A' 1298 ' ' ALA . 38.3 mt-30 -59.74 -51.77 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.069 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -76.24 -35.86 58.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.184 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' 1286 ' ' GLY . 0.1 OUTLIER -75.06 -33.37 61.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.497 -179.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.26 -7.18 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.537 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 55.63 51.29 12.83 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.117 0.485 . . . . 0.0 110.29 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.696 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.8 pt -127.13 149.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.324 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.8 151.04 21.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.004 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.558 ' CE1' HG21 ' A' 1284 ' ' ILE . 1.1 t80 -46.51 -54.59 8.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.716 0.293 . . . . 0.0 111.333 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.55 -36.55 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.696 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.8 OUTLIER -65.69 -49.31 69.01 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.837 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -54.01 -50.09 67.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.698 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.01 -29.77 71.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -68.8 -49.93 54.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.148 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.63 HG21 ' CB ' ' A' 1272 ' ' ALA . 26.6 mt -61.4 -44.43 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.853 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.533 HG22 ' HE ' ' A' 1320 ' ' ARG . 25.0 mt -67.55 -33.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.81 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -52.06 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.284 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.2 mt-30 -58.83 -36.84 75.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.254 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.578 ' HB3' HG13 ' A' 1311 ' ' VAL . 12.7 mtm -57.7 -37.79 74.11 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.608 ' N ' HG22 ' A' 1311 ' ' VAL . 7.1 tt0 -69.4 -32.69 71.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.146 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.76 -30.43 62.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.376 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.829 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -88.52 -20.28 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.8 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.46 13.78 29.6 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.983 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.795 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.5 mt -83.99 -36.23 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.673 0.389 . . . . 0.0 111.319 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' 1306 ' ' GLU . 27.2 m -121.05 152.66 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.412 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.521 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.6 OUTLIER -97.27 -177.93 4.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.422 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -65.84 133.17 50.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.431 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . 0.409 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 36.3 mt-30 -67.78 132.42 47.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.183 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -127.04 -44.08 0.24 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.97 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . 0.401 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 1.4 t60 -76.98 -154.7 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.56 91.88 4.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.369 . . . . 0.0 111.16 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.9 10.2 86.39 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.265 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 7.3 m-20 -107.78 122.13 46.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.067 0.433 . . . . 0.0 111.458 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.533 ' HE ' HG22 ' A' 1302 ' ' ILE . 0.3 OUTLIER -107.4 140.42 40.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' 1311 ' ' VAL . 36.3 tt0 -80.46 132.67 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.17 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' 1282 ' ' ALA . 31.3 t -91.81 118.71 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.95 -8.48 15.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.338 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.86 ' O ' HG22 ' A' 1277 ' ' THR . . . -100.27 129.87 27.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.244 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.04 159.15 23.89 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.505 2.137 . . . . 0.0 113.029 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.519 ' N ' ' HB ' ' A' 1277 ' ' THR . 62.7 Cg_exo -51.64 159.66 3.24 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.894 2.396 . . . . 0.0 112.503 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.86 -73.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.61 2.207 . . . . 0.0 112.306 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -123.46 71.61 1.09 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 5.0 p-80 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.852 0.358 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 146.56 87.78 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.55 63.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.247 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -57.75 -29.18 64.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.968 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.71 -39.09 4.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.872 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.832 HD21 ' NE2' ' A' 1308 ' ' GLN . 9.2 mt -82.98 160.0 22.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . 0.409 ' CB ' HG12 ' A' 1301 ' ' ILE . 20.6 t70 -86.56 144.8 38.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.48 -24.55 22.37 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.463 2.109 . . . . 0.0 112.497 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.2 mt -101.95 -1.36 32.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.751 ' CD2' HD22 ' A' 1265 ' ' LEU . 42.7 t80 -47.6 -56.27 7.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -52.39 -42.44 64.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.831 0.348 . . . . 0.0 111.055 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.405 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.4 mt-30 -69.85 -37.14 76.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.183 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.649 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -67.0 -40.42 87.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.753 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.591 ' CG1' HD13 ' A' 1310 ' ' ILE . 57.5 t -62.52 -47.37 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.451 ' HA ' ' OG1' ' A' 1277 ' ' THR . 50.7 tt0 -64.04 -32.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.677 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.433 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -66.98 -51.1 59.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.478 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.643 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.3 m -68.3 -38.18 79.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.247 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 43.5 p -69.46 -49.28 56.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.249 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' 1274 ' ' GLN . 1.4 mm-40 -59.89 -35.79 75.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.988 0.423 . . . . 0.0 110.411 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -6.18 48.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.025 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 19.9 mmm180 55.95 18.93 3.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.812 0.339 . . . . 0.0 110.553 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.56 131.29 18.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.643 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.643 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.55 116.41 29.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.633 0.254 . . . . 0.0 110.62 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.737 ' O ' HG23 ' A' 1287 ' ' VAL . 25.5 t -132.47 135.23 45.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' 1299 ' ' ALA . 36.8 mt -64.51 -41.54 92.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.199 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 31.6 t -70.19 -38.53 75.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.664 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -62.58 -49.43 73.53 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.479 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' 1283 ' ' SER . 21.8 t -66.63 -29.67 47.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.315 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.95 -55.67 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.163 0.506 . . . . 0.0 110.321 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -28.81 57.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -75.06 -37.29 61.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.367 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.17 -5.23 23.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.727 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 57.9 49.09 12.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.492 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' 1297 ' ' ARG . 11.2 pt -124.86 163.97 24.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.068 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -70.58 147.98 44.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.623 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.499 ' CE1' HG21 ' A' 1284 ' ' ILE . 91.2 t80 -45.6 -50.52 13.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.76 -41.91 57.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.598 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.498 ' HD3' HD11 ' A' 1301 ' ' ILE . 0.0 OUTLIER -67.16 -47.43 71.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.17 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.91 -49.13 69.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.956 0.408 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.82 -29.72 70.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.807 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -51.28 59.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.313 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.649 HG21 ' CB ' ' A' 1272 ' ' ALA . 25.6 mt -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.053 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.58 HG21 ' HG3' ' A' 1320 ' ' ARG . 22.0 mt -67.93 -33.79 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.733 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.03 -51.38 69.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.435 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 11.3 mt-30 -59.66 -36.51 76.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.281 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.704 ' HB3' HG13 ' A' 1311 ' ' VAL . 15.1 mtm -57.45 -37.64 73.16 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.587 ' N ' HG22 ' A' 1311 ' ' VAL . 5.4 tt0 -69.55 -32.88 71.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.55 61.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.69 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.832 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -89.2 -20.44 24.18 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.43 17.09 22.93 Favored Glycine 0 C--N 1.328 0.131 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.949 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.8 mt -86.25 -36.22 10.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 122.811 0.444 . . . . 0.0 111.265 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.704 HG13 ' HB3' ' A' 1305 ' ' MET . 32.6 m -120.63 164.01 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.446 ' CA ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.68 -177.96 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.131 0.491 . . . . 0.0 111.708 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -65.82 136.24 55.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.59 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . 0.421 ' CG ' ' HG2' ' A' 1320 ' ' ARG . 32.4 mt-30 -67.67 133.62 49.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.138 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -121.48 -46.99 0.3 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.908 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' 1319 ' ' ASN . 0.4 OUTLIER -84.73 -156.36 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.2 p30 -93.88 91.68 7.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.772 0.32 . . . . 0.0 111.243 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.96 10.08 86.48 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.479 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' 1316 ' ' HIS . 38.3 m-80 -98.6 122.06 41.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.201 0.501 . . . . 0.0 111.454 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.5 mmt180 -107.46 140.37 40.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.595 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.9 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.711 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 20.3 t -90.28 118.68 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 0.0 110.29 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.446 HD11 ' CA ' ' A' 1312 ' ' SER . 0.4 OUTLIER -107.77 -6.49 16.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.484 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.46 132.47 20.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.413 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.26 159.35 20.17 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.433 2.089 . . . . 0.0 112.924 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.507 ' N ' ' HB ' ' A' 1277 ' ' THR . 65.1 Cg_exo -51.69 157.39 5.43 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.944 2.429 . . . . 0.0 112.6 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.37 -36.91 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.79 30.97 6.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.796 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 5.2 m80 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.829 0.347 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 86.51 46.97 5.04 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.17 67.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.361 . . . . 0.0 111.062 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -67.89 -21.54 65.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.074 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.21 -31.04 8.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.8 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.84 HD22 ' CD2' ' A' 1269 ' ' PHE . 9.8 mt -77.51 160.02 28.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.28 144.4 46.67 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.325 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.29 -24.4 20.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.472 2.115 . . . . 0.0 112.556 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' 1291 ' ' PHE . 41.4 mt -102.04 -1.73 31.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.95 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.84 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.5 t80 -47.54 -55.46 9.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.52 -41.35 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.995 0.426 . . . . 0.0 110.391 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 0.0 OUTLIER -66.67 -43.48 84.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.013 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.63 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -63.41 -40.26 96.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' 1269 ' ' PHE . 25.3 t -61.75 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' 1278 ' ' GLU . 23.1 tt0 -64.17 -32.23 73.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.705 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.479 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.46 -51.42 57.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.454 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.8 m -69.05 -39.93 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.623 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.801 HG22 ' O ' ' A' 1324 ' ' ALA . 76.2 p -67.74 -49.86 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.365 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.2 mt-10 -59.91 -36.63 77.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.964 0.411 . . . . 0.0 110.479 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.22 -6.25 53.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.016 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.1 mmm180 57.35 17.51 3.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.813 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 22.6 mttt -145.66 134.28 22.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.749 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.641 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -114.59 116.39 28.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.679 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.877 ' O ' HG23 ' A' 1287 ' ' VAL . 5.0 p -132.54 140.76 48.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.137 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 21.9 mt -69.55 -40.79 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.313 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 37.1 t -66.91 -43.78 82.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.116 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -59.3 -49.53 77.49 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.793 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' 1283 ' ' SER . 15.9 t -65.12 -30.71 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.649 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 13.0 mt-30 -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.217 0.532 . . . . 0.0 109.978 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -35.8 58.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.186 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.446 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.1 tp60 -75.01 -34.91 61.98 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.612 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.0 m-85 -103.2 -6.66 21.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.606 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 55.6 55.15 7.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.039 0.447 . . . . 0.0 110.458 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.429 HG21 ' HE ' ' A' 1297 ' ' ARG . 13.5 pt -131.88 147.87 32.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.49 147.93 22.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.182 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.612 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.3 t80 -45.3 -50.24 12.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 111.446 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.78 -42.6 58.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.429 ' HE ' HG21 ' A' 1293 ' ' ILE . 0.0 OUTLIER -64.3 -49.23 72.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -53.9 -50.12 67.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.07 -29.69 71.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.063 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -68.08 -51.08 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.208 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.63 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.4 mt -59.53 -43.38 90.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.462 HG21 ' HG3' ' A' 1320 ' ' ARG . 19.9 mt -68.98 -33.63 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.915 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.14 -52.05 65.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.236 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.443 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 25.4 mt-30 -59.41 -36.92 76.77 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.226 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.601 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.5 mtm -57.35 -37.81 73.15 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' 1311 ' ' VAL . 3.1 tt0 -69.39 -33.07 72.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.01 -29.75 63.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.261 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.823 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -89.25 -20.29 24.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.782 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.77 12.74 31.61 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.949 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.4 mt -83.07 -36.19 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.654 0.382 . . . . 0.0 111.341 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' 1306 ' ' GLU . 35.4 m -122.75 155.11 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.378 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.539 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -102.53 -177.97 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.188 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.82 132.17 48.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.343 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -67.91 130.93 44.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.326 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -116.96 -40.45 0.76 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.884 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.47 -165.3 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.6 p30 -86.92 91.77 8.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.054 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.83 10.06 86.49 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.21 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -98.91 122.04 41.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.076 0.438 . . . . 0.0 111.543 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.462 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.1 mmt180 -107.48 140.32 40.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.6 132.66 34.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.889 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' 1282 ' ' ALA . 31.8 t -92.24 118.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.539 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -108.51 -4.76 16.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.381 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.801 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.24 130.66 22.73 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.395 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.59 158.74 22.1 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.563 2.175 . . . . 0.0 113.153 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.523 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.8 Cg_exo -52.2 163.19 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.044 2.496 . . . . 0.0 112.712 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.99 -37.03 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -130.17 -45.52 1.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.001 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 39.1 t70 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.936 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 95.99 38.74 4.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.493 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -69.05 -30.82 69.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.63 -27.37 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.72 -29.66 8.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.807 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.791 HD22 ' CD2' ' A' 1269 ' ' PHE . 8.4 mt -74.31 160.01 31.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.951 0.405 . . . . 0.0 110.932 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' 1268 ' ' LEU . 19.3 t70 -84.87 143.02 39.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.051 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.11 -23.87 23.75 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.388 2.059 . . . . 0.0 112.421 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.566 HD12 ' NH1' ' A' 1297 ' ' ARG . 74.4 mt -97.73 -6.65 32.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.524 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.791 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.5 t80 -47.29 -55.95 7.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.42 -40.99 62.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.957 0.408 . . . . 0.0 110.318 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.566 ' HB3' ' CE2' ' A' 1291 ' ' PHE . 0.1 OUTLIER -64.79 -49.16 71.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.892 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.641 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -60.31 -40.77 91.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.625 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' 1277 ' ' THR . 84.3 t -61.23 -48.52 88.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.406 ' HA ' ' HG1' ' A' 1277 ' ' THR . 33.8 mt-30 -65.46 -30.29 71.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.877 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.402 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.1 t80 -68.13 -49.08 63.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.438 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' 1282 ' ' ALA . 35.2 m -69.75 -40.75 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.293 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.834 HG22 ' O ' ' A' 1324 ' ' ALA . 76.4 p -67.62 -48.52 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.18 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -59.11 -38.12 78.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.493 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -90.68 -6.56 54.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.028 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.2 mmm180 59.76 15.71 5.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.938 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -145.55 136.94 25.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.785 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -116.3 116.36 27.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.908 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.871 ' O ' HG23 ' A' 1287 ' ' VAL . 13.1 t -132.52 139.14 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.199 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.519 HG23 ' CB ' ' A' 1298 ' ' ALA . 31.3 mt -68.43 -38.46 79.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.51 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.8 t -68.78 -42.47 77.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.871 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.73 -48.23 87.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.661 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' 1283 ' ' SER . 14.2 t -66.05 -30.94 51.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 110.673 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 21.9 mt-30 -60.88 -50.49 73.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.144 0.497 . . . . 0.0 110.048 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -76.32 -36.53 58.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.157 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.412 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -74.94 -33.95 62.01 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.566 -179.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.3 m-85 -103.14 -6.38 22.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.535 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' 1292 ' ' ARG . 13.8 mtp-105 53.95 54.96 8.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.097 0.475 . . . . 0.0 110.23 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.484 HG21 ' NH1' ' A' 1297 ' ' ARG . 13.9 pt -130.86 152.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.578 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -58.75 148.14 39.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.791 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.588 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 91.2 t80 -44.96 -51.85 9.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.54 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -40.99 57.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.744 HH12 HD11 ' A' 1301 ' ' ILE . 0.1 OUTLIER -64.93 -47.87 76.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.99 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' 1288 ' ' GLN . . . -56.37 -50.18 72.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -62.54 -29.88 70.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -68.08 -49.84 58.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.258 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.744 HD11 HH12 ' A' 1297 ' ' ARG . 40.2 mt -60.18 -44.21 94.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.059 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.491 HG21 ' HG3' ' A' 1320 ' ' ARG . 19.4 mt -68.68 -33.51 60.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.836 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -52.04 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.32 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.441 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 29.1 mt-30 -60.05 -36.39 77.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.341 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.593 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.7 mtm -57.05 -38.89 73.87 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.632 ' N ' HG22 ' A' 1311 ' ' VAL . 0.4 OUTLIER -68.81 -33.94 74.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.239 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -71.47 -30.82 66.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.47 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.788 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -88.78 -20.21 25.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.868 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.05 12.69 31.07 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.894 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.74 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.1 mt -82.53 -36.03 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 122.8 0.44 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.632 HG22 ' N ' ' A' 1306 ' ' GLU . 35.8 m -124.01 158.98 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.254 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.466 ' CA ' HD11 ' A' 1323 ' ' LEU . 1.0 OUTLIER -98.66 179.25 4.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 0.0 111.602 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.85 135.06 54.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.438 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.73 139.49 56.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.039 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -140.18 -46.67 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.808 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -74.05 -157.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -102.37 91.67 4.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 111.103 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.73 10.0 86.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.481 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -107.75 122.13 46.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.229 0.514 . . . . 0.0 111.781 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.491 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.9 mmt180 -107.28 140.33 40.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.204 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' 1311 ' ' VAL . 1.5 tp10 -83.39 132.72 34.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.976 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' 1282 ' ' ALA . 25.0 t -91.39 118.78 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.982 0.42 . . . . 0.0 110.222 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.466 HD11 ' CA ' ' A' 1312 ' ' SER . 0.5 OUTLIER -109.02 -6.23 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.448 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.834 ' O ' HG22 ' A' 1277 ' ' THR . . . -104.68 132.49 20.87 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.414 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.83 158.56 16.01 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.493 2.129 . . . . 0.0 113.043 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.51 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.0 Cg_exo -53.27 163.49 2.37 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.97 2.447 . . . . 0.0 112.526 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.75 -36.43 2.13 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.298 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -132.93 51.66 2.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.9 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.867 0.365 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -93.9 44.12 2.39 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -64.02 -29.02 70.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 111.155 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -57.85 -27.91 63.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.53 -36.09 6.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 0.0 110.81 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.811 HD21 ' NE2' ' A' 1308 ' ' GLN . 9.9 mt -73.68 160.03 32.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . 0.405 ' CB ' HG12 ' A' 1301 ' ' ILE . 10.0 t70 -84.62 143.99 41.96 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.404 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.35 -25.53 18.55 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.519 2.146 . . . . 0.0 112.869 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' 1291 ' ' PHE . 36.6 mt -102.06 -0.15 34.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.805 ' CD2' HD22 ' A' 1265 ' ' LEU . 43.5 t80 -47.7 -56.38 7.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.41 -42.78 64.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.477 ' NE2' HD23 ' A' 1268 ' ' LEU . 16.4 mt-30 -69.48 -36.51 76.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.241 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.673 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -67.75 -41.65 83.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.684 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.553 HG13 HG21 ' A' 1310 ' ' ILE . 97.9 t -61.99 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' 1278 ' ' GLU . 0.4 OUTLIER -64.77 -32.41 74.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.615 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.408 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -67.41 -50.71 58.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.666 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' 1282 ' ' ALA . 32.8 m -68.23 -37.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.335 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.887 HG22 ' O ' ' A' 1324 ' ' ALA . 43.2 p -69.98 -48.83 56.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.222 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' 1274 ' ' GLN . 6.2 mm-40 -59.66 -35.16 73.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.527 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -95.97 -4.16 43.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.8 mmm180 54.95 19.42 2.66 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.906 0.384 . . . . 0.0 110.873 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . 0.427 ' N ' HG21 ' A' 1322 ' ' VAL . 1.4 mttp -145.46 131.64 19.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.96 116.42 29.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.642 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.815 ' O ' HG23 ' A' 1287 ' ' VAL . 30.2 t -132.46 141.84 48.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.651 HD13 ' HB2' ' A' 1299 ' ' ALA . 62.2 mt -70.29 -43.44 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 27.7 t -68.06 -40.59 82.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.883 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.07 60.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.781 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' 1283 ' ' SER . 22.3 t -65.19 -29.93 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.266 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' 1293 ' ' ILE . 13.3 tt0 -59.8 -51.86 67.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -76.28 -35.59 58.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.065 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.414 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.06 -33.3 61.7 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.596 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.16 -7.85 20.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.762 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 56.62 51.78 10.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.161 0.505 . . . . 0.0 110.29 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.464 HG21 HD12 ' A' 1268 ' ' LEU . 19.1 pt -129.17 146.03 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.11 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -50.89 149.77 6.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.319 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' 1284 ' ' ILE . 87.8 t80 -47.64 -53.43 14.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.444 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.77 -36.95 39.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -67.07 -50.21 62.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.175 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -55.21 -46.35 75.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.628 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.651 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -65.91 -29.9 70.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.175 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -49.36 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.315 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.673 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.0 mt -60.66 -42.43 91.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.965 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.554 ' HA ' ' HE3' ' A' 1305 ' ' MET . 26.5 mt -68.76 -35.29 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -51.09 70.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.486 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.417 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 17.4 mt-30 -59.88 -37.04 78.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.428 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.611 ' HB3' HG13 ' A' 1311 ' ' VAL . 19.6 mtm -56.98 -38.39 72.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.604 ' N ' HG22 ' A' 1311 ' ' VAL . 2.2 tt0 -69.93 -32.81 71.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.37 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.54 -31.47 65.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.426 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.811 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.7 OUTLIER -88.12 -20.3 25.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.918 -178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.63 13.81 29.1 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.719 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.2 mt -82.85 -36.42 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 122.892 0.477 . . . . 0.0 111.251 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' 1305 ' ' MET . 26.7 m -121.31 160.49 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.541 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.435 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -106.97 -178.53 3.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.516 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.95 134.89 53.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.65 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 149.98 49.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.894 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -137.01 -45.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.243 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' 1317 ' ' ASN . 9.7 t-160 -76.29 -112.45 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' 1316 ' ' HIS . 0.5 OUTLIER -138.1 91.78 2.6 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.902 0.382 . . . . 0.0 111.123 179.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.7 10.08 86.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.996 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -107.12 123.62 48.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 0.0 111.411 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.534 ' HD3' HG21 ' A' 1302 ' ' ILE . 0.0 OUTLIER -107.06 140.24 40.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.351 179.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' 1311 ' ' VAL . 15.3 tp10 -75.37 132.58 41.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.992 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 20.6 t -87.3 118.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -105.7 -19.04 13.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.269 -178.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.887 ' O ' HG22 ' A' 1277 ' ' THR . . . -91.96 133.49 30.41 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.262 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.19 159.02 15.26 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.498 2.132 . . . . 0.0 113.02 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.489 ' N ' ' HB ' ' A' 1277 ' ' THR . 56.6 Cg_exo -52.01 159.35 3.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.903 2.402 . . . . 0.0 112.477 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.83 -36.91 1.34 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 112.394 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -130.53 64.11 1.56 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.911 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 8.6 m80 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.793 0.33 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -159.31 -84.32 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -67.94 -28.96 67.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.3 -25.89 64.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.46 -35.08 5.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.859 0.361 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.825 HD21 ' NE2' ' A' 1308 ' ' GLN . 9.4 mt -92.42 160.06 15.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.87 143.64 43.62 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.43 -24.18 27.08 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.394 2.063 . . . . 0.0 112.272 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.718 HD23 ' NE2' ' A' 1271 ' ' GLN . 65.9 mt -97.53 -5.37 35.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.6 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.741 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.0 t80 -47.47 -55.93 8.06 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.52 -40.77 62.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.396 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.718 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.2 OUTLIER -67.52 -43.26 81.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.082 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -63.08 -41.19 99.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.905 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' 1269 ' ' PHE . 29.7 t -61.1 -48.51 88.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' 1278 ' ' GLU . 45.0 tt0 -63.18 -33.56 75.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.441 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.6 t80 -65.9 -51.6 57.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.62 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.638 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.2 m -69.31 -38.46 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.7 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.85 HG22 ' O ' ' A' 1324 ' ' ALA . 51.4 p -69.23 -49.86 52.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.21 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.4 mt-10 -59.8 -36.37 76.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.971 0.415 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -91.81 -6.49 51.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.018 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.6 mmm180 56.9 18.12 3.7 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.887 0.375 . . . . 0.0 110.744 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 132.35 20.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.737 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.638 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.98 116.49 29.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.788 ' O ' HG23 ' A' 1287 ' ' VAL . 0.5 OUTLIER -132.29 141.37 48.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.903 0.382 . . . . 0.0 111.139 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' 1299 ' ' ALA . 25.4 mt -69.13 -43.31 81.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 21.3 t -67.01 -40.3 87.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.978 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.65 -51.12 60.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' 1283 ' ' SER . 21.1 t -64.83 -29.91 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.311 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' 1293 ' ' ILE . 10.7 tt0 -59.75 -52.68 64.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.092 0.472 . . . . 0.0 110.135 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 -35.23 58.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.18 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.435 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -34.67 61.78 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.632 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.14 -7.38 21.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 56.82 55.02 6.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.135 0.493 . . . . 0.0 110.526 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' 1288 ' ' GLN . 13.3 pt -133.23 145.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -51.06 148.86 7.71 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.491 ' CE1' HG21 ' A' 1284 ' ' ILE . 89.2 t80 -47.05 -52.7 14.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.824 0.345 . . . . 0.0 111.543 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.72 -38.5 47.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 110.052 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -50.59 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.068 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.53 -44.43 72.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.429 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -66.94 -29.74 69.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -50.55 53.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.567 HG21 ' CB ' ' A' 1272 ' ' ALA . 20.8 mt -59.92 -42.33 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.01 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.544 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.9 mt -69.45 -34.6 62.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.774 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.94 -52.05 65.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.393 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.434 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 31.6 mt-30 -58.41 -38.03 76.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.259 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.566 ' HB3' HG13 ' A' 1311 ' ' VAL . 21.3 mtm -57.53 -37.33 72.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.326 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.626 ' N ' HG22 ' A' 1311 ' ' VAL . 2.2 tt0 -69.21 -32.66 72.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.181 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.825 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.4 OUTLIER -87.25 -20.31 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.715 -178.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.5 12.94 31.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.009 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.3 mt -83.65 -34.92 10.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.473 -0.363 . . . . 0.0 111.403 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' 1306 ' ' GLU . 35.6 m -124.44 154.4 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.622 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.44 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.1 OUTLIER -104.47 179.65 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.93 131.47 46.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -67.99 148.36 51.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.989 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -124.25 -58.5 0.18 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.634 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . 0.413 ' CE1' ' OD1' ' A' 1317 ' ' ASN . 21.1 t-160 -63.85 -106.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.949 -0.148 . . . . 0.0 110.806 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . 0.413 ' OD1' ' CE1' ' A' 1316 ' ' HIS . 18.2 p-10 -138.11 91.83 2.6 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 120.892 0.377 . . . . 0.0 111.089 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.89 1.72 79.6 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.026 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -88.52 122.22 31.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.944 0.372 . . . . 0.0 111.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.544 ' HG3' HG21 ' A' 1302 ' ' ILE . 4.7 mtt180 -107.22 140.2 40.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.54 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' 1311 ' ' VAL . 19.7 tp10 -81.95 132.66 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.767 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.5 t -88.81 118.61 34.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 110.047 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -106.31 -13.03 15.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.38 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' 1277 ' ' THR . . . -99.22 132.34 23.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.275 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.46 159.04 22.57 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.525 2.15 . . . . 0.0 113.026 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.515 ' N ' ' HB ' ' A' 1277 ' ' THR . 57.2 Cg_exo -51.64 152.31 12.97 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.038 2.492 . . . . 0.0 112.687 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -63.23 -70.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.625 2.217 . . . . 0.0 112.318 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 2.7 m-85 65.21 -74.52 0.05 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.045 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.926 179.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 76.2 m80 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.807 0.337 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 64.44 53.49 35.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.602 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -67.19 -30.78 70.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -59.0 -27.28 65.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.6 -34.1 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.664 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.541 HD21 ' NE2' ' A' 1308 ' ' GLN . 3.3 mt -75.1 160.15 30.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.995 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . 0.425 ' CB ' HG12 ' A' 1301 ' ' ILE . 9.8 t70 -80.38 141.74 53.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -51.73 -24.13 17.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.349 2.033 . . . . 0.0 112.584 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.639 HD23 ' NE2' ' A' 1271 ' ' GLN . 59.2 mt -102.11 -4.51 25.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.035 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.843 ' O ' HG23 ' A' 1273 ' ' VAL . 39.9 t80 -47.67 -53.11 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -46.08 66.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.0 110.294 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.639 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.1 OUTLIER -63.9 -43.25 96.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.25 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.602 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -62.1 -39.36 92.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.982 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' 1269 ' ' PHE . 17.2 t -61.65 -49.57 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.425 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.0 OUTLIER -62.61 -33.28 74.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.841 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.415 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.5 t80 -66.49 -50.87 61.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.0 m -69.57 -38.02 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.432 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.84 HG22 ' O ' ' A' 1324 ' ' ALA . 67.1 p -69.31 -50.25 48.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' 1274 ' ' GLN . 3.0 mm-40 -59.17 -36.78 75.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.484 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -92.69 -6.14 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' 1276 ' ' VAL . 29.1 mmm180 56.01 18.74 3.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.817 0.341 . . . . 0.0 110.651 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' 1322 ' ' VAL . 24.1 mttp -145.62 133.67 21.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.61 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -116.85 116.23 27.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.898 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.814 ' O ' HG23 ' A' 1287 ' ' VAL . 0.5 OUTLIER -132.54 143.25 49.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.022 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 16.1 mt -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.508 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 14.8 t -67.38 -40.59 85.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.059 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.65 -50.41 67.94 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.778 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' 1283 ' ' SER . 13.4 t -65.51 -30.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 110.635 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 18.7 mt-30 -60.76 -51.54 68.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.061 0.458 . . . . 0.0 109.936 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.28 -36.58 58.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.097 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.427 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.98 -34.37 61.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.714 0.293 . . . . 0.0 111.626 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.15 -6.51 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.562 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 54.67 54.97 8.46 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.077 0.465 . . . . 0.0 110.49 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.483 HG21 HD12 ' A' 1268 ' ' LEU . 14.7 pt -131.97 150.39 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.583 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -55.61 148.32 26.82 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.252 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.1 t80 -45.96 -50.99 14.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.559 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.76 -40.67 55.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.467 ' HD2' ' CD1' ' A' 1293 ' ' ILE . 0.1 OUTLIER -64.88 -49.74 69.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.558 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.98 -49.54 68.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.86 -30.0 71.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -49.8 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.985 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.557 HG21 ' CB ' ' A' 1272 ' ' ALA . 33.6 mt -60.71 -45.55 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.842 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.474 HG22 ' HE ' ' A' 1320 ' ' ARG . 21.0 mt -66.79 -32.46 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.864 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -52.2 59.67 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.8 OUTLIER -57.86 -33.32 68.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.758 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.604 ' HB3' HG13 ' A' 1311 ' ' VAL . 14.3 mtm -62.7 -39.37 93.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' 1311 ' ' VAL . 28.1 tt0 -66.35 -32.28 73.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.416 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -74.88 -42.11 58.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.281 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.541 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -74.4 -20.19 60.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.604 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.42 15.3 30.29 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.743 HG23 ' HB3' ' A' 1324 ' ' ALA . 10.0 mt -83.64 -35.28 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.65 0.38 . . . . 0.0 111.502 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' 1306 ' ' GLU . 29.6 m -122.4 159.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.573 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.42 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.19 178.19 4.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -66.01 131.53 46.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.819 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -67.95 144.01 55.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.957 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -119.36 -50.97 0.29 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.601 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . 0.461 ' CE1' ' ND2' ' A' 1317 ' ' ASN . 14.1 t-160 -71.56 -106.34 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.99 -0.124 . . . . 0.0 110.718 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . 0.461 ' ND2' ' CE1' ' A' 1316 ' ' HIS . 7.0 p30 -138.04 91.87 2.61 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.957 0.408 . . . . 0.0 111.065 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.84 1.0 77.01 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.022 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -87.13 122.24 30.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.474 ' HE ' HG22 ' A' 1302 ' ' ILE . 2.2 mtt-85 -107.18 140.2 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.655 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' 1311 ' ' VAL . 13.5 tt0 -83.61 132.72 34.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.749 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' 1282 ' ' ALA . 19.3 t -87.92 118.57 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.321 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.42 HD11 ' CB ' ' A' 1312 ' ' SER . 0.8 OUTLIER -105.81 -10.25 16.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.053 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' 1277 ' ' THR . . . -100.21 129.91 27.16 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.192 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -82.62 158.48 16.54 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.573 2.182 . . . . 0.0 113.175 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.439 ' N ' ' HB ' ' A' 1277 ' ' THR . 51.5 Cg_exo -53.97 164.26 2.63 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.993 2.462 . . . . 0.0 112.32 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.38 -42.92 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.701 2.268 . . . . 0.0 112.432 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -139.8 63.52 1.48 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.881 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.779 0.323 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 105.27 -114.54 4.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -57.41 -27.54 62.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 111.273 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -58.99 -29.07 66.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.06 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.76 -30.67 7.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.966 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.518 HD13 ' CD1' ' A' 1269 ' ' PHE . 6.7 mt -69.01 160.0 31.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.029 0.442 . . . . 0.0 111.266 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 8.7 t0 -75.77 141.38 72.0 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.0 -24.57 10.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.441 2.094 . . . . 0.0 112.945 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' 1291 ' ' PHE . 60.0 mt -102.18 -5.03 24.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' 1273 ' ' VAL . 45.9 t80 -47.66 -52.67 17.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.6 t0 -52.67 -42.2 64.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 0.0 110.328 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.56 -43.06 81.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.989 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -61.64 -38.98 89.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.873 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' 1269 ' ' PHE . 21.2 t -62.13 -52.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.476 ' HG3' ' HG3' ' A' 1327 ' ' PRO . 0.8 OUTLIER -61.43 -30.62 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.941 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.479 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 3.1 t80 -68.91 -51.04 44.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.697 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' 1282 ' ' ALA . 35.3 m -69.74 -36.93 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.403 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.837 HG22 ' O ' ' A' 1324 ' ' ALA . 65.9 p -69.68 -50.76 40.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.352 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' 1274 ' ' GLN . 2.5 mm-40 -61.01 -35.19 76.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -7.99 52.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.793 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 56.65 18.04 3.44 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . 0.401 ' N ' HG21 ' A' 1322 ' ' VAL . 7.7 mttm -145.66 133.44 21.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.644 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -115.47 116.44 28.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.723 0.297 . . . . 0.0 110.779 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.825 ' O ' HG23 ' A' 1287 ' ' VAL . 11.1 t -132.49 141.31 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.16 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.707 HD13 ' HB2' ' A' 1299 ' ' ALA . 72.3 mt -68.6 -47.62 76.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.4 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 25.8 t -63.8 -40.68 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.043 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.96 62.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.969 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -64.35 -29.96 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.446 ' HG3' ' HA ' ' A' 1295 ' ' TYR . 0.0 OUTLIER -60.8 -50.84 71.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.108 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -36.35 58.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.994 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.412 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.6 OUTLIER -75.09 -32.91 61.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.725 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.5 m-85 -103.2 -7.78 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.761 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 59.05 50.35 8.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' 1288 ' ' GLN . 10.2 pt -126.56 171.39 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -77.01 154.06 42.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.924 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.5 ' CE1' HG21 ' A' 1284 ' ' ILE . 82.6 t80 -49.11 -55.84 10.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.822 0.311 . . . . 0.0 111.251 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -33.42 22.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 110.113 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -70.32 -50.89 34.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.865 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.494 ' HB3' HG23 ' A' 1284 ' ' ILE . . . -55.78 -46.74 77.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.555 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.707 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -66.79 -29.98 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.98 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -67.42 -48.93 65.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.893 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.567 HG21 ' CB ' ' A' 1272 ' ' ALA . 50.1 mt -61.39 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.789 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' 1284 ' ' ILE . 20.0 mt -63.09 -31.69 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.734 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -47.6 82.98 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.635 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 2.8 mt-30 -60.64 -33.4 72.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.197 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.683 ' HB3' HG13 ' A' 1311 ' ' VAL . 0.6 OUTLIER -61.6 -40.32 94.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.605 ' N ' HG22 ' A' 1311 ' ' VAL . 12.5 tt0 -65.86 -35.72 81.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.871 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.93 -41.36 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.265 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.511 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -74.72 -20.4 59.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.762 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 98.07 15.76 35.03 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.773 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.783 HG23 ' HB3' ' A' 1324 ' ' ALA . 8.6 mt -82.41 -36.18 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 122.791 0.436 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.683 HG13 ' HB3' ' A' 1305 ' ' MET . 26.8 m -120.23 162.41 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.475 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.53 -177.96 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -65.87 131.49 46.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 130.95 44.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.381 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -109.08 -44.09 1.13 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.927 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.4 -161.54 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.28 91.79 8.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.78 10.09 86.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.157 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -91.49 122.14 33.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.538 ' HD2' HG21 ' A' 1311 ' ' VAL . 0.2 OUTLIER -107.32 140.28 40.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.439 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' 1311 ' ' VAL . 14.4 tt0 -88.41 132.81 34.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' 1282 ' ' ALA . 21.2 t -90.67 118.69 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.487 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' 1312 ' ' SER . 0.7 OUTLIER -107.19 -18.3 13.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.021 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' 1277 ' ' THR . . . -91.46 130.17 40.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.292 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.01 158.61 23.94 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.474 2.116 . . . . 0.0 113.133 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.523 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.1 Cg_exo -52.44 161.46 2.8 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.017 2.478 . . . . 0.0 112.57 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . 0.476 ' HG3' ' HG3' ' A' 1274 ' ' GLN . 18.9 Cg_endo -59.36 -32.03 95.94 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.757 2.305 . . . . 0.0 112.241 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -91.31 48.43 1.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.952 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.754 0.312 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -175.19 77.82 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.45 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -65.48 -25.16 67.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.764 0.316 . . . . 0.0 111.306 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -56.84 -31.95 65.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 -35.35 5.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.821 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.821 HD21 ' NE2' ' A' 1308 ' ' GLN . 12.3 mt -74.46 160.06 31.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.033 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.25 144.49 62.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.215 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.62 -23.27 19.28 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.47 2.114 . . . . 0.0 112.16 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' 1291 ' ' PHE . 85.4 mt -99.2 -6.92 27.3 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.793 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.706 ' CD1' HD13 ' A' 1265 ' ' LEU . 38.4 t80 -47.54 -56.14 7.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.49 -40.1 61.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.848 0.356 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.45 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 17.4 mt-30 -71.0 -38.89 72.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.134 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.61 ' HA ' ' CZ ' ' A' 1291 ' ' PHE . . . -65.26 -40.01 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' 1269 ' ' PHE . 47.2 t -62.86 -47.55 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.431 ' HA ' ' OG1' ' A' 1277 ' ' THR . 0.5 OUTLIER -63.67 -33.55 75.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.729 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.411 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -66.14 -51.26 59.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.588 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -69.51 -37.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.437 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.867 HG22 ' O ' ' A' 1324 ' ' ALA . 44.5 p -69.96 -49.2 54.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' 1274 ' ' GLN . 9.6 mt-10 -60.34 -35.91 76.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.338 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -92.33 -6.18 50.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.911 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' 1276 ' ' VAL . 1.5 mmm180 56.93 17.7 3.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.766 0.317 . . . . 0.0 110.85 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 133.4 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.822 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.645 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.51 116.53 29.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.782 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.844 ' O ' HG23 ' A' 1287 ' ' VAL . 1.4 t -132.44 136.13 46.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.574 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 32.1 mt -66.41 -37.9 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.138 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.498 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 30.8 t -69.35 -43.11 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.85 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.17 -48.57 85.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.714 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' 1283 ' ' SER . 12.0 t -66.02 -31.27 52.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.683 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 19.3 mt-30 -59.92 -51.22 70.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 109.998 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -36.77 58.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.261 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.424 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.0 OUTLIER -74.96 -33.91 61.96 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.611 -179.005 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.61 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.11 -7.01 21.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.568 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 54.65 54.08 9.73 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.009 0.433 . . . . 0.0 110.261 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.21 146.72 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.516 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.44 149.0 10.57 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.314 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.598 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 89.6 t80 -46.48 -51.79 14.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -50.8 -39.7 53.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.197 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -50.67 64.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.574 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.88 -49.78 67.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.997 0.427 . . . . 0.0 110.544 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.11 -29.68 70.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.061 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -68.2 -51.63 43.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.549 HG21 ' CB ' ' A' 1272 ' ' ALA . 36.4 mt -59.57 -44.33 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.94 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.454 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.0 mt -67.91 -32.93 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -52.11 66.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.422 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.427 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 0.1 OUTLIER -60.2 -36.9 78.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.617 ' HB3' HG13 ' A' 1311 ' ' VAL . 16.9 mtm -56.94 -36.38 70.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 CA-C-O 121.557 0.694 . . . . 0.0 109.174 178.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' 1311 ' ' VAL . 4.6 tp10 -70.21 -33.14 71.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.055 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.41 62.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.475 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.821 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.4 OUTLIER -88.07 -20.43 25.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.908 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 101.57 16.05 25.51 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.958 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.637 HG23 ' HB3' ' A' 1324 ' ' ALA . 14.0 mt -85.26 -36.64 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.303 -0.448 . . . . 0.0 111.184 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' 1305 ' ' MET . 35.0 m -120.58 156.64 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.524 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -103.3 -178.19 3.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.108 0.48 . . . . 0.0 111.657 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.86 135.14 54.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.515 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -67.72 133.99 50.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.173 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -123.73 -42.96 0.36 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.797 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.56 -160.49 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 6.3 p30 -92.55 91.78 7.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.86 10.1 86.46 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.119 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -98.65 122.23 41.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 0.0 111.637 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.454 ' HG3' HG21 ' A' 1302 ' ' ILE . 7.8 mmt180 -107.24 140.27 40.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.168 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' 1311 ' ' VAL . 4.9 tp10 -87.48 132.67 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' 1282 ' ' ALA . 22.0 t -91.79 118.69 37.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 110.099 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.524 HD11 ' CB ' ' A' 1312 ' ' SER . 0.5 OUTLIER -107.82 -4.92 17.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.457 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' 1277 ' ' THR . . . -105.79 130.98 22.15 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.02 159.42 23.94 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.461 2.107 . . . . 0.0 113.041 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.518 ' N ' ' HB ' ' A' 1277 ' ' THR . 67.3 Cg_exo -51.47 158.49 3.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.081 2.521 . . . . 0.0 112.582 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.94 -74.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.691 2.261 . . . . 0.0 112.442 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -123.34 -45.52 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.96 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.926 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 5.2 t60 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.801 0.334 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . -105.08 -38.27 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -63.3 -24.74 67.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.319 . . . . 0.0 111.246 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -55.89 -33.22 64.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.117 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.26 -34.72 5.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.832 HD22 ' CD2' ' A' 1269 ' ' PHE . 10.9 mt -83.19 155.18 23.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' 1301 ' ' ILE . 19.7 t70 -74.48 144.98 81.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.376 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.46 -24.25 21.38 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.377 2.051 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.563 HD13 ' HB3' ' A' 1291 ' ' PHE . 44.3 mt -101.98 -1.76 31.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.909 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.832 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.1 t80 -47.7 -56.51 7.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.37 -41.81 63.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.074 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.411 ' HB2' ' HE2' ' A' 1291 ' ' PHE . 4.5 mt-30 -70.1 -37.48 75.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.661 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -65.91 -41.65 91.18 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.689 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.608 HG13 HG21 ' A' 1310 ' ' ILE . 57.6 t -61.75 -48.48 88.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.461 ' HA ' ' OG1' ' A' 1277 ' ' THR . 1.3 tm0? -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.786 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.435 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -66.87 -51.74 51.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.547 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.4 m -67.6 -37.43 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.121 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.872 HG22 ' O ' ' A' 1324 ' ' ALA . 42.6 p -69.47 -49.45 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.178 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.6 -35.03 73.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . 0.413 ' HE2' ' CE1' ' A' 1275 ' ' PHE . 2.7 mtmt -93.91 -6.98 44.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.018 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' 1276 ' ' VAL . 31.4 mmm180 58.04 17.2 4.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.625 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.6 133.58 21.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.627 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.34 116.44 29.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.818 ' O ' HG23 ' A' 1287 ' ' VAL . 4.4 t -132.39 138.26 47.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.359 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.572 HG12 HD12 ' A' 1302 ' ' ILE . 24.1 mt -67.92 -38.77 80.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.161 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.477 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 26.0 t -69.69 -42.83 73.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.962 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' 1290 ' ' GLN . . . -60.72 -50.18 70.47 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.584 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' 1283 ' ' SER . 21.2 t -65.44 -29.92 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.723 0.297 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 16.9 mt-30 -60.41 -52.72 64.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.105 0.479 . . . . 0.0 110.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -76.31 -34.59 59.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.027 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.441 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 1.5 tp60 -75.12 -34.01 61.64 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.394 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.624 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.25 -6.44 22.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.704 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 54.77 51.53 13.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.174 0.512 . . . . 0.0 110.047 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.596 HG22 ' NH1' ' A' 1297 ' ' ARG . 16.6 pt -126.89 150.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.36 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -57.61 147.64 35.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.85 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.604 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 86.8 t80 -44.84 -49.5 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 111.47 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 7.3 p30 -50.77 -43.47 58.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.807 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.596 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.0 OUTLIER -65.3 -47.27 77.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.417 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.562 ' CB ' HG23 ' A' 1284 ' ' ILE . . . -53.8 -49.94 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.675 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -64.3 -29.78 70.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.015 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -49.79 56.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.409 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.661 HG21 ' CB ' ' A' 1272 ' ' ALA . 38.2 mt -60.88 -42.51 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.776 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.572 HD12 HG12 ' A' 1284 ' ' ILE . 29.1 mt -69.06 -35.3 68.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.741 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -52.01 66.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.384 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.446 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 16.1 mt-30 -59.32 -37.58 78.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.354 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.603 ' HB3' HG13 ' A' 1311 ' ' VAL . 17.4 mtm -57.13 -37.43 71.99 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' 1311 ' ' VAL . 2.8 tt0 -70.25 -32.33 70.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.141 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.67 -29.01 62.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.338 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.822 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.5 OUTLIER -90.13 -20.33 23.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.741 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 102.85 13.76 28.74 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.063 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' 1324 ' ' ALA . 11.1 mt -84.39 -35.84 11.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 122.799 0.439 . . . . 0.0 111.456 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' 1306 ' ' GLU . 30.3 m -122.03 155.84 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.732 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.495 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -108.74 -177.98 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.04 131.92 47.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.758 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -67.89 156.18 37.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.985 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -129.92 -57.3 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.701 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . 0.412 ' CE1' ' OD1' ' A' 1317 ' ' ASN . 20.0 t-160 -66.94 -104.07 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.508 0.154 . . . . 0.0 110.806 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . 0.412 ' OD1' ' CE1' ' A' 1316 ' ' HIS . 8.8 p-10 -138.08 91.85 2.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.851 0.358 . . . . 0.0 111.009 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.8 1.59 78.66 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.932 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -87.27 122.37 30.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.89 0.376 . . . . 0.0 111.079 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -107.18 140.13 40.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.399 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.0 tp10 -80.0 132.64 36.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.056 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' 1282 ' ' ALA . 18.2 t -88.55 118.56 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.495 HD11 ' CB ' ' A' 1312 ' ' SER . 0.6 OUTLIER -105.73 -13.88 15.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -178.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' 1277 ' ' THR . . . -97.47 132.6 24.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.35 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.51 159.02 19.5 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.553 2.169 . . . . 0.0 113.074 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.503 ' N ' ' HB ' ' A' 1277 ' ' THR . 53.9 Cg_exo -52.16 161.09 2.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.913 2.409 . . . . 0.0 112.66 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.91 -36.52 2.58 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.669 2.246 . . . . 0.0 112.25 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -60.81 -34.25 74.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.858 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 19.5 t-80 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.826 0.346 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 164.26 101.37 0.16 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.548 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -69.59 -27.47 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 111.246 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -56.42 -29.36 61.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.022 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.51 -44.87 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.967 0.413 . . . . 0.0 110.631 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.563 HD21 ' NE2' ' A' 1308 ' ' GLN . 6.9 mt -70.93 157.5 38.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.141 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.62 143.78 79.43 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.197 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.66 -23.63 15.72 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.256 1.971 . . . . 0.0 112.217 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' 1291 ' ' PHE . 59.5 mt -102.08 -5.48 24.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.777 ' O ' HG23 ' A' 1273 ' ' VAL . 39.4 t80 -47.71 -54.13 13.03 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -52.61 -41.69 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -67.52 -42.67 82.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.609 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -62.78 -39.12 93.21 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.72 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' 1269 ' ' PHE . 21.6 t -62.04 -51.27 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.7 tt0 -61.79 -31.57 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.894 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.439 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.8 t80 -68.25 -50.88 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.632 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' 1282 ' ' ALA . 34.2 m -69.18 -37.27 76.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.287 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.845 HG22 ' O ' ' A' 1324 ' ' ALA . 74.1 p -69.64 -50.64 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' 1274 ' ' GLN . 8.3 mm-40 -59.46 -36.09 75.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.0 110.404 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -8.25 48.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' 1276 ' ' VAL . 30.9 mmm180 57.71 17.74 4.3 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.462 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . 0.408 ' N ' HG21 ' A' 1322 ' ' VAL . 29.7 mttt -145.61 132.1 19.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.792 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.648 ' HA ' HG12 ' A' 1276 ' ' VAL . . . -113.02 116.49 30.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.727 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.791 ' O ' HG23 ' A' 1287 ' ' VAL . 34.6 t -132.29 139.87 48.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 111.276 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' 1299 ' ' ALA . 22.5 mt -68.48 -43.31 83.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . . . . . . . . . 2.8 t -67.16 -41.18 86.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.978 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -60.49 -51.14 60.59 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.79 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' 1283 ' ' SER . 21.8 t -64.52 -29.96 48.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 120.958 0.409 . . . . 0.0 110.263 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' 1293 ' ' ILE . 15.7 tt0 -59.63 -53.07 62.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.248 0.547 . . . . 0.0 110.208 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -35.16 59.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.102 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.424 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.8 OUTLIER -75.09 -33.34 61.64 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.683 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.4 m-85 -103.27 -7.71 20.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 57.56 52.39 8.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.067 0.461 . . . . 0.0 110.494 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . 0.674 HG22 ' NH1' ' A' 1297 ' ' ARG . 13.2 pt -130.01 148.33 33.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.031 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -54.48 150.28 16.93 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.924 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.45 ' CE1' HG21 ' A' 1284 ' ' ILE . 89.1 t80 -47.59 -51.28 21.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.78 -38.54 48.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.529 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.674 ' NH1' HG22 ' A' 1293 ' ' ILE . 0.1 OUTLIER -66.92 -49.38 65.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.139 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.469 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -54.62 -45.77 73.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.666 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.537 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -67.05 -29.87 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.063 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -49.97 57.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.046 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.609 HG21 ' CB ' ' A' 1272 ' ' ALA . 39.9 mt -60.57 -45.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.786 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.544 HG22 ' HE ' ' A' 1320 ' ' ARG . 19.8 mt -66.12 -32.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.853 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -52.2 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.534 ' HB3' ' CE2' ' A' 1269 ' ' PHE . 0.0 OUTLIER -60.14 -32.03 70.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.758 178.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.674 ' HB3' HG13 ' A' 1311 ' ' VAL . 13.8 mtm -61.3 -39.05 89.03 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' 1311 ' ' VAL . 1.7 tt0 -67.22 -32.93 74.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.372 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -73.05 -42.11 63.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.42 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.563 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.8 OUTLIER -76.31 -20.28 57.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.871 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 100.53 16.37 27.01 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.997 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' 1324 ' ' ALA . 13.0 mt -83.12 -37.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 122.76 0.424 . . . . 0.0 111.279 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' 1305 ' ' MET . 34.8 m -120.65 159.54 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.507 ' CB ' HD11 ' A' 1323 ' ' LEU . 0.3 OUTLIER -107.6 -177.92 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.867 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -65.74 130.68 44.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.419 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -67.91 131.37 45.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.384 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -104.55 -36.88 2.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.935 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -92.94 -158.64 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -86.24 91.83 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 111.216 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.99 10.12 86.45 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.423 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -93.12 122.01 35.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.11 0.455 . . . . 0.0 111.198 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.564 ' HD2' HG21 ' A' 1311 ' ' VAL . 0.7 OUTLIER -107.45 140.3 40.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.566 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' 1311 ' ' VAL . 0.8 OUTLIER -84.52 132.71 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.253 . . . . 0.0 110.622 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' 1282 ' ' ALA . 18.3 t -89.51 118.69 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.94 0.4 . . . . 0.0 110.319 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.507 HD11 ' CB ' ' A' 1312 ' ' SER . 0.8 OUTLIER -106.51 -19.99 13.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.931 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.845 ' O ' HG22 ' A' 1277 ' ' THR . . . -89.67 129.86 45.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.9 158.88 21.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.094 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.498 ' N ' ' HB ' ' A' 1277 ' ' THR . 50.1 Cg_exo -53.13 164.32 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.922 2.414 . . . . 0.0 112.411 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.34 -35.21 14.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.617 2.211 . . . . 0.0 112.232 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -129.5 -68.75 0.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.894 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1260 ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1261 ' ' GLY . . . . . . . . . . . . . . . 98.95 -44.29 1.73 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.547 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1262 ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.21 67.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.254 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1263 ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.46 -34.94 64.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1264 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.05 -34.39 5.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1265 ' ' LEU . . . . . 0.824 HD21 ' NE2' ' A' 1308 ' ' GLN . 10.2 mt -89.1 159.89 17.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.144 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1266 ' ' ASP . . . . . . . . . . . . . 19.6 t70 -85.87 145.11 40.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.365 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1267 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -52.52 -24.03 21.04 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1268 ' ' LEU . . . . . 0.735 HD23 ' NE2' ' A' 1271 ' ' GLN . 45.2 mt -102.05 -1.52 31.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.862 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1269 ' ' PHE . . . . . 0.818 ' CD2' HD22 ' A' 1265 ' ' LEU . 41.6 t80 -47.56 -56.88 6.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1270 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.34 -41.04 62.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1271 ' ' GLN . . . . . 0.735 ' NE2' HD23 ' A' 1268 ' ' LEU . 0.4 OUTLIER -66.78 -42.3 86.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 178.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1272 ' ' ALA . . . . . 0.623 ' CB ' HG21 ' A' 1301 ' ' ILE . . . -65.01 -41.9 94.91 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1273 ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' 1269 ' ' PHE . 61.1 t -60.11 -48.16 89.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1274 ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' 1278 ' ' GLU . 2.5 tt0 -64.13 -33.26 75.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.744 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1275 ' ' PHE . . . . . 0.448 ' CD2' ' HE1' ' A' 1291 ' ' PHE . 2.4 t80 -65.65 -50.7 64.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.585 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1276 ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' 1282 ' ' ALA . 33.5 m -69.28 -40.26 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.492 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1277 ' ' THR . . . . . 0.853 HG22 ' O ' ' A' 1324 ' ' ALA . 67.0 p -67.99 -49.53 61.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1278 ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' 1274 ' ' GLN . 11.7 mm-40 -59.68 -36.3 76.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1279 ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -92.28 -6.06 51.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.22 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1280 ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' 1276 ' ' VAL . 28.0 mmm180 58.24 16.84 4.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 110.9 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1281 ' ' LYS . . . . . . . . . . . . . 2.9 mttm -145.61 134.75 22.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1282 ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' 1322 ' ' VAL . . . -115.67 116.43 28.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.665 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1283 ' ' SER . . . . . 0.879 ' O ' HG23 ' A' 1287 ' ' VAL . 8.7 p -132.52 140.76 48.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1284 ' ' ILE . . . . . 0.571 ' CG2' ' HB3' ' A' 1298 ' ' ALA . 21.2 mt -69.22 -40.5 80.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.287 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1285 ' ' SER . . . . . 0.505 ' HA ' ' OE1' ' A' 1288 ' ' GLN . 45.5 t -67.8 -42.79 81.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.014 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1286 ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.46 78.29 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.706 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1287 ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' 1283 ' ' SER . 15.5 t -65.49 -30.74 51.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1288 ' ' GLN . . . . . 0.601 ' NE2' ' HB2' ' A' 1295 ' ' TYR . 15.1 mt-30 -60.22 -51.37 69.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.216 0.532 . . . . 0.0 109.949 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1289 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -36.1 58.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.233 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1290 ' ' GLN . . . . . 0.439 ' HB3' ' HD1' ' A' 1291 ' ' PHE . 0.2 OUTLIER -75.02 -34.64 61.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.618 -178.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1291 ' ' PHE . . . . . 0.59 ' CZ ' ' HA ' ' A' 1272 ' ' ALA . 2.2 m-85 -103.31 -6.48 21.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.551 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1292 ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 54.96 55.01 8.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.06 0.457 . . . . 0.0 110.381 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1293 ' ' ILE . . . . . . . . . . . . . 15.2 pt -131.73 147.26 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.435 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1294 ' ' GLY . . . . . . . . . . . . . . . -52.99 149.29 11.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.284 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1295 ' ' TYR . . . . . 0.601 ' HB2' ' NE2' ' A' 1288 ' ' GLN . 88.0 t80 -46.77 -51.46 16.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.458 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1296 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -39.45 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.458 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1297 ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' 1301 ' ' ILE . 0.3 OUTLIER -66.23 -49.49 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.27 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1298 ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' 1284 ' ' ILE . . . -53.95 -49.36 68.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.642 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1299 ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' 1284 ' ' ILE . . . -63.81 -29.79 70.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1300 ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -68.55 -50.52 51.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.244 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1301 ' ' ILE . . . . . 0.623 HG21 ' CB ' ' A' 1272 ' ' ALA . 29.5 mt -60.13 -43.49 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.833 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1302 ' ' ILE . . . . . 0.489 HG21 ' HG3' ' A' 1320 ' ' ARG . 20.2 mt -68.83 -33.69 60.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.928 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1303 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.89 66.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.335 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1304 ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' 1265 ' ' LEU . 22.9 mt-30 -59.43 -36.76 76.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.303 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1305 ' ' MET . . . . . 0.583 ' HB3' HG13 ' A' 1311 ' ' VAL . 17.1 mtm -57.01 -38.54 73.24 Favored 'General case' 0 C--O 1.228 -0.058 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1306 ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' 1311 ' ' VAL . 5.1 tt0 -69.46 -33.04 72.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.303 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1307 ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.09 63.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.404 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1308 ' ' GLN . . . . . 0.824 ' NE2' HD21 ' A' 1265 ' ' LEU . 0.6 OUTLIER -89.18 -20.32 24.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1309 ' ' GLY . . . . . . . . . . . . . . . 103.26 13.89 27.52 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.963 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1310 ' ' ILE . . . . . 0.772 HG23 ' HB3' ' A' 1324 ' ' ALA . 12.4 mt -83.67 -38.49 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 122.743 0.417 . . . . 0.0 111.266 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1311 ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' 1306 ' ' GLU . 32.6 m -120.22 155.78 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.144 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1312 ' ' SER . . . . . 0.435 ' CB ' HD11 ' A' 1323 ' ' LEU . 1.0 OUTLIER -96.46 -179.9 4.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.623 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1313 ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -65.9 134.69 53.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.396 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1314 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 138.69 56.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.077 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1315 ' ' GLY . . . . . . . . . . . . . . . -136.64 -46.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.789 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1316 ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.76 -157.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1317 ' ' ASN . . . . . . . . . . . . . 4.9 p30 -100.52 91.79 4.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.887 0.375 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1318 ' ' GLY . . . . . . . . . . . . . . . 77.78 10.06 86.48 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.462 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1319 ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -105.04 122.09 45.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.16 0.48 . . . . 0.0 111.65 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1320 ' ' ARG . . . . . 0.489 ' HG3' HG21 ' A' 1302 ' ' ILE . 2.7 mmt180 -107.6 140.33 40.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.31 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1321 ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' 1311 ' ' VAL . 3.3 tt0 -85.44 132.67 34.18 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.862 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1322 ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' 1282 ' ' ALA . 29.4 t -92.86 118.69 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.967 0.413 . . . . 0.0 110.139 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1323 ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' 1312 ' ' SER . 0.4 OUTLIER -108.11 -13.54 14.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.233 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1324 ' ' ALA . . . . . 0.853 ' O ' HG22 ' A' 1277 ' ' THR . . . -95.57 130.41 32.03 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1325 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.24 159.29 23.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.531 2.154 . . . . 0.0 113.028 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1326 ' ' PRO . . . . . 0.525 ' N ' ' HB ' ' A' 1277 ' ' THR . 63.0 Cg_exo -51.68 159.67 3.28 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.06 2.507 . . . . 0.0 112.678 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1327 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.17 -36.88 2.2 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.728 2.286 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1328 ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -120.26 27.29 8.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1329 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.957 -179.923 . . . . . . . . 1 1 . 1 stop_ save_